1	Available	JJ	O	available	amod	2	SENT_1	[p1l680t88r826b115],
2	online	NN	O	online	_	0	SENT_1	[p1l839t88r933b115],
3	at	IN	O	at	_	0	SENT_1	[p1l946t89r975b115],
4	www.sciencedirect.com	NNP	O	www.sciencedirect.com	prep_at	2	SENT_1	[p1l985t88r1361b115],

1	`	``	O	`	_	0	SENT_2	[p1l38t211r53b227],
2	'	''	O	'	_	0	SENT_2	[p1l38t211r53b227],
3	+	CC	O	+	_	0	SENT_2	[p1l38t211r53b227],
4	7	CD	NUMBER	7	num	6	SENT_2	[p1l744t150r849b225],
5	:	:	O	:	_	0	SENT_2	[p1l744t150r849b225],
6	’	CD	NUMBER	’	conj_+	2	SENT_2	[p1l744t150r849b225],
7	ScienceDirect	NNP	O	ScienceDirect	dep	6	SENT_2	[p1l885t165r1297b222],
8	Leukemia	NNP	O	Leukemia	prep	7	SENT_2	[p1l1783t143r2126b207],
9	Ex	FW	O	ex	dep	8	SENT_2	[p1l59t226r170b278],
10	'	''	O	'	_	0	SENT_2	[p1l210t243r245b276],
11	+	CC	O	+	_	0	SENT_2	[p1l210t243r245b276],
12	Research	NNP	O	Research	nn	15	SENT_2	[p1l1804t212r2106b279],
13	ELSEVIER	NNP	O	ELSEVIER	nn	15	SENT_2	[p1l37t296r256b331],
14	Leukemia	NNP	ORGANIZATION	Leukemia	nn	15	SENT_2	[p1l738t307r871b331],
15	Research	NNP	ORGANIZATION	Research	conj_+	2	SENT_2	[p1l879t307r1000b331],
16	31	CD	NUMBER	31	number	17	SENT_2	[p1l1010t307r1039b331],
17	(	CD	NUMBER	(	dep	15	SENT_2	[p1l1052t307r1138b336],
18	2007	CD	DATE	2007	dep	2	SENT_2	[p1l1052t307r1138b336],
19	)	CD	NUMBER	)	num	20	SENT_2	[p1l1052t307r1138b336],
20	1669-1674	CD	DATE	1669-1674	dep	18	SENT_2	[p1l1151t307r1296b331],

1	A	DT	O	a	det	2	SENT_3	[p1l1783t322r2126b331],
2	www.elsevier.com/locate/leukres	NNS	O	www.elsevier.com/locate/leukres	_	0	SENT_3	[p1l1682t347r2126b371],

1	MTHFR	NN	O	mthfr	nn	2	SENT_4	[p1l229t447r471b495],
2	polymorphisms	NNS	O	polymorphism	nsubj	3	SENT_4	[p1l489t446r944b510],
3	’	VBP	O	’	_	0	SENT_4	[p1l489t446r944b510],
4	inﬂuence	NN	O	inﬂuence	dobj	3	SENT_4	[p1l970t446r1227b495],
5	on	IN	O	on	_	0	SENT_4	[p1l1248t462r1316b495],
6	outcome	NN	O	outcome	prep_on	3	SENT_4	[p1l1336t454r1576b495],
7	and	CC	O	and	_	0	SENT_4	[p1l1597t446r1696b495],
8	toxicity	NN	O	toxicity	prep_on	3	SENT_4	[p1l1715t446r1928b510],
9	in	IN	O	in	_	0	SENT_4	[p1l504t528r557b577],
10	acute	JJ	O	acute	amod	11	SENT_4	[p1l578t536r723b577],
11	lymphoblastic	JJ	O	lymphoblastic	amod	13	SENT_4	[p1l743t528r1140b592],
12	leukemia	NN	O	leukemia	nn	13	SENT_4	[p1l1161t528r1418b577],
13	patients	NNS	O	patient	prep_in	6	SENT_4	[p1l1436t528r1652b592],

1	Patrizia	NNP	PERSON	Patrizia	nn	2	SENT_5	[p1l194t652r358b690],
2	Chiusolo	NNP	PERSON	Chiusolo	_	0	SENT_5	[p1l372t652r564b690],
3	a	DT	O	a	det	5	SENT_5	[p1l574t650r639b697],
4	’	JJ	O	’	amod	5	SENT_5	[p1l574t650r639b697],
5	*	NN	O	*	dep	2	SENT_5	[p1l574t650r639b697],
6	,	,	O	,	_	0	SENT_5	[p1l574t650r639b697],
7	Giovanni	NNP	ORGANIZATION	Giovanni	nn	8	SENT_5	[p1l657t652r853b690],
8	Reddiconto	NNP	ORGANIZATION	Reddiconto	appos	5	SENT_5	[p1l869t652r1115b690],
9	3	CD	NUMBER	3	num	8	SENT_5	[p1l1125t650r1155b697],
10	,	,	O	,	_	0	SENT_5	[p1l1125t650r1155b697],
11	Giuliana	NNP	PERSON	Giuliana	nn	12	SENT_5	[p1l1173t652r1357b690],
12	Farinaa	NNP	PERSON	Farinaa	appos	5	SENT_5	[p1l1371t650r1546b697],
13	,	,	O	,	_	0	SENT_5	[p1l1371t650r1546b697],
14	Alice	NNP	PERSON	Alice	nn	15	SENT_5	[p1l1562t652r1678b690],
15	Mannoccib	NNP	PERSON	Mannoccib	appos	5	SENT_5	[p1l1693t641r1948b697],
16	,	,	O	,	_	0	SENT_5	[p1l1693t641r1948b697],
17	Alessia	NNP	PERSON	Alessia	nn	18	SENT_5	[p1l236t714r394b752],
18	Fiorini	NNP	PERSON	Fiorini	appos	5	SENT_5	[p1l408t714r565b759],
19	,	,	O	,	_	0	SENT_5	[p1l408t714r565b759],
20	Mariangela	NNP	PERSON	Mariangela	nn	21	SENT_5	[p1l582t714r828b763],
21	Palladino	NNP	PERSON	Palladino	appos	5	SENT_5	[p1l841t714r1042b752],
22	a	DT	O	a	dep	21	SENT_5	[p1l1052t712r1082b759],
23	,	,	O	,	_	0	SENT_5	[p1l1052t712r1082b759],
24	Giuseppe	NNP	PERSON	Giuseppe	nn	26	SENT_5	[p1l1100t714r1301b763],
25	La	NNP	PERSON	La	nn	26	SENT_5	[p1l1316t715r1373b752],
26	Torreb	NNP	PERSON	Torreb	appos	5	SENT_5	[p1l1387t703r1542b759],
27	,	,	O	,	_	0	SENT_5	[p1l1387t703r1542b759],
28	Luana	NNP	PERSON	Luana	nn	29	SENT_5	[p1l1559t715r1693b752],
29	Fianchi	NNP	PERSON	Fianchi	appos	26	SENT_5	[p1l1707t714r1867b752],
30	3	CD	NUMBER	3	dep	29	SENT_5	[p1l1877t712r1907b759],
31	,	,	O	,	_	0	SENT_5	[p1l1877t712r1907b759],

1	Federica	NNP	PERSON	Federica	nn	2	SENT_6	[p1l358t776r543b814],
2	Soraa	NNP	PERSON	Soraa	_	0	SENT_6	[p1l559t774r694b821],
3	,	,	O	,	_	0	SENT_6	[p1l559t774r694b821],
4	Luca	NNP	PERSON	Luca	nn	5	SENT_6	[p1l710t777r818b814],
5	Laurentia	NNP	PERSON	Laurentia	appos	2	SENT_6	[p1l832t774r1052b821],
6	,	,	O	,	_	0	SENT_6	[p1l832t774r1052b821],
7	Giuseppe	NNP	PERSON	Giuseppe	nn	8	SENT_6	[p1l1070t776r1271b825],
8	Leonea	NNP	PERSON	Leonea	appos	2	SENT_6	[p1l1286t774r1459b821],
9	,	,	O	,	_	0	SENT_6	[p1l1286t774r1459b821],
10	Simona	NNP	PERSON	Simona	nn	11	SENT_6	[p1l1477t776r1640b814],
11	Sicaa	NNP	PERSON	Sicaa	appos	2	SENT_6	[p1l1656t774r1772b814],
12	a	DT	O	a	det	14	SENT_6	[p1l382t865r393b877],
13	Hematology	NNP	ORGANIZATION	Hematology	nn	14	SENT_6	[p1l403t866r565b896],
14	Department	NNP	ORGANIZATION	Department	dep	2	SENT_6	[p1l574t867r737b896],
15	,	,	O	,	_	0	SENT_6	[p1l574t867r737b896],
16	Universita	NNP	ORGANIZATION	Universita	nn	20	SENT_6	[p1l753t866r888b890],
17	Cattolica	NNP	ORGANIZATION	Cattolica	nn	20	SENT_6	[p1l899t866r1020b890],
18	del	NNP	ORGANIZATION	del	nn	20	SENT_6	[p1l1030t866r1070b890],
19	Sacro	NNP	ORGANIZATION	Sacro	nn	20	SENT_6	[p1l1079t866r1153b890],
20	Cuore	NNP	ORGANIZATION	Cuore	conj_and	14	SENT_6	[p1l1165t866r1249b893],
21	,	,	O	,	_	0	SENT_6	[p1l1165t866r1249b893],
22	Largo	NNP	ORGANIZATION	Largo	nn	24	SENT_6	[p1l1260t867r1340b896],
23	A.	NNP	ORGANIZATION	A.	nn	24	SENT_6	[p1l1347t866r1374b890],
24	Gemelli	NNP	ORGANIZATION	Gemelli	conj_and	14	SENT_6	[p1l1387t866r1491b890],
25	8	CD	NUMBER	8	num	24	SENT_6	[p1l1500t866r1521b893],
26	,	,	O	,	_	0	SENT_6	[p1l1500t866r1521b893],
27	00168	CD	NUMBER	00168	num	28	SENT_6	[p1l1533t866r1615b889],
28	Rome	NNP	LOCATION	Rome	conj_and	14	SENT_6	[p1l1623t867r1704b893],
29	,	,	O	,	_	0	SENT_6	[p1l1623t867r1704b893],
30	Italy	NNP	LOCATION	Italy	nn	32	SENT_6	[p1l1715t866r1776b896],
31	b	NN	O	b	nn	32	SENT_6	[p1l365t901r377b918],
32	Epidemiology	NNP	O	Epidemiology	conj_and	14	SENT_6	[p1l388t907r572b937],
33	and	CC	O	and	_	0	SENT_6	[p1l581t907r631b931],
34	Biostatistics	NNP	O	Biostatistics	nn	35	SENT_6	[p1l638t908r800b931],
35	Unit	NNP	O	Unit	conj_and	14	SENT_6	[p1l813t908r873b934],
36	,	,	O	,	_	0	SENT_6	[p1l813t908r873b934],
37	Hygiene	NNP	ORGANIZATION	Hygiene	nn	38	SENT_6	[p1l885t908r995b937],
38	Institute	NNP	ORGANIZATION	Institute	appos	35	SENT_6	[p1l1004t908r1117b934],
39	,	,	O	,	_	0	SENT_6	[p1l1004t908r1117b934],
40	Universita	NNP	ORGANIZATION	Universita	nn	44	SENT_6	[p1l1132t908r1268b931],
41	Cattolica	NNP	ORGANIZATION	Cattolica	nn	44	SENT_6	[p1l1279t907r1400b931],
42	del	NNP	ORGANIZATION	del	nn	44	SENT_6	[p1l1409t907r1450b931],
43	Sacro	NNP	ORGANIZATION	Sacro	nn	44	SENT_6	[p1l1458t908r1533b931],
44	Cuore	NNP	ORGANIZATION	Cuore	appos	35	SENT_6	[p1l1544t908r1628b934],
45	,	,	O	,	_	0	SENT_6	[p1l1544t908r1628b934],
46	Rome	NNP	LOCATION	Rome	appos	35	SENT_6	[p1l1640t908r1720b934],
47	,	,	O	,	_	0	SENT_6	[p1l1640t908r1720b934],
48	Italy	NNP	LOCATION	Italy	appos	35	SENT_6	[p1l1732t907r1793b937],

1	Received	VBN	O	receive	_	0	SENT_7	[p1l440t948r562b972],
2	21	CD	DATE	21	dobj	1	SENT_7	[p1l571t948r600b972],
3	December	NNP	DATE	December	tmod	1	SENT_7	[p1l612t948r749b972],
4	2006	CD	DATE	2006	num	3	SENT_7	[p1l758t948r831b976],
5	;	:	O	;	_	0	SENT_7	[p1l758t948r831b976],
6	received	VBN	O	receive	parataxis	1	SENT_7	[p1l841t948r952b972],
7	in	IN	O	in	_	0	SENT_7	[p1l961t948r985b972],
8	revised	JJ	O	revised	amod	9	SENT_7	[p1l994t948r1089b972],
9	form	NN	O	form	prep_in	6	SENT_7	[p1l1098t948r1162b972],
10	23	CD	DATE	23	num	9	SENT_7	[p1l1171t948r1202b972],
11	March	NNP	DATE	March	tmod	9	SENT_7	[p1l1212t948r1298b972],
12	2007	CD	DATE	2007	num	11	SENT_7	[p1l1308t948r1381b976],
13	;	:	O	;	_	0	SENT_7	[p1l1308t948r1381b976],
14	accepted	VBN	O	accept	parataxis	1	SENT_7	[p1l1392t948r1507b979],
15	30	CD	DATE	30	dobj	14	SENT_7	[p1l1517t948r1548b972],
16	March	NNP	DATE	March	tmod	14	SENT_7	[p1l1557t948r1643b972],
17	2007	CD	DATE	2007	num	16	SENT_7	[p1l1653t948r1717b972],

1	Available	JJ	O	available	amod	2	SENT_8	[p1l878t989r1003b1013],
2	online	NN	O	online	_	0	SENT_8	[p1l1013t989r1094b1013],
3	18	CD	DATE	18	dep	2	SENT_8	[p1l1107t989r1135b1013],
4	May	NNP	DATE	May	tmod	3	SENT_8	[p1l1145t990r1205b1020],
5	2007	CD	DATE	2007	num	4	SENT_8	[p1l1215t989r1279b1013],

1	Abstract	JJ	O	abstract	nsubjpass	18	SENT_9	[p1l33t1146r172b1173],
2	Recently	RB	DATE	recently	advmod	18	SENT_9	[p1l71t1218r203b1252],
3	the	DT	O	the	det	4	SENT_9	[p1l214t1218r258b1244],
4	inﬂuence	NN	O	inﬂuence	nsubjpass	18	SENT_9	[p1l270t1218r406b1244],
5	of	IN	O	of	_	0	SENT_9	[p1l418t1218r450b1244],
6	polymorphisms	NNS	O	polymorphism	prep_of	4	SENT_9	[p1l458t1218r689b1252],
7	of	IN	O	of	_	0	SENT_9	[p1l702t1218r734b1244],
8	different	JJ	O	different	amod	9	SENT_9	[p1l743t1218r870b1244],
9	genes	NNS	O	gene	prep_of	6	SENT_9	[p1l881t1226r964b1252],
10	involved	VBN	O	involve	partmod	9	SENT_9	[p1l976t1218r1104b1244],
11	in	IN	O	in	_	0	SENT_9	[p1l1115t1218r1143b1244],
12	metabolism	NN	O	metabolism	prep_in	10	SENT_9	[p1l1154t1218r1328b1244],
13	of	IN	O	of	_	0	SENT_9	[p1l1339t1218r1372b1244],
14	chemoterapic	JJ	O	chemoterapic	amod	15	SENT_9	[p1l1381t1218r1580b1252],
15	agents	NNS	O	agent	prep_of	12	SENT_9	[p1l1593t1222r1685b1252],
16	have	VBP	O	have	aux	18	SENT_9	[p1l1697t1218r1766b1244],
17	been	VBN	O	be	auxpass	18	SENT_9	[p1l1777t1218r1847b1244],
18	studied	VBN	O	study	_	0	SENT_9	[p1l1859t1218r1965b1244],
19	especially	RB	O	especially	advmod	18	SENT_9	[p1l1977t1218r2125b1252],
20	in	IN	O	in	_	0	SENT_9	[p1l34t1263r62b1289],
21	childhood	NN	O	childhood	nn	24	SENT_9	[p1l73t1263r222b1289],
22	acute	JJ	O	acute	amod	24	SENT_9	[p1l234t1267r310b1289],
23	lymphoblastic	JJ	O	lymphoblastic	amod	24	SENT_9	[p1l322t1263r532b1297],
24	leukemia	NN	O	leukemia	prep_in	18	SENT_9	[p1l544t1263r680b1289],
25	(	CD	NUMBER	(	num	27	SENT_9	[p1l692t1263r795b1296],
26	ALL	NN	O	all	nn	27	SENT_9	[p1l692t1263r795b1296],
27	)	NN	O	)	dep	24	SENT_9	[p1l692t1263r795b1296],
28	.	.	O	.	_	0	SENT_9	[p1l692t1263r795b1296],

1	We	PRP	O	we	nsubj	2	SENT_10	[p1l808t1264r856b1290],
2	evaluated	VBD	O	evaluate	_	0	SENT_10	[p1l868t1263r1008b1290],
3	the	DT	O	the	det	4	SENT_10	[p1l1019t1263r1064b1289],
4	inﬂuence	NN	O	inﬂuence	dep	14	SENT_10	[p1l1075t1263r1211b1289],
5	of	IN	O	of	_	0	SENT_10	[p1l1223t1263r1256b1289],
6	C677T	NN	O	c677t	nn	10	SENT_10	[p1l1265t1263r1367b1290],
7	and	CC	O	and	_	0	SENT_10	[p1l1379t1263r1432b1290],
8	A1298C	NN	O	a1298c	nn	10	SENT_10	[p1l1443t1263r1568b1290],
9	methylenetetrahydrofolate	NN	O	methylenetetrahydrofolate	nn	10	SENT_10	[p1l1580t1263r1973b1297],
10	reductase	NN	O	reductase	prep_of	4	SENT_10	[p1l1984t1263r2125b1290],
11	(	CD	NUMBER	(	num	12	SENT_10	[p1l35t1308r185b1340],
12	MTHFR	NN	O	mthfr	dep	14	SENT_10	[p1l35t1308r185b1340],
13	)	CD	NUMBER	)	num	14	SENT_10	[p1l35t1308r185b1340],
14	polymorphisms	NNS	O	polymorphism	dep	2	SENT_10	[p1l196t1308r427b1342],
15	on	IN	O	on	_	0	SENT_10	[p1l439t1316r475b1334],
16	time	NN	O	time	prep_on	14	SENT_10	[p1l485t1308r550b1334],
17	to	TO	O	to	_	0	SENT_10	[p1l561t1312r588b1334],
18	relapse	NN	O	relapse	prep_to	16	SENT_10	[p1l599t1308r704b1342],
19	and	CC	O	and	_	0	SENT_10	[p1l715t1308r768b1334],
20	survival	NN	O	survival	prep_to	16	SENT_10	[p1l779t1308r895b1334],
21	and	CC	O	and	_	0	SENT_10	[p1l906t1308r959b1334],
22	on	IN	O	on	_	0	SENT_10	[p1l969t1316r1005b1334],
23	methotrexate	NN	O	methotrexate	nn	26	SENT_10	[p1l1015t1308r1209b1334],
24	(	CD	NUMBER	(	num	26	SENT_10	[p1l1220t1308r1325b1340],
25	MTX	NN	O	mtx	nn	26	SENT_10	[p1l1220t1308r1325b1340],
26	)	NN	O	)	prep_on	16	SENT_10	[p1l1220t1308r1325b1340],
27	toxicity	NN	O	toxicity	dobj	2	SENT_10	[p1l1336t1308r1449b1342],
28	in	IN	O	in	_	0	SENT_10	[p1l1460t1308r1488b1334],
29	82	CD	NUMBER	82	num	32	SENT_10	[p1l1500t1308r1534b1334],
30	ALL	NN	O	all	nn	32	SENT_10	[p1l1545t1308r1617b1334],
31	adult	JJ	O	adult	amod	32	SENT_10	[p1l1628t1308r1701b1334],
32	patients	NNS	O	patient	prep_in	27	SENT_10	[p1l1711t1308r1834b1342],
33	.	.	O	.	_	0	SENT_10	[p1l1711t1308r1834b1342],

1	Relapse	VB	O	relapse	_	0	SENT_11	[p1l71t1352r188b1386],
2	free	JJ	O	free	amod	3	SENT_11	[p1l198t1352r255b1378],
3	survival	NN	O	survival	dobj	1	SENT_11	[p1l267t1352r383b1378],
4	and	CC	O	and	_	0	SENT_11	[p1l394t1352r446b1378],
5	event	NN	O	event	conj_and	3	SENT_11	[p1l456t1356r535b1378],
6	free	JJ	O	free	amod	7	SENT_11	[p1l545t1352r602b1378],
7	survival	NN	O	survival	nsubj	20	SENT_11	[p1l613t1352r729b1378],
8	between	IN	O	between	_	0	SENT_11	[p1l739t1352r863b1378],
9	homozygous	JJ	O	homozygous	amod	13	SENT_11	[p1l873t1352r1062b1386],
10	wild-type	JJ	O	wild-type	amod	13	SENT_11	[p1l1073t1352r1215b1386],
11	and	CC	O	and	_	0	SENT_11	[p1l1226t1352r1279b1378],
12	variant	JJ	O	variant	conj_and	10	SENT_11	[p1l1289t1352r1391b1378],
13	patients	NNS	O	patient	prep_between	7	SENT_11	[p1l1400t1352r1515b1386],
14	in	IN	O	in	_	0	SENT_11	[p1l1526t1352r1554b1378],
15	both	DT	O	both	det	16	SENT_11	[p1l1564t1352r1630b1378],
16	polymorphisms	NNS	O	polymorphism	prep_in	13	SENT_11	[p1l1639t1352r1870b1386],
17	were	VBD	O	be	cop	20	SENT_11	[p1l1881t1360r1953b1378],
18	not	RB	O	not	neg	20	SENT_11	[p1l1963t1356r2010b1378],
19	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_11	[p1l2021t1352r2124b1386, p1l34t1397r123b1431],
20	different	JJ	O	different	dep	1	SENT_11	[p1l134t1397r267b1423],
21	.	.	O	.	_	0	SENT_11	[p1l134t1397r267b1423],

1	However	RB	O	however	advmod	4	SENT_12	[p1l279t1397r419b1428],
2	,	,	O	,	_	0	SENT_12	[p1l279t1397r419b1428],
3	we	PRP	O	we	nsubj	4	SENT_12	[p1l430t1405r472b1423],
4	observed	VBD	O	observe	_	0	SENT_12	[p1l482t1397r615b1423],
5	an	DT	O	a	det	6	SENT_12	[p1l625t1405r659b1423],
6	association	NN	O	association	dobj	4	SENT_12	[p1l669t1397r833b1423],
7	between	IN	O	between	_	0	SENT_12	[p1l842t1397r966b1423],
8	677TT	CD	NUMBER	677tt	prep_between	6	SENT_12	[p1l976t1397r1076b1423],
9	variant	NN	O	variant	nsubj	19	SENT_12	[p1l1086t1397r1188b1423],
10	and	CC	O	and	_	0	SENT_12	[p1l1197t1397r1250b1423],
11	survival	NN	O	survival	nsubj	19	SENT_12	[p1l1260t1397r1376b1423],
12	in	IN	O	in	_	0	SENT_12	[p1l1386t1397r1414b1423],
13	a	DT	O	a	det	14	SENT_12	[p1l1424t1405r1440b1423],
14	subset	NN	O	subset	prep_in	9	SENT_12	[p1l1450t1397r1541b1423],
15	of	IN	O	of	_	0	SENT_12	[p1l1551t1397r1583b1423],
16	ALL	NN	O	all	nn	17	SENT_12	[p1l1590t1397r1662b1423],
17	patients	NNS	O	patient	prep_of	14	SENT_12	[p1l1671t1397r1785b1431],
18	homogenously	RB	O	homogenously	advmod	19	SENT_12	[p1l1795t1397r2014b1431],
19	treated	VBN	O	treat	rcmod	6	SENT_12	[p1l2024t1397r2125b1423],
20	with	IN	O	with	_	0	SENT_12	[p1l34t1442r99b1468],
21	MTX-based	JJ	MISC	mtx-based	amod	24	SENT_12	[p1l111t1442r291b1468],
22	maintenance	NN	O	maintenance	nn	24	SENT_12	[p1l302t1442r490b1468],
23	(	NN	O	(	nn	24	SENT_12	[p1l503t1442r531b1476],
24	p	NN	O	p	prep_with	19	SENT_12	[p1l503t1442r531b1476],
25	=	JJ	O	=	amod	27	SENT_12	[p1l539t1442r650b1474],
26	0.02	CD	NUMBER	0.02	tmod	25	SENT_12	[p1l539t1442r650b1474],
27	)	NN	O	)	dobj	19	SENT_12	[p1l539t1442r650b1474],
28	.	.	O	.	_	0	SENT_12	[p1l539t1442r650b1474],

1	In	IN	O	in	_	0	SENT_13	[p1l664t1443r694b1468],
2	the	DT	O	the	det	4	SENT_13	[p1l706t1442r750b1468],
3	same	JJ	O	same	amod	4	SENT_13	[p1l764t1450r838b1468],
4	subgroup	NN	O	subgroup	prep_in	6	SENT_13	[p1l851t1442r988b1476],
5	we	PRP	O	we	nsubj	6	SENT_13	[p1l1000t1450r1042b1468],
6	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_13	[p1l1054t1442r1205b1468],
7	the	DT	O	the	det	8	SENT_13	[p1l1216t1442r1261b1468],
8	role	NN	O	role	dobj	6	SENT_13	[p1l1272t1442r1330b1468],
9	of	IN	O	of	_	0	SENT_13	[p1l1342t1442r1374b1468],
10	677TT	NN	O	677tt	nn	11	SENT_13	[p1l1384t1442r1484b1468],
11	variant	NN	O	variant	prep_of	8	SENT_13	[p1l1496t1442r1598b1468],
12	on	IN	O	on	_	0	SENT_13	[p1l1610t1450r1646b1468],
13	toxicity	NN	O	toxicity	prep_on	6	SENT_13	[p1l1658t1442r1770b1476],
14	during	IN	O	during	_	0	SENT_13	[p1l1783t1442r1879b1476],
15	MTX	NN	O	mtx	nn	16	SENT_13	[p1l1891t1443r1973b1468],
16	treatment	NN	O	treatment	prep_during	6	SENT_13	[p1l1985t1446r2125b1468],
17	(	CD	NUMBER	(	num	18	SENT_13	[p1l35t1487r63b1520],
18	p	NN	O	p	dep	16	SENT_13	[p1l35t1487r63b1520],
19	=	JJ	O	=	amod	21	SENT_13	[p1l71t1498r91b1508],
20	0.003	CD	NUMBER	0.003	tmod	19	SENT_13	[p1l98t1487r201b1519],
21	)	NN	O	)	dep	18	SENT_13	[p1l98t1487r201b1519],
22	.	.	O	.	_	0	SENT_13	[p1l98t1487r201b1519],

1	©	RB	O	©	advmod	2	SENT_14	[p1l34t1532r60b1558],
2	2007	CD	DATE	2007	_	0	SENT_14	[p1l72t1532r144b1558],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_14	[p1l155t1532r277b1558],
4	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_14	[p1l286t1532r345b1558],
5	.	.	O	.	_	0	SENT_14	[p1l286t1532r345b1558],

1	All	DT	O	all	det	2	SENT_15	[p1l357t1532r403b1558],
2	rights	NNS	O	rights	nsubj	3	SENT_15	[p1l413t1532r497b1566],
3	reserved	VBN	O	reserve	_	0	SENT_15	[p1l508t1532r641b1558],
4	.	.	O	.	_	0	SENT_15	[p1l508t1532r641b1558],

1	Keywords	NNS	O	keyword	_	0	SENT_16	[p1l33t1617r171b1648],
2	:	:	O	:	_	0	SENT_16	[p1l33t1617r171b1648],
3	ALL	NN	O	all	dep	1	SENT_16	[p1l191t1618r262b1645],
4	;	:	O	;	_	0	SENT_16	[p1l191t1618r262b1645],
5	MTHFR	NN	O	mthfr	dep	3	SENT_16	[p1l273t1618r394b1645],
6	;	:	O	;	_	0	SENT_16	[p1l273t1618r394b1645],
7	Outcome	NNP	O	Outcome	dep	5	SENT_16	[p1l405t1617r533b1645],
8	;	:	O	;	_	0	SENT_16	[p1l405t1617r533b1645],
9	Polymorphisms	NNP	O	Polymorphisms	dep	5	SENT_16	[p1l544t1617r759b1648],
10	;	:	O	;	_	0	SENT_16	[p1l544t1617r759b1648],
11	Toxicity	NN	O	toxicity	dep	9	SENT_16	[p1l770t1617r879b1648],

1	1	LS	NUMBER	1	_	0	SENT_17	[p1l12t1861r71b1924],
2	.	.	O	.	_	0	SENT_17	[p1l12t1861r71b1924],

1	Introduction	NN	O	introduction	_	0	SENT_18	[p1l120t1861r603b1925],

1	Despite	IN	O	despite	_	0	SENT_19	[p1l116t2076r386b2157],
2	actual	JJ	O	actual	amod	4	SENT_19	[p1l417t2076r625b2138],
3	chemotherapy	NN	O	chemotherapy	nn	4	SENT_19	[p1l655t2076r1157b2157],
4	protocols	NNS	O	protocol	prep_despite	21	SENT_19	[p1l1185t2076r1515b2157],
5	cure	VBP	O	cure	rcmod	4	SENT_19	[p1l1546t2095r1696b2138],
6	almost	RB	O	almost	quantmod	7	SENT_19	[p1l1727t2076r1963b2138],
7	80	CD	PERCENT	80	num	8	SENT_19	[p1l1994t2076r2148b2139],
8	%	NN	PERCENT	%	dobj	5	SENT_19	[p1l1994t2076r2148b2139],
9	of	IN	O	of	_	0	SENT_19	[p1l9t2183r86b2246],
10	pediatric	JJ	O	pediatric	amod	11	SENT_19	[p1l102t2183r412b2264],
11	patients	NNS	O	patient	prep_of	8	SENT_19	[p1l434t2183r709b2264],
12	with	IN	O	with	_	0	SENT_19	[p1l735t2183r891b2246],
13	ALL	NN	O	all	prep_with	5	SENT_19	[p1l913t2184r1103b2257],
14	,	,	O	,	_	0	SENT_19	[p1l913t2184r1103b2257],
15	the	DT	O	the	det	16	SENT_19	[p1l1130t2183r1236b2246],
16	majority	NN	O	majority	nsubj	21	SENT_19	[p1l1259t2183r1559b2264],
17	of	IN	O	of	_	0	SENT_19	[p1l1583t2183r1660b2246],
18	adult	JJ	O	adult	amod	19	SENT_19	[p1l1679t2183r1855b2246],
19	patients	NNS	O	patient	prep_of	16	SENT_19	[p1l1875t2183r2149b2264],
20	still	RB	O	still	advmod	21	SENT_19	[p1l11t2289r140b2351],
21	die	VB	O	die	_	0	SENT_19	[p1l172t2289r277b2351],
22	for	IN	O	for	_	0	SENT_19	[p1l309t2289r412b2351],
23	this	DT	O	this	det	24	SENT_19	[p1l441t2289r566b2351],
24	disease	NN	O	disease	prep_for	21	SENT_19	[p1l599t2289r872b2351],
25	.	.	O	.	_	0	SENT_19	[p1l599t2289r872b2351],

1	Advances	NNS	O	advance	nsubj	9	SENT_20	[p1l907t2289r1253b2351],
2	in	IN	O	in	_	0	SENT_20	[p1l1286t2289r1353b2350],
3	cure	NN	O	cure	nn	4	SENT_20	[p1l1385t2309r1535b2351],
4	rates	NNS	O	rate	prep_in	1	SENT_20	[p1l1565t2298r1730b2351],
5	in	IN	O	in	_	0	SENT_20	[p1l1763t2289r1830b2350],
6	children	NNS	O	child	prep_in	4	SENT_20	[p1l1862t2289r2152b2351],
7	could	MD	O	could	aux	9	SENT_20	[p1l9t2395r205b2457],
8	be	VB	O	be	cop	9	SENT_20	[p1l233t2395r315b2457],
9	attributable	JJ	O	attributable	_	0	SENT_20	[p1l347t2395r748b2457],
10	to	TO	O	to	_	0	SENT_20	[p1l778t2404r844b2457],
11	the	DT	O	the	det	12	SENT_20	[p1l874t2395r980b2457],
12	identiﬁcation	NN	O	identiﬁcation	prep_to	9	SENT_20	[p1l1010t2394r1480b2457],
13	of	IN	O	of	_	0	SENT_20	[p1l1510t2394r1587b2457],
14	prognostic	JJ	O	prognostic	amod	15	SENT_20	[p1l1609t2395r1984b2476],
15	features	NNS	O	feature	prep_of	12	SENT_20	[p1l2015t2395r2149b2457, p1l8t2512r177b2566],
16	together	RB	O	together	_	0	SENT_20	[p1l210t2503r503b2584],
17	with	IN	O	with	_	0	SENT_20	[p1l533t2503r690b2566],
18	intensiﬁed	JJ	O	intensiﬁed	amod	19	SENT_20	[p1l721t2503r1091b2566],
19	chemotherapy	NN	O	chemotherapy	prep_together_with	9	SENT_20	[p1l1122t2503r1624b2584],
20	and	CC	O	and	_	0	SENT_20	[p1l1658t2503r1784b2566],
21	improved	VBD	O	improve	conj_and	9	SENT_20	[p1l1814t2503r2152b2584],
22	supportive	JJ	O	supportive	amod	23	SENT_20	[p1l11t2610r379b2691],
23	therapy	NN	O	therapy	dobj	21	SENT_20	[p1l397t2610r674b2691],
24	.	.	O	.	_	0	SENT_20	[p1l397t2610r674b2691],

1	Several	JJ	O	several	amod	3	SENT_21	[p1l698t2610r958b2673],
2	prognostic	JJ	O	prognostic	amod	3	SENT_21	[p1l975t2610r1349b2691],
3	factors	NNS	O	factor	nsubjpass	6	SENT_21	[p1l1369t2610r1606b2672],
4	have	VBP	O	have	aux	6	SENT_21	[p1l1625t2610r1788b2673],
5	been	VBN	O	be	auxpass	6	SENT_21	[p1l1805t2610r1972b2672],
6	used	VBN	O	use	_	0	SENT_21	[p1l1989t2610r2152b2672],
7	to	TO	O	to	aux	8	SENT_21	[p1l8t2725r74b2778],
8	stratify	VB	O	stratify	xcomp	6	SENT_21	[p1l101t2715r348b2797],
9	ALL	NN	O	all	nn	10	SENT_21	[p1l371t2716r542b2777],
10	patients	NNS	O	patient	nsubj	13	SENT_21	[p1l563t2716r861b2797],
11	’	CD	NUMBER	’	num	13	SENT_21	[p1l563t2716r861b2797],
12	risk	NN	O	risk	nn	13	SENT_21	[p1l891t2716r1025b2778],
13	[	NN	O	[	xcomp	8	SENT_21	[p1l1052t2716r1254b2791],
14	1	CD	NUMBER	1	num	15	SENT_21	[p1l1052t2716r1254b2791],
15	—	NN	O	—	dep	13	SENT_21	[p1l1052t2716r1254b2791],
16	3	CD	NUMBER	3	num	17	SENT_21	[p1l1052t2716r1254b2791],
17	]	NN	O	]	dep	13	SENT_21	[p1l1052t2716r1254b2791],
18	.	.	O	.	_	0	SENT_21	[p1l1052t2716r1254b2791],

1	These	DT	O	these	det	3	SENT_22	[p1l1281t2716r1492b2778],
2	prognostic	JJ	O	prognostic	amod	3	SENT_22	[p1l1513t2716r1888b2797],
3	factors	NNS	O	factor	nsubj	4	SENT_22	[p1l1912t2716r2149b2778],
4	include	VBP	O	include	_	0	SENT_22	[p1l8t2824r269b2887],
5	clinical	JJ	O	clinical	amod	8	SENT_22	[p1l309t2824r568b2887],
6	and	CC	O	and	_	0	SENT_22	[p1l609t2824r735b2887],
7	biological	JJ	O	biological	amod	8	SENT_22	[p1l772t2824r1128b2905],
8	characteristics	NNS	O	characteristic	nsubj	9	SENT_22	[p1l1168t2824r1674b2887],
9	evaluable	JJ	O	evaluable	xcomp	4	SENT_22	[p1l1716t2824r2050b2887],
10	at	IN	O	at	_	0	SENT_22	[p1l2091t2834r2153b2887],
11	diagnosis	NN	O	diagnosis	nn	13	SENT_22	[p1l9t2931r342b3012],
12	(	CD	NUMBER	(	num	13	SENT_22	[p1l367t2932r535b3012],
13	age	NN	O	age	nn	37	SENT_22	[p1l367t2932r535b3012],
14	,	,	O	,	_	0	SENT_22	[p1l367t2932r535b3012],
15	white	JJ	O	white	amod	18	SENT_22	[p1l559t2931r754b2994],
16	blood	NN	O	blood	nn	18	SENT_22	[p1l774t2931r978b2993],
17	cell	NN	O	cell	nn	18	SENT_22	[p1l998t2931r1124b2993],
18	count	NN	O	count	nn	37	SENT_22	[p1l1146t2940r1360b3005],
19	,	,	O	,	_	0	SENT_22	[p1l1146t2940r1360b3005],
20	cytogenetic	JJ	O	cytogenetic	nn	37	SENT_22	[p1l1385t2931r1791b3012],
21	or	CC	O	or	_	0	SENT_22	[p1l1814t2950r1887b2993],
22	molecular	JJ	O	molecular	amod	23	SENT_22	[p1l1906t2931r2149b2993, p1l8t3038r147b3101],
23	aberration	NN	O	aberration	nn	37	SENT_22	[p1l173t3038r531b3101],
24	and	CC	O	and	_	0	SENT_22	[p1l559t3038r685b3101],
25	more	RBR	O	more	advmod	26	SENT_22	[p1l710t3058r891b3101],
26	recently	RB	DATE	recently	advmod	28	SENT_22	[p1l917t3038r1202b3119],
27	the	DT	O	the	det	28	SENT_22	[p1l1229t3038r1336b3101],
28	type	NN	O	type	nn	37	SENT_22	[p1l1362t3048r1514b3119],
29	of	IN	O	of	_	0	SENT_22	[p1l1541t3038r1618b3101],
30	early	JJ	O	early	amod	31	SENT_22	[p1l1639t3038r1814b3119],
31	response	NN	O	response	prep_of	28	SENT_22	[p1l1840t3058r2151b3119],
32	to	TO	O	to	_	0	SENT_22	[p1l8t3154r74b3208],
33	prednisone	NN	O	prednisone	nn	35	SENT_22	[p1l95t3145r486b3226],
34	pre	JJ	O	pre	amod	35	SENT_22	[p1l507t3146r1034b3226],
35	—	NN	O	—	prep_to	31	SENT_22	[p1l507t3146r1034b3226],
36	treatment	NN	O	treatment	nn	37	SENT_22	[p1l507t3146r1034b3226],
37	)	NN	O	)	prep_at	9	SENT_22	[p1l507t3146r1034b3226],
38	.	.	O	.	_	0	SENT_22	[p1l507t3146r1034b3226],

1	Recently	RB	DATE	recently	dep	3	SENT_23	[p1l1060t3145r1375b3226],
2	the	DT	O	the	det	3	SENT_23	[p1l1397t3145r1503b3208],
3	inﬂuence	NN	O	inﬂuence	_	0	SENT_23	[p1l1525t3145r1850b3208],
4	of	IN	O	of	_	0	SENT_23	[p1l1873t3145r1950b3208],
5	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_23	[p1l1964t3145r2149b3226, p1l8t3251r401b3332],
6	of	IN	O	of	_	0	SENT_23	[p1l444t3250r521b3313],
7	different	JJ	O	different	amod	8	SENT_23	[p1l556t3251r860b3313],
8	genes	NNS	O	gene	prep_of	5	SENT_23	[p1l899t3270r1097b3332],
9	involved	VBN	O	involve	partmod	3	SENT_23	[p1l1139t3251r1444b3314],
10	in	IN	O	in	_	0	SENT_23	[p1l1483t3251r1550b3312],
11	the	DT	O	the	det	12	SENT_23	[p1l1590t3251r1696b3313],
12	metabolism	NN	O	metabolism	prep_in	9	SENT_23	[p1l1737t3251r2153b3313],
13	of	IN	O	of	_	0	SENT_23	[p1l9t3359r86b3422],
14	chemoterapeutic	JJ	O	chemoterapeutic	amod	15	SENT_23	[p1l116t3359r702b3440],
15	agents	NNS	O	agent	prep_of	12	SENT_23	[p1l739t3369r961b3440],
16	as	IN	O	as	mark	20	SENT_23	[p1l1000t3379r1068b3422],
17	prognostic	JJ	O	prognostic	amod	18	SENT_23	[p1l1103t3359r1477b3440],
18	factors	NNS	O	factor	nsubj	20	SENT_23	[p1l1513t3359r1751b3422],
19	have	VBP	O	have	aux	20	SENT_23	[p1l1787t3359r1950b3422],
20	been	VBN	O	be	advcl	9	SENT_23	[p1l1984t3359r2152b3422],

1	*	NN	O	*	_	0	SENT_24	[p1l58t3612r80b3637],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_24	[p1l116t3614r538b3679],
3	author	NN	O	author	dobj	2	SENT_24	[p1l560t3614r749b3664],
4	.	.	O	.	_	0	SENT_24	[p1l560t3614r749b3664],

1	Tel.	NNP	O	Tel.	_	0	SENT_25	[p1l773t3614r894b3664],
2	:	:	O	:	_	0	SENT_25	[p1l773t3614r894b3664],
3	+39 063550395	CD	NUMBER	+39 063550395	number	4	SENT_25	[p1l1049t3614r1421b3673],[p1l920t3614r1027b3665],
4	3	CD	NUMBER	3	dep	1	SENT_25	[p1l1049t3614r1421b3673],
5	;	:	O	;	_	0	SENT_25	[p1l1049t3614r1421b3673],
6	fax	NN	O	fax	dep	4	SENT_25	[p1l1444t3614r1548b3664],
7	:	:	O	:	_	0	SENT_25	[p1l1444t3614r1548b3664],
8	+39 063017319	CD	NUMBER	+39 063017319	dep	6	SENT_25	[p1l1703t3614r2036b3665],[p1l1573t3614r1681b3665],
9	.	.	O	.	_	0	SENT_25	[p1l1703t3614r2036b3665],

1	E-mail	NN	O	e-mail	nn	2	SENT_26	[p1l117t3705r312b3755],
2	address	NN	O	address	_	0	SENT_26	[p1l331t3705r568b3755],
3	:	:	O	:	_	0	SENT_26	[p1l331t3705r568b3755],
4	p.chiusolo@rm.unicatt.it	NN	O	p.chiusolo@rm.unicatt.it	dep	2	SENT_26	[p1l591t3705r1303b3770],
5	(	CD	NUMBER	(	num	8	SENT_26	[p1l1324t3706r1390b3767],
6	P.	NNP	PERSON	P.	nn	8	SENT_26	[p1l1324t3706r1390b3767],
7	Chiusolo	NNP	PERSON	Chiusolo	nn	8	SENT_26	[p1l1414t3705r1707b3767],
8	)	NN	O	)	dep	4	SENT_26	[p1l1414t3705r1707b3767],
9	.	.	O	.	_	0	SENT_26	[p1l1414t3705r1707b3767],

1	0145	CD	DATE	0145	number	2	SENT_27	[p2l9t103r370b162],
2	—	CD	DATE	—	num	3	SENT_27	[p2l9t103r370b162],
3	2126	CD	DATE	2126	nsubj	7	SENT_27	[p2l9t103r370b162],
4	/	:	O	/	punct	5	SENT_27	[p2l9t103r370b162],
5	$	$	MONEY	$	dep	3	SENT_27	[p2l9t103r370b162],
6	—	CD	MONEY	—	num	5	SENT_27	[p2l390t137r427b142],
7	see	VBP	O	see	_	0	SENT_27	[p2l447t122r534b157],
8	front	JJ	O	front	amod	9	SENT_27	[p2l554t107r693b157],
9	matter	NN	O	matter	dobj	7	SENT_27	[p2l711t114r893b157],
10	©	CD	NUMBER	©	num	13	SENT_27	[p2l913t107r963b157],
11	2007	CD	DATE	2007	num	13	SENT_27	[p2l985t107r1123b157],
12	Elsevier	NNP	ORGANIZATION	Elsevier	nn	13	SENT_27	[p2l1145t107r1377b157],
13	Ltd.	NNP	ORGANIZATION	Ltd.	dep	9	SENT_27	[p2l1395t107r1507b157],
14	.	.	O	.	_	0	SENT_27	[p2l1395t107r1507b157],

1	All	DT	O	all	det	2	SENT_28	[p2l1530t107r1620b156],
2	rights	NNS	O	rights	nsubj	3	SENT_28	[p2l1639t107r1799b172],
3	reserved	VBN	O	reserve	_	0	SENT_28	[p2l1820t107r2074b157],
4	.	.	O	.	_	0	SENT_28	[p2l1820t107r2074b157],

1	doi	FW	O	doi	nsubj	7	SENT_29	[p2l9t195r987b261],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_29	[p2l9t195r987b261],
3	/	:	O	/	punct	5	SENT_29	[p2l9t195r987b261],
4	j.	NN	O	j.	nsubj	5	SENT_29	[p2l9t195r987b261],
5	leukres	VBZ	O	leukre	dep	1	SENT_29	[p2l9t195r987b261],
6	.2007.03.028	CD	NUMBER	.2007.03.028	dobj	5	SENT_29	[p2l9t195r987b261],
7	studied	VBN	O	study	_	0	SENT_29	[p2l10t291r263b354],
8	especially	RB	O	especially	advmod	7	SENT_29	[p2l293t291r646b372],
9	in	IN	O	in	_	0	SENT_29	[p2l677t291r744b353],
10	childhood	NN	O	childhood	nn	11	SENT_29	[p2l775t291r1130b354],
11	ALL	NN	O	all	prep_in	7	SENT_29	[p2l1158t292r1330b353],
12	[	CD	NUMBER	[	number	13	SENT_29	[p2l1366t292r1479b367],
13	4	CD	NUMBER	4	num	14	SENT_29	[p2l1366t292r1479b367],
14	]	NN	O	]	dobj	7	SENT_29	[p2l1366t292r1479b367],
15	.	.	O	.	_	0	SENT_29	[p2l1366t292r1479b367],

1	Genetic	JJ	O	genetic	amod	2	SENT_30	[p2l1515t291r1787b354],
2	polymorphisms	NNS	O	polymorphism	nsubj	8	SENT_30	[p2l1818t291r2144b372, p2l6t398r256b479],
3	in	IN	O	in	_	0	SENT_30	[p2l298t398r365b460],
4	patients	NNS	O	patient	prep_in	2	SENT_30	[p2l405t398r679b479],
5	with	IN	O	with	_	0	SENT_30	[p2l723t398r879b461],
6	ALL	NN	O	all	prep_with	4	SENT_30	[p2l919t398r1090b460],
7	can	MD	O	can	aux	8	SENT_30	[p2l1132t417r1252b460],
8	alter	VB	O	alter	_	0	SENT_30	[p2l1295t398r1451b460],
9	drug	NN	O	drug	nn	10	SENT_30	[p2l1491t398r2146b479],
10	—	NN	O	—	dobj	8	SENT_30	[p2l1491t398r2146b479],
11	metabolizing	VBG	O	metabolize	xcomp	8	SENT_30	[p2l1491t398r2146b479],
12	enzymes	NNS	O	enzyme	dobj	11	SENT_30	[p2l8t523r336b585],
13	,	,	O	,	_	0	SENT_30	[p2l8t523r336b585],
14	transporters	NNS	O	transporter	dobj	11	SENT_30	[p2l371t513r788b585],
15	and	CC	O	and	_	0	SENT_30	[p2l824t504r949b566],
16	targets	NNS	O	target	conj_and	12	SENT_30	[p2l981t513r1233b585],
17	,	,	O	,	_	0	SENT_30	[p2l981t513r1233b585],
18	therefore	RB	O	therefore	advmod	8	SENT_30	[p2l1269t504r1588b566],
19	they	PRP	O	they	nsubj	21	SENT_30	[p2l1621t504r1770b585],
20	can	MD	O	can	aux	21	SENT_30	[p2l1803t523r1924b566],
21	inﬂuence	VB	O	inﬂuence	ccomp	8	SENT_30	[p2l1956t504r2144b566, p2l8t632r168b675],
22	both	DT	O	both	preconj	23	SENT_30	[p2l195t612r353b675],
23	efﬁcacy	NN	O	efﬁcacy	dobj	21	SENT_30	[p2l382t612r657b693],
24	and	CC	O	and	_	0	SENT_30	[p2l687t612r812b675],
25	toxicity	NN	O	toxicity	conj_and	23	SENT_30	[p2l840t612r1110b693],
26	of	IN	O	of	_	0	SENT_30	[p2l1140t612r1217b675],
27	chemotherapeutic	JJ	O	chemotherapeutic	amod	28	SENT_30	[p2l1239t612r1869b693],
28	agents	NNS	O	agent	prep_of	23	SENT_30	[p2l1901t622r2142b693],
29	.	.	O	.	_	0	SENT_30	[p2l1901t622r2142b693],

1	Actually	RB	O	actually	advmod	9	SENT_31	[p2l7t719r311b800],
2	this	DT	O	this	det	3	SENT_31	[p2l337t719r462b781],
3	type	NN	O	type	nsubjpass	9	SENT_31	[p2l490t728r640b800],
4	of	IN	O	of	_	0	SENT_31	[p2l668t719r745b781],
5	genetic	JJ	O	genetic	amod	6	SENT_31	[p2l765t719r1018b800],
6	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_31	[p2l1044t719r1596b800],
7	are	VBP	O	be	auxpass	9	SENT_31	[p2l1626t738r1730b781],
8	not	RB	O	not	neg	9	SENT_31	[p2l1756t728r1869b781],
9	used	VBN	O	use	_	0	SENT_31	[p2l1893t719r2055b781],
10	to	TO	O	to	aux	11	SENT_31	[p2l2080t728r2146b781],
11	individualize	VB	O	individualize	xcomp	9	SENT_31	[p2l7t826r468b889],
12	ALL	NN	O	all	nn	14	SENT_31	[p2l493t827r665b888],
13	speciﬁc	NN	O	speciﬁc	nn	14	SENT_31	[p2l693t826r958b907],
14	treatment	NN	O	treatment	dobj	11	SENT_31	[p2l985t836r1321b889],
15	however	RB	O	however	advmod	19	SENT_31	[p2l1344t826r1646b889],
16	they	PRP	O	they	nsubjpass	19	SENT_31	[p2l1669t826r1818b907],
17	could	MD	O	could	aux	19	SENT_31	[p2l1845t826r2041b889],
18	be	VB	O	be	auxpass	19	SENT_31	[p2l2064t826r2146b889],
19	considered	VBN	O	consider	dep	14	SENT_31	[p2l8t933r392b996],
20	as	IN	O	as	_	0	SENT_31	[p2l423t953r491b996],
21	responsible	JJ	O	responsible	prep_as	19	SENT_31	[p2l522t933r926b1014],
22	of	IN	O	of	_	0	SENT_31	[p2l958t933r1035b996],
23	altered	JJ	O	altered	amod	24	SENT_31	[p2l1061t933r1300b996],
24	sensitivity	NN	O	sensitivity	prep_of	19	SENT_31	[p2l1332t933r1691b1014],
25	of	IN	O	of	_	0	SENT_31	[p2l1722t933r1799b996],
26	leukemic	JJ	O	leukemic	amod	27	SENT_31	[p2l1823t933r2145b996],
27	cells	NNS	O	cell	prep_of	24	SENT_31	[p2l8t1039r166b1101],
28	to	TO	O	to	_	0	SENT_31	[p2l211t1048r277b1101],
29	drugs	NNS	O	drug	prep_to	19	SENT_31	[p2l321t1039r534b1120],
30	.	.	O	.	_	0	SENT_31	[p2l321t1039r534b1120],

1	The	DT	O	the	det	3	SENT_32	[p2l581t1039r717b1101],
2	pharmacological	JJ	O	pharmacological	amod	3	SENT_32	[p2l759t1039r1352b1120],
3	pathway	NN	O	pathway	nsubj	7	SENT_32	[p2l1394t1039r1694b1120],
4	of	IN	O	of	_	0	SENT_32	[p2l1738t1038r1815b1101],
5	MTX	NNP	O	MTX	prep_of	3	SENT_32	[p2l1851t1040r2047b1100],
6	is	VBZ	O	be	cop	7	SENT_32	[p2l2090t1039r2145b1101],
7	useful	JJ	O	useful	_	0	SENT_32	[p2l7t1147r222b1210],
8	to	TO	O	to	aux	9	SENT_32	[p2l258t1157r324b1210],
9	identify	VB	O	identify	xcomp	7	SENT_32	[p2l360t1147r634b1228],
10	genes	NNS	O	gene	dobj	9	SENT_32	[p2l671t1167r869b1228],
11	and	CC	O	and	_	0	SENT_32	[p2l908t1147r1033b1210],
12	polymorphisms	NNS	O	polymorphism	conj_and	10	SENT_32	[p2l1066t1147r1619b1228],
13	that	WDT	O	that	nsubj	14	SENT_32	[p2l1655t1147r1789b1210],
14	inﬂuence	VBP	O	inﬂuence	rcmod	10	SENT_32	[p2l1822t1147r2146b1210],
15	the	DT	O	the	det	16	SENT_32	[p2l7t1254r113b1316],
16	response	NN	O	response	dobj	14	SENT_32	[p2l147t1273r457b1335],
17	to	TO	O	to	_	0	SENT_32	[p2l492t1263r558b1316],
18	ALL	NN	O	all	nn	19	SENT_32	[p2l593t1254r765b1316],
19	chemotherapy	NN	O	chemotherapy	prep_to	14	SENT_32	[p2l799t1254r1313b1335],
20	.	.	O	.	_	0	SENT_32	[p2l799t1254r1313b1335],

1	An	DT	O	a	det	3	SENT_33	[p2l1352t1254r1459b1316],
2	important	JJ	O	important	amod	3	SENT_33	[p2l1493t1254r1839b1335],
3	enzyme	NN	O	enzyme	nsubj	11	SENT_33	[p2l1872t1273r2146b1335],
4	in	IN	O	in	_	0	SENT_33	[p2l7t1360r74b1421],
5	the	DT	O	the	det	8	SENT_33	[p2l128t1360r234b1422],
6	folate/methotrexate	NN	O	folate/methotrexate	nn	8	SENT_33	[p2l288t1360r978b1423],
7	metabolism	NN	O	metabolism	nn	8	SENT_33	[p2l1032t1360r1448b1422],
8	pathway	NN	O	pathway	prep_in	3	SENT_33	[p2l1499t1360r1798b1441],
9	is	VBZ	O	be	cop	11	SENT_33	[p2l1853t1360r1908b1422],
10	5,10	CD	NUMBER	5,10	num	11	SENT_33	[p2l1965t1359r2144b1434, p2l7t1468r946b1549],
11	methylenetetrahydrofolate	NN	O	methylenetetrahydrofolate	_	0	SENT_33	[p2l1965t1359r2144b1434, p2l7t1468r946b1549],
12	reductase	NN	O	reductase	nn	15	SENT_33	[p2l1004t1468r1338b1531],
13	(	CD	NUMBER	(	num	15	SENT_33	[p2l1400t1469r1779b1546],
14	MTHFR	NN	O	mthfr	nn	15	SENT_33	[p2l1400t1469r1779b1546],
15	)	NN	O	)	dep	11	SENT_33	[p2l1400t1469r1779b1546],
16	.	.	O	.	_	0	SENT_33	[p2l1400t1469r1779b1546],

1	MT	NNP	O	MT	nn	2	SENT_34	[p2l1841t1470r1974b1530],
2	HFR	NNP	O	HFR	nsubj	3	SENT_34	[p2l1976t1470r2148b1530],
3	catalyzes	VBZ	O	catalyze	_	0	SENT_34	[p2l8t1574r330b1655],
4	conversion	NN	O	conversion	dobj	3	SENT_34	[p2l374t1574r758b1637],
5	of	IN	O	of	_	0	SENT_34	[p2l801t1574r877b1636],
6	5,10	CD	NUMBER	5,10	number	7	SENT_34	[p2l915t1573r2037b1655],
7	—	CD	NUMBER	—	num	8	SENT_34	[p2l915t1573r2037b1655],
8	methylenetetrahydrofolate	NN	O	methylenetetrahydrofolate	prep_of	4	SENT_34	[p2l915t1573r2037b1655],
9	to	TO	O	to	_	0	SENT_34	[p2l2080t1583r2146b1636],
10	5	CD	NUMBER	5	number	11	SENT_34	[p2l9t1682r896b1763],
11	—	CD	NUMBER	—	num	12	SENT_34	[p2l9t1682r896b1763],
12	methyltetrahydrofolate	NN	O	methyltetrahydrofolate	prep_to	3	SENT_34	[p2l9t1682r896b1763],
13	in	IN	O	in	_	0	SENT_34	[p2l943t1682r1010b1744],
14	the	DT	O	the	det	17	SENT_34	[p2l1056t1682r1162b1745],
15	folic	JJ	O	folic	amod	17	SENT_34	[p2l1210t1682r1369b1745],
16	acid	NN	O	acid	nn	17	SENT_34	[p2l1419t1682r1564b1745],
17	cycle	NN	O	cycle	prep_in	12	SENT_34	[p2l1610t1682r1793b1763],
18	[	CD	NUMBER	[	number	19	SENT_34	[p2l1847t1682r1960b1758],
19	5	CD	NUMBER	5	num	20	SENT_34	[p2l1847t1682r1960b1758],
20	]	NN	O	]	dep	17	SENT_34	[p2l1847t1682r1960b1758],
21	.	.	O	.	_	0	SENT_34	[p2l1847t1682r1960b1758],

1	The	DT	O	the	det	5	SENT_35	[p2l2011t1682r2146b1745],
2	MT	NNP	O	MT	nn	5	SENT_35	[p2l7t1791r138b1851],
3	HFR	NNP	O	HFR	nn	5	SENT_35	[p2l141t1791r313b1851],
4	polymorphisms	NNS	O	polymorphism	nn	5	SENT_35	[p2l329t1789r881b1870],
5	C677T	NN	O	c677t	nsubj	8	SENT_35	[p2l901t1789r1146b1852],
6	and	CC	O	and	_	0	SENT_35	[p2l1166t1789r1291b1852],
7	A1298C	NN	O	a1298c	conj_and	5	SENT_35	[p2l1308t1789r1606b1853],
8	affect	VBP	O	affect	_	0	SENT_35	[p2l1627t1789r1825b1852],
9	MTHFR	NN	O	mthfr	nn	10	SENT_35	[p2l1841t1791r2148b1851],
10	enzyme	NN	O	enzyme	dobj	8	SENT_35	[p2l8t1914r282b1976],
11	causing	VBG	O	cause	partmod	10	SENT_35	[p2l314t1895r583b1976],
12	a	DT	O	a	det	13	SENT_35	[p2l617t1914r653b1957],
13	reduction	NN	O	reduction	dobj	11	SENT_35	[p2l683t1895r1018b1957],
14	of	IN	O	of	_	0	SENT_35	[p2l1051t1895r1127b1957],
15	its	PRP$	O	its	poss	16	SENT_35	[p2l1153t1895r1233b1957],
16	activity	NN	O	activity	prep_of	13	SENT_35	[p2l1268t1895r1542b1976],
17	,	,	O	,	_	0	SENT_35	[p2l1268t1895r1542b1976],
18	altered	JJ	O	altered	amod	19	SENT_35	[p2l1579t1895r1818b1957],
19	distribution	NN	O	distribution	conj_and	13	SENT_35	[p2l1850t1895r2144b1957, p2l7t2002r144b2064],
20	of	IN	O	of	_	0	SENT_35	[p2l164t2002r241b2064],
21	intracellular	JJ	O	intracellular	amod	23	SENT_35	[p2l255t2002r685b2064],
22	folate	NN	O	folate	nn	23	SENT_35	[p2l704t2002r904b2064],
23	metabolites	NNS	O	metabolite	prep_of	19	SENT_35	[p2l924t2002r1331b2064],
24	and	CC	O	and	_	0	SENT_35	[p2l1354t2002r1480b2064],
25	increased	VBN	O	increase	amod	26	SENT_35	[p2l1499t2002r1834b2064],
26	levels	NNS	O	level	dobj	11	SENT_35	[p2l1853t2002r2053b2064],
27	of	IN	O	of	_	0	SENT_35	[p2l2076t2002r2153b2064],
28	homocysteine	NN	O	homocysteine	prep_of	26	SENT_35	[p2l7t2109r499b2190],
29	[	CD	NUMBER	[	num	28	SENT_35	[p2l534t2109r714b2185],
30	6,7	CD	NUMBER	6,7	num	31	SENT_35	[p2l534t2109r714b2185],
31	]	NN	O	]	dep	28	SENT_35	[p2l534t2109r714b2185],
32	.	.	O	.	_	0	SENT_35	[p2l534t2109r714b2185],

1	Since	IN	O	since	mark	3	SENT_36	[p2l749t2109r942b2172],
2	MTHFR	NN	O	mthfr	nsubj	3	SENT_36	[p2l970t2110r1276b2171],
3	play	VBP	O	play	_	0	SENT_36	[p2l1302t2109r1454b2190],
4	this	DT	O	this	det	6	SENT_36	[p2l1483t2109r1607b2171],
5	important	JJ	O	important	amod	6	SENT_36	[p2l1638t2109r1984b2190],
6	role	NN	O	role	dobj	3	SENT_36	[p2l2010t2109r2146b2171],

1	1670	CD	DATE	1670	num	3	SENT_37	[p2l357t2265r419b2289],
2	P.	NNP	PERSON	P.	nn	3	SENT_37	[p2l995t2266r1016b2289],
3	Chiusolo	NNP	PERSON	Chiusolo	_	0	SENT_37	[p2l1030t2265r1147b2289],
4	er	FW	O	er	nn	5	SENT_37	[p2l1157t2270r1181b2289],
5	al.	FW	O	al.	dep	3	SENT_37	[p2l1189t2265r1219b2289],
6	/	:	O	/	punct	3	SENT_37	[p2l1229t2266r1244b2289],
7	Leukemia	NNP	ORGANIZATION	Leukemia	nn	8	SENT_37	[p2l1248t2265r1376b2289],
8	Research	NNP	ORGANIZATION	Research	dep	3	SENT_37	[p2l1385t2265r1507b2289],
9	3	CD	NUMBER	3	num	10	SENT_37	[p2l1516t2265r1546b2289],
10	]	NN	O	]	dep	8	SENT_37	[p2l1516t2265r1546b2289],
11	(	CD	NUMBER	(	number	12	SENT_37	[p2l1558t2265r1644b2294],
12	2007	CD	DATE	2007	num	10	SENT_37	[p2l1558t2265r1644b2294],
13	)	CD	NUMBER	)	number	14	SENT_37	[p2l1558t2265r1644b2294],
14	1669-1674	CD	DATE	1669-1674	num	10	SENT_37	[p2l1656t2265r1803b2289],

1	in	IN	O	in	_	0	SENT_38	[p2l7t2433r74b2495],
2	folate	JJ	O	folate	amod	3	SENT_38	[p2l103t2433r303b2495],
3	metabolism	NN	O	metabolism	prep_in	16	SENT_38	[p2l332t2433r765b2507],
4	,	,	O	,	_	0	SENT_38	[p2l332t2433r765b2507],
5	differences	NNS	O	difference	nsubj	16	SENT_38	[p2l798t2433r1187b2495],
6	in	IN	O	in	_	0	SENT_38	[p2l1217t2433r1284b2495],
7	its	PRP$	O	its	poss	8	SENT_38	[p2l1313t2433r1393b2495],
8	activity	NN	O	activity	prep_in	5	SENT_38	[p2l1425t2433r1686b2514],
9	due	JJ	O	due	_	0	SENT_38	[p2l1716t2433r1841b2495],
10	to	TO	O	to	_	0	SENT_38	[p2l1870t2442r1936b2495],
11	these	DT	O	these	det	14	SENT_38	[p2l1966t2433r2146b2495],
12	two	CD	NUMBER	two	num	14	SENT_38	[p2l7t2550r136b2603],
13	gene	NN	O	gene	nn	14	SENT_38	[p2l176t2560r340b2621],
14	variants	NNS	O	variant	prep_due_to	8	SENT_38	[p2l378t2540r653b2603],
15	might	MD	O	might	aux	16	SENT_38	[p2l692t2540r900b2621],
16	modulate	VB	O	modulate	_	0	SENT_38	[p2l935t2540r1264b2603],
17	therapeutic	JJ	O	therapeutic	amod	18	SENT_38	[p2l1302t2540r1694b2621],
18	response	NN	O	response	dobj	16	SENT_38	[p2l1732t2560r2042b2621],
19	to	TO	O	to	_	0	SENT_38	[p2l2080t2550r2146b2603],
20	antifolate	JJ	O	antifolate	amod	22	SENT_38	[p2l9t2647r341b2710],
21	chemoterapeutic	JJ	O	chemoterapeutic	amod	22	SENT_38	[p2l367t2647r952b2728],
22	agents	NNS	O	agent	prep_to	16	SENT_38	[p2l981t2657r1222b2728],
23	.	.	O	.	_	0	SENT_38	[p2l981t2657r1222b2728],

1	The	DT	O	the	det	2	SENT_39	[p2l114t2753r250b2815],
2	frequencies	NNS	O	frequency	nsubj	11	SENT_39	[p2l269t2752r676b2834],
3	of	IN	O	of	_	0	SENT_39	[p2l698t2752r775b2815],
4	the	DT	O	the	det	5	SENT_39	[p2l788t2753r894b2815],
5	MTHFR	NN	O	mthfr	prep_of	2	SENT_39	[p2l913t2754r1220b2814],
6	677	CD	NUMBER	677	num	10	SENT_39	[p2l1239t2752r1366b2816],
7	and	CC	O	and	_	0	SENT_39	[p2l1390t2753r1516b2815],
8	1298	CD	DATE	1298	num	10	SENT_39	[p2l1542t2753r1706b2816],
9	variant	JJ	O	variant	amod	10	SENT_39	[p2l1729t2753r1973b2815],
10	alleles	NNS	O	allele	dep	5	SENT_39	[p2l1993t2753r2144b2815, p2l7t2861r102b2924],
11	vary	VBP	O	vary	_	0	SENT_39	[p2l143t2881r296b2942],
12	by	IN	O	by	_	0	SENT_39	[p2l335t2861r423b2942],
13	ethnicity	NN	O	ethnicity	prep_by	11	SENT_39	[p2l464t2861r785b2942],
14	.	.	O	.	_	0	SENT_39	[p2l464t2861r785b2942],

1	In	IN	O	in	_	0	SENT_40	[p2l829t2863r901b2923],
2	Europe	NNP	LOCATION	Europe	prep_in	12	SENT_40	[p2l940t2863r1195b2942],
3	8	CD	PERCENT	8	num	2	SENT_40	[p2l1238t2862r1481b2924],
4	—	CD	PERCENT	—	number	5	SENT_40	[p2l1238t2862r1481b2924],
5	20	CD	PERCENT	20	num	6	SENT_40	[p2l1238t2862r1481b2924],
6	%	NN	PERCENT	%	nsubj	12	SENT_40	[p2l1238t2862r1481b2924],
7	of	IN	O	of	_	0	SENT_40	[p2l1526t2861r1603b2924],
8	the	DT	O	the	det	10	SENT_40	[p2l1636t2861r1742b2924],
9	Caucasian	JJ	LOCATION	caucasian	amod	10	SENT_40	[p2l1783t2861r2147b2924],
10	population	NN	O	population	prep_of	6	SENT_40	[p2l6t2968r387b3049],
11	is	VBZ	O	be	cop	12	SENT_40	[p2l402t2968r457b3030],
12	homozygous	JJ	O	homozygous	_	0	SENT_40	[p2l474t2968r926b3049],
13	for	IN	O	for	mark	23	SENT_40	[p2l945t2968r1048b3030],
14	the	DT	O	the	det	16	SENT_40	[p2l1062t2968r1168b3030],
15	677T	NN	O	677t	nn	16	SENT_40	[p2l1185t2968r1370b3031],
16	allele	NN	O	allele	nsubj	23	SENT_40	[p2l1387t2968r1576b3030],
17	and	CC	O	and	_	0	SENT_40	[p2l1594t2968r1720b3030],
18	almost	RB	O	almost	quantmod	19	SENT_40	[p2l1736t2968r1971b3030],
19	40	CD	PERCENT	40	num	20	SENT_40	[p2l1985t2968r2143b3031],
20	%	NN	PERCENT	%	nsubj	23	SENT_40	[p2l1985t2968r2143b3031],
21	is	VBZ	O	be	cop	23	SENT_40	[p2l7t3075r62b3138],
22	heterozygous	JJ	O	heterozygous	amod	23	SENT_40	[p2l109t3075r581b3156],
23	[	NN	O	[	advcl	12	SENT_40	[p2l636t3076r816b3151],
24	8,9	CD	NUMBER	8,9	num	25	SENT_40	[p2l636t3076r816b3151],
25	]	NN	O	]	dep	23	SENT_40	[p2l636t3076r816b3151],
26	.	.	O	.	_	0	SENT_40	[p2l636t3076r816b3151],

1	Heterozygotes	NNS	O	heterozygote	nsubj	2	SENT_41	[p2l866t3077r1377b3156],
2	have	VBP	O	have	_	0	SENT_41	[p2l1424t3075r1587b3138],
3	approximately	RB	O	approximately	quantmod	4	SENT_41	[p2l1636t3075r2146b3156],
4	60	CD	PERCENT	60	dep	5	SENT_41	[p2l8t3182r164b3245],
5	%	NN	PERCENT	%	dep	7	SENT_41	[p2l8t3182r164b3245],
6	enzyme	NN	O	enzyme	nn	7	SENT_41	[p2l187t3202r461b3263],
7	activity	NN	O	activity	dobj	2	SENT_41	[p2l482t3182r755b3263],
8	.	.	O	.	_	0	SENT_41	[p2l482t3182r755b3263],

1	Regarding	VBG	O	regard	_	0	SENT_42	[p2l778t3182r1145b3263],
2	1298	CD	DATE	1298	num	3	SENT_42	[p2l1173t3183r1337b3246],
3	polymorphism	NN	O	polymorphism	prep_regarding	9	SENT_42	[p2l1357t3182r1878b3263],
4	10	CD	PERCENT	10	num	5	SENT_42	[p2l1904t3183r2052b3245],
5	%	NN	PERCENT	%	nsubj	9	SENT_42	[p2l1904t3183r2052b3245],
6	of	IN	O	of	_	0	SENT_42	[p2l2076t3182r2153b3245],
7	subjects	NNS	O	subject	prep_of	5	SENT_42	[p2l10t3289r290b3370],
8	are	VBP	O	be	cop	9	SENT_42	[p2l312t3308r417b3351],
9	homozygous	JJ	O	homozygous	_	0	SENT_42	[p2l435t3289r887b3370],
10	and	CC	O	and	_	0	SENT_42	[p2l910t3289r1035b3351],
11	almost	RB	O	almost	quantmod	12	SENT_42	[p2l1054t3289r1290b3351],
12	40	CD	PERCENT	40	num	13	SENT_42	[p2l1306t3289r1464b3352],
13	%	NN	PERCENT	%	conj_and	9	SENT_42	[p2l1306t3289r1464b3352],
14	heterozygous	JJ	O	heterozygous	amod	17	SENT_42	[p2l1486t3289r1957b3370],
15	[	NN	O	[	dep	14	SENT_42	[p2l1984t3289r2142b3365],
16	10	CD	NUMBER	10	num	15	SENT_42	[p2l1984t3289r2142b3365],
17	]	NN	O	]	dep	9	SENT_42	[p2l1984t3289r2142b3365],
18	.	.	O	.	_	0	SENT_42	[p2l1984t3289r2142b3365],

1	Several	JJ	O	several	amod	2	SENT_43	[p2l9t3396r268b3459],
2	reports	NNS	O	report	nsubj	4	SENT_43	[p2l290t3406r535b3477],
3	have	VBP	O	have	aux	4	SENT_43	[p2l559t3396r722b3459],
4	described	VBN	O	describe	_	0	SENT_43	[p2l746t3396r1085b3459],
5	association	NN	O	association	dobj	4	SENT_43	[p2l1109t3396r1502b3459],
6	between	IN	O	between	_	0	SENT_43	[p2l1523t3396r1819b3459],
7	MTHFR	NNP	O	MTHFR	nn	8	SENT_43	[p2l1841t3398r2148b3458],
8	Variants	NNS	O	variant	prep_between	5	SENT_43	[p2l7t3503r283b3566],
9	and	CC	O	and	_	0	SENT_43	[p2l317t3503r442b3566],
10	clinical	JJ	O	clinical	amod	11	SENT_43	[p2l472t3503r731b3566],
11	outcome	NN	O	outcome	prep_between	5	SENT_43	[p2l763t3512r1086b3577],
12	,	,	O	,	_	0	SENT_43	[p2l763t3512r1086b3577],
13	toxicity	NN	O	toxicity	conj_and	11	SENT_43	[p2l1119t3503r1389b3584],
14	and	CC	O	and	_	0	SENT_43	[p2l1421t3503r1547b3566],
15	susceptibility	NN	O	susceptibility	conj_and	11	SENT_43	[p2l1579t3503r2049b3584],
16	to	TO	O	to	_	0	SENT_43	[p2l2080t3513r2146b3566],
17	ALL	NN	O	all	prep_to	4	SENT_43	[p2l7t3609r178b3670],
18	especially	RB	O	especially	advmod	17	SENT_43	[p2l204t3609r557b3690],
19	in	IN	O	in	_	0	SENT_43	[p2l582t3609r649b3670],
20	pediatric	JJ	O	pediatric	amod	21	SENT_43	[p2l672t3609r982b3690],
21	population	NN	O	population	prep_in	17	SENT_43	[p2l1008t3609r1388b3690],
22	[	CD	NUMBER	[	number	23	SENT_43	[p2l1419t3608r1710b3684],
23	11	CD	NUMBER	11	num	24	SENT_43	[p2l1419t3608r1710b3684],
24	—	NN	O	—	dep	17	SENT_43	[p2l1419t3608r1710b3684],
25	16	CD	NUMBER	16	num	26	SENT_43	[p2l1419t3608r1710b3684],
26	]	NN	O	]	dep	24	SENT_43	[p2l1419t3608r1710b3684],
27	.	.	O	.	_	0	SENT_43	[p2l1419t3608r1710b3684],

1	In	IN	O	in	_	0	SENT_44	[p2l114t3719r186b3779],
2	a	DT	O	a	det	4	SENT_44	[p2l212t3737r249b3780],
3	previous	JJ	O	previous	amod	4	SENT_44	[p2l270t3717r572b3798],
4	paper	NN	O	paper	prep_in	6	SENT_44	[p2l597t3737r795b3798],
5	we	PRP	O	we	nsubj	6	SENT_44	[p2l819t3737r919b3780],
6	demonstrated	VBD	O	demonstrate	_	0	SENT_44	[p2l945t3717r1423b3780],
7	a	DT	O	a	det	9	SENT_44	[p2l1448t3737r1485b3780],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_44	[p2l1511t3717r1879b3798],
9	association	NN	O	association	dobj	6	SENT_44	[p2l1903t3717r2144b3780, p3l9t20r183b82],

1	between	IN	O	between	dep	13	SENT_45	[p3l210t20r506b83],
2	MTHFR	NNP	O	MTHFR	nn	4	SENT_45	[p3l534t21r840b82],
3	677TT	NNP	O	677TT	nn	4	SENT_45	[p3l869t20r1108b83],
4	genotype	NN	O	genotype	pobj	1	SENT_45	[p3l1137t29r1460b101],
5	and	CC	O	and	_	0	SENT_45	[p3l1491t20r1616b82],
6	hematological	JJ	O	hematological	amod	9	SENT_45	[p3l1643t20r2146b101],
7	and	CC	O	and	_	0	SENT_45	[p3l9t126r134b188],
8	hepatic	JJ	O	hepatic	amod	9	SENT_45	[p3l170t126r424b207],
9	toxicity	NN	O	toxicity	conj_and	1	SENT_45	[p3l463t126r733b207],
10	in	IN	O	in	_	0	SENT_45	[p3l770t126r838b187],
11	ALL	NN	O	all	prep_in	9	SENT_45	[p3l875t126r1046b187],
12	adult	JJ	O	adult	amod	13	SENT_45	[p3l1085t126r1260b188],
13	patients	NNS	O	patient	nsubj	19	SENT_45	[p3l1295t126r1569b207],
14	during	IN	O	during	_	0	SENT_45	[p3l1610t126r1838b207],
15	maintenance	NN	O	maintenance	nn	16	SENT_45	[p3l1876t126r2144b188, p3l7t254r212b297],
16	chemotherapy	NN	O	chemotherapy	prep_during	13	SENT_45	[p3l255t234r756b315],
17	with	IN	O	with	_	0	SENT_45	[p3l799t234r955b297],
18	MT	NN	O	mt	prep_with	16	SENT_45	[p3l996t236r1128b296],
19	X	NN	O	x	_	0	SENT_45	[p3l1129t236r1192b296],
20	which	WDT	O	which	nsubj	24	SENT_45	[p3l1234t234r1450b297],
21	is	VBZ	O	be	cop	24	SENT_45	[p3l1491t234r1546b297],
22	a	DT	O	a	det	24	SENT_45	[p3l1592t254r1628b297],
23	chemoterapic	JJ	O	chemoterapic	amod	24	SENT_45	[p3l1669t234r2145b315],
24	agent	NN	O	agent	ccomp	19	SENT_45	[p3l9t350r200b422],
25	that	WDT	O	that	nsubj	26	SENT_45	[p3l228t341r361b403],
26	interrupt	VBP	O	interrupt	rcmod	24	SENT_45	[p3l391t341r697b422],
27	folic	JJ	O	folic	amod	29	SENT_45	[p3l726t341r885b403],
28	acid	NN	O	acid	nn	29	SENT_45	[p3l919t341r1064b403],
29	cycle	NN	O	cycle	nsubj	32	SENT_45	[p3l1095t341r1278b422],
30	[	CD	NUMBER	[	number	31	SENT_45	[p3l1315t341r1473b417],
31	13	CD	NUMBER	13	num	32	SENT_45	[p3l1315t341r1473b417],
32	]	NN	O	]	xcomp	26	SENT_45	[p3l1315t341r1473b417],
33	.	.	O	.	_	0	SENT_45	[p3l1315t341r1473b417],

1	More	RBR	O	more	advmod	2	SENT_46	[p3l1508t342r1699b403],
2	recently	RB	DATE	recently	advmod	5	SENT_46	[p3l1728t341r2014b422],
3	we	PRP	O	we	nsubj	5	SENT_46	[p3l2045t360r2146b404],
4	also	RB	O	also	advmod	5	SENT_46	[p3l9t448r147b511],
5	reported	VBD	O	report	_	0	SENT_46	[p3l171t448r468b529],
6	no	DT	O	no	det	7	SENT_46	[p3l490t468r576b511],
7	association	NN	O	association	dobj	5	SENT_46	[p3l603t448r995b511],
8	between	IN	O	between	_	0	SENT_46	[p3l1018t448r1314b511],
9	677	CD	NUMBER	677	num	13	SENT_46	[p3l1339t448r1465b511],
10	and	CC	O	and	_	0	SENT_46	[p3l1494t448r1619b511],
11	1298	CD	DATE	1298	num	13	SENT_46	[p3l1651t449r1815b512],
12	MTHFR	NN	O	mthfr	nn	13	SENT_46	[p3l1841t450r2148b510],
13	polymorphisms	NNS	O	polymorphism	prep_between	7	SENT_46	[p3l6t555r558b636],
14	and	CC	O	and	_	0	SENT_46	[p3l586t555r712b618],
15	adult	JJ	O	adult	amod	17	SENT_46	[p3l738t555r914b618],
16	ALL	NN	O	all	nn	17	SENT_46	[p3l937t556r1108b617],
17	susceptibility	NN	O	susceptibility	conj_and	7	SENT_46	[p3l1136t555r1606b636],
18	[	CD	NUMBER	[	number	19	SENT_46	[p3l1637t555r1795b631],
19	16	CD	NUMBER	16	num	20	SENT_46	[p3l1637t555r1795b631],
20	]	NN	O	]	dep	17	SENT_46	[p3l1637t555r1795b631],
21	.	.	O	.	_	0	SENT_46	[p3l1637t555r1795b631],

1	Since	IN	O	since	mark	4	SENT_47	[p3l117t661r309b724],
2	MTHFR	NN	O	mthfr	nsubj	4	SENT_47	[p3l342t662r648b723],
3	might	MD	O	might	aux	4	SENT_47	[p3l680t661r887b742],
4	affect	VB	O	affect	advcl	17	SENT_47	[p3l920t660r1118b723],
5	sensitivity	NN	O	sensitivity	dobj	4	SENT_47	[p3l1152t661r1510b742],
6	to	TO	O	to	_	0	SENT_47	[p3l1544t670r1610b723],
7	MTX	NN	O	mtx	prep_to	4	SENT_47	[p3l1643t662r1839b722],
8	through	IN	O	through	_	0	SENT_47	[p3l1871t661r2147b742],
9	its	PRP$	O	its	poss	10	SENT_47	[p3l7t769r87b832],
10	impact	NN	O	impact	prep_through	4	SENT_47	[p3l127t769r369b850],
11	on	IN	O	on	_	0	SENT_47	[p3l407t789r493b832],
12	folate	JJ	O	folate	amod	13	SENT_47	[p3l532t769r732b832],
13	cycle	NN	O	cycle	prep_on	10	SENT_47	[p3l771t769r955b850],
14	our	PRP$	O	we	poss	16	SENT_47	[p3l995t789r1112b832],
15	primary	JJ	O	primary	amod	16	SENT_47	[p3l1147t769r1428b850],
16	goal	NN	O	goal	nsubj	17	SENT_47	[p3l1468t769r1618b850],
17	was	VBD	O	be	_	0	SENT_47	[p3l1657t789r1790b832],
18	to	TO	O	to	aux	19	SENT_47	[p3l1830t779r1896b832],
19	correlate	VB	O	correlate	xcomp	17	SENT_47	[p3l1937t789r2144b832, p3l7t876r133b938],
20	both	CC	O	both	preconj	25	SENT_47	[p3l160t876r318b938],
21	677	CD	NUMBER	677	num	25	SENT_47	[p3l347t876r474b939],
22	and	CC	O	and	_	0	SENT_47	[p3l506t876r632b938],
23	1298	CD	DATE	1298	num	25	SENT_47	[p3l667t876r831b939],
24	MTHFR	NN	O	mthfr	nn	25	SENT_47	[p3l862t877r1168b938],
25	polymorphisms	NNS	O	polymorphism	dobj	19	SENT_47	[p3l1194t876r1746b957],
26	with	IN	O	with	_	0	SENT_47	[p3l1776t876r1932b939],
27	event	NN	O	event	nn	29	SENT_47	[p3l1960t885r2148b939],
28	free	JJ	O	free	amod	29	SENT_47	[p3l7t982r143b1043],
29	survival	NN	O	survival	prep_with	25	SENT_47	[p3l176t982r453b1044],
30	(	CD	NUMBER	(	num	31	SENT_47	[p3l486t982r661b1058],
31	EFS	NNS	O	ef	dep	29	SENT_47	[p3l486t982r661b1058],
32	and	CC	O	and	_	0	SENT_47	[p3l697t982r822b1043],
33	DFS	NN	O	df	nn	34	SENT_47	[p3l851t982r1039b1058],
34	)	NN	O	)	prep_with	25	SENT_47	[p3l851t982r1039b1058],
35	and	CC	O	and	_	0	SENT_47	[p3l1074t982r1199b1043],
36	overall	JJ	O	overall	amod	37	SENT_47	[p3l1229t982r1471b1044],
37	survival	NN	O	survival	dobj	19	SENT_47	[p3l1504t982r1781b1044],
38	(	CD	NUMBER	(	num	40	SENT_47	[p3l1814t982r1980b1058],
39	OS	NN	O	os	nn	40	SENT_47	[p3l1814t982r1980b1058],
40	)	NN	O	)	dep	37	SENT_47	[p3l1814t982r1980b1058],
41	in	IN	O	in	_	0	SENT_47	[p3l2013t982r2080b1043],
42	a	DT	O	a	det	43	SENT_47	[p3l2111t1001r2148b1043],
43	group	NN	O	group	prep_in	19	SENT_47	[p3l8t1109r212b1170],
44	of	IN	O	of	_	0	SENT_47	[p3l236t1089r313b1152],
45	ALL	NN	O	all	nn	47	SENT_47	[p3l328t1090r499b1151],
46	adult	JJ	O	adult	amod	47	SENT_47	[p3l523t1089r699b1152],
47	patients	NNS	O	patient	prep_of	43	SENT_47	[p3l717t1089r1011b1170],
48	.	.	O	.	_	0	SENT_47	[p3l717t1089r1011b1170],

1	We	PRP	O	we	nsubj	3	SENT_48	[p3l1037t1091r1151b1152],
2	also	RB	O	also	advmod	3	SENT_48	[p3l1176t1089r1314b1152],
3	evaluated	VBD	O	evaluate	_	0	SENT_48	[p3l1338t1089r1673b1152],
4	the	DT	O	the	det	5	SENT_48	[p3l1694t1089r1800b1152],
5	inﬂuence	NN	O	inﬂuence	dobj	3	SENT_48	[p3l1822t1089r2146b1152],
6	of	IN	O	of	_	0	SENT_48	[p3l8t1196r85b1258],
7	these	DT	O	these	det	9	SENT_48	[p3l108t1196r289b1258],
8	MTHFR	NN	O	mthfr	nn	9	SENT_48	[p3l319t1197r625b1258],
9	polymorphisms	NNS	O	polymorphism	prep_of	5	SENT_48	[p3l653t1196r1205b1277],
10	on	IN	O	on	_	0	SENT_48	[p3l1238t1215r1324b1258],
11	toxicity	NN	O	toxicity	prep_on	9	SENT_48	[p3l1353t1196r1623b1277],
12	in	IN	O	in	_	0	SENT_48	[p3l1653t1196r1720b1258],
13	a	DT	O	a	det	14	SENT_48	[p3l1752t1215r1789b1258],
14	subgroup	NN	O	subgroup	prep_in	3	SENT_48	[p3l1820t1196r2146b1277],
15	of	IN	O	of	_	0	SENT_48	[p3l8t1303r85b1366],
16	patients	NNS	O	patient	prep_of	14	SENT_48	[p3l113t1303r388b1384],
17	homogenously	RB	O	homogenously	advmod	18	SENT_48	[p3l425t1303r948b1384],
18	treated	VBN	O	treat	partmod	16	SENT_48	[p3l984t1303r1225b1366],
19	with	IN	O	with	_	0	SENT_48	[p3l1260t1303r1416b1366],
20	methotrexate	NN	O	methotrexate	nn	21	SENT_48	[p3l1452t1303r2148b1366],
21	—	NN	O	—	prep_with	18	SENT_48	[p3l1452t1303r2148b1366],
22	based	VBN	O	base	partmod	21	SENT_48	[p3l1452t1303r2148b1366],
23	maintenance	NN	O	maintenance	dobj	22	SENT_48	[p3l7t1386r473b1448],
24	.	.	O	.	_	0	SENT_48	[p3l7t1386r473b1448],

1	2	LS	NUMBER	2	_	0	SENT_49	[p3l7t1609r70b1672],
2	.	.	O	.	_	0	SENT_49	[p3l7t1609r70b1672],

1	Patients	NNS	O	patient	_	0	SENT_50	[p3l119t1609r422b1672],
2	and	CC	O	and	_	0	SENT_50	[p3l448t1610r589b1672],
3	methods	NNS	O	method	conj_and	1	SENT_50	[p3l613t1610r933b1672],

1	Subjects	NNS	O	subject	nsubj	10	SENT_51	[p3l117t1823r412b1904],
2	in	IN	O	in	_	0	SENT_51	[p3l432t1823r499b1885],
3	this	DT	O	this	det	6	SENT_51	[p3l516t1823r640b1886],
4	retrospective	JJ	O	retrospective	amod	6	SENT_51	[p3l659t1823r1115b1904],
5	cohort	NN	O	cohort	nn	6	SENT_51	[p3l1133t1823r1360b1886],
6	study	NN	O	study	prep_in	1	SENT_51	[p3l1379t1823r1566b1904],
7	were	VBD	O	be	cop	10	SENT_51	[p3l1584t1843r1754b1886],
8	82	CD	NUMBER	82	num	10	SENT_51	[p3l1776t1824r1858b1886],
9	consecutive	JJ	O	consecutive	amod	10	SENT_51	[p3l1877t1843r2144b1886, p3l6t1930r179b1993],
10	patients	NNS	O	patient	_	0	SENT_51	[p3l202t1930r476b2011],
11	with	IN	O	with	_	0	SENT_51	[p3l501t1930r657b1993],
12	ALL	NN	O	all	prep_with	10	SENT_51	[p3l680t1930r851b1992],
13	receiving	VBG	O	receive	partmod	12	SENT_51	[p3l873t1930r1201b2011],
14	chemotherapy	NN	O	chemotherapy	dobj	13	SENT_51	[p3l1226t1930r1740b2011],
15	,	,	O	,	_	0	SENT_51	[p3l1226t1930r1740b2011],
16	enrolled	VBN	O	enrol	partmod	14	SENT_51	[p3l1767t1930r2057b1992],
17	in	IN	O	in	_	0	SENT_51	[p3l2080t1930r2147b1992],
18	different	JJ	O	different	amod	19	SENT_51	[p3l8t2037r311b2100],
19	protocols	NNS	O	protocol	prep_in	16	SENT_51	[p3l328t2037r657b2118],
20	according	VBG	O	accord	_	0	SENT_51	[p3l681t2037r1028b2118],
21	to	TO	O	to	prepc_according_to	16	SENT_51	[p3l1048t2047r1114b2100],
22	their	PRP$	O	they	poss	29	SENT_51	[p3l1135t2037r1298b2100],
23	age	NN	O	age	nn	25	SENT_51	[p3l1318t2057r1457b2118],
24	,	,	O	,	_	0	SENT_51	[p3l1318t2057r1457b2118],
25	immunophenotype	NN	O	immunophenotype	nn	29	SENT_51	[p3l1480t2037r2146b2118],
26	and	CC	O	and	_	0	SENT_51	[p3l9t2144r134b2207],
27	cytogenetical	JJ	O	cytogenetical	conj_and	25	SENT_51	[p3l157t2144r628b2225],
28	risk	NN	O	risk	nn	29	SENT_51	[p3l650t2144r784b2207],
29	[	NN	O	[	pobj	16	SENT_51	[p3l812t2145r1057b2220],
30	17,18	CD	NUMBER	17,18	num	31	SENT_51	[p3l812t2145r1057b2220],
31	]	NN	O	]	dep	29	SENT_51	[p3l812t2145r1057b2220],
32	treated	VBN	O	treat	partmod	29	SENT_51	[p3l1086t2144r1327b2207],
33	in	IN	O	in	_	0	SENT_51	[p3l1350t2144r1416b2206],
34	our	PRP$	O	we	poss	35	SENT_51	[p3l1440t2164r1557b2207],
35	Institution	NNP	O	Institution	prep_in	32	SENT_51	[p3l1579t2144r1943b2207],
36	since	IN	O	since	_	0	SENT_51	[p3l1969t2144r2146b2207],
37	1986	CD	DATE	1986	prep_since	35	SENT_51	[p3l16t2249r201b2313],
38	.	.	O	.	_	0	SENT_51	[p3l16t2249r201b2313],

1	High	JJ	O	high	amod	4	SENT_52	[p3l235t2250r577b2331],
2	—	NN	O	—	nn	4	SENT_52	[p3l235t2250r577b2331],
3	risk	NN	O	risk	nn	4	SENT_52	[p3l235t2250r577b2331],
4	patients	NNS	O	patient	nsubjpass	6	SENT_52	[p3l604t2250r878b2331],
5	were	VBD	O	be	auxpass	6	SENT_52	[p3l910t2269r1080b2313],
6	submitted	VBN	O	submit	_	0	SENT_52	[p3l1113t2250r1461b2312],
7	to	TO	O	to	_	0	SENT_52	[p3l1490t2259r1555b2312],
8	allogeneic	JJ	O	allogeneic	amod	11	SENT_52	[p3l1588t2250r1949b2331],
9	stem	NN	O	stem	nn	11	SENT_52	[p3l1984t2259r2148b2312],
10	cell	NN	O	cell	nn	11	SENT_52	[p3l8t2358r133b2421],
11	transplantation	NN	O	transplantation	prep_to	6	SENT_52	[p3l158t2358r686b2439],
12	in	IN	O	in	_	0	SENT_52	[p3l711t2358r778b2420],
13	the	DT	O	the	det	14	SENT_52	[p3l803t2358r909b2421],
14	presence	NN	O	presence	prep_in	11	SENT_52	[p3l933t2378r1244b2439],
15	of	IN	O	of	_	0	SENT_52	[p3l1270t2358r1347b2421],
16	a	DT	O	a	det	18	SENT_52	[p3l1367t2378r1404b2421],
17	suitable	JJ	O	suitable	amod	18	SENT_52	[p3l1430t2358r1702b2421],
18	donor	NN	O	donor	prep_of	14	SENT_52	[p3l1728t2358r1946b2421],
19	.	.	O	.	_	0	SENT_52	[p3l1728t2358r1946b2421],

1	All	DT	O	all	det	2	SENT_53	[p3l114t2465r225b2527],
2	patients	NNS	O	patient	nsubj	6	SENT_53	[p3l249t2465r523b2546],
3	were	VBD	O	be	cop	6	SENT_53	[p3l551t2484r721b2528],
4	European	JJ	MISC	european	amod	6	SENT_53	[p3l746t2466r1086b2546],
5	Caucasian	JJ	MISC	caucasian	amod	6	SENT_53	[p3l1111t2465r1475b2528],
6	ethnicity	NN	O	ethnicity	_	0	SENT_53	[p3l1500t2465r1822b2546],
7	.	.	O	.	_	0	SENT_53	[p3l1500t2465r1822b2546],

1	Fifty	CD	NUMBER	fifty	num	3	SENT_54	[p3l113t2571r447b2652],
2	—	CD	NUMBER	—	num	3	SENT_54	[p3l113t2571r447b2652],
3	ﬁve	NN	O	ﬁve	nsubj	7	SENT_54	[p3l113t2571r447b2652],
4	of	IN	O	of	_	0	SENT_54	[p3l506t2570r583b2633],
5	these	DT	O	these	det	6	SENT_54	[p3l634t2571r815b2633],
6	patients	NNS	O	patient	prep_of	3	SENT_54	[p3l871t2571r1146b2652],
7	received	VBD	O	receive	_	0	SENT_54	[p3l1204t2571r1502b2634],
8	a	DT	O	a	det	11	SENT_54	[p3l1561t2590r1597b2633],
9	homogeneous	JJ	O	homogeneous	amod	11	SENT_54	[p3l1653t2571r2145b2652],
10	maintenance	NN	O	maintenance	nn	11	SENT_54	[p3l7t2679r455b2742],
11	therapy	NN	O	therapy	dobj	7	SENT_54	[p3l484t2679r748b2760],
12	with	IN	O	with	_	0	SENT_54	[p3l777t2679r933b2742],
13	MTX	NN	O	mtx	prep_with	7	SENT_54	[p3l961t2681r1157b2741],
14	administered	VBN	O	administer	partmod	13	SENT_54	[p3l1187t2679r1645b2742],
15	weekly	JJ	SET	weekly	dobj	14	SENT_54	[p3l1673t2679r1927b2760],
16	intramuscularly	RB	O	intramuscularly	advmod	14	SENT_54	[p3l1956t2679r2144b2742, p3l7t2785r401b2866],
17	at	IN	O	at	_	0	SENT_54	[p3l435t2795r497b2847],
18	a	DT	O	a	det	22	SENT_54	[p3l529t2805r566b2847],
19	variable	JJ	O	variable	amod	22	SENT_54	[p3l597t2785r879b2848],
20	dosage	NN	O	dosage	nn	22	SENT_54	[p3l912t2785r1156b2866],
21	15-30	CD	NUMBER	15-30	num	22	SENT_54	[p3l1197t2785r1409b2848],
22	mg/m2	NN	O	mg/m2	prep_at	14	SENT_54	[p3l1427t2768r1666b2866],
23	for	IN	O	for	_	0	SENT_54	[p3l1704t2785r1807b2847],
24	almost	RB	O	almost	quantmod	25	SENT_54	[p3l1839t2785r2074b2847],
25	2	CD	DURATION	2	num	26	SENT_54	[p3l2106t2785r2146b2847],
26	years	NNS	NUMBER	year	prep_for	14	SENT_54	[p3l7t2887r210b2947],
27	.	.	O	.	_	0	SENT_54	[p3l7t2887r210b2947],

1	Characteristics	NNS	O	characteristic	nsubjpass	5	SENT_55	[p3l115t2974r640b3037],
2	of	IN	O	of	_	0	SENT_55	[p3l668t2974r745b3037],
3	patients	NNS	O	patient	prep_of	1	SENT_55	[p3l763t2974r1037b3055],
4	are	VBP	O	be	auxpass	5	SENT_55	[p3l1066t2994r1169b3037],
5	reported	VBN	O	report	_	0	SENT_55	[p3l1194t2974r1491b3055],
6	in	IN	O	in	_	0	SENT_55	[p3l1514t2974r1582b3036],
7	Table	NNP	O	Table	prep_in	5	SENT_55	[p3l1606t2974r1799b3037],
8	1	CD	NUMBER	1	num	7	SENT_55	[p3l1833t2975r1884b3037],
9	.	.	O	.	_	0	SENT_55	[p3l1833t2975r1884b3037],

1	Medical	JJ	O	medical	amod	2	SENT_56	[p3l114t3080r404b3142],
2	records	NNS	O	record	nsubjpass	7	SENT_56	[p3l429t3080r689b3142],
3	and	CC	O	and	_	0	SENT_56	[p3l719t3080r844b3142],
4	patient	NN	O	patient	nn	5	SENT_56	[p3l868t3080r1111b3161],
5	databases	NNS	O	database	conj_and	2	SENT_56	[p3l1137t3080r1473b3142],
6	were	VBD	O	be	auxpass	7	SENT_56	[p3l1502t3099r1672b3143],
7	reviewed	VBN	O	review	_	0	SENT_56	[p3l1698t3080r2020b3142],
8	for	IN	O	for	_	0	SENT_56	[p3l2045t3080r2148b3142],
9	the	DT	O	the	det	10	SENT_56	[p3l7t3188r113b3251],
10	purpose	NN	O	purpose	prep_for	7	SENT_56	[p3l137t3208r418b3269],
11	of	IN	O	of	_	0	SENT_56	[p3l444t3188r521b3251],
12	this	DT	O	this	det	13	SENT_56	[p3l540t3188r664b3251],
13	study	NN	O	study	prep_of	10	SENT_56	[p3l694t3188r894b3269],
14	.	.	O	.	_	0	SENT_56	[p3l694t3188r894b3269],

1	Data	NNS	O	datum	nsubj	3	SENT_57	[p3l114t3297r281b3358],
2	collected	VBN	O	collect	partmod	1	SENT_57	[p3l322t3295r642b3358],
3	included	VBD	O	include	_	0	SENT_57	[p3l682t3295r1006b3358],
4	:	:	O	:	_	0	SENT_57	[p3l682t3295r1006b3358],
5	age	NN	O	age	nsubj	25	SENT_57	[p3l1055t3315r1194b3376],
6	,	,	O	,	_	0	SENT_57	[p3l1055t3315r1194b3376],
7	sex	NN	O	sex	conj_and	5	SENT_57	[p3l1242t3315r1373b3369],
8	,	,	O	,	_	0	SENT_57	[p3l1242t3315r1373b3369],
9	cytogenetic	JJ	O	cytogenetic	amod	10	SENT_57	[p3l1419t3295r1824b3376],
10	features	NNS	O	feature	conj_and	5	SENT_57	[p3l1867t3295r2145b3358],
11	and	CC	O	and	_	0	SENT_57	[p3l9t3401r134b3463],
12	WBC	NN	ORGANIZATION	wbc	nn	13	SENT_57	[p3l180t3401r380b3464],
13	count	NN	O	count	conj_and	5	SENT_57	[p3l430t3410r627b3463],
14	at	IN	O	at	_	0	SENT_57	[p3l675t3410r736b3463],
15	diagnosis	NN	O	diagnosis	prep_at	13	SENT_57	[p3l783t3401r1136b3482],
16	,	,	O	,	_	0	SENT_57	[p3l783t3401r1136b3482],
17	occurrence	NN	O	occurrence	appos	15	SENT_57	[p3l1188t3420r1575b3463],
18	of	IN	O	of	_	0	SENT_57	[p3l1624t3400r1701b3463],
19	hematopoi	NN	O	hematopous	nn	23	SENT_57	[p3l1742t3401r2144b3482],
20	—	CD	NUMBER	—	num	23	SENT_57	[p3l1742t3401r2144b3482],
21	etic	JJ	O	etic	amod	23	SENT_57	[p3l8t3508r132b3571],
22	toxicity	NN	O	toxicity	nn	23	SENT_57	[p3l167t3508r437b3589],
23	(	NN	O	(	prep_of	17	SENT_57	[p3l475t3508r1201b3589],
24	polymorphonuclear	JJ	O	polymorphonuclear	amod	25	SENT_57	[p3l475t3508r1201b3589],
25	leucocytes	NNS	O	leucocyte	parataxis	3	SENT_57	[p3l1234t3508r1604b3589],
26	<	VBG	O	<	partmod	25	SENT_57	[p3l1625t3523r1670b3571],
27	0.5	CD	NUMBER	0.5	dobj	26	SENT_57	[p3l1689t3508r1794b3571],
28	x	CC	O	x	_	0	SENT_57	[p3l1826t3528r1872b3569],
29	109	CD	NUMBER	109	num	31	SENT_57	[p3l1909t3491r2020b3571],
30	L	NN	O	l	nn	31	SENT_57	[p3l2042t3509r2143b3586],
31	)	NN	O	)	dobj	26	SENT_57	[p3l2042t3509r2143b3586],
32	,	,	O	,	_	0	SENT_57	[p3l2042t3509r2143b3586],
33	hepato	NN	O	hepato	nn	35	SENT_57	[p3l6t3616r544b3697],
34	—	NN	O	—	nn	35	SENT_57	[p3l6t3616r544b3697],
35	toxicity	NN	O	toxicity	conj_x	27	SENT_57	[p3l6t3616r544b3697],
36	(	CD	NUMBER	(	npadvmod	37	SENT_57	[p3l568t3616r862b3693],
37	>	JJR	O	>	amod	35	SENT_57	[p3l568t3616r862b3693],
38	2	CD	NUMBER	2	number	39	SENT_57	[p3l568t3616r862b3693],
39	—	CD	NUMBER	—	dep	41	SENT_57	[p3l568t3616r862b3693],
40	fold	JJ	O	fold	dep	41	SENT_57	[p3l568t3616r862b3693],
41	increase	NN	O	increase	dep	37	SENT_57	[p3l882t3616r1171b3678],
42	in	IN	O	in	_	0	SENT_57	[p3l1193t3616r1260b3678],
43	serum	NN	O	serum	nn	44	SENT_57	[p3l1283t3635r1497b3678],
44	bilirubin	NN	O	bilirubin	prep_in	37	SENT_57	[p3l1515t3616r1822b3678],
45	and	CC	O	and	_	0	SENT_57	[p3l1844t3616r1969b3678],
46	liver	NN	O	liver	nn	47	SENT_57	[p3l1989t3616r2148b3679],
47	transaminases	NNS	O	transaminase	conj_and	27	SENT_57	[p3l7t3723r532b3801],
48	)	CD	NUMBER	)	dep	47	SENT_57	[p3l7t3723r532b3801],
49	according	VBG	O	accord	_	0	SENT_57	[p3l553t3723r899b3804],
50	to	TO	O	to	prepc_according_to	26	SENT_57	[p3l916t3733r981b3786],
51	NCI	NNP	ORGANIZATION	NCI	nn	52	SENT_57	[p3l998t3724r1150b3786],
52	criteria	NNS	O	criterion	pobj	26	SENT_57	[p3l1166t3723r1435b3798],
53	,	,	O	,	_	0	SENT_57	[p3l1166t3723r1435b3798],
54	incidence	NN	O	incidence	appos	52	SENT_57	[p3l1454t3723r1793b3786],
55	of	IN	O	of	_	0	SENT_57	[p3l1810t3723r1887b3786],
56	relapse	NN	O	relapse	prep_of	54	SENT_57	[p3l1895t3723r2146b3804],
57	and	CC	O	and	_	0	SENT_57	[p4l9t20r134b83],
58	death	NN	O	death	prep_of	54	SENT_57	[p4l159t20r349b83],
59	during	IN	O	during	_	0	SENT_57	[p4l375t20r604b101],
60	follow	VB	O	follow	prep_during	26	SENT_57	[p4l629t20r994b101],
61	—	RB	O	—	advmod	60	SENT_57	[p4l629t20r994b101],
62	up	RB	O	up	advmod	60	SENT_57	[p4l629t20r994b101],
63	.	.	O	.	_	0	SENT_57	[p4l629t20r994b101],

1	Peripheral	JJ	O	peripheral	amod	3	SENT_58	[p4l114t126r478b207],
2	blood	NN	O	blood	nn	3	SENT_58	[p4l514t126r717b188],
3	samples	NNS	O	sample	nsubjpass	5	SENT_58	[p4l756t126r1036b207],
4	were	VBD	O	be	auxpass	5	SENT_58	[p4l1075t145r1245b189],
5	obtained	VBN	O	obtain	_	0	SENT_58	[p4l1283t126r1588b188],
6	after	IN	O	after	_	0	SENT_58	[p4l1626t126r1787b188],
7	informed	VBN	O	inform	amod	8	SENT_58	[p4l1822t126r2148b188],
8	consent	NN	O	consent	prep_after	5	SENT_58	[p4l8t244r279b297],
9	for	IN	O	for	_	0	SENT_58	[p4l302t234r405b297],
10	the	DT	O	the	det	11	SENT_58	[p4l428t234r534b297],
11	use	NN	O	use	prep_for	8	SENT_58	[p4l559t254r676b297],
12	in	IN	O	in	_	0	SENT_58	[p4l701t234r768b296],
13	biological	JJ	O	biological	amod	14	SENT_58	[p4l792t234r1147b315],
14	studies	NNS	O	study	prep_in	11	SENT_58	[p4l1175t234r1435b297],
15	.	.	O	.	_	0	SENT_58	[p4l1175t234r1435b297],

1	Genotyping	VBG	O	genotype	_	0	SENT_59	[p4l115t341r532b422],
2	for	IN	O	for	_	0	SENT_59	[p4l573t341r676b404],
3	the	DT	O	the	det	7	SENT_59	[p4l714t341r821b404],
4	MTHFRC677T	NN	O	mthfrc677t	nn	7	SENT_59	[p4l861t341r1414b404],
5	and	CC	O	and	_	0	SENT_59	[p4l1456t341r1581b404],
6	A1298C	NN	O	a1298c	nn	7	SENT_59	[p4l1621t341r1919b405],
7	polymorphisms	NNS	O	polymorphism	prep_for	1	SENT_59	[p4l1960t341r2144b422, p4l7t447r399b528],
8	was	VBD	O	be	auxpass	9	SENT_59	[p4l447t466r580b510],
9	performed	VBN	O	perform	aux	1	SENT_59	[p4l627t446r998b528],
10	using	VBG	O	use	xcomp	9	SENT_59	[p4l1042t447r1233b528],
11	polymerase	NN	O	polymerase	nn	17	SENT_59	[p4l1279t447r1688b528],
12	chain	NN	O	chain	nn	17	SENT_59	[p4l1735t447r1925b509],
13	reaction/restriction	NN	O	reaction/restriction	nn	17	SENT_59	[p4l1970t466r2144b509, p4l7t555r530b618],
14	fragment	NN	O	fragment	nn	17	SENT_59	[p4l575t555r895b636],
15	length	NN	O	length	nn	17	SENT_59	[p4l938t555r1159b636],
16	polymorphism	NN	O	polymorphism	nn	17	SENT_59	[p4l1202t555r1722b636],
17	method	NN	O	method	dobj	10	SENT_59	[p4l1766t555r2032b618],
18	as	IN	O	as	_	0	SENT_59	[p4l2077t575r2145b618],
19	Table	NNP	O	Table	prep_as	17	SENT_59	[p4l9t655r163b706],
20	1	CD	NUMBER	1	num	21	SENT_59	[p4l190t656r211b705],
21	Patients	NNPS	O	Patients	nsubj	1	SENT_59	[p4l8t745r249b795],
22	’	CD	NUMBER	’	num	23	SENT_59	[p4l8t745r249b795],
23	characteristics	NNS	O	characteristic	dep	21	SENT_59	[p4l276t744r681b795],

1	Gender	NN	O	gender	_	0	SENT_60	[p4l10t868r218b918],

1	Male	JJ	O	male	_	0	SENT_61	[p4l80t957r225b1007],
2	46	CD	NUMBER	46	tmod	1	SENT_61	[p4l1598t956r1667b1007],
3	Female	JJ	O	female	dep	1	SENT_61	[p4l80t1046r288b1096],
4	36	CD	NUMBER	36	tmod	3	SENT_61	[p4l1600t1045r1667b1096],

1	Median	JJ	MISC	median	amod	4	SENT_62	[p4l8t1179r225b1229],
2	age	NN	O	age	nn	4	SENT_62	[p4l246t1195r342b1244],
3	(	CD	NUMBER	(	num	4	SENT_62	[p4l364t1180r556b1244],
4	years	NNS	NUMBER	year	_	0	SENT_62	[p4l364t1180r556b1244],
5	)	CD	NUMBER	)	num	7	SENT_62	[p4l364t1180r556b1244],
6	(	NN	O	(	nn	7	SENT_62	[p4l581t1180r781b1244],
7	range	NN	O	range	dep	4	SENT_62	[p4l581t1180r781b1244],
8	)	CD	NUMBER	)	number	9	SENT_62	[p4l581t1180r781b1244],
9	31.5	CD	NUMBER	31.5	num	10	SENT_62	[p4l1600t1179r1718b1230],
10	(	NN	O	(	dep	7	SENT_62	[p4l1743t1179r1964b1241],
11	12-75	CD	NUMBER	12-75	num	12	SENT_62	[p4l1743t1179r1964b1241],
12	)	NN	O	)	dep	4	SENT_62	[p4l1743t1179r1964b1241],

1	FAB	NN	O	fab	nn	2	SENT_63	[p4l8t1578r136b1627],
2	phenotype	NN	O	phenotype	_	0	SENT_63	[p4l160t1578r456b1643],

1	B	NN	O	b	_	0	SENT_64	[p4l80t1667r223b1716],
2	.	.	O	.	_	0	SENT_64	[p4l80t1667r223b1716],

1	—	NN	O	—	_	0	SENT_65	[p4l80t1667r223b1716],
2	.	.	O	.	_	0	SENT_65	[p4l80t1667r223b1716],

1	L1	NN	O	l1	_	0	SENT_66	[p4l80t1667r223b1716],
2	+	CC	O	+	cc	3	SENT_66	[p4l244t1679r281b1716],
3	L2	NN	O	l2	dep	1	SENT_66	[p4l295t1667r372b1716],
4	64	CD	NUMBER	64	num	5	SENT_66	[p4l1599t1667r1667b1717],
5	B	NN	O	b	dep	3	SENT_66	[p4l80t1756r226b1806],
6	.	.	O	.	_	0	SENT_66	[p4l80t1756r226b1806],

1	—	NN	O	—	_	0	SENT_67	[p4l80t1756r226b1806],
2	.	.	O	.	_	0	SENT_67	[p4l80t1756r226b1806],

1	L3	NN	O	l3	_	0	SENT_68	[p4l80t1756r226b1806],
2	7	CD	NUMBER	7	num	3	SENT_68	[p4l1634t1757r1665b1806],
3	T	NN	O	t	dep	1	SENT_68	[p4l80t1846r122b1893],
4	1	CD	NUMBER	1	number	5	SENT_68	[p4l1605t1845r1626b1893],
5	1	CD	NUMBER	1	dep	3	SENT_68	[p4l1641t1845r1661b1893],

1	Cytogenetic	JJ	O	cytogenetic	amod	2	SENT_69	[p4l9t1978r351b2043],
2	risk	NN	O	risk	_	0	SENT_69	[p4l371t1978r479b2029],

1	High	JJ	O	high	amod	2	SENT_70	[p4l80t2067r221b2132],
2	28	CD	NUMBER	28	_	0	SENT_70	[p4l1599t2068r1665b2118],
3	Low	JJ	O	low	amod	5	SENT_70	[p4l80t2158r207b2207],
4	45	CD	NUMBER	45	tmod	3	SENT_70	[p4l1598t2156r1664b2207],
5	n.e.	NN	O	n.e.	dep	2	SENT_70	[p4l80t2261r178b2296],
6	9	CD	NUMBER	9	dep	5	SENT_70	[p4l1635t2246r1666b2296],

1	Median	JJ	MISC	median	amod	8	SENT_71	[p4l8t2349r225b2399],
2	WBC	NN	MISC	wbc	nn	8	SENT_71	[p4l244t2349r405b2399],
3	(	NN	O	(	nn	8	SENT_71	[p4l428t2335r601b2411],
4	X109	NN	O	x109	nn	8	SENT_71	[p4l428t2335r601b2411],
5	L-1	NN	O	l-1	nn	8	SENT_71	[p4l620t2335r757b2411],
6	)	CD	NUMBER	)	num	8	SENT_71	[p4l620t2335r757b2411],
7	(	NN	O	(	nn	8	SENT_71	[p4l781t2350r981b2414],
8	range	NN	O	range	_	0	SENT_71	[p4l781t2350r981b2414],
9	)	CD	NUMBER	)	number	10	SENT_71	[p4l781t2350r981b2414],
10	15.315	CD	NUMBER	15.315	dep	8	SENT_71	[p4l1605t2349r1789b2399],
11	(	CD	NUMBER	(	num	13	SENT_71	[p4l1815t2349r2124b2411],
12	0.45	CD	NUMBER	0.45	num	13	SENT_71	[p4l1815t2349r2124b2411],
13	—	NN	O	—	dep	10	SENT_71	[p4l1815t2349r2124b2411],
14	357	CD	NUMBER	357	num	15	SENT_71	[p4l1815t2349r2124b2411],
15	)	NN	O	)	dep	8	SENT_71	[p4l1815t2349r2124b2411],

1	Toxicity	NN	O	toxicity	_	0	SENT_72	[p4l9t2838r243b2904],
2	32	CD	PERCENT	32	num	1	SENT_72	[p4l1600t2839r1667b2889],
3	(	CD	PERCENT	(	number	4	SENT_72	[p4l1682t2839r1854b2901],
4	40	CD	PERCENT	40	num	5	SENT_72	[p4l1682t2839r1854b2901],
5	%	NN	PERCENT	%	dep	1	SENT_72	[p4l1682t2839r1854b2901],
6	)	CD	NUMBER	)	dep	5	SENT_72	[p4l1682t2839r1854b2901],

1	Hematopoietic	JJ	O	hematopoietic	amod	3	SENT_73	[p4l80t2927r498b2993],
2	1	CD	NUMBER	1	number	3	SENT_73	[p4l1605t2928r1626b2977],
3	1	CD	NUMBER	1	_	0	SENT_73	[p4l1640t2928r1661b2977],
4	Hepatic	JJ	O	hepatic	amod	5	SENT_73	[p4l80t3016r299b3082],
5	10	CD	NUMBER	10	dep	3	SENT_73	[p4l1605t3017r1667b3067],
6	Combined	VBN	O	combine	partmod	3	SENT_73	[p4l81t3106r377b3156],
7	1	CD	NUMBER	1	number	8	SENT_73	[p4l1605t3106r1626b3155],
8	1	CD	NUMBER	1	dobj	6	SENT_73	[p4l1640t3106r1661b3155],

1	Disease	NN	O	disease	nn	2	SENT_74	[p4l8t3239r229b3289],
2	status	NN	O	status	_	0	SENT_74	[p4l251t3247r408b3289],

1	Relapsed	VBN	O	relapse	_	0	SENT_75	[p4l80t3328r341b3393],
2	37	CD	PERCENT	37	number	3	SENT_75	[p4l1600t3329r1665b3379],
3	(	CD	PERCENT	(	dobj	1	SENT_75	[p4l1682t3328r1854b3390],
4	45	CD	PERCENT	45	num	5	SENT_75	[p4l1682t3328r1854b3390],
5	%	NN	PERCENT	%	dep	3	SENT_75	[p4l1682t3328r1854b3390],
6	)	CD	NUMBER	)	dep	15	SENT_75	[p4l1682t3328r1854b3390],
7	Non-relapsed	JJ	O	non-relapsed	amod	9	SENT_75	[p4l80t3417r464b3482],
8	44	CD	PERCENT	44	number	9	SENT_75	[p4l1598t3417r1667b3467],
9	(	CD	PERCENT	(	dep	6	SENT_75	[p4l1682t3417r1854b3479],
10	54	CD	PERCENT	54	number	11	SENT_75	[p4l1682t3417r1854b3479],
11	%	NN	PERCENT	%	amod	9	SENT_75	[p4l1682t3417r1854b3479],
12	)	CD	NUMBER	)	num	13	SENT_75	[p4l1682t3417r1854b3479],
13	n.e.	NN	O	n.e.	dep	15	SENT_75	[p4l80t3522r178b3556],
14	1	CD	NUMBER	1	num	15	SENT_75	[p4l1641t3507r1661b3555],
15	(	NN	O	(	dep	18	SENT_75	[p4l1682t3506r1818b3567],
16	1	CD	PERCENT	1	num	17	SENT_75	[p4l1682t3506r1818b3567],
17	%	NN	PERCENT	%	dep	15	SENT_75	[p4l1682t3506r1818b3567],
18	)	CD	NUMBER	)	dep	3	SENT_75	[p4l1682t3506r1818b3567],

1	Survival	NN	O	survival	nn	2	SENT_76	[p4l10t3640r245b3690],
2	status	NN	O	status	_	0	SENT_76	[p4l268t3647r425b3690],

1	Alive	JJ	O	alive	amod	2	SENT_77	[p4l80t3729r234b3778],
2	34	CD	PERCENT	34	_	0	SENT_77	[p4l1600t3729r1667b3779],
3	(	CD	PERCENT	(	num	5	SENT_77	[p4l1682t3729r1767b3790],
4	41	CD	PERCENT	41	num	5	SENT_77	[p4l1682t3729r1767b3790],
5	%	NN	PERCENT	%	dep	2	SENT_77	[p4l1778t3729r1854b3790],
6	)	CD	NUMBER	)	dep	2	SENT_77	[p4l1778t3729r1854b3790],

1	Dead	JJ	O	dead	amod	2	SENT_78	[p5l80t20r230b69],
2	48	CD	PERCENT	48	_	0	SENT_78	[p5l1598t20r1665b70],
3	(	CD	PERCENT	(	number	4	SENT_78	[p5l1682t20r1854b81],
4	59	CD	PERCENT	59	num	5	SENT_78	[p5l1682t20r1854b81],
5	%	NN	PERCENT	%	dep	2	SENT_78	[p5l1682t20r1854b81],
6	)	CD	NUMBER	)	dep	5	SENT_78	[p5l1682t20r1854b81],

1	Median	JJ	MISC	median	dep	2	SENT_79	[p5l8t153r226b204],
2	follow	VBP	O	follow	_	0	SENT_79	[p5l245t153r522b218],
3	—	CD	NUMBER	—	number	5	SENT_79	[p5l245t153r522b218],
4	up	IN	O	up	quantmod	5	SENT_79	[p5l245t153r522b218],
5	(	CD	NUMBER	(	num	6	SENT_79	[p5l545t153r797b215],
6	months	NNS	NUMBER	month	dobj	2	SENT_79	[p5l545t153r797b215],
7	)	CD	NUMBER	)	num	9	SENT_79	[p5l545t153r797b215],
8	(	NN	O	(	nn	9	SENT_79	[p5l821t154r1021b218],
9	range	NN	O	range	dep	6	SENT_79	[p5l821t154r1021b218],
10	)	CD	NUMBER	)	number	11	SENT_79	[p5l821t154r1021b218],
11	21	CD	NUMBER	21	num	12	SENT_79	[p5l1599t154r1661b203],
12	(	NN	O	(	dep	9	SENT_79	[p5l1682t154r1902b215],
13	1	CD	NUMBER	1	num	16	SENT_79	[p5l1682t154r1902b215],
14	—	NN	O	—	nn	16	SENT_79	[p5l1682t154r1902b215],
15	240	CD	NUMBER	240	num	16	SENT_79	[p5l1682t154r1902b215],
16	)	NN	O	)	nsubj	2	SENT_79	[p5l1682t154r1902b215],

1	described	VBN	O	describe	_	0	SENT_80	[p5l10t407r350b469],
2	elsewhere	RB	O	elsewhere	advmod	1	SENT_80	[p5l385t407r736b470],
3	[	RB	O	[	dep	4	SENT_80	[p5l778t407r979b482],
4	7,19	CD	NUMBER	7,19	num	5	SENT_80	[p5l778t407r979b482],
5	]	NN	O	]	pobj	2	SENT_80	[p5l778t407r979b482],
6	in	IN	O	in	_	0	SENT_80	[p5l1020t407r1088b468],
7	the	DT	O	the	det	10	SENT_80	[p5l1123t407r1229b469],
8	Molecular	JJ	O	molecular	amod	10	SENT_80	[p5l1264t407r1631b469],
9	Biology	NNP	O	Biology	nn	10	SENT_80	[p5l1665t407r1950b488],
10	Laboratory	NNP	O	Laboratory	prep_in	1	SENT_80	[p5l1985t407r2149b469, p5l10t524r264b595],
11	of	IN	O	of	_	0	SENT_80	[p5l290t514r367b577],
12	our	PRP$	O	we	poss	13	SENT_80	[p5l387t534r505b577],
13	Institution	NNP	O	Institution	prep_of	10	SENT_80	[p5l528t514r911b577],
14	.	.	O	.	_	0	SENT_80	[p5l528t514r911b577],

1	2	LS	NUMBER	2	_	0	SENT_81	[p5l8t757r132b820],
2	.	.	O	.	_	0	SENT_81	[p5l8t757r132b820],
3	]	SYM	O	]	dep	1	SENT_81	[p5l8t757r132b820],

1	.	.	O	.	_	0	SENT_82	[p5l8t757r132b820],

1	Statistical	JJ	O	statistical	amod	2	SENT_83	[p5l188t757r544b820],
2	analysis	NN	O	analysis	_	0	SENT_83	[p5l568t757r858b837],

1	The	DT	O	the	det	3	SENT_84	[p5l116t971r252b1034],
2	primary	JJ	O	primary	amod	3	SENT_84	[p5l285t971r565b1052],
3	outcomes	NNS	O	outcome	nsubj	10	SENT_84	[p5l600t981r937b1034],
4	of	IN	O	of	_	0	SENT_84	[p5l973t971r1050b1034],
5	interest	NN	O	interest	prep_of	3	SENT_84	[p5l1076t971r1339b1034],
6	were	VBD	O	be	cop	10	SENT_84	[p5l1370t991r1541b1034],
7	relapse	NN	O	relapse	nn	10	SENT_84	[p5l1573t971r1824b1052],
8	and	CC	O	and	_	0	SENT_84	[p5l1859t971r1985b1034],
9	survival	NN	O	survival	nn	10	SENT_84	[p5l2020t991r2149b1034, p5l9t1078r180b1141],
10	rates	NNS	O	rate	_	0	SENT_84	[p5l209t1087r395b1152],
11	,	,	O	,	_	0	SENT_84	[p5l209t1087r395b1152],
12	whilst	IN	O	whilst	mark	17	SENT_84	[p5l428t1078r645b1141],
13	the	DT	O	the	det	15	SENT_84	[p5l672t1078r778b1140],
14	secondary	JJ	O	secondary	amod	15	SENT_84	[p5l811t1078r1167b1159],
15	outcome	NN	O	outcome	nsubj	17	SENT_84	[p5l1198t1087r1502b1140],
16	was	VBD	O	be	cop	17	SENT_84	[p5l1532t1097r1665b1141],
17	development	NN	O	development	dep	10	SENT_84	[p5l1697t1078r2153b1159],
18	of	IN	O	of	_	0	SENT_84	[p5l10t1185r87b1248],
19	toxicity	NN	O	toxicity	prep_of	17	SENT_84	[p5l110t1185r380b1266],
20	in	IN	O	in	_	0	SENT_84	[p5l411t1185r478b1247],
21	the	DT	O	the	det	22	SENT_84	[p5l507t1185r613b1248],
22	subset	NN	O	subset	prep_in	19	SENT_84	[p5l646t1185r866b1248],
23	of	IN	O	of	_	0	SENT_84	[p5l895t1185r972b1248],
24	patients	NNS	O	patient	prep_of	22	SENT_84	[p5l994t1185r1269b1266],
25	receiving	VBG	O	receive	partmod	24	SENT_84	[p5l1299t1185r1627b1266],
26	homogeneous	JJ	O	homogeneous	amod	27	SENT_84	[p5l1657t1185r2150b1266],
27	maintenance	NN	O	maintenance	dobj	25	SENT_84	[p5l9t1291r458b1353],
28	with	IN	O	with	_	0	SENT_84	[p5l484t1291r640b1353],
29	MTX	NN	O	mtx	prep_with	25	SENT_84	[p5l664t1293r878b1353],
30	.	.	O	.	_	0	SENT_84	[p5l664t1293r878b1353],

1	The	DT	O	the	det	3	SENT_85	[p5l116t1398r252b1460],
2	X2	NN	O	x2	nn	3	SENT_85	[p5l285t1381r365b1476],
3	test	NN	O	test	nsubjpass	13	SENT_85	[p5l399t1407r540b1472],
4	,	,	O	,	_	0	SENT_85	[p5l399t1407r540b1472],
5	Fisher	NNP	PERSON	Fisher	nn	7	SENT_85	[p5l571t1398r794b1460],
6	exact	JJ	O	exact	amod	7	SENT_85	[p5l822t1407r1008b1460],
7	test	NN	O	test	nsubjpass	13	SENT_85	[p5l1035t1407r1158b1460],
8	and	CC	O	and	_	0	SENT_85	[p5l1188t1398r1313b1460],
9	Yates	NNP	PERSON	Yates	nn	11	SENT_85	[p5l1342t1398r1554b1460],
10	’	CD	NUMBER	’	num	11	SENT_85	[p5l1342t1398r1554b1460],
11	correction	NN	O	correction	nsubjpass	13	SENT_85	[p5l1593t1398r1952b1460],
12	were	VBD	O	be	auxpass	13	SENT_85	[p5l1981t1418r2151b1461],
13	used	VBN	O	use	_	0	SENT_85	[p5l8t1505r171b1568],
14	to	TO	O	to	aux	15	SENT_85	[p5l198t1515r264b1568],
15	ﬁnd	VB	O	ﬁnd	xcomp	13	SENT_85	[p5l294t1505r430b1568],
16	signiﬁcant	JJ	O	signiﬁcant	amod	17	SENT_85	[p5l460t1505r829b1586],
17	differences	NNS	O	difference	dobj	15	SENT_85	[p5l856t1505r1245b1568],
18	among	IN	O	among	_	0	SENT_85	[p5l1277t1525r1515b1586],
19	two	CD	NUMBER	two	num	21	SENT_85	[p5l1543t1515r1673b1568],
20	primary	JJ	O	primary	amod	21	SENT_85	[p5l1701t1505r1982b1586],
21	outcomes	NNS	O	outcome	prep_among	17	SENT_85	[p5l2012t1514r2149b1568, p5l10t1632r254b1686],
22	,	,	O	,	_	0	SENT_85	[p5l2012t1514r2149b1568, p5l10t1632r254b1686],
23	death	NN	O	death	appos	21	SENT_85	[p5l280t1612r470b1675],
24	and	CC	O	and	_	0	SENT_85	[p5l494t1612r620b1675],
25	relapse	NN	O	relapse	conj_and	23	SENT_85	[p5l639t1612r910b1693],
26	,	,	O	,	_	0	SENT_85	[p5l639t1612r910b1693],
27	with	IN	O	with	_	0	SENT_85	[p5l936t1612r1092b1675],
28	respect	NN	O	respect	prep_with	15	SENT_85	[p5l1113t1621r1366b1693],
29	to	TO	O	to	_	0	SENT_85	[p5l1386t1621r1452b1675],
30	WBC	NNP	ORGANIZATION	WBC	nn	33	SENT_85	[p5l1474t1612r1675b1675],
31	and	CC	O	and	_	0	SENT_85	[p5l1700t1612r1825b1675],
32	MTHFR	NNP	O	MTHFR	conj_and	30	SENT_85	[p5l1846t1614r2153b1674],
33	genotypes	NNS	O	genotype	prep_to	15	SENT_85	[p5l10t1726r386b1798],
34	.	.	O	.	_	0	SENT_85	[p5l10t1726r386b1798],

1	Correlation	NN	O	correlation	nsubj	8	SENT_86	[p5l117t1825r521b1888],
2	of	IN	O	of	_	0	SENT_86	[p5l542t1825r619b1888],
3	MTHFR	NN	O	mthfr	nn	4	SENT_86	[p5l634t1827r940b1887],
4	genotypes	NNS	O	genotype	prep_of	1	SENT_86	[p5l961t1835r1318b1906],
5	with	IN	O	with	_	0	SENT_86	[p5l1341t1825r1497b1888],
6	clinical	JJ	O	clinical	amod	7	SENT_86	[p5l1518t1825r1778b1888],
7	characteristics	NNS	O	characteristic	prep_with	4	SENT_86	[p5l1800t1825r2149b1888, p5l9t1932r188b1994],
8	(	VBP	O	(	_	0	SENT_86	[p5l221t1932r469b2009],
9	WBC	NNP	ORGANIZATION	WBC	nsubjpass	21	SENT_86	[p5l221t1932r469b2009],
10	,	,	O	,	_	0	SENT_86	[p5l221t1932r469b2009],
11	cytogenetic	JJ	O	cytogenetic	amod	12	SENT_86	[p5l502t1932r908b2013],
12	risk	NN	O	risk	appos	9	SENT_86	[p5l937t1932r1088b2006],
13	,	,	O	,	_	0	SENT_86	[p5l937t1932r1088b2006],
14	therapy	NN	O	therapy	nn	15	SENT_86	[p5l1120t1932r1659b2013],
15	—	NN	O	—	appos	9	SENT_86	[p5l1120t1932r1659b2013],
16	related	JJ	O	related	amod	18	SENT_86	[p5l1120t1932r1659b2013],
17	toxicity	NN	O	toxicity	nn	18	SENT_86	[p5l1687t1932r1985b2013],
18	)	NN	O	)	dep	15	SENT_86	[p5l1687t1932r1985b2013],
19	was	VBD	O	be	auxpass	21	SENT_86	[p5l2017t1951r2150b1995],
20	also	RB	O	also	advmod	21	SENT_86	[p5l11t2040r149b2102],
21	performed	VBN	O	perform	ccomp	8	SENT_86	[p5l174t2039r546b2120],
22	using	VBG	O	use	xcomp	21	SENT_86	[p5l569t2039r760b2120],
23	the	DT	O	the	det	24	SENT_86	[p5l786t2040r892b2102],
24	x2	NN	O	x2	dobj	22	SENT_86	[p5l921t2022r1001b2118],
25	or	CC	O	or	_	0	SENT_86	[p5l1032t2059r1105b2102],
26	Fisher	NNP	PERSON	Fisher	poss	29	SENT_86	[p5l1128t2039r1406b2102],
27	’s	POS	O	’s	_	0	SENT_86	[p5l1128t2039r1406b2102],
28	exact	JJ	O	exact	amod	29	SENT_86	[p5l1434t2049r1620b2102],
29	test	NN	O	test	dobj	22	SENT_86	[p5l1643t2049r1782b2102],
30	.	.	O	.	_	0	SENT_86	[p5l1643t2049r1782b2102],

1	We	PRP	O	we	nsubj	2	SENT_87	[p5l115t2148r230b2209],
2	used	VBD	O	use	_	0	SENT_87	[p5l264t2146r427b2209],
3	Kaplan	NNP	PERSON	Kaplan	nn	5	SENT_87	[p5l461t2146r715b2227],
4	Meyer	NNP	PERSON	Meyer	nn	5	SENT_87	[p5l749t2148r980b2227],
5	analysis	NN	O	analysis	dobj	2	SENT_87	[p5l1014t2146r1317b2227],
6	,	,	O	,	_	0	SENT_87	[p5l1014t2146r1317b2227],
7	with	IN	O	with	_	0	SENT_87	[p5l1355t2146r1511b2209],
8	differences	NNS	O	difference	prep_with	2	SENT_87	[p5l1545t2146r1935b2209],
9	compared	VBN	O	compare	prep	8	SENT_87	[p5l1971t2166r2149b2209, p5l8t2252r205b2333],
10	by	IN	O	by	pcomp	9	SENT_87	[p5l228t2252r315b2333],
11	the	DT	O	the	det	12	SENT_87	[p5l341t2252r447b2314],
12	Log	NN	O	log	pobj	10	SENT_87	[p5l471t2252r833b2333],
13	.	.	O	.	_	0	SENT_87	[p5l471t2252r833b2333],

1	—	NN	O	—	_	0	SENT_88	[p5l471t2252r833b2333],
2	.	.	O	.	_	0	SENT_88	[p5l471t2252r833b2333],

1	Rank	NNP	O	Rank	nsubj	2	SENT_89	[p5l471t2252r833b2333],
2	test	NN	O	test	_	0	SENT_89	[p5l855t2261r997b2326],
3	,	,	O	,	_	0	SENT_89	[p5l855t2261r997b2326],
4	to	TO	O	to	aux	5	SENT_89	[p5l1024t2261r1090b2314],
5	estimate	VB	O	estimate	dep	33	SENT_89	[p5l1116t2252r1410b2314],
6	relapse	NN	O	relapse	dobj	5	SENT_89	[p5l1434t2252r1685b2333],
7	free	JJ	O	free	advmod	5	SENT_89	[p5l1710t2252r1846b2314],
8	survival	NN	O	survival	nn	11	SENT_89	[p5l1874t2252r2151b2315],
9	(	CD	NUMBER	(	num	11	SENT_89	[p5l11t2361r222b2438],
10	RFS	NN	O	rf	nn	11	SENT_89	[p5l11t2361r222b2438],
11	)	NN	O	)	dep	7	SENT_89	[p5l11t2361r222b2438],
12	and	CC	O	and	_	0	SENT_89	[p5l245t2360r371b2423],
13	EFS	NN	O	ef	conj_and	11	SENT_89	[p5l388t2361r536b2423],
14	and	CC	O	and	_	0	SENT_89	[p5l560t2360r685b2423],
15	to	TO	O	to	aux	16	SENT_89	[p5l703t2370r769b2423],
16	compare	VB	O	compare	conj_and	5	SENT_89	[p5l789t2380r1093b2441],
17	time	NN	O	time	dobj	16	SENT_89	[p5l1112t2360r1268b2423],
18	to	TO	O	to	_	0	SENT_89	[p5l1287t2370r1353b2423],
19	relapse	NN	O	relapse	prep_to	16	SENT_89	[p5l1371t2360r1622b2441],
20	and	CC	O	and	_	0	SENT_89	[p5l1643t2360r1769b2423],
21	death	NN	O	death	prep_to	16	SENT_89	[p5l1787t2360r1977b2423],
22	with	IN	O	with	_	0	SENT_89	[p5l1996t2360r2152b2423],
23	respect	NN	O	respect	prep_with	16	SENT_89	[p5l8t2477r261b2548],
24	of	IN	O	of	_	0	SENT_89	[p5l288t2467r365b2530],
25	age	NN	O	age	prep_of	23	SENT_89	[p5l388t2487r507b2548],
26	(	CD	NUMBER	(	num	25	SENT_89	[p5l537t2467r875b2544],
27	stratiﬁed	VBN	O	stratiﬁed	partmod	25	SENT_89	[p5l537t2467r875b2544],
28	in	IN	O	in	_	0	SENT_89	[p5l902t2467r969b2529],
29	three	CD	NUMBER	three	num	30	SENT_89	[p5l995t2467r1171b2530],
30	groups	NNS	O	group	prep_in	27	SENT_89	[p5l1200t2487r1459b2548],
31	:	:	O	:	_	0	SENT_89	[p5l1200t2487r1459b2548],
32	0-24	CD	NUMBER	0-24	num	33	SENT_89	[p5l1493t2467r1667b2530],
33	years	NNS	NUMBER	year	appos	2	SENT_89	[p5l1695t2487r1900b2548],
34	,	,	O	,	_	0	SENT_89	[p5l1695t2487r1900b2548],
35	25-59	CD	NUMBER	25-59	num	36	SENT_89	[p5l1932t2467r2150b2531],
36	years	NNS	NUMBER	year	appos	33	SENT_89	[p5l9t2592r214b2654],
37	,	,	O	,	_	0	SENT_89	[p5l9t2592r214b2654],
38	60-80	CD	NUMBER	60-80	num	39	SENT_89	[p5l251t2572r470b2636],
39	years	NNS	NUMBER	year	appos	33	SENT_89	[p5l503t2573r738b2654],
40	)	RB	O	)	advmod	39	SENT_89	[p5l503t2573r738b2654],
41	,	,	O	,	_	0	SENT_89	[p5l503t2573r738b2654],
42	gender	NN	O	gender	appos	33	SENT_89	[p5l775t2573r1030b2654],
43	,	,	O	,	_	0	SENT_89	[p5l775t2573r1030b2654],
44	WBC	NNP	ORGANIZATION	WBC	appos	2	SENT_89	[p5l1064t2573r1264b2636],
45	(	CD	NUMBER	(	num	44	SENT_89	[p5l1301t2573r1592b2650],
46	divided	VBN	O	divide	partmod	44	SENT_89	[p5l1301t2573r1592b2650],
47	in	IN	O	in	_	0	SENT_89	[p5l1624t2573r1691b2634],
48	two	CD	NUMBER	two	num	49	SENT_89	[p5l1723t2582r1853b2635],
49	groups	NNS	O	group	prep_in	46	SENT_89	[p5l1887t2592r2146b2654],
50	:	:	O	:	_	0	SENT_89	[p5l1887t2592r2146b2654],
51	<	JJR	O	<	appos	2	SENT_89	[p5l10t2680r146b2743],
52	50	CD	NUMBER	50	number	53	SENT_89	[p5l10t2680r146b2743],
53	x	NN	O	x	amod	51	SENT_89	[p5l175t2700r220b2741],
54	109	CD	NUMBER	109	num	55	SENT_89	[p5l257t2663r368b2743],
55	L	NN	O	l	dep	51	SENT_89	[p5l391t2682r443b2742],
56	and	CC	O	and	_	0	SENT_89	[p5l494t2680r620b2743],
57	350	CD	NUMBER	350	conj_and	33	SENT_89	[p5l674t2680r822b2754],
58	x	CC	O	x	_	0	SENT_89	[p5l851t2700r897b2741],
59	109	CD	NUMBER	109	num	61	SENT_89	[p5l933t2663r1044b2743],
60	L	NN	O	l	nn	61	SENT_89	[p5l1067t2681r1168b2757],
61	)	NN	O	)	conj_and	33	SENT_89	[p5l1067t2681r1168b2757],
62	,	,	O	,	_	0	SENT_89	[p5l1067t2681r1168b2757],
63	cytogenetic	JJ	O	cytogenetic	amod	66	SENT_89	[p5l1221t2680r1628b2761],
64	risk	NN	O	risk	nn	66	SENT_89	[p5l1677t2680r1812b2743],
65	(	NN	O	(	nn	66	SENT_89	[p5l1862t2681r2149b2758],
66	t	NN	O	t	dobj	2	SENT_89	[p5l1862t2681r2149b2758],
67	(	CD	NUMBER	(	number	68	SENT_89	[p5l1862t2681r2149b2758],
68	9	CD	NUMBER	9	num	66	SENT_89	[p5l1862t2681r2149b2758],
69	;	:	O	;	_	0	SENT_89	[p5l1862t2681r2149b2758],
70	22	CD	NUMBER	22	num	71	SENT_89	[p5l1862t2681r2149b2758],
71	)	NN	O	)	dep	66	SENT_89	[p5l1862t2681r2149b2758],
72	,	,	O	,	_	0	SENT_89	[p5l1862t2681r2149b2758],

1	P.	NNP	PERSON	P.	nn	2	SENT_90	[p5l675t2837r696b2860],
2	Chiusolo	NNP	PERSON	Chiusolo	_	0	SENT_90	[p5l710t2836r827b2860],
3	et	FW	O	et	nn	4	SENT_90	[p5l837t2841r861b2860],
4	al.	FW	O	al.	dep	2	SENT_90	[p5l869t2836r899b2860],
5	/	:	O	/	punct	2	SENT_90	[p5l909t2837r924b2860],
6	Leukemia	NNP	ORGANIZATION	Leukemia	nn	7	SENT_90	[p5l928t2836r1056b2860],
7	Research	NNP	ORGANIZATION	Research	dep	2	SENT_90	[p5l1065t2836r1187b2860],
8	31	CD	NUMBER	31	number	9	SENT_90	[p5l1196t2836r1226b2860],
9	(	CD	NUMBER	(	num	10	SENT_90	[p5l1238t2836r1324b2865],
10	2007	CD	DATE	2007	dep	7	SENT_90	[p5l1238t2836r1324b2865],
11	)	CD	NUMBER	)	number	12	SENT_90	[p5l1238t2836r1324b2865],
12	1669-1674 1671	CD	DURATION	1669-1674 1671	num	10	SENT_90	[p5l2065t2836r2124b2860],[p5l1336t2836r1483b2860],

1	Table	NNP	O	Table	_	0	SENT_91	[p5l33t2929r105b2953],
2	2	CD	NUMBER	2	num	4	SENT_91	[p5l115t2929r130b2953],
3	Genotype	NN	O	genotype	nn	4	SENT_91	[p5l34t2970r162b3001],
4	frequencies	NNS	O	frequency	dep	1	SENT_91	[p5l171t2970r330b3001],
5	,	,	O	,	_	0	SENT_91	[p5l171t2970r330b3001],
6	clinical	JJ	O	clinical	amod	8	SENT_91	[p5l341t2970r437b2994],
7	risk	NN	O	risk	nn	8	SENT_91	[p5l446t2970r496b2994],
8	factors	NNS	O	factor	conj_and	4	SENT_91	[p5l505t2970r593b2994],
9	and	CC	O	and	_	0	SENT_91	[p5l604t2970r651b2994],
10	events	NNS	O	event	conj_and	4	SENT_91	[p5l660t2974r741b2994],

1	677	CD	NUMBER	677	num	2	SENT_92	[p5l465t3032r513b3056],
2	genotype	NN	O	genotype	_	0	SENT_92	[p5l523t3036r644b3063],
3	1298	CD	DATE	1298	num	4	SENT_92	[p5l1391t3032r1452b3056],
4	genotype	NN	O	genotype	dep	2	SENT_92	[p5l1463t3036r1583b3063],

1	All	DT	O	all	det	2	SENT_93	[p5l7t3181r91b3228],
2	patients	NNS	O	patient	dep	11	SENT_93	[p5l110t3181r317b3242],
3	(	IN	O	(	_	0	SENT_93	[p5l340t3182r391b3239],
4	n	NN	O	n	prep_(	2	SENT_93	[p5l340t3182r391b3239],
5	=	JJ	O	=	amod	4	SENT_93	[p5l406t3201r441b3219],
6	82	CD	NUMBER	82	number	7	SENT_93	[p5l457t3181r541b3239],
7	)	CD	NUMBER	)	dep	5	SENT_93	[p5l457t3181r541b3239],
8	28	CD	NUMBER	28	num	9	SENT_93	[p5l886t3181r948b3228],
9	(	NN	O	(	dep	11	SENT_93	[p5l964t3181r1128b3239],
10	34	CD	PERCENT	34	num	11	SENT_93	[p5l964t3181r1128b3239],
11	%	NN	PERCENT	%	dep	19	SENT_93	[p5l964t3181r1128b3239],
12	)	CD	PERCENT	)	number	13	SENT_93	[p5l964t3181r1128b3239],
13	32	CD	PERCENT	32	dep	11	SENT_93	[p5l1371t3181r1434b3228],
14	(	CD	PERCENT	(	num	16	SENT_93	[p5l1448t3181r1611b3239],
15	40	CD	PERCENT	40	num	16	SENT_93	[p5l1448t3181r1611b3239],
16	%	NN	PERCENT	%	dep	13	SENT_93	[p5l1448t3181r1611b3239],
17	)	CD	NUMBER	)	number	18	SENT_93	[p5l1448t3181r1611b3239],
18	22	CD	NUMBER	22	num	19	SENT_93	[p5l1853t3181r1918b3228],
19	(	NN	O	(	dep	24	SENT_93	[p5l1932t3181r2095b3239],
20	26	CD	PERCENT	26	num	21	SENT_93	[p5l1932t3181r2095b3239],
21	%	NN	PERCENT	%	dep	19	SENT_93	[p5l1932t3181r2095b3239],
22	)	CD	NUMBER	)	num	24	SENT_93	[p5l1932t3181r2095b3239],
23	GB	NN	O	gb	nn	24	SENT_93	[p5l8t3278r96b3325],
24	(	NN	O	(	dep	33	SENT_93	[p5l120t3278r257b3336],
25	510	CD	NUMBER	510	dep	24	SENT_93	[p5l120t3278r257b3336],
26	x	CC	O	x	_	0	SENT_93	[p5l279t3292r313b3323],
27	109	CD	NUMBER	109	num	28	SENT_93	[p5l341t3265r425b3325],
28	L-1	NN	O	l-1	dep	24	SENT_93	[p5l443t3265r572b3336],
29	)	CD	NUMBER	)	number	30	SENT_93	[p5l443t3265r572b3336],
30	12	CD	NUMBER	12	num	31	SENT_93	[p5l892t3278r950b3324],
31	(	NN	O	(	dep	28	SENT_93	[p5l972t3278r1186b3336],
32	34.3	CD	PERCENT	34.3	num	33	SENT_93	[p5l972t3278r1186b3336],
33	%	NN	PERCENT	%	dep	41	SENT_93	[p5l972t3278r1186b3336],
34	)	CD	NUMBER	)	number	35	SENT_93	[p5l972t3278r1186b3336],
35	13	CD	NUMBER	13	num	36	SENT_93	[p5l1375t3278r1431b3325],
36	(	NN	O	(	dep	33	SENT_93	[p5l1455t3278r1669b3336],
37	37.1	CD	PERCENT	37.1	number	38	SENT_93	[p5l1455t3278r1669b3336],
38	%	NN	PERCENT	%	amod	36	SENT_93	[p5l1455t3278r1669b3336],
39	)	CD	NUMBER	)	number	40	SENT_93	[p5l1455t3278r1669b3336],
40	10	CD	NUMBER	10	num	41	SENT_93	[p5l1859t3278r1918b3325],
41	(	NN	O	(	dep	46	SENT_93	[p5l1939t3277r2153b3336],
42	28.6	CD	PERCENT	28.6	num	43	SENT_93	[p5l1939t3277r2153b3336],
43	%	NN	PERCENT	%	dep	41	SENT_93	[p5l1939t3277r2153b3336],
44	)	CD	NUMBER	)	num	46	SENT_93	[p5l1939t3277r2153b3336],
45	GB	NN	O	gb	nn	46	SENT_93	[p5l8t3361r96b3408],
46	(	NN	O	(	dep	49	SENT_93	[p5l120t3361r244b3419],
47	>	JJR	O	>	dep	46	SENT_93	[p5l120t3361r244b3419],
48	10	CD	NUMBER	10	num	49	SENT_93	[p5l120t3361r244b3419],
49	X	NN	O	x	dep	51	SENT_93	[p5l266t3375r300b3406],
50	109	CD	NUMBER	109	num	51	SENT_93	[p5l328t3348r412b3408],
51	L-1	NN	O	l-1	dep	59	SENT_93	[p5l430t3348r559b3419],
52	)	CD	NUMBER	)	number	53	SENT_93	[p5l430t3348r559b3419],
53	16	CD	NUMBER	16	num	54	SENT_93	[p5l892t3360r1128b3419],
54	(	NN	O	(	dep	51	SENT_93	[p5l892t3360r1128b3419],
55	34	CD	PERCENT	34	number	56	SENT_93	[p5l892t3360r1128b3419],
56	%	NN	PERCENT	%	amod	54	SENT_93	[p5l892t3360r1128b3419],
57	)	CD	NUMBER	)	number	58	SENT_93	[p5l892t3360r1128b3419],
58	19	CD	PERCENT	19	num	59	SENT_93	[p5l1375t3361r1433b3409],
59	(	NN	PERCENT	(	dep	64	SENT_93	[p5l1455t3361r1669b3419],
60	40.4	CD	PERCENT	40.4	num	61	SENT_93	[p5l1455t3361r1669b3419],
61	%	NN	PERCENT	%	dep	59	SENT_93	[p5l1455t3361r1669b3419],
62	)	CD	NUMBER	)	number	63	SENT_93	[p5l1455t3361r1669b3419],
63	47	CD	NUMBER	47	num	64	SENT_93	[p5l1852t3361r1916b3408],
64	(	NN	O	(	dep	67	SENT_93	[p5l1939t3361r2153b3419],
65	25.5	CD	PERCENT	25.5	num	66	SENT_93	[p5l1939t3361r2153b3419],
66	%	NN	PERCENT	%	dep	64	SENT_93	[p5l1939t3361r2153b3419],
67	)	CD	NUMBER	)	_	0	SENT_93	[p5l1939t3361r2153b3419],

1	Low-risk	JJ	O	low-risk	amod	2	SENT_94	[p5l7t3487r253b3535],
2	karyotype	NN	O	karyotype	dep	9	SENT_94	[p5l270t3487r539b3548],
3	15	CD	PERCENT	15	number	4	SENT_94	[p5l892t3487r948b3535],
4	(	CD	PERCENT	(	dep	2	SENT_94	[p5l972t3487r1186b3545],
5	33.3	CD	PERCENT	33.3	num	6	SENT_94	[p5l972t3487r1186b3545],
6	%	NN	PERCENT	%	dep	4	SENT_94	[p5l972t3487r1186b3545],
7	)	CD	PERCENT	)	dep	9	SENT_94	[p5l972t3487r1186b3545],
8	18	CD	PERCENT	18	num	9	SENT_94	[p5l1375t3488r1432b3535],
9	(	NN	PERCENT	(	dep	16	SENT_94	[p5l1456t3487r1669b3545],
10	40.0	CD	PERCENT	40.0	num	11	SENT_94	[p5l1456t3487r1669b3545],
11	%	NN	PERCENT	%	dep	9	SENT_94	[p5l1456t3487r1669b3545],
12	)	CD	NUMBER	)	number	13	SENT_94	[p5l1456t3487r1669b3545],
13	12	CD	NUMBER	12	num	14	SENT_94	[p5l1859t3488r1918b3534],
14	(	NN	O	(	dep	11	SENT_94	[p5l1939t3487r2153b3545],
15	26.7	CD	PERCENT	26.7	num	16	SENT_94	[p5l1939t3487r2153b3545],
16	%	NN	PERCENT	%	dep	21	SENT_94	[p5l1939t3487r2153b3545],
17	)	CD	NUMBER	)	num	20	SENT_94	[p5l1939t3487r2153b3545],
18	High	JJ	O	high	amod	20	SENT_94	[p5l7t3570r266b3631],
19	—	NN	O	—	nn	20	SENT_94	[p5l7t3570r266b3631],
20	risk	NN	O	risk	dep	16	SENT_94	[p5l7t3570r266b3631],
21	karyotype	NN	O	karyotype	dep	25	SENT_94	[p5l283t3570r551b3631],
22	11	CD	PERCENT	11	num	21	SENT_94	[p5l892t3571r945b3617],
23	(	CD	PERCENT	(	num	25	SENT_94	[p5l972t3570r1186b3628],
24	39.3	CD	PERCENT	39.3	num	25	SENT_94	[p5l972t3570r1186b3628],
25	%	NN	PERCENT	%	dep	33	SENT_94	[p5l972t3570r1186b3628],
26	)	CD	NUMBER	)	number	27	SENT_94	[p5l972t3570r1186b3628],
27	8	CD	PERCENT	8	num	28	SENT_94	[p5l1405t3571r1432b3618],
28	(	NN	PERCENT	(	dep	25	SENT_94	[p5l1456t3570r1669b3628],
29	28.6	CD	PERCENT	28.6	num	30	SENT_94	[p5l1456t3570r1669b3628],
30	%	NN	PERCENT	%	dep	28	SENT_94	[p5l1456t3570r1669b3628],
31	)	CD	NUMBER	)	number	32	SENT_94	[p5l1456t3570r1669b3628],
32	9	CD	NUMBER	9	num	30	SENT_94	[p5l1887t3571r1917b3618],
33	(	NN	O	(	dep	35	SENT_94	[p5l1939t3570r2153b3628],
34	32.1	CD	PERCENT	32.1	num	35	SENT_94	[p5l1939t3570r2153b3628],
35	%	NN	PERCENT	%	dep	45	SENT_94	[p5l1939t3570r2153b3628],
36	)	CD	NUMBER	)	num	37	SENT_94	[p5l1939t3570r2153b3628],
37	Toxicity	NN	O	toxicity	dep	35	SENT_94	[p5l7t3667r228b3728],
38	present	JJ	DATE	present	amod	37	SENT_94	[p5l247t3674r442b3728],
39	10	CD	PERCENT	10	number	40	SENT_94	[p5l892t3667r950b3714],
40	(	CD	PERCENT	(	prep	38	SENT_94	[p5l972t3667r1186b3725],
41	30.3	CD	PERCENT	30.3	num	42	SENT_94	[p5l972t3667r1186b3725],
42	%	NN	PERCENT	%	dep	40	SENT_94	[p5l972t3667r1186b3725],
43	)	CD	NUMBER	)	num	45	SENT_94	[p5l972t3667r1186b3725],
44	10	CD	NUMBER	10	num	45	SENT_94	[p5l1375t3667r1434b3714],
45	(	NN	O	(	dep	52	SENT_94	[p5l1455t3667r1669b3725],
46	30.3	CD	PERCENT	30.3	num	47	SENT_94	[p5l1455t3667r1669b3725],
47	%	NN	PERCENT	%	dep	45	SENT_94	[p5l1455t3667r1669b3725],
48	)	CD	NUMBER	)	number	49	SENT_94	[p5l1455t3667r1669b3725],
49	13	CD	NUMBER	13	num	50	SENT_94	[p5l1859t3667r1915b3714],
50	(	NN	O	(	dep	47	SENT_94	[p5l1939t3667r2153b3725],
51	39.4	CD	PERCENT	39.4	num	52	SENT_94	[p5l1939t3667r2153b3725],
52	%	NN	PERCENT	%	dep	62	SENT_94	[p5l1939t3667r2153b3725],
53	)	CD	NUMBER	)	num	54	SENT_94	[p5l1939t3667r2153b3725],
54	Toxicity	NN	O	toxicity	dep	52	SENT_94	[p5l7t3750r228b3811],
55	absent	JJ	O	absent	amod	54	SENT_94	[p5l249t3750r420b3797],
56	18	CD	PERCENT	18	number	57	SENT_94	[p5l892t3750r948b3797],
57	(	CD	PERCENT	(	prep	55	SENT_94	[p5l972t3750r1186b3808],
58	36.7	CD	PERCENT	36.7	num	59	SENT_94	[p5l972t3750r1186b3808],
59	%	NN	PERCENT	%	dep	57	SENT_94	[p5l972t3750r1186b3808],
60	)	CD	NUMBER	)	number	61	SENT_94	[p5l972t3750r1186b3808],
61	22	CD	NUMBER	22	num	62	SENT_94	[p5l1370t3750r1434b3796],
62	(	NN	O	(	dep	67	SENT_94	[p5l1455t3750r1669b3808],
63	44.9	CD	PERCENT	44.9	num	64	SENT_94	[p5l1455t3750r1669b3808],
64	%	NN	PERCENT	%	dep	62	SENT_94	[p5l1455t3750r1669b3808],
65	)	CD	NUMBER	)	number	66	SENT_94	[p5l1455t3750r1669b3808],
66	9	CD	NUMBER	9	num	67	SENT_94	[p5l1887t3750r1917b3798],
67	(	NN	O	(	dep	70	SENT_94	[p5l1939t3750r2153b3808],
68	18.4	CD	PERCENT	18.4	num	69	SENT_94	[p5l1939t3750r2153b3808],
69	%	NN	PERCENT	%	dep	67	SENT_94	[p5l1939t3750r2153b3808],
70	)	CD	NUMBER	)	_	0	SENT_94	[p5l1939t3750r2153b3808],

1	Relapsed	VBN	O	relapse	_	0	SENT_95	[p6l7t29r254b90],
2	16	CD	PERCENT	16	dobj	1	SENT_95	[p6l892t29r950b77],
3	(	CD	PERCENT	(	number	4	SENT_95	[p6l972t29r1186b87],
4	36.4	CD	PERCENT	36.4	num	5	SENT_95	[p6l972t29r1186b87],
5	%	NN	PERCENT	%	dep	2	SENT_95	[p6l972t29r1186b87],
6	)	CD	NUMBER	)	number	7	SENT_95	[p6l972t29r1186b87],
7	16	CD	PERCENT	16	num	8	SENT_95	[p6l1375t29r1434b77],
8	(	NN	PERCENT	(	dep	13	SENT_95	[p6l1455t29r1669b87],
9	36.4	CD	PERCENT	36.4	num	10	SENT_95	[p6l1455t29r1669b87],
10	%	NN	PERCENT	%	dep	8	SENT_95	[p6l1455t29r1669b87],
11	)	CD	NUMBER	)	dep	13	SENT_95	[p6l1455t29r1669b87],
12	12	CD	NUMBER	12	num	13	SENT_95	[p6l1859t30r1918b76],
13	(	NN	O	(	dep	2	SENT_95	[p6l1939t29r2153b87],
14	27.3	CD	PERCENT	27.3	num	15	SENT_95	[p6l1939t29r2153b87],
15	%	NN	PERCENT	%	dep	13	SENT_95	[p6l1939t29r2153b87],
16	)	CD	NUMBER	)	num	17	SENT_95	[p6l1939t29r2153b87],
17	Non	NNP	O	Non	dep	15	SENT_95	[p6l7t112r370b173],
18	—	CD	NUMBER	—	num	17	SENT_95	[p6l7t112r370b173],
19	relapsed	VBD	O	relapse	dep	1	SENT_95	[p6l7t112r370b173],
20	12	CD	PERCENT	12	dobj	19	SENT_95	[p6l892t113r950b159],
21	(	CD	PERCENT	(	number	22	SENT_95	[p6l972t113r1186b171],
22	32.4	CD	PERCENT	32.4	num	23	SENT_95	[p6l972t113r1186b171],
23	%	NN	PERCENT	%	dep	20	SENT_95	[p6l972t113r1186b171],
24	)	CD	NUMBER	)	num	26	SENT_95	[p6l972t113r1186b171],
25	16	CD	NUMBER	16	num	26	SENT_95	[p6l1375t112r1434b160],
26	(	NN	O	(	dep	36	SENT_95	[p6l1455t113r1669b171],
27	43.2	CD	PERCENT	43.2	num	28	SENT_95	[p6l1455t113r1669b171],
28	%	NN	PERCENT	%	dep	26	SENT_95	[p6l1455t113r1669b171],
29	)	CD	NUMBER	)	number	30	SENT_95	[p6l1455t113r1669b171],
30	9	CD	NUMBER	9	num	31	SENT_95	[p6l1887t113r1917b160],
31	(	NN	O	(	dep	28	SENT_95	[p6l1939t113r2153b170],
32	24.3	CD	PERCENT	24.3	number	33	SENT_95	[p6l1939t113r2153b170],
33	%	NN	PERCENT	%	amod	31	SENT_95	[p6l1939t113r2153b170],
34	)	CD	NUMBER	)	dep	36	SENT_95	[p6l1939t113r2153b170],
35	Dead	JJ	O	dead	amod	36	SENT_95	[p6l7t209r148b256],
36	18	CD	PERCENT	18	dep	44	SENT_95	[p6l892t209r948b256],
37	(	CD	PERCENT	(	num	39	SENT_95	[p6l972t209r1186b267],
38	37.5	CD	PERCENT	37.5	num	39	SENT_95	[p6l972t209r1186b267],
39	%	NN	PERCENT	%	dep	36	SENT_95	[p6l972t209r1186b267],
40	)	CD	NUMBER	)	number	41	SENT_95	[p6l972t209r1186b267],
41	19	CD	PERCENT	19	num	42	SENT_95	[p6l1375t209r1433b257],
42	(	NN	PERCENT	(	dep	39	SENT_95	[p6l1455t209r1669b267],
43	39.6	CD	PERCENT	39.6	num	44	SENT_95	[p6l1455t209r1669b267],
44	%	NN	PERCENT	%	dep	50	SENT_95	[p6l1455t209r1669b267],
45	)	CD	NUMBER	)	number	46	SENT_95	[p6l1455t209r1669b267],
46	11	CD	NUMBER	11	num	47	SENT_95	[p6l1859t209r1913b255],
47	(	NN	O	(	dep	44	SENT_95	[p6l1939t209r2153b267],
48	22.9	CD	PERCENT	22.9	number	49	SENT_95	[p6l1939t209r2153b267],
49	%	NN	PERCENT	%	amod	47	SENT_95	[p6l1939t209r2153b267],
50	)	CD	NUMBER	)	dep	52	SENT_95	[p6l1939t209r2153b267],
51	Alive	JJ	O	alive	amod	52	SENT_95	[p6l7t292r152b339],
52	10	CD	PERCENT	10	dep	60	SENT_95	[p6l892t292r951b339],
53	(	CD	PERCENT	(	num	55	SENT_95	[p6l972t292r1186b350],
54	29.4	CD	PERCENT	29.4	num	55	SENT_95	[p6l972t292r1186b350],
55	%	NN	PERCENT	%	dep	52	SENT_95	[p6l972t292r1186b350],
56	)	CD	NUMBER	)	number	57	SENT_95	[p6l972t292r1186b350],
57	13	CD	NUMBER	13	num	58	SENT_95	[p6l1375t292r1431b339],
58	(	NN	O	(	dep	55	SENT_95	[p6l1455t292r1669b350],
59	38.2	CD	PERCENT	38.2	num	60	SENT_95	[p6l1455t292r1669b350],
60	%	NN	PERCENT	%	dep	20	SENT_95	[p6l1455t292r1669b350],
61	)	CD	NUMBER	)	number	62	SENT_95	[p6l1455t292r1669b350],
62	11	CD	NUMBER	11	num	63	SENT_95	[p6l1859t292r1913b338],
63	(	NN	O	(	dep	60	SENT_95	[p6l1939t292r2153b350],
64	32.4	CD	PERCENT	32.4	number	65	SENT_95	[p6l1939t292r2153b350],
65	%	NN	PERCENT	%	amod	63	SENT_95	[p6l1939t292r2153b350],
66	)	CD	NUMBER	)	nsubj	1	SENT_95	[p6l1939t292r2153b350],

1	p	NN	O	p	nsubj	2	SENT_96	[p6l6t1712r45b1758],
2	indicates	VBZ	O	indicate	_	0	SENT_96	[p6l66t1695r316b1745],
3	p-value	NN	O	p-value	dobj	2	SENT_96	[p6l331t1695r548b1758],
4	of	IN	O	of	_	0	SENT_96	[p6l569t1695r630b1744],
5	X2	NN	O	x2	nn	6	SENT_96	[p6l648t1682r712b1757],
6	test	NN	O	test	prep_of	3	SENT_96	[p6l736t1702r848b1745],
7	.	.	O	.	_	0	SENT_96	[p6l736t1702r848b1745],

1	t	NN	O	t	nsubj	23	SENT_97	[p6l15t1893r171b1970],
2	(	CD	NUMBER	(	number	3	SENT_97	[p6l15t1893r171b1970],
3	4	CD	NUMBER	4	dep	1	SENT_97	[p6l15t1893r171b1970],
4	;	:	O	;	_	0	SENT_97	[p6l15t1893r171b1970],
5	l	NN	O	l	tmod	23	SENT_97	[p6l15t1893r171b1970],
6	1	CD	NUMBER	1	num	7	SENT_97	[p6l190t1893r272b1969],
7	)	NN	O	)	nsubj	23	SENT_97	[p6l190t1893r272b1969],
8	,	,	O	,	_	0	SENT_97	[p6l190t1893r272b1969],
9	t	NN	O	t	nn	10	SENT_97	[p6l293t1893r380b1969],
10	(	NN	O	(	appos	7	SENT_97	[p6l293t1893r380b1969],
11	l	NN	O	l	tmod	10	SENT_97	[p6l293t1893r380b1969],
12	;	:	O	;	_	0	SENT_97	[p6l396t1912r409b1966],
13	19	CD	NUMBER	19	num	14	SENT_97	[p6l424t1893r529b1969],
14	)	NN	O	)	nsubj	23	SENT_97	[p6l424t1893r529b1969],
15	and	CC	O	and	_	0	SENT_97	[p6l550t1892r675b1955],
16	complex	NN	O	complex	nn	17	SENT_97	[p6l691t1892r993b1973],
17	karyotype	NN	O	karyotype	nsubj	23	SENT_97	[p6l1009t1892r1363b1973],
18	were	VBD	O	be	auxpass	19	SENT_97	[p6l1380t1912r1550b1955],
19	considered	VBN	O	consider	rcmod	17	SENT_97	[p6l1567t1892r1951b1955],
20	hi	UH	O	hi	dep	22	SENT_97	[p6l1966t1892r2033b1954],
21	ghrisk	NN	O	ghrisk	nn	22	SENT_97	[p6l2037t1892r2150b1973, p6l12t1999r146b2061],
22	factors	NNS	O	factor	dobj	19	SENT_97	[p6l169t1999r457b2076],
23	)	VBP	O	)	_	0	SENT_97	[p6l169t1999r457b2076],
24	,	,	O	,	_	0	SENT_97	[p6l169t1999r457b2076],
25	677	CD	NUMBER	677	num	29	SENT_97	[p6l487t1999r614b2062],
26	and	CC	O	and	_	0	SENT_97	[p6l643t1999r769b2061],
27	1298	CD	DATE	1298	conj_and	25	SENT_97	[p6l801t1999r965b2062],
28	MTHFR	NN	O	mthfr	nn	29	SENT_97	[p6l993t2000r1299b2061],
29	genotypes	NNS	O	genotype	dobj	23	SENT_97	[p6l1324t2008r1700b2080],
30	.	.	O	.	_	0	SENT_97	[p6l1324t2008r1700b2080],

1	Cox	NN	O	cox	nn	3	SENT_98	[p6l121t2107r266b2169],
2	regression	NN	O	regression	nn	3	SENT_98	[p6l291t2106r655b2187],
3	models	NNS	O	model	nsubjpass	11	SENT_98	[p6l681t2106r935b2169],
4	for	IN	O	for	_	0	SENT_98	[p6l963t2106r1066b2169],
5	the	DT	O	the	det	7	SENT_98	[p6l1090t2106r1196b2169],
6	outcomes	NNS	O	outcome	nn	7	SENT_98	[p6l1224t2116r1561b2169],
7	relapse	NN	O	relapse	prep_for	3	SENT_98	[p6l1588t2106r1839b2187],
8	and	CC	O	and	_	0	SENT_98	[p6l1867t2106r1993b2169],
9	survival	NN	O	survival	prep_for	3	SENT_98	[p6l2021t2126r2150b2169, p6l13t2213r184b2276],
10	were	VBD	O	be	auxpass	11	SENT_98	[p6l222t2233r392b2276],
11	performed	VBN	O	perform	_	0	SENT_98	[p6l429t2213r817b2294],
12	.	.	O	.	_	0	SENT_98	[p6l429t2213r817b2294],

1	The	DT	O	the	det	2	SENT_99	[p6l859t2213r995b2276],
2	risk	NN	O	risk	nsubjpass	4	SENT_99	[p6l1032t2213r1166b2276],
3	were	VBD	O	be	auxpass	4	SENT_99	[p6l1203t2233r1373b2276],
4	calculated	VBN	O	calculate	_	0	SENT_99	[p6l1412t2213r1771b2276],
5	as	IN	O	as	mark	8	SENT_99	[p6l1809t2233r1878b2276],
6	hazard	NN	O	hazard	nn	7	SENT_99	[p6l1916t2213r2153b2276],
7	ratios	NNS	O	ratio	nsubj	8	SENT_99	[p6l12t2319r206b2381],
8	(	VBP	O	(	advcl	4	SENT_99	[p6l246t2319r421b2396],
9	HR	NN	DURATION	hr	nn	10	SENT_99	[p6l246t2319r421b2396],
10	)	NN	O	)	dobj	8	SENT_99	[p6l246t2319r421b2396],
11	and	CC	O	and	_	0	SENT_99	[p6l461t2319r586b2381],
12	95	CD	PERCENT	95	number	13	SENT_99	[p6l621t2318r777b2382],
13	%	NN	PERCENT	%	amod	14	SENT_99	[p6l621t2318r777b2382],
14	CI	NN	O	ci	dobj	8	SENT_99	[p6l817t2319r920b2382],
15	.	.	O	.	_	0	SENT_99	[p6l817t2319r920b2382],

1	The	DT	O	the	det	2	SENT_100	[p6l959t2319r1095b2381],
2	models	NNS	O	model	nsubjpass	4	SENT_100	[p6l1130t2319r1384b2381],
3	were	VBD	O	be	auxpass	4	SENT_100	[p6l1421t2338r1591b2381],
4	built	VBN	O	build	_	0	SENT_100	[p6l1625t2318r1787b2381],
5	using	VBG	O	use	xcomp	4	SENT_100	[p6l1819t2318r2010b2400],
6	the	DT	O	the	det	12	SENT_100	[p6l2046t2319r2152b2381],
7	stepwise	JJ	O	stepwise	amod	12	SENT_100	[p6l16t2427r317b2508],
8	procedure	NN	O	procedure	dep	12	SENT_100	[p6l341t2427r696b2508],
9	(	CD	NUMBER	(	num	8	SENT_100	[p6l724t2427r1096b2505],
10	backward	RB	O	backward	dep	8	SENT_100	[p6l724t2427r1096b2505],
11	elimination	NN	O	elimination	nn	12	SENT_100	[p6l1121t2427r1571b2504],
12	)	NN	O	)	dobj	5	SENT_100	[p6l1121t2427r1571b2504],
13	.	.	O	.	_	0	SENT_100	[p6l1121t2427r1571b2504],

1	The	DT	O	the	det	2	SENT_101	[p6l120t2533r256b2595],
2	level	NN	O	level	nsubjpass	6	SENT_101	[p6l289t2533r455b2596],
3	of	IN	O	of	_	0	SENT_101	[p6l489t2533r566b2595],
4	signiﬁcance	NN	O	signiﬁcance	prep_of	2	SENT_101	[p6l595t2533r1015b2614],
5	was	VBD	O	be	auxpass	6	SENT_101	[p6l1048t2552r1181b2596],
6	performed	VBN	O	perform	_	0	SENT_101	[p6l1214t2533r1585b2614],
7	to	TO	O	to	_	0	SENT_101	[p6l1616t2543r1682b2595],
8	p	NN	O	p	prep_to	6	SENT_101	[p6l1708t2554r1756b2613],
9	<	JJR	O	<	dep	15	SENT_101	[p6l1776t2533r1990b2596],
10	0.05	CD	NUMBER	0.05	nsubjpass	15	SENT_101	[p6l1776t2533r1990b2596],
11	and	CC	O	and	_	0	SENT_101	[p6l2028t2533r2153b2595],
12	data	NNS	O	datum	nn	13	SENT_101	[p6l14t2640r160b2702],
13	processing	NN	O	processing	conj_and	10	SENT_101	[p6l191t2640r571b2721],
14	were	VBD	O	be	auxpass	15	SENT_101	[p6l605t2659r775b2703],
15	performed	VBN	O	perform	dep	6	SENT_101	[p6l808t2640r1179b2721],
16	with	IN	O	with	_	0	SENT_101	[p6l1212t2640r1368b2703],
17	SPSS	NN	ORGANIZATION	spss	prep_with	15	SENT_101	[p6l1404t2640r1593b2703],
18	12.0	CD	NUMBER	12.0	num	20	SENT_101	[p6l1639t2640r1784b2703],
19	statistical	JJ	O	statistical	amod	20	SENT_101	[p6l1821t2640r2152b2702],
20	software	NN	O	software	dobj	15	SENT_101	[p6l16t2747r316b2809],
21	for	IN	O	for	_	0	SENT_101	[p6l342t2747r445b2809],
22	Windows	NNP	MISC	Windows	prep_for	20	SENT_101	[p6l467t2747r820b2809],
23	.	.	O	.	_	0	SENT_101	[p6l467t2747r820b2809],

1	3	LS	NUMBER	3	_	0	SENT_102	[p6l13t2970r75b3033],
2	.	.	O	.	_	0	SENT_102	[p6l13t2970r75b3033],

1	Results	NNS	O	result	_	0	SENT_103	[p6l125t2971r399b3033],

1	The	DT	O	the	det	3	SENT_104	[p6l120t3184r256b3246],
2	genotypes	NNS	O	genotype	nn	3	SENT_104	[p6l281t3193r637b3265],
3	frequencies	NNS	O	frequency	nsubj	11	SENT_104	[p6l664t3184r1070b3265],
4	were	VBD	O	be	cop	5	SENT_104	[p6l1097t3203r1266b3247],
5	consistent	JJ	O	consistent	_	0	SENT_104	[p6l1292t3184r1647b3246],
6	with	IN	O	with	_	0	SENT_104	[p6l1670t3184r1826b3247],
7	previous	JJ	O	previous	amod	9	SENT_104	[p6l1849t3184r2150b3265],
8	published	VBN	O	publish	amod	9	SENT_104	[p6l11t3291r358b3372],
9	reports	NNS	O	report	prep_with	5	SENT_104	[p6l380t3301r624b3372],
10	and	CC	O	and	_	0	SENT_104	[p6l651t3291r777b3354],
11	were	VBD	O	be	conj_and	5	SENT_104	[p6l800t3311r970b3354],
12	in	IN	O	in	_	0	SENT_104	[p6l994t3291r1061b3353],
13	Hardy	NNP	O	Hardy	prep_in	11	SENT_104	[p6l1084t3291r1692b3372],
14	.	.	O	.	_	0	SENT_104	[p6l1084t3291r1692b3372],

1	—	NN	O	—	_	0	SENT_105	[p6l1084t3291r1692b3372],
2	.	.	O	.	_	0	SENT_105	[p6l1084t3291r1692b3372],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_106	[p6l1084t3291r1692b3372],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_106	[p6l1716t3291r2148b3372],
3	.	.	O	.	_	0	SENT_106	[p6l1716t3291r2148b3372],

1	Clinical	JJ	O	clinical	amod	2	SENT_107	[p6l121t3398r400b3461],
2	characteristics	NNS	O	characteristic	nsubj	6	SENT_107	[p6l441t3398r946b3461],
3	and	CC	O	and	_	0	SENT_107	[p6l990t3398r1116b3461],
4	prognostic	JJ	O	prognostic	amod	5	SENT_107	[p6l1154t3398r1528b3479],
5	factors	NNS	O	factor	conj_and	2	SENT_107	[p6l1570t3398r1807b3461],
6	(	VBP	O	(	dep	31	SENT_107	[p6l1852t3398r2040b3475],
7	such	JJ	O	such	_	0	SENT_107	[p6l1852t3398r2040b3475],
8	as	IN	O	as	_	0	SENT_107	[p6l2083t3418r2150b3461],
9	sex	NN	O	sex	nn	15	SENT_107	[p6l16t3523r147b3578],
10	,	,	O	,	_	0	SENT_107	[p6l16t3523r147b3578],
11	age	NN	O	age	dep	15	SENT_107	[p6l202t3523r340b3585],
12	,	,	O	,	_	0	SENT_107	[p6l202t3523r340b3585],
13	FAB	NN	O	fab	dep	15	SENT_107	[p6l393t3504r934b3585],
14	—	CD	NUMBER	—	num	15	SENT_107	[p6l393t3504r934b3585],
15	genotype	NN	O	genotype	prep_such_as	27	SENT_107	[p6l393t3504r934b3585],
16	,	,	O	,	_	0	SENT_107	[p6l393t3504r934b3585],
17	WBC	NNP	ORGANIZATION	WBC	nsubjpass	27	SENT_107	[p6l986t3504r1207b3578],
18	,	,	O	,	_	0	SENT_107	[p6l986t3504r1207b3578],
19	karyotype	NN	O	karyotype	nn	20	SENT_107	[p6l1259t3504r1641b3585],
20	)	NN	O	)	appos	17	SENT_107	[p6l1259t3504r1641b3585],
21	of	IN	O	of	_	0	SENT_107	[p6l1695t3504r1771b3566],
22	82	CD	NUMBER	82	num	24	SENT_107	[p6l1818t3504r1901b3567],
23	genotyped	JJ	O	genotyped	amod	24	SENT_107	[p6l1953t3523r2150b3585, p6l12t3612r209b3693],
24	patients	NNS	O	patient	prep_of	20	SENT_107	[p6l236t3612r510b3693],
25	were	VBD	O	be	auxpass	27	SENT_107	[p6l542t3632r712b3675],
26	not	RB	O	not	neg	27	SENT_107	[p6l741t3622r854b3675],
27	associated	VBN	O	associate	ccomp	6	SENT_107	[p6l883t3612r1246b3675],
28	with	IN	O	with	_	0	SENT_107	[p6l1275t3612r1431b3675],
29	MTHFR	NN	O	mthfr	nn	30	SENT_107	[p6l1459t3614r1765b3674],
30	genotypes	NNS	O	genotype	prep_with	27	SENT_107	[p6l1794t3622r2150b3693],
31	(	VBP	O	(	_	0	SENT_107	[p6l16t3718r236b3794],
32	Table	NNP	O	Table	dobj	31	SENT_107	[p6l16t3718r236b3794],
33	2	CD	NUMBER	2	num	32	SENT_107	[p6l262t3718r350b3794],
34	)	CD	NUMBER	)	nsubj	31	SENT_107	[p6l262t3718r350b3794],
35	.	.	O	.	_	0	SENT_107	[p6l262t3718r350b3794],

1	No	DT	O	no	det	2	SENT_108	[p7l120t24r225b85],
2	predisposition	NN	O	predisposition	nsubjpass	13	SENT_108	[p7l249t22r754b103],
3	of	IN	O	of	_	0	SENT_108	[p7l778t22r855b85],
4	a	DT	O	a	det	6	SENT_108	[p7l874t42r911b85],
5	certain	JJ	O	certain	amod	6	SENT_108	[p7l934t22r1174b85],
6	genotype	NN	O	genotype	prep_of	2	SENT_108	[p7l1198t32r1522b103],
7	to	TO	O	to	_	0	SENT_108	[p7l1546t32r1612b85],
8	relapse	NN	O	relapse	prep_to	6	SENT_108	[p7l1636t22r1886b103],
9	or	CC	O	or	_	0	SENT_108	[p7l1912t42r1984b85],
10	progression	NN	O	progression	prep_to	6	SENT_108	[p7l2005t42r2150b103, p7l14t129r308b210],
11	could	MD	O	could	aux	13	SENT_108	[p7l338t129r533b192],
12	be	VB	O	be	auxpass	13	SENT_108	[p7l561t129r643b192],
13	observed	VBN	O	observe	_	0	SENT_108	[p7l674t129r1010b192],
14	:	:	O	:	_	0	SENT_108	[p7l674t129r1010b192],
15	on	IN	O	on	dep	19	SENT_108	[p7l1046t149r1132b192],
16	univariate	JJ	O	univariate	amod	17	SENT_108	[p7l1161t129r1511b192],
17	analysis	NN	O	analysis	pobj	15	SENT_108	[p7l1542t129r1845b210],
18	,	,	O	,	_	0	SENT_108	[p7l1542t129r1845b210],
19	patients	NNS	O	patient	conj_and	13	SENT_108	[p7l1876t129r2150b210],
20	with	IN	O	with	_	0	SENT_108	[p7l13t235r169b297],
21	the	DT	O	the	det	23	SENT_108	[p7l209t235r315b297],
22	MTHFR	NN	O	mthfr	nn	23	SENT_108	[p7l355t236r661b296],
23	C677T	NN	O	c677t	prep_with	19	SENT_108	[p7l701t235r946b297],
24	and	CC	O	and	_	0	SENT_108	[p7l987t235r1113b297],
25	A1298C	NN	O	a1298c	nn	27	SENT_108	[p7l1152t235r1450b298],
26	variant	JJ	O	variant	amod	27	SENT_108	[p7l1493t235r1737b297],
27	alleles	NNS	O	allele	nsubj	30	SENT_108	[p7l1777t235r1999b297],
28	did	VBD	O	do	aux	30	SENT_108	[p7l2042t235r2153b297],
29	not	RB	O	not	neg	30	SENT_108	[p7l12t352r126b405],
30	show	VB	O	show	conj_and	13	SENT_108	[p7l162t342r341b405],
31	signiﬁcantly	RB	O	signiﬁcantly	advmod	32	SENT_108	[p7l379t342r814b423],
32	increased	VBN	O	increase	dep	30	SENT_108	[p7l849t342r1184b405],
33	relapse	NN	O	relapse	nn	36	SENT_108	[p7l1217t342r1467b423],
34	and	CC	O	and	_	0	SENT_108	[p7l1503t342r1629b405],
35	mortality	NN	O	mortality	conj_and	33	SENT_108	[p7l1662t342r1986b423],
36	risk	NN	O	risk	iobj	32	SENT_108	[p7l2020t342r2154b405],
37	(	CD	NUMBER	(	num	40	SENT_108	[p7l16t431r126b527],
38	X2	NN	O	x2	nn	40	SENT_108	[p7l16t431r126b527],
39	test	NN	O	test	nn	40	SENT_108	[p7l160t458r283b511],
40	p	NN	O	p	dobj	32	SENT_108	[p7l303t449r589b528],
41	=	JJ	O	=	amod	40	SENT_108	[p7l303t449r589b528],
42	0.82	CD	NUMBER	0.82	tmod	41	SENT_108	[p7l303t449r589b528],
43	and	CC	O	and	_	0	SENT_108	[p7l621t448r746b511],
44	0.59	CD	NUMBER	0.59	tmod	41	SENT_108	[p7l775t448r926b512],
45	for	IN	O	for	_	0	SENT_108	[p7l957t448r1061b511],
46	677	CD	NUMBER	677	prep_for	40	SENT_108	[p7l1090t448r1217b511],
47	and	CC	O	and	_	0	SENT_108	[p7l1251t448r1376b511],
48	p	NN	O	p	dep	50	SENT_108	[p7l1396t470r1445b528],
49	=	JJ	O	=	amod	48	SENT_108	[p7l1465t448r1681b511],
50	O.	NNP	O	O.	conj_and	13	SENT_108	[p7l1465t448r1681b511],
51	36	CD	NUMBER	36	num	50	SENT_108	[p7l1465t448r1681b511],
52	and	CC	O	and	_	0	SENT_108	[p7l1714t448r1839b511],
53	0.72	CD	NUMBER	0.72	conj_and	13	SENT_108	[p7l1868t449r2021b511],
54	for	IN	O	for	_	0	SENT_108	[p7l2051t448r2154b511],
55	1298	CD	DATE	1298	prep_for	50	SENT_108	[p7l21t555r208b629],
56	,	,	O	,	_	0	SENT_108	[p7l21t555r208b629],
57	respectively	RB	O	respectively	advmod	55	SENT_108	[p7l240t555r717b636],
58	)	CD	NUMBER	)	dep	55	SENT_108	[p7l240t555r717b636],
59	;	:	O	;	_	0	SENT_108	[p7l240t555r717b636],
60	this	DT	O	this	det	61	SENT_108	[p7l751t555r875b617],
61	evidence	NN	O	evidence	nsubjpass	63	SENT_108	[p7l908t555r1219b617],
62	was	VBD	O	be	auxpass	63	SENT_108	[p7l1250t574r1383b617],
63	conﬁrmed	VBN	O	conﬁrmed	parataxis	13	SENT_108	[p7l1415t555r1775b617],
64	even	RB	O	even	advmod	65	SENT_108	[p7l1805t574r1967b617],
65	conTable	JJ	O	contable	acomp	63	SENT_108	[p7l1997t574r2150b617, p7l12t797r167b846],

1	3	CD	NUMBER	3	_	0	SENT_109	[p7l189t797r217b846],
2	sidering	VBG	O	sider	partmod	1	SENT_109	[p7l11t874r293b955],
3	the	DT	O	the	det	5	SENT_109	[p7l318t874r424b937],
4	following	VBG	O	follow	amod	5	SENT_109	[p7l450t874r791b955],
5	subsets	NNS	O	subset	dobj	2	SENT_109	[p7l820t874r1071b937],
6	of	IN	O	of	_	0	SENT_109	[p7l1098t874r1175b937],
7	patients	NNS	O	patient	prep_of	5	SENT_109	[p7l1192t874r1467b955],
8	at	IN	O	at	_	0	SENT_109	[p7l1496t884r1558b937],
9	good	JJ	O	good	amod	10	SENT_109	[p7l1581t874r1757b955],
10	prognosis	NN	O	prognosis	prep_at	7	SENT_109	[p7l1780t874r2145b955],
11	:	:	O	:	_	0	SENT_109	[p7l1780t874r2145b955],
12	19	CD	NUMBER	19	num	13	SENT_109	[p7l16t980r93b1043],
13	patients	NNS	O	patient	npadvmod	16	SENT_109	[p7l131t980r406b1061],
14	with	IN	O	with	_	0	SENT_109	[p7l445t980r602b1043],
15	WBC	NN	ORGANIZATION	wbc	prep_with	13	SENT_109	[p7l638t980r838b1043],
16	<	JJR	O	<	amod	31	SENT_109	[p7l859t980r1009b1043],
17	10	CD	NUMBER	10	number	18	SENT_109	[p7l859t980r1009b1043],
18	X	NN	O	x	dep	16	SENT_109	[p7l1038t1000r1084b1041],
19	109	CD	NUMBER	109	num	20	SENT_109	[p7l1120t963r1232b1043],
20	L	NN	O	l	dep	18	SENT_109	[p7l1255t981r1307b1042],
21	and	CC	O	and	_	0	SENT_109	[p7l1346t980r1472b1042],
22	normal	JJ	O	normal	amod	23	SENT_109	[p7l1508t980r1758b1042],
23	karyotype	NN	O	karyotype	npadvmod	29	SENT_109	[p7l1795t980r2151b1061],
24	and	CC	O	and	_	0	SENT_109	[p7l10t1089r135b1151],
25	37	CD	NUMBER	37	num	26	SENT_109	[p7l161t1089r242b1151],
26	patients	NNS	O	patient	conj_and	23	SENT_109	[p7l267t1088r542b1169],
27	with	IN	O	with	_	0	SENT_109	[p7l569t1088r725b1151],
28	WBC	NN	ORGANIZATION	wbc	prep_with	23	SENT_109	[p7l747t1089r947b1151],
29	<	JJR	O	<	conj_and	16	SENT_109	[p7l968t1104r1014b1151],
30	50	CD	NUMBER	50	num	31	SENT_109	[p7l1033t1088r1118b1151],
31	X	NN	O	x	dep	1	SENT_109	[p7l1147t1108r1193b1149],
32	109	CD	NUMBER	109	num	37	SENT_109	[p7l1230t1071r1341b1151],
33	L	NN	O	l	amod	37	SENT_109	[p7l1364t1090r1416b1150],
34	and	CC	O	and	_	0	SENT_109	[p7l1441t1088r1567b1151],
35	low	JJ	O	low	amod	37	SENT_109	[p7l1590t1088r1718b1151],
36	cytogenetic	JJ	O	cytogenetic	amod	37	SENT_109	[p7l1744t1088r2150b1169],
37	risk	NN	O	risk	dep	31	SENT_109	[p7l7t1194r157b1256],
38	.	.	O	.	_	0	SENT_109	[p7l7t1194r157b1256],

1	No	DT	O	no	det	2	SENT_110	[p7l115t1301r221b1362],
2	association	NN	O	association	nsubjpass	5	SENT_110	[p7l259t1300r652b1362],
3	could	MD	O	could	aux	5	SENT_110	[p7l688t1300r885b1362],
4	be	VB	O	be	auxpass	5	SENT_110	[p7l918t1300r1001b1362],
5	found	VBN	O	find	_	0	SENT_110	[p7l1037t1299r1243b1362],
6	between	IN	O	between	_	0	SENT_110	[p7l1277t1300r1574b1363],
7	MTHFR	NN	O	mthfr	nn	8	SENT_110	[p7l1609t1301r1915b1361],
8	genotypes	NNS	O	genotype	prep_between	5	SENT_110	[p7l1951t1319r2149b1381, p7l8t1418r192b1489],
9	and	CC	O	and	_	0	SENT_110	[p7l214t1408r339b1471],
10	RFS	NNS	O	rf	prep_between	5	SENT_110	[p7l356t1409r508b1471],
11	and	CC	O	and	_	0	SENT_110	[p7l532t1408r657b1471],
12	EFS	NNS	O	ef	conj_and	10	SENT_110	[p7l673t1409r821b1471],
13	at	IN	O	at	_	0	SENT_110	[p7l845t1418r907b1471],
14	2	CD	DURATION	2	num	15	SENT_110	[p7l924t1409r964b1470],
15	years	NNS	NUMBER	year	prep_at	5	SENT_110	[p7l982t1428r1167b1489],
16	in	IN	O	in	_	0	SENT_110	[p7l1186t1408r1253b1470],
17	any	DT	O	any	det	18	SENT_110	[p7l1272t1428r1395b1489],
18	subgroup	NN	O	subgroup	prep_in	15	SENT_110	[p7l1416t1408r1743b1489],
19	of	IN	O	of	_	0	SENT_110	[p7l1762t1408r1839b1471],
20	patients	NNS	O	patient	prep_of	18	SENT_110	[p7l1849t1408r2145b1489],
21	:	:	O	:	_	0	SENT_110	[p7l1849t1408r2145b1489],
22	Kaplan	NNP	PERSON	Kaplan	nn	23	SENT_110	[p7l10t1515r264b1596],
23	Meier	NNP	PERSON	Meier	nsubj	48	SENT_110	[p7l296t1515r509b1577],
24	analysis	NN	O	analysis	nsubj	25	SENT_110	[p7l542t1515r823b1596],
25	showed	VBD	O	show	rcmod	23	SENT_110	[p7l862t1515r1128b1578],
26	that	IN	O	that	complm	36	SENT_110	[p7l1159t1515r1293b1577],
27	homozygous	JJ	O	homozygous	amod	31	SENT_110	[p7l1323t1515r1776b1596],
28	wild	JJ	O	wild	amod	31	SENT_110	[p7l1811t1515r2151b1596],
29	—	NN	O	—	nn	31	SENT_110	[p7l1811t1515r2151b1596],
30	type	NN	O	type	nn	31	SENT_110	[p7l1811t1515r2151b1596],
31	patients	NNS	O	patient	nsubj	36	SENT_110	[p7l7t1621r282b1702],
32	for	IN	O	for	_	0	SENT_110	[p7l313t1621r416b1683],
33	C677T	NN	O	c677t	prep_for	31	SENT_110	[p7l444t1620r689b1684],
34	and	CC	O	and	_	0	SENT_110	[p7l720t1621r845b1683],
35	A1298C	NN	O	a1298c	conj_and	33	SENT_110	[p7l873t1621r1171b1684],
36	had	VBD	O	have	ccomp	25	SENT_110	[p7l1201t1621r1329b1683],
37	respectively	RB	O	respectively	advmod	36	SENT_110	[p7l1356t1621r1783b1702],
38	a	DT	O	a	det	44	SENT_110	[p7l1814t1640r1851b1683],
39	51.15	CD	PERCENT	51.15	number	43	SENT_110	[p7l1879t1620r2147b1684],
40	%	NN	PERCENT	%	dep	43	SENT_110	[p7l1879t1620r2147b1684],
41	and	CC	O	and	_	0	SENT_110	[p7l10t1729r135b1792],
42	64.65	CD	PERCENT	64.65	conj_and	43	SENT_110	[p7l167t1729r435b1792],
43	%	NN	PERCENT	%	num	44	SENT_110	[p7l167t1729r435b1792],
44	RFS	NN	O	rf	dobj	36	SENT_110	[p7l471t1730r646b1803],
45	,	,	O	,	_	0	SENT_110	[p7l471t1730r646b1803],
46	heterozygous	JJ	O	heterozygous	amod	47	SENT_110	[p7l680t1729r1153b1810],
47	patients	NNS	O	patient	appos	44	SENT_110	[p7l1185t1729r1460b1810],
48	had	VBD	O	have	parataxis	5	SENT_110	[p7l1493t1729r1621b1792],
49	a	DT	O	a	dep	51	SENT_110	[p7l1653t1749r1690b1792],
50	58.66	CD	PERCENT	58.66	num	51	SENT_110	[p7l1721t1729r1989b1792],
51	%	NN	PERCENT	%	dobj	48	SENT_110	[p7l1721t1729r1989b1792],
52	and	CC	O	and	_	0	SENT_110	[p7l2027t1729r2152b1792],
53	46.57	CD	PERCENT	46.57	num	54	SENT_110	[p7l8t1835r300b1909],
54	%	NN	PERCENT	%	dobj	48	SENT_110	[p7l8t1835r300b1909],
55	,	,	O	,	_	0	SENT_110	[p7l8t1835r300b1909],
56	and	CC	O	and	_	0	SENT_110	[p7l328t1835r454b1897],
57	homozygous	JJ	O	homozygous	amod	59	SENT_110	[p7l475t1835r929b1916],
58	variant	JJ	O	variant	amod	59	SENT_110	[p7l954t1835r1198b1898],
59	patients	NNS	O	patient	nsubj	60	SENT_110	[p7l1219t1835r1493b1916],
60	had	VBD	O	have	parataxis	5	SENT_110	[p7l1518t1835r1646b1897],
61	a	DT	O	a	det	67	SENT_110	[p7l1670t1855r1707b1897],
62	46.56	CD	PERCENT	46.56	number	66	SENT_110	[p7l1728t1835r1998b1898],
63	%	NN	PERCENT	%	dep	66	SENT_110	[p7l1728t1835r1998b1898],
64	and	CC	O	and	_	0	SENT_110	[p7l2026t1835r2152b1897],
65	75	CD	PERCENT	75	conj_and	66	SENT_110	[p7l9t1943r166b2006],
66	%	NN	PERCENT	%	num	67	SENT_110	[p7l9t1943r166b2006],
67	RFS	NN	O	rf	dobj	60	SENT_110	[p7l194t1944r346b2006],
68	at	IN	O	at	_	0	SENT_110	[p7l377t1953r439b2006],
69	2	CD	DURATION	2	num	70	SENT_110	[p7l464t1944r504b2005],
70	years	NNS	NUMBER	year	prep_at	60	SENT_110	[p7l529t1963r734b2024],
71	.	.	O	.	_	0	SENT_110	[p7l529t1963r734b2024],

1	Comparison	NN	O	comparison	nsubj	22	SENT_111	[p7l117t2050r550b2131],
2	of	IN	O	of	_	0	SENT_111	[p7l609t2050r685b2113],
3	RFS	NN	O	rf	prep_of	1	SENT_111	[p7l737t2050r889b2113],
4	and	CC	O	and	_	0	SENT_111	[p7l952t2050r1078b2113],
5	EFS	NN	O	ef	prep_of	1	SENT_111	[p7l1134t2051r1282b2113],
6	between	IN	O	between	_	0	SENT_111	[p7l1343t2050r1639b2113],
7	homozygous	JJ	O	homozygous	amod	10	SENT_111	[p7l1696t2050r2149b2131],
8	wild	JJ	O	wild	amod	10	SENT_111	[p7l9t2156r348b2237],
9	—	NN	O	—	nn	10	SENT_111	[p7l9t2156r348b2237],
10	type	NN	O	type	prep_between	3	SENT_111	[p7l9t2156r348b2237],
11	and	CC	O	and	_	0	SENT_111	[p7l413t2156r538b2218],
12	variant	JJ	O	variant	amod	13	SENT_111	[p7l600t2156r844b2219],
13	patients	NNS	O	patient	prep_of	1	SENT_111	[p7l905t2156r1179b2237],
14	in	IN	O	in	_	0	SENT_111	[p7l1244t2156r1311b2217],
15	both	DT	O	both	det	19	SENT_111	[p7l1372t2156r1530b2218],
16	677	CD	NUMBER	677	num	19	SENT_111	[p7l1593t2155r1720b2219],
17	and	CC	O	and	_	0	SENT_111	[p7l1788t2156r1913b2218],
18	1298	CD	DATE	1298	conj_and	16	SENT_111	[p7l1983t2156r2148b2219],
19	polymorphisms	NNS	O	polymorphism	prep_in	13	SENT_111	[p7l7t2264r560b2345],
20	was	VBD	O	be	cop	22	SENT_111	[p7l611t2284r744b2327],
21	not	RB	O	not	neg	22	SENT_111	[p7l795t2274r908b2327],
22	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_111	[p7l959t2264r1327b2345],
23	by	IN	O	by	_	0	SENT_111	[p7l1373t2264r1461b2345],
24	the	DT	O	the	det	28	SENT_111	[p7l1510t2264r1616b2327],
25	log	NN	O	log	nn	28	SENT_111	[p7l1665t2264r1983b2345],
26	—	CD	NUMBER	—	num	28	SENT_111	[p7l1665t2264r1983b2345],
27	rank	NN	O	rank	nn	28	SENT_111	[p7l1665t2264r1983b2345],
28	test	NN	O	test	prep_by	22	SENT_111	[p7l2029t2273r2153b2327],
29	(	NN	O	(	nn	30	SENT_111	[p7l11t2371r336b2451],
30	p	NN	O	p	dep	28	SENT_111	[p7l11t2371r336b2451],
31	=	JJ	O	=	amod	30	SENT_111	[p7l11t2371r336b2451],
32	0.79	CD	NUMBER	0.79	tmod	31	SENT_111	[p7l11t2371r336b2451],
33	,	,	O	,	_	0	SENT_111	[p7l11t2371r336b2451],
34	0.53	CD	NUMBER	0.53	num	32	SENT_111	[p7l393t2371r542b2434],
35	and	CC	O	and	_	0	SENT_111	[p7l601t2371r727b2434],
36	0.3	CD	NUMBER	0.3	tmod	31	SENT_111	[p7l780t2371r907b2445],
37	,	,	O	,	_	0	SENT_111	[p7l780t2371r907b2445],
38	0.57	CD	NUMBER	0.57	appos	28	SENT_111	[p7l965t2371r1138b2445],
39	,	,	O	,	_	0	SENT_111	[p7l965t2371r1138b2445],
40	respectively	RB	O	respectively	advmod	28	SENT_111	[p7l1193t2371r1669b2452],
41	)	CD	NUMBER	)	dep	28	SENT_111	[p7l1193t2371r1669b2452],
42	,	,	O	,	_	0	SENT_111	[p7l1193t2371r1669b2452],
43	whilst	IN	O	whilst	mark	49	SENT_111	[p7l1726t2371r1943b2434],
44	RFS	NN	O	rf	nsubjpass	49	SENT_111	[p7l1995t2371r2147b2434],
45	and	CC	O	and	_	0	SENT_111	[p7l10t2477r135b2539],
46	EFS	NN	O	ef	nsubjpass	49	SENT_111	[p7l192t2477r340b2540],
47	were	VBD	O	be	auxpass	49	SENT_111	[p7l403t2496r573b2540],
48	signiﬁcantly	RB	O	signiﬁcantly	advmod	49	SENT_111	[p7l635t2477r1071b2558],
49	decreased	VBN	O	decrease	dep	22	SENT_111	[p7l1130t2477r1498b2551],
50	,	,	O	,	_	0	SENT_111	[p7l1130t2477r1498b2551],
51	as	IN	O	as	mark	52	SENT_111	[p7l1562t2496r1630b2539],
52	expected	VBN	O	expect	parataxis	49	SENT_111	[p7l1690t2477r2023b2558],
53	,	,	O	,	_	0	SENT_111	[p7l1690t2477r2023b2558],
54	in	IN	O	in	_	0	SENT_111	[p7l2084t2477r2151b2538],
55	the	DT	O	the	det	56	SENT_111	[p7l8t2585r115b2648],
56	presence	NN	O	presence	prep_in	49	SENT_111	[p7l167t2605r478b2666],
57	of	IN	O	of	_	0	SENT_111	[p7l533t2585r610b2648],
58	high	JJ	O	high	amod	61	SENT_111	[p7l657t2585r980b2666],
59	—	NN	O	—	nn	61	SENT_111	[p7l657t2585r980b2666],
60	risk	NN	O	risk	nn	61	SENT_111	[p7l657t2585r980b2666],
61	karyotype	NN	O	karyotype	prep_of	56	SENT_111	[p7l1031t2585r1386b2666],
62	and	CC	O	and	_	0	SENT_111	[p7l1442t2585r1567b2648],
63	age	NN	O	age	dep	66	SENT_111	[p7l1622t2585r1911b2666],
64	>	JJR	O	>	amod	63	SENT_111	[p7l1622t2585r1911b2666],
65	60	CD	DURATION	60	num	66	SENT_111	[p7l1622t2585r1911b2666],
66	years	NNS	NUMBER	year	conj_and	56	SENT_111	[p7l1965t2605r2149b2666],
67	(	CD	NUMBER	(	num	68	SENT_111	[p7l11t2692r79b2772],
68	p	NN	O	p	npadvmod	69	SENT_111	[p7l11t2692r79b2772],
69	<	JJR	O	<	amod	56	SENT_111	[p7l98t2707r145b2754],
70	0.001	CD	NUMBER	0.001	dep	56	SENT_111	[p7l163t2692r354b2755],
71	and	CC	O	and	_	0	SENT_111	[p7l389t2692r515b2754],
72	p	NN	O	p	conj_and	56	SENT_111	[p7l532t2713r581b2772],
73	=	JJ	O	=	amod	72	SENT_111	[p7l601t2718r647b2743],
74	0.03	CD	NUMBER	0.03	tmod	73	SENT_111	[p7l666t2692r838b2766],
75	,	,	O	,	_	0	SENT_111	[p7l666t2692r838b2766],
76	respectively	RB	O	respectively	advmod	49	SENT_111	[p7l866t2692r1292b2773],
77	for	IN	O	for	mark	83	SENT_111	[p7l1319t2692r1422b2754],
78	both	DT	O	both	preconj	80	SENT_111	[p7l1445t2692r1603b2754],
79	outcomes	NNS	O	outcome	nn	80	SENT_111	[p7l1630t2693r1996b2769],
80	)	NN	O	)	nsubj	83	SENT_111	[p7l1630t2693r1996b2769],
81	and	CC	O	and	_	0	SENT_111	[p7l2027t2692r2152b2754],
82	RFS	NN	O	rf	conj_and	80	SENT_111	[p7l8t2800r160b2862],
83	was	VBD	O	be	dep	49	SENT_111	[p7l216t2819r349b2862],
84	longer	RBR	O	longer	advmod	83	SENT_111	[p7l402t2799r629b2880],
85	in	IN	O	in	_	0	SENT_111	[p7l678t2799r745b2861],
86	the	DT	O	the	det	87	SENT_111	[p7l796t2799r902b2862],
87	presence	NN	O	presence	prep_in	83	SENT_111	[p7l952t2819r1263b2880],
88	of	IN	O	of	_	0	SENT_111	[p7l1315t2799r1392b2862],
89	FAB	NN	O	fab	prep_of	87	SENT_111	[p7l1436t2800r1726b2862],
90	.	.	O	.	_	0	SENT_111	[p7l1436t2800r1726b2862],

1	—	NN	O	—	_	0	SENT_112	[p7l1436t2800r1726b2862],
2	.	.	O	.	_	0	SENT_112	[p7l1436t2800r1726b2862],

1	L3	NN	O	l3	nn	2	SENT_113	[p7l1436t2800r1726b2862],
2	phenotype	NN	O	phenotype	_	0	SENT_113	[p7l1780t2799r2151b2880],
3	(	CD	NUMBER	(	num	4	SENT_113	[p7l11t2905r364b2985],
4	p	NN	O	p	dep	2	SENT_113	[p7l11t2905r364b2985],
5	=	JJ	O	=	amod	7	SENT_113	[p7l11t2905r364b2985],
6	0.04	CD	NUMBER	0.04	tmod	5	SENT_113	[p7l11t2905r364b2985],
7	)	NN	O	)	dep	4	SENT_113	[p7l11t2905r364b2985],
8	.	.	O	.	_	0	SENT_113	[p7l11t2905r364b2985],

1	The	DT	O	the	det	4	SENT_114	[p7l116t3012r252b3074],
2	Cox	NN	O	cox	nn	4	SENT_114	[p7l303t3012r449b3075],
3	regression	NN	O	regression	nn	4	SENT_114	[p7l498t3012r863b3093],
4	analysis	NN	O	analysis	nsubj	22	SENT_114	[p7l915t3012r1218b3093],
5	,	,	O	,	_	0	SENT_114	[p7l915t3012r1218b3093],
6	containing	VBG	O	contain	partmod	4	SENT_114	[p7l1273t3012r1646b3093],
7	gender	NN	O	gender	dobj	6	SENT_114	[p7l1698t3012r1953b3093],
8	,	,	O	,	_	0	SENT_114	[p7l1698t3012r1953b3093],
9	age	NN	O	age	conj_and	7	SENT_114	[p7l2009t3031r2148b3093],
10	,	,	O	,	_	0	SENT_114	[p7l2009t3031r2148b3093],
11	WBC	NNP	ORGANIZATION	WBC	conj_and	7	SENT_114	[p7l7t3121r228b3194],
12	,	,	O	,	_	0	SENT_114	[p7l7t3121r228b3194],
13	karyotype	NN	O	karyotype	conj_and	7	SENT_114	[p7l263t3120r638b3201],
14	,	,	O	,	_	0	SENT_114	[p7l263t3120r638b3201],
15	FAB	NN	O	fab	nn	16	SENT_114	[p7l673t3121r833b3182],
16	phenotype	NN	O	phenotype	conj_and	7	SENT_114	[p7l869t3120r1240b3201],
17	and	CC	O	and	_	0	SENT_114	[p7l1274t3120r1400b3183],
18	MT	NN	O	mt	nn	20	SENT_114	[p7l1430t3122r1563b3182],
19	HFR	NN	O	hfr	nn	20	SENT_114	[p7l1565t3122r1738b3182],
20	genotypes	NNS	O	genotype	conj_and	7	SENT_114	[p7l1770t3130r2148b3201],
21	,	,	O	,	_	0	SENT_114	[p7l1770t3130r2148b3201],
22	showed	VBD	O	show	_	0	SENT_114	[p7l11t3227r277b3290],
23	an	DT	O	a	det	26	SENT_114	[p7l315t3247r395b3290],
24	increased	VBN	O	increase	amod	26	SENT_114	[p7l431t3227r767b3290],
25	HR	NN	DURATION	hr	nn	26	SENT_114	[p7l803t3229r925b3289],
26	relapse	NN	O	relapse	dobj	22	SENT_114	[p7l960t3227r1211b3308],
27	and	CC	O	and	_	0	SENT_114	[p7l1249t3227r1375b3290],
28	mortality	NN	O	mortality	dobj	22	SENT_114	[p7l1410t3227r1735b3308],
29	in	IN	O	in	_	0	SENT_114	[p7l1772t3227r1839b3289],
30	patients	NNS	O	patient	prep_in	28	SENT_114	[p7l1874t3227r2149b3308],
31	with	IN	O	with	_	0	SENT_114	[p7l9t3333r165b3396],
32	high	JJ	O	high	amod	35	SENT_114	[p7l198t3333r521b3414],
33	—	NN	O	—	nn	35	SENT_114	[p7l198t3333r521b3414],
34	risk	NN	O	risk	nn	35	SENT_114	[p7l198t3333r521b3414],
35	karyotype	NN	O	karyotype	prep_with	30	SENT_114	[p7l552t3333r907b3414],
36	(	CD	NUMBER	(	tmod	35	SENT_114	[p7l944t3333r1415b3414],
37	respectively	RB	O	respectively	advmod	36	SENT_114	[p7l944t3333r1415b3414],
38	:	:	O	:	_	0	SENT_114	[p7l944t3333r1415b3414],
39	HR	NN	DURATION	hr	dep	35	SENT_114	[p7l1455t3333r1832b3407],
40	=	JJ	O	=	amod	39	SENT_114	[p7l1455t3333r1832b3407],
41	4.33	CD	NUMBER	4.33	tmod	40	SENT_114	[p7l1455t3333r1832b3407],
42	,	,	O	,	_	0	SENT_114	[p7l1455t3333r1832b3407],
43	95	CD	PERCENT	95	number	44	SENT_114	[p7l1871t3332r2027b3396],
44	%	NN	PERCENT	%	amod	45	SENT_114	[p7l1871t3332r2027b3396],
45	CI	NN	O	ci	appos	35	SENT_114	[p7l2065t3333r2151b3396],
46	[	CD	NUMBER	[	number	47	SENT_114	[p7l14t3440r506b3516],
47	2.160	CD	NUMBER	2.160	num	48	SENT_114	[p7l14t3440r506b3516],
48	—	NN	O	—	dep	61	SENT_114	[p7l14t3440r506b3516],
49	8.715	CD	NUMBER	8.715	num	50	SENT_114	[p7l14t3440r506b3516],
50	]	NN	O	]	dep	48	SENT_114	[p7l14t3440r506b3516],
51	and	CC	O	and	_	0	SENT_114	[p7l551t3440r677b3503],
52	HR	NN	DURATION	hr	dep	61	SENT_114	[p7l713t3440r1090b3514],
53	=	JJ	O	=	amod	52	SENT_114	[p7l713t3440r1090b3514],
54	3.67	CD	NUMBER	3.67	tmod	53	SENT_114	[p7l713t3440r1090b3514],
55	,	,	O	,	_	0	SENT_114	[p7l713t3440r1090b3514],
56	95	CD	PERCENT	95	number	57	SENT_114	[p7l1132t3440r1289b3504],
57	%	NN	PERCENT	%	amod	54	SENT_114	[p7l1132t3440r1289b3504],
58	CI	NN	O	ci	dep	61	SENT_114	[p7l1330t3441r1417b3503],
59	[	CD	NUMBER	[	num	58	SENT_114	[p7l1460t3441r1985b3518],
60	1.901	CD	NUMBER	1.901	num	61	SENT_114	[p7l1460t3441r1985b3518],
61	—	NN	O	—	dep	28	SENT_114	[p7l1460t3441r1985b3518],
62	7.090	CD	NUMBER	7.090	number	63	SENT_114	[p7l1460t3441r1985b3518],
63	]	CD	NUMBER	]	num	64	SENT_114	[p7l1460t3441r1985b3518],
64	)	NN	O	)	dep	61	SENT_114	[p7l1460t3441r1985b3518],
65	and	CC	O	and	advmod	64	SENT_114	[p7l2026t3440r2152b3503],

1	Toxicities	NNS	O	toxicity	dep	7	SENT_115	[p7l33t3593r162b3616],
2	and	CC	O	and	_	0	SENT_115	[p7l173t3593r219b3616],
3	MTHFR	NN	O	mthfr	nn	4	SENT_115	[p7l228t3593r342b3616],
4	genotypes	NNS	O	genotype	conj_and	1	SENT_115	[p7l351t3597r484b3623],
5	among	IN	O	among	_	0	SENT_115	[p7l495t3600r583b3623],
6	patients	NNS	O	patient	prep_among	1	SENT_115	[p7l592t3593r694b3623],
7	evaluable	JJ	O	evaluable	_	0	SENT_115	[p7l705t3593r829b3616],
8	for	IN	O	for	dep	7	SENT_115	[p7l838t3593r877b3616],
9	MTX	NN	O	mtx	nn	12	SENT_115	[p7l885t3593r958b3616],
10	intol	NN	O	intol	nn	12	SENT_115	[p7l967t3593r1027b3616],
11	eeee	NN	O	eeee	nn	12	SENT_115	[p7l1029t3600r1085b3616],
12	ce	NN	O	ce	pobj	8	SENT_115	[p7l1086t3600r1114b3616],

1	No	DT	O	no	det	5	SENT_116	[p7l828t3651r868b3674],
2	toxicity	NN	O	toxicity	nn	5	SENT_116	[p7l877t3651r978b3681],
3	Hematopoietic	JJ	MISC	hematopoietic	amod	5	SENT_116	[p7l1107t3651r1301b3681],
4	toxicity	NN	O	toxicity	nn	5	SENT_116	[p7l1310t3651r1411b3681],
5	Hepatotoxicity	NN	O	hepatotoxicity	_	0	SENT_116	[p7l1540t3651r1736b3681],
6	Combined	VBN	O	combine	partmod	5	SENT_116	[p7l1865t3651r2002b3674],
7	toxicitya	NN	O	toxicitya	dobj	6	SENT_116	[p7l2011t3650r2124b3681],

1	MTHFR	NN	O	mthfr	nn	4	SENT_117	[p8l33t41r147b64],
2	677	CD	NUMBER	677	num	4	SENT_117	[p8l157t40r204b64],
3	genotype	NN	O	genotype	nn	4	SENT_117	[p8l215t44r335b71],
4	CC	NN	O	cc	_	0	SENT_117	[p8l67t81r109b105],
5	(	CD	NUMBER	(	num	8	SENT_117	[p8l120t81r267b112],
6	wild	JJ	O	wild	amod	8	SENT_117	[p8l120t81r267b112],
7	—	NN	O	—	nn	8	SENT_117	[p8l120t81r267b112],
8	type	NN	O	type	dep	4	SENT_117	[p8l120t81r267b112],
9	)	CD	NUMBER	)	dep	8	SENT_117	[p8l120t81r267b112],
10	plus	CC	O	plus	prep	9	SENT_117	[p8l277t81r331b112],
11	CT	NNP	O	CT	dep	10	SENT_117	[p8l341t81r382b105],
12	(	CD	NUMBER	(	num	11	SENT_117	[p8l392t81r589b112],
13	heterozygous	JJ	O	heterozygous	amod	16	SENT_117	[p8l392t81r589b112],
14	)	NN	O	)	nn	16	SENT_117	[p8l392t81r589b112],
15	(	NN	O	(	nn	16	SENT_117	[p8l600t82r625b110],
16	n	NN	O	n	dep	24	SENT_117	[p8l600t82r625b110],
17	:42	CD	NUMBER	:42	num	18	SENT_117	[p8l633t81r699b110],
18	)	CD	NUMBER	)	dep	16	SENT_117	[p8l633t81r699b110],
19	TT	NN	ORGANIZATION	tt	dep	24	SENT_117	[p8l67t123r106b146],
20	(	CD	NUMBER	(	num	19	SENT_117	[p8l117t122r306b153],
21	homozygous	JJ	O	homozygous	amod	24	SENT_117	[p8l117t122r306b153],
22	)	NN	O	)	nn	24	SENT_117	[p8l117t122r306b153],
23	(	NN	O	(	nn	24	SENT_117	[p8l317t123r342b151],
24	n	NN	O	n	dep	36	SENT_117	[p8l317t123r342b151],
25	=	JJ	O	=	quantmod	27	SENT_117	[p8l349t132r367b142],
26	13	CD	NUMBER	13	number	27	SENT_117	[p8l376t122r416b151],
27	)	CD	NUMBER	)	num	31	SENT_117	[p8l376t122r416b151],
28	MTHFR	NNP	O	MTHFR	nn	31	SENT_117	[p8l33t185r147b208],
29	1298	CD	DATE	1298	num	31	SENT_117	[p8l159t185r221b209],
30	genotype	NN	O	genotype	nn	31	SENT_117	[p8l231t189r352b215],
31	CC	NN	O	cc	dep	24	SENT_117	[p8l67t226r109b249],
32	(	CD	NUMBER	(	num	35	SENT_117	[p8l120t226r267b256],
33	wild	JJ	O	wild	amod	35	SENT_117	[p8l120t226r267b256],
34	—	NN	O	—	nn	35	SENT_117	[p8l120t226r267b256],
35	type	NN	O	type	dep	31	SENT_117	[p8l120t226r267b256],
36	)	CD	NUMBER	)	dep	41	SENT_117	[p8l120t226r267b256],
37	plus	CC	O	plus	prep	36	SENT_117	[p8l277t226r331b256],
38	CT	NNP	O	CT	dep	37	SENT_117	[p8l341t226r382b249],
39	(	CD	NUMBER	(	num	38	SENT_117	[p8l392t226r589b256],
40	heterozygous	JJ	O	heterozygous	amod	41	SENT_117	[p8l392t226r589b256],
41	)	NN	O	)	dep	9	SENT_117	[p8l392t226r589b256],
42	(	CD	NUMBER	(	num	43	SENT_117	[p8l600t226r625b255],
43	r1	NN	O	r1	dep	41	SENT_117	[p8l600t226r625b255],
44	=	JJ	O	=	dep	43	SENT_117	[p8l633t236r650b245],
45	51	CD	NUMBER	51	num	47	SENT_117	[p8l657t226r699b255],
46	)	CD	NUMBER	)	num	47	SENT_117	[p8l657t226r699b255],
47	TT	NN	ORGANIZATION	tt	iobj	44	SENT_117	[p8l67t268r107b290],
48	(	CD	NUMBER	(	num	50	SENT_117	[p8l117t267r306b297],
49	homozygous	JJ	O	homozygous	amod	50	SENT_117	[p8l117t267r306b297],
50	)	NN	O	)	nn	55	SENT_117	[p8l117t267r306b297],
51	(	CD	NUMBER	(	num	52	SENT_117	[p8l317t267r342b296],
52	r1	NN	O	r1	dep	50	SENT_117	[p8l317t267r342b296],
53	=	JJ	O	=	amod	55	SENT_117	[p8l349t277r367b286],
54	4	CD	NUMBER	4	tmod	53	SENT_117	[p8l373t267r399b296],
55	)	NN	O	)	dobj	44	SENT_117	[p8l373t267r399b296],

1	20	CD	PERCENT	20	_	0	SENT_118	[p8l829t226r861b249],
2	(	CD	PERCENT	(	number	3	SENT_118	[p8l867t226r972b255],
3	39.2	CD	PERCENT	39.2	num	4	SENT_118	[p8l867t226r972b255],
4	%	NN	PERCENT	%	dep	1	SENT_118	[p8l867t226r972b255],
5	)	CD	NUMBER	)	number	6	SENT_118	[p8l867t226r972b255],
6	4	CD	NUMBER	4	num	7	SENT_118	[p8l845t267r964b296],
7	(	NN	O	(	dep	4	SENT_118	[p8l845t267r964b296],
8	10o	CD	PERCENT	10o	num	9	SENT_118	[p8l845t267r964b296],
9	%	NN	PERCENT	%	dep	7	SENT_118	[p8l845t267r964b296],
10	)	CD	NUMBER	)	dep	1	SENT_118	[p8l845t267r964b296],

1	9	CD	NUMBER	9	num	2	SENT_119	[p8l1540t226r1667b255],
2	(	NN	O	(	_	0	SENT_119	[p8l1540t226r1667b255],
3	17.6	CD	PERCENT	17.6	num	4	SENT_119	[p8l1540t226r1667b255],
4	%	NN	PERCENT	%	dep	2	SENT_119	[p8l1540t226r1667b255],
5	)	CD	NUMBER	)	num	6	SENT_119	[p8l1540t226r1667b255],
6	O	NN	O	o	dep	2	SENT_119	[p8l1540t267r1555b290],

1	Among	IN	O	among	_	0	SENT_120	[p8l33t347r132b377],
2	MTHFR	NN	O	mthfr	nn	4	SENT_120	[p8l142t348r256b370],
3	C677T	NN	O	c677t	nn	4	SENT_120	[p8l265t347r357b370],
4	polymorphism	NN	O	polymorphism	prep_among	8	SENT_120	[p8l366t347r566b377],
5	,	,	O	,	_	0	SENT_120	[p8l366t347r566b377],
6	toxicity	NN	O	toxicity	nsubj	8	SENT_120	[p8l577t347r677b377],
7	was	VBD	O	be	cop	8	SENT_120	[p8l687t354r737b370],
8	present	JJ	DATE	present	dep	28	SENT_120	[p8l747t351r843b377],
9	in	IN	O	in	_	0	SENT_120	[p8l852t347r877b370],
10	19	CD	NUMBER	19	prep_in	8	SENT_120	[p8l890t347r918b371],
11	of	IN	O	of	_	0	SENT_120	[p8l929t347r958b370],
12	42	CD	NUMBER	42	num	13	SENT_120	[p8l965t347r997b370],
13	CC	NN	O	cc	prep_of	10	SENT_120	[p8l1007t347r1050b370],
14	plus	CC	O	plus	_	0	SENT_120	[p8l1059t347r1114b377],
15	CT	NN	O	ct	nn	16	SENT_120	[p8l1124t347r1166b370],
16	patients	NNS	O	patient	prep_in	8	SENT_120	[p8l1175t347r1277b377],
17	(	VBP	O	(	rcmod	16	SENT_120	[p8l1288t347r1393b376],
18	45.2	CD	PERCENT	45.2	num	19	SENT_120	[p8l1288t347r1393b376],
19	%	NN	PERCENT	%	dobj	17	SENT_120	[p8l1288t347r1393b376],
20	)	CD	NUMBER	)	tmod	17	SENT_120	[p8l1288t347r1393b376],
21	and	CC	O	and	_	0	SENT_120	[p8l1405t347r1451b370],
22	in	IN	O	in	_	0	SENT_120	[p8l1461t347r1486b370],
23	12	CD	TIME	12	conj_and	10	SENT_120	[p8l1499t347r1527b370],
24	of	IN	TIME	of	_	0	SENT_120	[p8l1538t347r1566b370],
25	13	CD	TIME	13	num	27	SENT_120	[p8l1577t347r1604b370],
26	TT	NN	O	tt	nn	27	SENT_120	[p8l1616t348r1656b370],
27	patients	NNS	O	patient	prep_of	23	SENT_120	[p8l1665t347r1767b377],
28	(	VBP	O	(	_	0	SENT_120	[p8l1778t347r1883b376],
29	92.3	CD	PERCENT	92.3	num	30	SENT_120	[p8l1778t347r1883b376],
30	%	NN	PERCENT	%	dobj	28	SENT_120	[p8l1778t347r1883b376],
31	)	CD	NUMBER	)	num	33	SENT_120	[p8l1778t347r1883b376],
32	(	NN	O	(	nn	33	SENT_120	[p8l1895t347r1920b377],
33	p	NN	O	p	nsubj	28	SENT_120	[p8l1895t347r1920b377],
34	=	JJ	O	=	amod	33	SENT_120	[p8l1927t347r2032b375],
35	0.003	CD	NUMBER	0.003	tmod	34	SENT_120	[p8l1927t347r2032b375],
36	,	,	O	,	_	0	SENT_120	[p8l1927t347r2032b375],
37	Fisher	NNP	PERSON	Fisher	nn	40	SENT_120	[p8l2043t347r2126b370],
38	exact	JJ	O	exact	amod	40	SENT_120	[p8l34t391r103b411],
39	test	NN	O	test	nn	40	SENT_120	[p8l111t388r174b416],
40	)	NN	O	)	appos	33	SENT_120	[p8l111t388r174b416],
41	.	.	O	.	_	0	SENT_120	[p8l111t388r174b416],

1	3	CD	NUMBER	3	_	0	SENT_121	[p8l58t427r69b439],
2	Hematopoietic	JJ	O	hematopoietic	amod	5	SENT_121	[p8l83t428r277b458],
3	and	CC	O	and	_	0	SENT_121	[p8l288t428r335b451],
4	hepatic	JJ	O	hepatic	amod	5	SENT_121	[p8l343t428r438b458],
5	toxicity	NN	O	toxicity	dep	1	SENT_121	[p8l448t428r553b458],
6	.	.	O	.	_	0	SENT_121	[p8l448t428r553b458],

1	1672	CD	DATE	1672	_	0	SENT_122	[p8l37t475r100b499],

1	Table	NNP	O	Table	_	0	SENT_123	[p8l34t568r106b592],
2	4	CD	NUMBER	4	num	5	SENT_123	[p8l115t568r131b592],
3	Cox	NNP	ORGANIZATION	Cox	nn	5	SENT_123	[p8l35t609r89b633],
4	proportional	JJ	O	proportional	amod	5	SENT_123	[p8l98t609r261b640],
5	hazards	NNS	O	hazard	dep	1	SENT_123	[p8l270t609r370b633],
6	multivariate	JJ	O	multivariate	amod	7	SENT_123	[p8l380t609r538b633],
7	models	NNS	O	model	tmod	5	SENT_123	[p8l547t609r642b633],
8	relative	JJ	O	relative	advmod	7	SENT_123	[p8l651t609r749b633],
9	to	TO	O	to	_	0	SENT_123	[p8l758t613r783b633],
10	maintenance	NN	O	maintenance	nn	11	SENT_123	[p8l792t609r959b633],
11	subgroup	NN	O	subgroup	prep_to	8	SENT_123	[p8l969t609r1091b640],

1	P.	NNP	PERSON	P.	nn	2	SENT_124	[p8l676t476r697b499],
2	Chiusolo	NNP	PERSON	Chiusolo	_	0	SENT_124	[p8l710t475r828b499],
3	et	FW	O	et	nn	4	SENT_124	[p8l838t480r861b499],
4	al.	FW	O	al.	dep	2	SENT_124	[p8l869t475r900b499],
5	/	:	O	/	punct	2	SENT_124	[p8l909t476r924b499],
6	Leukemia	NNP	ORGANIZATION	Leukemia	nn	7	SENT_124	[p8l929t475r1057b499],
7	Research	NNP	ORGANIZATION	Research	dep	2	SENT_124	[p8l1065t475r1187b499],
8	31	CD	NUMBER	31	number	9	SENT_124	[p8l1197t475r1227b499],
9	(	CD	NUMBER	(	num	10	SENT_124	[p8l1239t476r1248b504],
10	2007	CD	DATE	2007	dep	7	SENT_124	[p8l1249t475r1325b504],
11	)	CD	NUMBER	)	number	12	SENT_124	[p8l1249t475r1325b504],
12	1669-1674	CD	DATE	1669-1674	num	10	SENT_124	[p8l1336t475r1483b499],

1	Cytogenetic	JJ	O	cytogenetic	amod	2	SENT_125	[p8l7t824r364b891],
2	risk	NN	O	risk	_	0	SENT_125	[p8l385t824r497b876],

1	Lowb	NNP	O	Lowb	_	0	SENT_126	[p8l81t894r242b961],
2	vs.	FW	O	vs.	prep	1	SENT_126	[p8l268t925r347b961],
3	high	JJ	O	high	amod	4	SENT_126	[p8l371t909r503b976],
4	8.569	CD	NUMBER	8.569	pobj	2	SENT_126	[p8l1465t909r1626b962],
5	<	JJR	O	<	dep	1	SENT_126	[p8l1947t909r2148b961],
6	0.001	CD	NUMBER	0.001	dep	5	SENT_126	[p8l1947t909r2148b961],

1	WBC	NNP	O	WBC	_	0	SENT_127	[p8l6t1048r174b1100],

1	g10	NN	O	g10	nn	2	SENT_128	[p8l86t1141r210b1202],
2	X	NN	O	x	dep	9	SENT_128	[p8l234t1157r272b1191],
3	109	CD	NUMBER	109	num	5	SENT_128	[p8l303t1127r395b1193],
4	L-1	NN	O	l-1	nn	5	SENT_128	[p8l415t1127r526b1192],
5	b	NN	O	b	dep	2	SENT_128	[p8l546t1126r572b1165],
6	vs.	CC	O	vs.	_	0	SENT_128	[p8l598t1157r677b1193],
7	>	JJR	O	>	dep	2	SENT_128	[p8l702t1141r816b1193],
8	10	CD	NUMBER	10	dep	9	SENT_128	[p8l702t1141r816b1193],
9	x	NN	O	x	dep	13	SENT_128	[p8l839t1157r878b1191],
10	109	CD	NUMBER	109	num	11	SENT_128	[p8l909t1127r1001b1193],
11	L-1	NN	O	l-1	dep	9	SENT_128	[p8l1021t1127r1132b1192],
12	1.375	CD	NUMBER	1.375	num	13	SENT_128	[p8l1470t1140r1625b1193],
13	0.454	CD	NUMBER	0.454	_	0	SENT_128	[p8l1989t1140r2154b1193],

1	Gender	NN	O	gender	_	0	SENT_129	[p8l8t1280r226b1332],

1	Maleb	NNP	O	Maleb	_	0	SENT_130	[p8l81t1358r260b1424],
2	vs.	CC	O	vs.	dep	1	SENT_130	[p8l286t1389r365b1424],
3	female	JJ	O	female	amod	5	SENT_130	[p8l390t1372r590b1424],
4	0.887	CD	NUMBER	0.887	num	5	SENT_130	[p8l1463t1372r1626b1424],
5	0.795	CD	NUMBER	0.795	dep	2	SENT_130	[p8l1989t1372r2151b1425],

1	Age	NN	O	age	_	0	SENT_131	[p8l7t1512r129b1578],

1	25-59	CD	NUMBER	25-59	dep	10	SENT_132	[p8l82t1602r264b1656],
2	yearsb	JJ	O	yearsb	amod	1	SENT_132	[p8l287t1589r469b1671],
3	vs.	CC	O	vs.	prep	1	SENT_132	[p8l496t1619r575b1655],
4	0-24	CD	NUMBER	0-24	num	5	SENT_132	[p8l599t1603r745b1655],
5	years	NNS	NUMBER	year	dep	3	SENT_132	[p8l767t1619r921b1671],
6	0.909	CD	NUMBER	0.909	number	7	SENT_132	[p8l1463t1603r1626b1656],
7	0.845	CD	NUMBER	0.845	num	5	SENT_132	[p8l1989t1603r2151b1655],
8	25-59	CD	NUMBER	25-59	num	9	SENT_132	[p8l82t1695r264b1748],
9	yearsb	NN	O	yearsb	dep	10	SENT_132	[p8l287t1681r469b1763],
10	VS.	NNP	O	VS.	dep	14	SENT_132	[p8l496t1712r575b1748],
11	60-80	CD	NUMBER	60-80	num	12	SENT_132	[p8l600t1695r783b1748],
12	years	NNS	NUMBER	year	dep	10	SENT_132	[p8l804t1712r958b1763],
13	1.966	CD	NUMBER	1.966	num	14	SENT_132	[p8l1470t1695r1627b1748],
14	0.209	CD	NUMBER	0.209	_	0	SENT_132	[p8l1989t1696r2153b1748],

1	677	CD	NUMBER	677	num	2	SENT_133	[p8l8t1834r114b1887],
2	genotype	NN	O	genotype	_	0	SENT_133	[p8l138t1843r408b1902],

1	677CCb	JJ	O	677ccb	_	0	SENT_134	[p8l82t1913r318b1979],
2	vs.	CC	O	vs.	prep	1	SENT_134	[p8l344t1943r423b1979],
3	677TT	JJ	O	677tt	amod	6	SENT_134	[p8l449t1926r649b1979],
4	0.541	CD	NUMBER	0.541	number	5	SENT_134	[p8l1463t1927r1622b1979],
5	0.229	CD	NUMBER	0.229	num	6	SENT_134	[p8l1989t1927r2153b1980],
6	677Ccb	NN	O	677ccb	dep	2	SENT_134	[p8l82t2005r318b2071],
7	vs.	FW	O	vs.	nn	8	SENT_134	[p8l344t2036r423b2071],
8	677CT	FW	O	677ct	dep	1	SENT_134	[p8l449t2019r653b2071],
9	1.019	CD	NUMBER	1.019	number	10	SENT_134	[p8l1470t2019r1626b2072],
10	0.971	CD	NUMBER	0.971	dep	8	SENT_134	[p8l1989t2019r2148b2072],

1	1298	CD	DATE	1298	num	2	SENT_135	[p8l14t2159r151b2211],
2	genotype	NN	O	genotype	_	0	SENT_135	[p8l175t2166r446b2225],

1	1298AAb	NN	O	1298aab	dep	6	SENT_136	[p8l88t2236r364b2303],
2	vs.	CC	O	vs.	prep	1	SENT_136	[p8l390t2266r469b2302],
3	1298CC	NN	O	1298cc	dep	2	SENT_136	[p8l500t2250r739b2303],
4	0.219	CD	NUMBER	0.219	dep	6	SENT_136	[p8l1463t2250r1626b2303],
5	0.142	CD	NUMBER	0.142	num	6	SENT_136	[p8l1989t2250r2154b2302],
6	1298AAb	NN	O	1298aab	dep	10	SENT_136	[p8l89t2328r364b2395],
7	vs.	CC	O	vs.	prep	6	SENT_136	[p8l390t2359r469b2394],
8	1298AC	NN	O	1298ac	dep	7	SENT_136	[p8l500t2343r740b2395],
9	0.627	CD	NUMBER	0.627	num	10	SENT_136	[p8l1463t2342r1626b2395],
10	0.321	CD	NUMBER	0.321	_	0	SENT_136	[p8l1989t2343r2148b2395],

1	FAB	NN	O	fab	nn	2	SENT_137	[p8l6t2482r140b2533],
2	phenotype	NN	O	phenotype	_	0	SENT_137	[p8l164t2481r474b2548],

1	FAB	NN	O	fab	_	0	SENT_138	[p8l81t2559r321b2624],
2	.	.	O	.	_	0	SENT_138	[p8l81t2559r321b2624],

1	—	NN	O	—	_	0	SENT_139	[p8l81t2559r321b2624],
2	.	.	O	.	_	0	SENT_139	[p8l81t2559r321b2624],

1	Bb	NNP	O	Bb	nn	2	SENT_140	[p8l81t2559r321b2624],
2	Vs.	NNP	O	Vs.	_	0	SENT_140	[p8l347t2589r426b2625],
3	FAB-L3	NN	O	fab-l3	dep	2	SENT_140	[p8l450t2573r692b2625],
4	0.729	CD	NUMBER	0.729	number	5	SENT_140	[p8l1463t2573r1626b2626],
5	0.686	CD	NUMBER	0.686	num	6	SENT_140	[p8l1989t2573r2153b2625],
6	FAB	NN	O	fab	dep	3	SENT_140	[p8l81t2651r321b2717],
7	.	.	O	.	_	0	SENT_140	[p8l81t2651r321b2717],

1	—	NN	O	—	_	0	SENT_141	[p8l81t2651r321b2717],
2	.	.	O	.	_	0	SENT_141	[p8l81t2651r321b2717],

1	Bb	NNP	O	Bb	_	0	SENT_142	[p8l81t2651r321b2717],
2	vs.	CC	O	vs.	prep	1	SENT_142	[p8l347t2682r426b2717],
3	FAB	NN	O	fab	dep	2	SENT_142	[p8l450t2666r659b2717],
4	.	.	O	.	_	0	SENT_142	[p8l450t2666r659b2717],

1	—	NN	O	—	_	0	SENT_143	[p8l450t2666r659b2717],
2	.	.	O	.	_	0	SENT_143	[p8l450t2666r659b2717],

1	T	NN	O	t	dep	11	SENT_144	[p8l450t2666r659b2717],
2	1.048	CD	NUMBER	1.048	num	1	SENT_144	[p8l1470t2666r1626b2718],
3	0.948	CD	NUMBER	0.948	number	4	SENT_144	[p8l1989t2666r2152b2718],
4	3.227	CD	NUMBER	3.227	num	5	SENT_144	[p8l8t2772r404b2823],
5	—	NN	O	—	dep	1	SENT_144	[p8l8t2772r404b2823],
6	22.407	CD	NUMBER	22.407	number	7	SENT_144	[p8l8t2772r404b2823],
7	9.775	CD	NUMBER	9.775	npadvmod	8	SENT_144	[p8l741t2771r899b2823],
8	<	JJR	O	<	amod	5	SENT_144	[p8l1215t2772r1412b2823],
9	0.001	CD	NUMBER	0.001	dep	11	SENT_144	[p8l1215t2772r1412b2823],
10	3.361	CD	NUMBER	3.361	num	11	SENT_144	[p8l1755t2771r2153b2823],
11	—	NN	O	—	dep	19	SENT_144	[p8l1755t2771r2153b2823],
12	28.432	CD	NUMBER	28.432	number	13	SENT_144	[p8l1755t2771r2153b2823],
13	0.597	CD	NUMBER	0.597	num	14	SENT_144	[p8l6t2876r369b2928],
14	—	NN	O	—	dep	11	SENT_144	[p8l6t2876r369b2928],
15	3.164	CD	NUMBER	3.164	number	16	SENT_144	[p8l6t2876r369b2928],
16	1.073	CD	NUMBER	1.073	num	18	SENT_144	[p8l746t2877r898b2928],
17	0.882	CD	NUMBER	0.882	number	18	SENT_144	[p8l1256t2877r1417b2928],
18	0.420	CD	NUMBER	0.420	dep	14	SENT_144	[p8l1754t2876r2114b2928],
19	—	NN	O	—	dep	22	SENT_144	[p8l1754t2876r2114b2928],
20	2.745	CD	NUMBER	2.745	num	19	SENT_144	[p8l1754t2876r2114b2928],
21	0357-2200	CD	DURATION	0357-2200	num	22	SENT_144	[p8l6t2982r369b3033],
22	0.588	CD	NUMBER	0.588	dep	34	SENT_144	[p8l740t2982r899b3033],
23	0.283	CD	NUMBER	0.283	number	24	SENT_144	[p8l1256t2982r1414b3033],
24	0.223	CD	NUMBER	0.223	dep	22	SENT_144	[p8l1754t2981r2117b3033],
25	—	NN	O	—	nn	27	SENT_144	[p8l1754t2981r2117b3033],
26	1.550	CD	NUMBER	1.550	num	27	SENT_144	[p8l1754t2981r2117b3033],
27	O.	NNP	O	O.	dep	24	SENT_144	[p8l6t3085r369b3137],
28	350	CD	NUMBER	350	number	29	SENT_144	[p8l6t3085r369b3137],
29	—	CD	NUMBER	—	num	31	SENT_144	[p8l6t3085r369b3137],
30	2.364	CD	NUMBER	2.364	number	31	SENT_144	[p8l6t3085r369b3137],
31	0.637	CD	NUMBER	0.637	dep	24	SENT_144	[p8l740t3085r900b3137],
32	0.369	CD	NUMBER	0.369	num	34	SENT_144	[p8l1256t3085r1416b3138],
33	0.239	CD	NUMBER	0.239	num	34	SENT_144	[p8l1754t3086r2117b3138],
34	—	NN	O	—	dep	43	SENT_144	[p8l1754t3086r2117b3138],
35	1.704	CD	NUMBER	1.704	num	36	SENT_144	[p8l1754t3086r2117b3138],
36	O.	NNP	O	O.	dep	34	SENT_144	[p8l6t3177r363b3228],
37	684	CD	NUMBER	684	num	36	SENT_144	[p8l6t3177r363b3228],
38	—	CD	NUMBER	—	number	39	SENT_144	[p8l6t3177r363b3228],
39	5.651	CD	NUMBER	5.651	num	41	SENT_144	[p8l6t3177r363b3228],
40	3.492	CD	NUMBER	3.492	number	41	SENT_144	[p8l742t3177r902b3229],
41	0.016	CD	NUMBER	0.016	dep	36	SENT_144	[p8l1256t3177r1417b3228],
42	1.268	CD	NUMBER	1.268	num	43	SENT_144	[p8l1760t3177r2117b3229],
43	—	NN	O	—	dep	51	SENT_144	[p8l1760t3177r2117b3229],
44	9.614	CD	NUMBER	9.614	number	45	SENT_144	[p8l1760t3177r2117b3229],
45	0.199	CD	NUMBER	0.199	num	46	SENT_144	[p8l6t3282r369b3334],
46	—	NN	O	—	dep	43	SENT_144	[p8l6t3282r369b3334],
47	1.472	CD	NUMBER	1.472	number	48	SENT_144	[p8l6t3282r369b3334],
48	0.213	CD	NUMBER	0.213	num	50	SENT_144	[p8l740t3282r898b3333],
49	0.021	CD	NUMBER	0.021	number	50	SENT_144	[p8l1256t3282r1412b3333],
50	0.057	CD	NUMBER	0.057	dep	46	SENT_144	[p8l1754t3281r2114b3334],
51	—	NN	O	—	dep	54	SENT_144	[p8l1754t3281r2114b3334],
52	0.795	CD	NUMBER	0.795	num	51	SENT_144	[p8l1754t3281r2114b3334],
53	0.370	CD	NUMBER	0.370	num	54	SENT_144	[p8l6t3372r366b3424],
54	—	NN	O	—	dep	59	SENT_144	[p8l6t3372r366b3424],
55	2.805	CD	NUMBER	2.805	number	56	SENT_144	[p8l6t3372r366b3424],
56	1.006	CD	NUMBER	1.006	dep	54	SENT_144	[p8l746t3373r901b3424],
57	0.991	CD	NUMBER	0.991	num	58	SENT_144	[p8l1256t3373r1412b3425],
58	0.351	CD	NUMBER	0.351	dep	56	SENT_144	[p8l1754t3373r2115b3424],
59	—	NN	O	—	dep	62	SENT_144	[p8l1754t3373r2115b3424],
60	2.878	CD	NUMBER	2.878	num	59	SENT_144	[p8l1754t3373r2115b3424],
61	0.027	CD	NUMBER	0.027	num	62	SENT_144	[p8l6t3478r367b3530],
62	—	NN	O	—	dep	67	SENT_144	[p8l6t3478r367b3530],
63	1.768	CD	NUMBER	1.768	number	64	SENT_144	[p8l6t3478r367b3530],
64	0.496	CD	NUMBER	0.496	dep	62	SENT_144	[p8l740t3478r901b3531],
65	0.366	CD	NUMBER	0.366	num	66	SENT_144	[p8l1256t3478r1417b3530],
66	0.108	CD	NUMBER	0.108	dep	64	SENT_144	[p8l1754t3478r2115b3530],
67	—	NN	O	—	dep	70	SENT_144	[p8l1754t3478r2115b3530],
68	2.267	CD	NUMBER	2.267	num	67	SENT_144	[p8l1754t3478r2115b3530],
69	0.249	CD	NUMBER	0.249	num	70	SENT_144	[p8l6t3570r367b3622],
70	—	NN	O	—	dep	77	SENT_144	[p8l6t3570r367b3622],
71	1.578	CD	NUMBER	1.578	number	72	SENT_144	[p8l6t3570r367b3622],
72	0.333	CD	NUMBER	0.333	dep	70	SENT_144	[p8l740t3570r898b3622],
73	0.592	CD	NUMBER	0.592	num	74	SENT_144	[p8l1256t3570r1417b3622],
74	0.205	CD	NUMBER	0.205	dep	72	SENT_144	[p8l1754t3570r2117b3622],
75	—	NN	O	—	nn	77	SENT_144	[p8l1754t3570r2117b3622],
76	1.712	CD	NUMBER	1.712	num	77	SENT_144	[p8l1754t3570r2117b3622],
77	O.	NNP	O	O.	dep	84	SENT_144	[p8l6t3675r369b3727],
78	158	CD	NUMBER	158	num	79	SENT_144	[p8l6t3675r369b3727],
79	—	CD	NUMBER	—	dep	77	SENT_144	[p8l6t3675r369b3727],
80	3.372	CD	NUMBER	3.372	number	81	SENT_144	[p8l6t3675r369b3727],
81	0.830	CD	NUMBER	0.830	num	83	SENT_144	[p8l740t3676r902b3727],
82	0.819	CD	NUMBER	0.819	number	83	SENT_144	[p8l1256t3676r1416b3728],
83	0.169	CD	NUMBER	0.169	dep	79	SENT_144	[p8l1754t3675r2116b3728],
84	—	NN	O	—	_	0	SENT_144	[p8l1754t3675r2116b3728],
85	4.086	CD	NUMBER	4.086	num	84	SENT_144	[p8l1754t3675r2116b3728],

1	0.262	CD	NUMBER	0.262	_	0	SENT_145	[p9l6t26r369b78],
2	—	CD	NUMBER	—	number	3	SENT_145	[p9l6t26r369b78],
3	4	CD	NUMBER	4	num	1	SENT_145	[p9l6t26r369b78],
4	.	.	O	.	_	0	SENT_145	[p9l6t26r369b78],

1	l94	NN	O	l94	_	0	SENT_146	[p9l6t26r369b78],
2	0.857	CD	NUMBER	0.857	number	3	SENT_146	[p9l740t26r900b78],
3	0.858	CD	NUMBER	0.858	dep	1	SENT_146	[p9l1256t26r1415b78],
4	0	CD	NUMBER	0	dep	3	SENT_146	[p9l1754t26r2115b78],
5	.	.	O	.	_	0	SENT_146	[p9l1754t26r2115b78],

1	l59	NN	O	l59	_	0	SENT_147	[p9l1754t26r2115b78],
2	—	CD	NUMBER	—	number	3	SENT_147	[p9l1754t26r2115b78],
3	4.6	CD	NUMBER	4.6	dep	1	SENT_147	[p9l1754t26r2115b78],
4	l8	NN	O	l8	dep	3	SENT_147	[p9l1754t26r2115b78],

1	3	CD	NUMBER	3	nsubj	2	SENT_148	[p9l61t128r83b153],
2	Covariate	NNP	O	Covariate	_	0	SENT_148	[p9l116t129r402b180],
3	.	.	O	.	_	0	SENT_148	[p9l116t129r402b180],
4	'	''	O	'	_	0	SENT_148	[p9l56t199r81b236],

1	3	CD	NUMBER	3	_	0	SENT_149	[p9l56t199r81b236],
2	As	IN	O	as	dep	1	SENT_149	[p9l115t213r191b263],
3	reference	NN	O	reference	nn	4	SENT_149	[p9l211t212r476b263],
4	group	NN	O	group	pobj	2	SENT_149	[p9l497t228r675b278],
5	.	.	O	.	_	0	SENT_149	[p9l497t228r675b278],

1	an	DT	O	a	det	4	SENT_150	[p9l10t422r90b465],
2	increased	VBN	O	increase	amod	4	SENT_150	[p9l127t402r463b465],
3	HR	NN	DURATION	hr	nn	4	SENT_150	[p9l499t404r621b464],
4	mortality	NN	O	mortality	_	0	SENT_150	[p9l657t402r982b483],
5	in	IN	O	in	_	0	SENT_150	[p9l1019t402r1086b464],
6	patients	NNS	O	patient	dep	7	SENT_150	[p9l1121t402r1396b483],
7	older	JJR	O	older	prep_in	4	SENT_150	[p9l1436t402r1618b465],
8	than	IN	O	than	_	0	SENT_150	[p9l1653t402r1804b465],
9	24	CD	DURATION	24	num	10	SENT_150	[p9l1843t402r1927b464],
10	years	NNS	NUMBER	year	prep_than	7	SENT_150	[p9l1965t422r2149b483],
11	(	CD	NUMBER	(	num	12	SENT_150	[p9l11t508r160b585],
12	HR	NN	DURATION	hr	dep	10	SENT_150	[p9l11t508r160b585],
13	=	JJ	O	=	amod	7	SENT_150	[p9l178t534r224b559],
14	0.415	CD	NUMBER	0.415	tmod	13	SENT_150	[p9l243t507r460b582],
15	,	,	O	,	_	0	SENT_150	[p9l243t507r460b582],
16	95	CD	PERCENT	95	number	17	SENT_150	[p9l489t507r646b571],
17	%	NN	PERCENT	%	amod	18	SENT_150	[p9l489t507r646b571],
18	CI	NN	O	ci	appos	7	SENT_150	[p9l675t508r761b571],
19	[	CD	NUMBER	[	number	20	SENT_150	[p9l792t507r1338b585],
20	0.199	CD	NUMBER	0.199	num	21	SENT_150	[p9l792t507r1338b585],
21	—	NN	O	—	dep	7	SENT_150	[p9l792t507r1338b585],
22	0.863	CD	NUMBER	0.863	number	23	SENT_150	[p9l792t507r1338b585],
23	]	CD	NUMBER	]	num	24	SENT_150	[p9l792t507r1338b585],
24	)	NN	O	)	dep	21	SENT_150	[p9l792t507r1338b585],
25	.	.	O	.	_	0	SENT_150	[p9l792t507r1338b585],

1	Regarding	VBG	O	regard	_	0	SENT_151	[p9l115t616r483b697],
2	WBC	NN	ORGANIZATION	wbc	nn	3	SENT_151	[p9l501t617r702b679],
3	count	NN	O	count	prep_regarding	11	SENT_151	[p9l722t626r919b679],
4	at	IN	O	at	_	0	SENT_151	[p9l937t625r999b679],
5	diagnosis	NN	O	diagnosis	prep_at	3	SENT_151	[p9l1017t616r1370b697],
6	,	,	O	,	_	0	SENT_151	[p9l1017t616r1370b697],
7	on	IN	O	on	_	0	SENT_151	[p9l1393t636r1479b679],
8	univariate	JJ	O	univariate	amod	9	SENT_151	[p9l1496t616r1847b679],
9	analysis	NN	O	analysis	prep_on	3	SENT_151	[p9l1867t616r2149b697],
10	we	PRP	O	we	nsubj	11	SENT_151	[p9l8t743r109b786],
11	found	VBD	O	find	_	0	SENT_151	[p9l134t723r341b786],
12	an	DT	O	a	det	14	SENT_151	[p9l366t743r446b786],
13	increased	VBN	O	increase	amod	14	SENT_151	[p9l470t723r806b786],
14	risk	NN	O	risk	dobj	11	SENT_151	[p9l828t723r962b786],
15	of	IN	O	of	_	0	SENT_151	[p9l986t723r1063b786],
16	mortality	NN	O	mortality	prep_of	14	SENT_151	[p9l1081t723r1405b804],
17	among	IN	O	among	_	0	SENT_151	[p9l1432t743r1670b804],
18	patients	NNS	O	patient	prep_among	11	SENT_151	[p9l1694t723r1968b804],
19	with	IN	O	with	_	0	SENT_151	[p9l1995t723r2151b786],
20	WBC	NN	ORGANIZATION	wbc	dep	21	SENT_151	[p9l7t828r378b892],
21	>	JJR	O	>	prep_with	11	SENT_151	[p9l7t828r378b892],
22	50	CD	NUMBER	50	number	23	SENT_151	[p9l7t828r378b892],
23	X	NN	O	x	amod	21	SENT_151	[p9l407t848r453b890],
24	109	CD	NUMBER	109	num	25	SENT_151	[p9l489t811r601b892],
25	L	NN	O	l	dep	21	SENT_151	[p9l624t830r676b891],
26	(	CD	NUMBER	(	num	29	SENT_151	[p9l714t811r824b907],
27	X2	NN	O	x2	nn	29	SENT_151	[p9l714t811r824b907],
28	test	NN	O	test	nn	29	SENT_151	[p9l864t838r987b891],
29	p	NN	O	p	dep	25	SENT_151	[p9l1012t829r1393b909],
30	=	JJ	O	=	dep	36	SENT_151	[p9l1012t829r1393b909],
31	0.006	CD	NUMBER	0.006	num	32	SENT_151	[p9l1012t829r1393b909],
32	)	NN	O	)	dep	30	SENT_151	[p9l1012t829r1393b909],
33	,	,	O	,	_	0	SENT_151	[p9l1012t829r1393b909],
34	whilst	IN	O	whilst	mark	36	SENT_151	[p9l1432t829r1649b892],
35	there	EX	O	there	expl	36	SENT_151	[p9l1682t829r1858b891],
36	was	VBD	O	be	parataxis	11	SENT_151	[p9l1894t849r2027b892],
37	no	DT	O	no	det	39	SENT_151	[p9l2064t849r2150b891],
38	signiﬁcant	NN	O	signiﬁcant	nn	39	SENT_151	[p9l11t936r380b1017],
39	correlation	NN	O	correlation	npadvmod	42	SENT_151	[p9l410t936r794b999],
40	between	IN	O	between	_	0	SENT_151	[p9l824t936r1121b999],
41	WBC	NNP	ORGANIZATION	WBC	prep_between	39	SENT_151	[p9l1151t937r1352b999],
42	>	JJR	O	>	acomp	36	SENT_151	[p9l1372t952r1418b998],
43	10	CD	NUMBER	10	num	44	SENT_151	[p9l1444t937r1522b999],
44	X	NN	O	x	dobj	11	SENT_151	[p9l1551t956r1597b997],
45	109	CD	NUMBER	109	num	46	SENT_151	[p9l1634t919r1745b999],
46	L	NN	O	l	dep	44	SENT_151	[p9l1767t938r1820b998],
47	and	CC	O	and	_	0	SENT_151	[p9l1853t936r1979b999],
48	outcome	NN	O	outcome	conj_and	44	SENT_151	[p9l2011t946r2149b999, p9l9t1040r217b1083],
49	.	.	O	.	_	0	SENT_151	[p9l2011t946r2149b999, p9l9t1040r217b1083],

1	We	PRP	O	we	nsubj	3	SENT_152	[p9l114t1129r229b1189],
2	also	RB	O	also	advmod	3	SENT_152	[p9l289t1127r427b1189],
3	evaluated	VBD	O	evaluate	_	0	SENT_152	[p9l486t1127r821b1189],
4	the	DT	O	the	det	5	SENT_152	[p9l878t1127r984b1189],
5	association	NN	O	association	dobj	3	SENT_152	[p9l1043t1127r1437b1189],
6	between	IN	O	between	_	0	SENT_152	[p9l1492t1127r1789b1189],
7	MTHFR	NN	O	mthfr	prep_between	5	SENT_152	[p9l1845t1129r2152b1188],

1	C677T	NN	O	c677t	nn	4	SENT_153	[p9l9t1234r254b1297],
2	and	CC	O	and	_	0	SENT_153	[p9l289t1234r414b1297],
3	A1298C	NN	O	a1298c	conj_and	1	SENT_153	[p9l446t1234r746b1298],
4	polymorphisms	NNS	O	polymorphism	nsubj	20	SENT_153	[p9l779t1234r1332b1315],
5	and	CC	O	and	_	0	SENT_153	[p9l1369t1234r1495b1297],
6	MTX	NN	O	mtx	nn	7	SENT_153	[p9l1527t1236r1723b1296],
7	intolerance	NN	O	intolerance	nsubj	20	SENT_153	[p9l1756t1234r2150b1297],
8	in	IN	O	in	_	0	SENT_153	[p9l8t1340r75b1401],
9	a	DT	O	a	det	10	SENT_153	[p9l104t1359r141b1402],
10	subset	NN	O	subset	prep_in	7	SENT_153	[p9l170t1340r389b1402],
11	of	IN	O	of	_	0	SENT_153	[p9l416t1340r493b1402],
12	55	CD	NUMBER	55	num	13	SENT_153	[p9l516t1339r597b1403],
13	patients	NNS	O	patient	prep_of	10	SENT_153	[p9l628t1340r902b1421],
14	receiving	VBG	O	receive	partmod	13	SENT_153	[p9l931t1340r1258b1421],
15	homogenous	JJ	O	homogenous	amod	19	SENT_153	[p9l1286t1340r1760b1421],
16	,	,	O	,	_	0	SENT_153	[p9l1286t1340r1760b1421],
17	prolonged	JJ	O	prolonged	amod	19	SENT_153	[p9l1790t1340r2152b1421],
18	MTX	NN	O	mtx	nn	19	SENT_153	[p9l8t1448r438b1511],
19	—	NN	O	—	dobj	14	SENT_153	[p9l8t1448r438b1511],
20	based	VBN	O	base	_	0	SENT_153	[p9l8t1448r438b1511],
21	maintenance	NN	O	maintenance	nn	22	SENT_153	[p9l462t1448r911b1511],
22	regimen	NNS	O	regimen	dobj	20	SENT_153	[p9l935t1448r1226b1529],
23	for	IN	O	for	_	0	SENT_153	[p9l1251t1448r1354b1511],
24	almost	RB	O	almost	quantmod	25	SENT_153	[p9l1379t1448r1615b1511],
25	2	CD	DURATION	2	num	26	SENT_153	[p9l1639t1449r1679b1510],
26	years	NNS	NUMBER	year	prep_for	22	SENT_153	[p9l1705t1468r1909b1529],
27	.	.	O	.	_	0	SENT_153	[p9l1705t1468r1909b1529],

1	The	DT	O	the	det	4	SENT_154	[p9l115t1555r251b1618],
2	remaining	VBG	O	remain	amod	4	SENT_154	[p9l276t1555r636b1636],
3	27	CD	NUMBER	27	num	4	SENT_154	[p9l663t1555r745b1618],
4	patients	NNS	O	patient	nsubjpass	33	SENT_154	[p9l772t1555r1046b1636],
5	were	VBD	O	be	auxpass	6	SENT_154	[p9l1074t1575r1244b1618],
6	considered	VBN	O	consider	_	0	SENT_154	[p9l1270t1555r1655b1618],
7	not	RB	O	not	neg	8	SENT_154	[p9l1679t1565r1792b1618],
8	evaluable	JJ	O	evaluable	acomp	6	SENT_154	[p9l1816t1555r2150b1618],
9	for	IN	O	for	_	0	SENT_154	[p9l8t1661r112b1723],
10	toxicity	NN	O	toxicity	prep_for	8	SENT_154	[p9l138t1661r408b1742],
11	because	IN	O	because	mark	25	SENT_154	[p9l436t1661r717b1723],
12	high	JJ	O	high	amod	14	SENT_154	[p9l745t1661r1068b1742],
13	—	NN	O	—	nn	14	SENT_154	[p9l745t1661r1068b1742],
14	risk	NN	O	risk	nsubj	25	SENT_154	[p9l745t1661r1068b1742],
15	leukemia	NN	O	leukemia	nn	16	SENT_154	[p9l1094t1661r1420b1723],
16	patients	NNS	O	patient	nsubjpass	19	SENT_154	[p9l1445t1661r1720b1742],
17	were	VBD	O	be	auxpass	19	SENT_154	[p9l1751t1680r1921b1723],
18	either	RB	O	either	advmod	19	SENT_154	[p9l1951t1660r2153b1723],
19	shifted	VBN	O	shift	rcmod	14	SENT_154	[p9l11t1769r250b1832],
20	to	TO	O	to	_	0	SENT_154	[p9l265t1779r331b1832],
21	hi	UH	O	hi	prep_to	19	SENT_154	[p9l347t1769r414b1831],
22	gh	SYM	O	gh	dep	25	SENT_154	[p9l418t1769r697b1850],
23	—	CD	NUMBER	—	num	25	SENT_154	[p9l418t1769r697b1850],
24	dose	NN	O	dose	nn	25	SENT_154	[p9l418t1769r697b1850],
25	chemotherapy	NN	O	chemotherapy	dep	6	SENT_154	[p9l714t1769r1216b1850],
26	and	CC	O	and	_	0	SENT_154	[p9l1235t1769r1360b1832],
27	stem	NN	O	stem	nn	30	SENT_154	[p9l1379t1769r1715b1832],
28	—	NN	O	—	nn	30	SENT_154	[p9l1379t1769r1715b1832],
29	cell	NN	O	cell	nn	30	SENT_154	[p9l1379t1769r1715b1832],
30	transplantation	NN	O	transplantation	conj_and	25	SENT_154	[p9l1731t1769r2149b1850, p9l8t1876r163b1950],
31	,	,	O	,	_	0	SENT_154	[p9l1731t1769r2149b1850, p9l8t1876r163b1950],
32	or	CC	O	or	_	0	SENT_154	[p9l183t1895r256b1938],
33	developed	VBD	O	develop	conj_or	6	SENT_154	[p9l271t1876r632b1957],
34	early	JJ	O	early	amod	35	SENT_154	[p9l647t1876r822b1957],
35	relapse	NN	O	relapse	dobj	33	SENT_154	[p9l837t1876r1088b1957],
36	after	IN	O	after	_	0	SENT_154	[p9l1106t1876r1267b1938],
37	induction	NN	O	induction	nn	38	SENT_154	[p9l1281t1876r1616b1938],
38	chemotherapy	NN	O	chemotherapy	prep_after	33	SENT_154	[p9l1632t1876r2147b1957],
39	.	.	O	.	_	0	SENT_154	[p9l1632t1876r2147b1957],

1	For	IN	O	for	_	0	SENT_155	[p9l115t1985r237b2046],
2	statistical	JJ	O	statistical	amod	3	SENT_155	[p9l266t1983r597b2046],
3	analysis	NN	O	analysis	prep_for	5	SENT_155	[p9l627t1983r908b2064],
4	we	PRP	O	we	nsubj	23	SENT_155	[p9l938t2003r1039b2046],
5	cumulated	VBD	O	cumulate	_	0	SENT_155	[p9l1067t1983r1437b2046],
6	data	NNS	O	datum	dobj	5	SENT_155	[p9l1465t1983r1612b2046],
7	from	IN	O	from	_	0	SENT_155	[p9l1638t1983r1810b2046],
8	homozygous	JJ	O	homozygous	amod	11	SENT_155	[p9l1835t1983r2149b2064, p9l9t2110r172b2171],
9	wild	JJ	O	wild	amod	11	SENT_155	[p9l190t2090r529b2171],
10	—	NN	O	—	nn	11	SENT_155	[p9l190t2090r529b2171],
11	type	NN	O	type	prep_from	5	SENT_155	[p9l190t2090r529b2171],
12	and	CC	O	and	_	0	SENT_155	[p9l547t2090r673b2153],
13	heterozygous	JJ	O	heterozygous	amod	14	SENT_155	[p9l686t2090r1159b2171],
14	patients	NNS	O	patient	prep_from	5	SENT_155	[p9l1175t2090r1450b2171],
15	and	CC	O	and	_	0	SENT_155	[p9l1469t2090r1595b2153],
16	compared	VBD	O	compare	conj_and	5	SENT_155	[p9l1610t2090r1960b2171],
17	them	PRP	O	they	dobj	16	SENT_155	[p9l1974t2090r2152b2153],
18	with	IN	O	with	_	0	SENT_155	[p9l8t2196r165b2258],
19	homozygous	JJ	O	homozygous	amod	21	SENT_155	[p9l195t2196r648b2277],
20	variant	JJ	O	variant	amod	21	SENT_155	[p9l682t2196r927b2258],
21	patients	NNS	O	patient	prep_with	16	SENT_155	[p9l956t2196r1251b2277],
22	,	,	O	,	_	0	SENT_155	[p9l956t2196r1251b2277],
23	considering	VBG	O	consider	conj_and	5	SENT_155	[p9l1287t2196r1700b2277],
24	the	DT	O	the	det	27	SENT_155	[p9l1732t2196r1839b2258],
25	residual	JJ	O	residual	amod	27	SENT_155	[p9l1870t2196r2151b2258],
26	enzyme	NN	O	enzyme	nn	27	SENT_155	[p9l9t2324r283b2385],
27	activity	NN	O	activity	dobj	23	SENT_155	[p9l310t2304r571b2385],
28	in	IN	O	in	_	0	SENT_155	[p9l597t2304r664b2366],
29	heterozygotes	NNS	O	heterozygote	prep_in	23	SENT_155	[p9l688t2304r1200b2385],
30	.	.	O	.	_	0	SENT_155	[p9l688t2304r1200b2385],

1	When	WRB	O	when	advmod	5	SENT_156	[p9l114t2411r327b2474],
2	MTHFR	NNP	O	MTHFR	nn	3	SENT_156	[p9l380t2413r687b2473],
3	C677T	NN	O	c677t	nsubjpass	5	SENT_156	[p9l741t2411r986b2474],
4	was	VBD	O	be	auxpass	5	SENT_156	[p9l1040t2431r1173b2474],
5	considered	VBN	O	consider	advcl	9	SENT_156	[p9l1230t2411r1633b2485],
6	,	,	O	,	_	0	SENT_156	[p9l1230t2411r1633b2485],
7	toxicity	NN	O	toxicity	nsubj	9	SENT_156	[p9l1690t2411r1960b2492],
8	was	VBD	O	be	cop	9	SENT_156	[p9l2016t2431r2149b2474],
9	present	JJ	DATE	present	dep	29	SENT_156	[p9l7t2526r265b2598],
10	in	IN	O	in	_	0	SENT_156	[p9l315t2517r382b2579],
11	19	CD	NUMBER	19	prep_in	9	SENT_156	[p9l441t2517r517b2580],
12	of	IN	O	of	_	0	SENT_156	[p9l571t2517r648b2579],
13	42	CD	NUMBER	42	num	14	SENT_156	[p9l693t2517r779b2578],
14	CC	NN	O	cc	prep_of	11	SENT_156	[p9l832t2517r946b2580],
15	plus	CC	O	plus	_	0	SENT_156	[p9l998t2517r1143b2598],
16	CT	NN	O	ct	nn	17	SENT_156	[p9l1197t2517r1308b2580],
17	patients	NNS	O	patient	prep_in	9	SENT_156	[p9l1358t2517r1632b2598],
18	(	VBP	O	(	rcmod	17	SENT_156	[p9l1689t2516r1971b2594],
19	45.2	CD	PERCENT	45.2	num	20	SENT_156	[p9l1689t2516r1971b2594],
20	%	NN	PERCENT	%	dobj	18	SENT_156	[p9l1689t2516r1971b2594],
21	)	CD	NUMBER	)	tmod	18	SENT_156	[p9l1689t2516r1971b2594],
22	and	CC	O	and	_	0	SENT_156	[p9l2026t2517r2152b2579],
23	in	IN	O	in	_	0	SENT_156	[p9l8t2625r75b2687],
24	12	CD	TIME	12	prep_in	9	SENT_156	[p9l137t2626r215b2687],
25	of	IN	TIME	of	_	0	SENT_156	[p9l271t2625r348b2688],
26	13	CD	TIME	13	num	28	SENT_156	[p9l404t2626r478b2688],
27	TT	NN	O	tt	nn	28	SENT_156	[p9l537t2627r644b2687],
28	patients	NNS	O	patient	prep_of	24	SENT_156	[p9l697t2625r971b2706],
29	(	VBP	O	(	_	0	SENT_156	[p9l1030t2626r1245b2703],
30	92	CD	PERCENT	92	num	31	SENT_156	[p9l1030t2626r1245b2703],
31	%	NN	PERCENT	%	dobj	29	SENT_156	[p9l1030t2626r1245b2703],
32	)	CD	NUMBER	)	num	34	SENT_156	[p9l1030t2626r1245b2703],
33	(	NN	O	(	nn	34	SENT_156	[p9l1305t2626r1727b2705],
34	p	NN	O	p	nsubj	29	SENT_156	[p9l1305t2626r1727b2705],
35	=	JJ	O	=	amod	34	SENT_156	[p9l1305t2626r1727b2705],
36	0.003	CD	NUMBER	0.003	tmod	35	SENT_156	[p9l1305t2626r1727b2705],
37	,	,	O	,	_	0	SENT_156	[p9l1305t2626r1727b2705],
38	)	CD	NUMBER	)	appos	36	SENT_156	[p9l1305t2626r1727b2705],
39	,	,	O	,	_	0	SENT_156	[p9l1305t2626r1727b2705],
40	with	IN	O	with	_	0	SENT_156	[p9l1785t2625r1941b2688],
41	7/12	CD	PERCENT	7/12	number	42	SENT_156	[p9l1995t2626r2150b2688],
42	(	CD	PERCENT	(	amod	45	SENT_156	[p9l11t2732r226b2809],
43	54	CD	PERCENT	54	num	44	SENT_156	[p9l11t2732r226b2809],
44	%	NN	PERCENT	%	dep	42	SENT_156	[p9l11t2732r226b2809],
45	)	CD	NUMBER	)	prep_with	35	SENT_156	[p9l11t2732r226b2809],
46	showing	VBG	O	show	partmod	45	SENT_156	[p9l250t2732r544b2813],
47	hepatic	JJ	O	hepatic	nsubj	54	SENT_156	[p9l563t2732r818b2813],
48	plus	CC	O	plus	prep	47	SENT_156	[p9l837t2732r983b2813],
49	hematopoietic	JJ	O	hematopoietic	amod	50	SENT_156	[p9l1003t2732r1505b2813],
50	toxicity	NN	O	toxicity	dep	48	SENT_156	[p9l1525t2732r1796b2813],
51	(	CD	NUMBER	(	num	54	SENT_156	[p9l1817t2732r2038b2809],
52	Table	NNP	O	Table	nn	54	SENT_156	[p9l1817t2732r2038b2809],
53	3	CD	NUMBER	3	num	54	SENT_156	[p9l2059t2732r2147b2809],
54	)	NN	O	)	xcomp	46	SENT_156	[p9l2059t2732r2147b2809],
55	.	.	O	.	_	0	SENT_156	[p9l2059t2732r2147b2809],

1	Regarding	VBG	O	regard	_	0	SENT_157	[p9l8t2839r375b2920],
2	MTHFR	NN	O	mthfr	nn	4	SENT_157	[p9l422t2841r729b2901],
3	A1298C	NN	O	a1298c	nn	4	SENT_157	[p9l774t2840r1073b2903],
4	genotype	NN	O	genotype	prep_regarding	9	SENT_157	[p9l1122t2849r1465b2920],
5	,	,	O	,	_	0	SENT_157	[p9l1122t2849r1465b2920],
6	MTX	NN	O	mtx	nn	7	SENT_157	[p9l1514t2841r1710b2901],
7	intolerance	NN	O	intolerance	nsubjpass	9	SENT_157	[p9l1757t2839r2151b2902],
8	was	VBD	O	be	auxpass	9	SENT_157	[p9l8t2966r142b3009],
9	encountered	VBN	O	encounter	_	0	SENT_157	[p9l184t2946r619b3009],
10	in	IN	O	in	_	0	SENT_157	[p9l658t2946r725b3008],
11	31	CD	NUMBER	31	prep_in	9	SENT_157	[p9l767t2946r844b3009],
12	of	IN	O	of	_	0	SENT_157	[p9l893t2946r970b3009],
13	51	CD	NUMBER	51	num	17	SENT_157	[p9l1005t2946r1082b3009],
14	homozygous	JJ	O	homozygous	amod	17	SENT_157	[p9l1130t2946r1582b3027],
15	wild	JJ	O	wild	amod	17	SENT_157	[p9l1625t2946r1964b3027],
16	—	NN	O	—	nn	17	SENT_157	[p9l1625t2946r1964b3027],
17	type	NN	O	type	prep_of	11	SENT_157	[p9l1625t2946r1964b3027],
18	plus	CC	O	plus	prep	17	SENT_157	[p9l2003t2946r2149b3027],
19	heterozygous	JJ	O	heterozygous	amod	20	SENT_157	[p9l7t3052r480b3133],
20	patients	NNS	O	patient	dep	18	SENT_157	[p9l519t3052r793b3133],
21	(	IN	O	(	_	0	SENT_157	[p9l837t3051r1141b3129],
22	60.7	CD	PERCENT	60.7	number	23	SENT_157	[p9l837t3051r1141b3129],
23	%	NN	PERCENT	%	num	24	SENT_157	[p9l837t3051r1141b3129],
24	)	CD	NUMBER	)	prep_(	9	SENT_157	[p9l837t3051r1141b3129],
25	,	,	O	,	_	0	SENT_157	[p9l837t3051r1141b3129],
26	whilst	IN	O	whilst	mark	33	SENT_157	[p9l1183t3052r1400b3115],
27	none	NN	O	none	nsubj	33	SENT_157	[p9l1436t3071r1607b3114],
28	of	IN	O	of	_	0	SENT_157	[p9l1647t3052r1723b3114],
29	4	CD	NUMBER	4	num	32	SENT_157	[p9l1755t3052r1797b3113],
30	homozygous	JJ	O	homozygous	amod	32	SENT_157	[p9l1835t3052r2149b3133, p9l9t3180r172b3241],
31	variant	JJ	O	variant	amod	32	SENT_157	[p9l206t3160r451b3223],
32	patients	NNS	O	patient	prep_of	27	SENT_157	[p9l480t3160r755b3241],
33	developed	VBD	O	develop	dep	9	SENT_157	[p9l789t3160r1151b3241],
34	toxic	JJ	O	toxic	amod	35	SENT_157	[p9l1181t3160r1356b3223],
35	complications	NNS	O	complication	dobj	33	SENT_157	[p9l1390t3160r1886b3241],
36	during	IN	O	during	_	0	SENT_157	[p9l1921t3160r2150b3241],
37	maintenance	NN	O	maintenance	nn	38	SENT_157	[p9l8t3267r457b3330],
38	therapy	NN	O	therapy	prep_during	33	SENT_157	[p9l513t3267r790b3348],
39	.	.	O	.	_	0	SENT_157	[p9l513t3267r790b3348],

1	None	NN	O	none	nsubj	5	SENT_158	[p9l851t3269r1042b3330],
2	of	IN	O	of	_	0	SENT_158	[p9l1100t3267r1177b3330],
3	the	DT	O	the	det	4	SENT_158	[p9l1227t3267r1333b3330],
4	patients	NNS	O	patient	prep_of	1	SENT_158	[p9l1389t3267r1663b3348],
5	included	VBD	O	include	_	0	SENT_158	[p9l1722t3267r2028b3330],
6	in	IN	O	in	mark	10	SENT_158	[p9l2084t3267r2151b3329],
7	the	DT	O	the	det	9	SENT_158	[p9l8t3373r114b3435],
8	maintenance	NN	O	maintenance	nn	9	SENT_158	[p9l152t3373r601b3435],
9	group	NN	O	group	nsubj	10	SENT_158	[p9l640t3392r844b3454],
10	died	VBD	O	die	advcl	5	SENT_158	[p9l884t3373r1036b3435],
11	for	IN	O	for	_	0	SENT_158	[p9l1073t3373r1176b3435],
12	toxicity	NN	O	toxicity	prep_for	10	SENT_158	[p9l1212t3373r1494b3454],
13	.	.	O	.	_	0	SENT_158	[p9l1212t3373r1494b3454],

1	One	CD	NUMBER	one	num	2	SENT_159	[p9l1538t3373r1683b3436],
2	patient	NN	O	patient	nsubj	3	SENT_159	[p9l1720t3373r1963b3454],
3	died	VBD	O	die	_	0	SENT_159	[p9l2000t3373r2152b3435],
4	for	IN	O	for	_	0	SENT_159	[p9l8t3481r112b3544],
5	pulmonary	JJ	O	pulmonary	amod	6	SENT_159	[p9l153t3481r539b3562],
6	embolism	NN	O	embolism	prep_for	3	SENT_159	[p9l586t3481r936b3544],
7	and	CC	O	and	_	0	SENT_159	[p9l982t3481r1108b3544],
8	another	DT	O	another	det	9	SENT_159	[p9l1154t3481r1419b3544],
9	one	CD	NUMBER	one	prep_for	3	SENT_159	[p9l1464t3501r1589b3544],
10	for	IN	O	for	_	0	SENT_159	[p9l1635t3481r1738b3544],
11	Hodgkin	NN	PERSON	hodgkin	poss	13	SENT_159	[p9l1781t3481r2149b3562],
12	’s	POS	O	’s	_	0	SENT_159	[p9l1781t3481r2149b3562],
13	disease	NN	O	disease	prep_for	3	SENT_159	[p9l9t3587r282b3649],
14	.	.	O	.	_	0	SENT_159	[p9l9t3587r282b3649],

1	In	IN	O	in	_	0	SENT_160	[p9l114t3696r186b3756],
2	this	DT	O	this	det	3	SENT_160	[p9l206t3694r330b3757],
3	subgroup	NN	O	subgroup	pobj	1	SENT_160	[p9l355t3694r681b3775],
4	of	IN	O	of	_	0	SENT_160	[p9l704t3694r780b3757],
5	patients	NNS	O	patient	prep_of	3	SENT_160	[p9l793t3694r1067b3775],
6	receiving	VBG	O	receive	partmod	5	SENT_160	[p9l1089t3694r1416b3775],
7	homogeneous	JJ	O	homogeneous	amod	8	SENT_160	[p9l1437t3694r1928b3775],
8	MTX	NN	O	mtx	dobj	6	SENT_160	[p9l1950t3696r2147b3756],

1	treatment	NN	O	treatment	nsubj	5	SENT_161	[p10l7t29r360b93],
2	,	,	O	,	_	0	SENT_161	[p10l7t29r360b93],
3	677TT	NN	O	677tt	nn	4	SENT_161	[p10l392t19r630b82],
4	individuals	NNS	O	individual	appos	1	SENT_161	[p10l656t20r1047b82],
5	had	VBD	O	have	_	0	SENT_161	[p10l1074t20r1202b82],
6	a	DT	O	a	det	8	SENT_161	[p10l1229t39r1266b82],
7	worse	JJR	O	worse	amod	8	SENT_161	[p10l1291t39r1500b82],
8	outcome	NN	O	outcome	dobj	5	SENT_161	[p10l1527t29r1831b82],
9	in	IN	O	in	_	0	SENT_161	[p10l1857t20r1925b81],
10	terms	NNS	O	term	prep_in	8	SENT_161	[p10l1951t29r2144b82],
11	of	IN	O	of	_	0	SENT_161	[p10l8t127r85b190],
12	mortality	NN	O	mortality	prep_of	10	SENT_161	[p10l107t127r431b208],
13	than	IN	O	than	_	0	SENT_161	[p10l461t127r612b190],
14	wild	JJ	O	wild	amod	17	SENT_161	[p10l641t127r979b208],
15	—	NN	O	—	nn	17	SENT_161	[p10l641t127r979b208],
16	type	NN	O	type	nn	17	SENT_161	[p10l641t127r979b208],
17	patients	NNS	O	patient	prep_than	5	SENT_161	[p10l1008t127r1282b208],
18	in	IN	O	in	_	0	SENT_161	[p10l1312t127r1380b189],
19	multivariate	JJ	O	multivariate	amod	20	SENT_161	[p10l1408t127r1832b190],
20	analysis	NN	O	analysis	prep_in	17	SENT_161	[p10l1863t127r2144b208],
21	(	CD	NUMBER	(	num	22	SENT_161	[p10l9t234r159b309],
22	HR	NN	DURATION	hr	dep	17	SENT_161	[p10l9t234r159b309],
23	=	JJ	O	=	amod	22	SENT_161	[p10l177t259r222b284],
24	0.213	CD	NUMBER	0.213	tmod	23	SENT_161	[p10l241t233r458b306],
25	,	,	O	,	_	0	SENT_161	[p10l241t233r458b306],
26	95	CD	PERCENT	95	number	27	SENT_161	[p10l487t233r643b296],
27	%	NN	PERCENT	%	amod	28	SENT_161	[p10l487t233r643b296],
28	CI	NN	O	ci	appos	17	SENT_161	[p10l673t233r759b295],
29	[	CD	NUMBER	[	number	30	SENT_161	[p10l790t233r1314b309],
30	0.057	CD	NUMBER	0.057	num	28	SENT_161	[p10l790t233r1314b309],
31	.	.	O	.	_	0	SENT_161	[p10l790t233r1314b309],

1	—	NN	O	—	_	0	SENT_162	[p10l790t233r1314b309],
2	.	.	O	.	_	0	SENT_162	[p10l790t233r1314b309],

1	O.	NNP	O	O.	_	0	SENT_163	[p10l790t233r1314b309],
2	795	CD	NUMBER	795	number	3	SENT_163	[p10l790t233r1314b309],
3	]	CD	NUMBER	]	dep	1	SENT_163	[p10l790t233r1314b309],
4	)	NN	O	)	dep	3	SENT_163	[p10l790t233r1314b309],
5	(	CD	NUMBER	(	num	4	SENT_163	[p10l1344t233r1564b309],
6	Table	NNP	O	Table	dep	1	SENT_163	[p10l1344t233r1564b309],
7	4	CD	NUMBER	4	number	8	SENT_163	[p10l1589t233r1679b309],
8	)	CD	NUMBER	)	dep	6	SENT_163	[p10l1589t233r1679b309],
9	.	.	O	.	_	0	SENT_163	[p10l1589t233r1679b309],

1	4	LS	NUMBER	4	_	0	SENT_164	[p10l7t471r69b533],
2	.	.	O	.	_	0	SENT_164	[p10l7t471r69b533],

1	Discussion	NN	O	discussion	_	0	SENT_165	[p10l118t470r518b533],

1	In	IN	O	in	_	0	SENT_166	[p10l114t686r186b746],
2	this	DT	O	this	det	3	SENT_166	[p10l212t684r336b747],
3	study	NN	O	study	prep_in	5	SENT_166	[p10l368t684r555b765],
4	we	PRP	O	we	nsubj	5	SENT_166	[p10l583t704r683b747],
5	evaluated	VBD	O	evaluate	_	0	SENT_166	[p10l711t684r1046b747],
6	the	DT	O	the	det	7	SENT_166	[p10l1071t684r1178b747],
7	inﬂuence	NN	O	inﬂuence	dobj	5	SENT_166	[p10l1205t684r1529b747],
8	of	IN	O	of	_	0	SENT_166	[p10l1557t684r1634b747],
9	standard	JJ	O	standard	amod	11	SENT_166	[p10l1657t684r1955b747],
10	risks	NNS	O	risk	nn	11	SENT_166	[p10l1980t684r2144b747],
11	factor	NN	O	factor	prep_of	7	SENT_166	[p10l7t791r214b854],
12	(	RB	O	(	advmod	5	SENT_166	[p10l253t792r350b868],
13	as	IN	O	as	_	0	SENT_166	[p10l253t792r350b868],
14	cytogenetics	NNS	O	cytogenetic	nn	15	SENT_166	[p10l392t791r832b872],
15	features	NNS	O	feature	prep_as	5	SENT_166	[p10l873t791r1172b865],
16	,	,	O	,	_	0	SENT_166	[p10l873t791r1172b865],
17	WBC	NN	ORGANIZATION	wbc	nn	18	SENT_166	[p10l1212t791r1413b854],
18	count	NN	O	count	prep_as	5	SENT_166	[p10l1454t801r1651b854],
19	at	IN	O	at	_	0	SENT_166	[p10l1690t800r1752b854],
20	diagnosis	NN	O	diagnosis	prep_at	18	SENT_166	[p10l1790t791r2143b872],
21	,	,	O	,	_	0	SENT_166	[p10l1790t791r2143b872],
22	sex	NN	O	sex	prep_as	5	SENT_166	[p10l10t916r141b971],
23	,	,	O	,	_	0	SENT_166	[p10l10t916r141b971],
24	and	CC	O	and	_	0	SENT_166	[p10l176t897r301b959],
25	immunological	JJ	O	immunological	amod	27	SENT_166	[p10l330t897r868b978],
26	phenotype	NN	O	phenotype	nn	27	SENT_166	[p10l897t897r1295b978],
27	)	NN	O	)	conj_and	15	SENT_166	[p10l897t897r1295b978],
28	and	CC	O	and	_	0	SENT_166	[p10l1329t897r1454b959],
29	MTHFR	NN	O	mthfr	nn	30	SENT_166	[p10l1483t898r1790b958],
30	polymorphisms	NNS	O	polymorphism	conj_and	15	SENT_166	[p10l1817t897r2144b978, p10l6t1005r255b1086],
31	on	IN	O	on	_	0	SENT_166	[p10l294t1025r380b1068],
32	OS	NNP	O	OS	prep_on	5	SENT_166	[p10l417t1006r522b1068],
33	and	CC	O	and	_	0	SENT_166	[p10l564t1005r689b1068],
34	EFS	NNP	O	EFS	prep_on	5	SENT_166	[p10l724t1006r871b1068],
35	in	IN	O	in	_	0	SENT_166	[p10l911t1005r978b1067],
36	a	DT	O	a	det	37	SENT_166	[p10l1015t1025r1052b1068],
37	population	NN	O	population	prep_in	5	SENT_166	[p10l1085t1005r1466b1086],
38	of	IN	O	of	_	0	SENT_166	[p10l1502t1005r1579b1068],
39	82	CD	NUMBER	82	num	42	SENT_166	[p10l1612t1006r1695b1068],
40	consecutive	JJ	O	consecutive	amod	42	SENT_166	[p10l1732t1005r2146b1068],
41	adult	JJ	O	adult	amod	42	SENT_166	[p10l9t1112r185b1175],
42	patients	NNS	O	patient	prep_of	37	SENT_166	[p10l207t1112r481b1193],
43	affected	VBN	O	affect	partmod	42	SENT_166	[p10l509t1112r791b1175],
44	by	IN	O	by	_	0	SENT_166	[p10l814t1112r901b1193],
45	ALL	NN	O	all	agent	43	SENT_166	[p10l926t1113r1116b1175],
46	.	.	O	.	_	0	SENT_166	[p10l926t1113r1116b1175],

1	It	PRP	O	it	nsubjpass	4	SENT_167	[p10l114t1219r167b1280],
2	has	VBZ	O	have	aux	4	SENT_167	[p10l222t1218r337b1280],
3	been	VBN	O	be	auxpass	4	SENT_167	[p10l396t1218r563b1280],
4	shown	VBN	O	show	_	0	SENT_167	[p10l623t1218r849b1280],
5	that	IN	O	that	complm	35	SENT_167	[p10l905t1218r1038b1280],
6	cytogenetic	JJ	O	cytogenetic	amod	7	SENT_167	[p10l1095t1218r1500b1299],
7	alterations	NNS	O	alteration	nsubj	35	SENT_167	[p10l1561t1218r1926b1280],
8	such	JJ	O	such	_	0	SENT_167	[p10l1988t1218r2147b1280],
9	as	IN	O	as	_	0	SENT_167	[p10l9t1346r76b1389],
10	t	NN	O	t	prep_such_as	7	SENT_167	[p10l139t1327r397b1404],
11	(	CD	NUMBER	(	number	12	SENT_167	[p10l139t1327r397b1404],
12	9	CD	NUMBER	9	dep	10	SENT_167	[p10l139t1327r397b1404],
13	;	:	O	;	_	0	SENT_167	[p10l139t1327r397b1404],
14	22	CD	NUMBER	22	num	15	SENT_167	[p10l139t1327r397b1404],
15	)	NN	O	)	dep	10	SENT_167	[p10l139t1327r397b1404],
16	,	,	O	,	_	0	SENT_167	[p10l139t1327r397b1404],
17	t	NN	O	t	appos	15	SENT_167	[p10l461t1327r696b1404],
18	(	CD	NUMBER	(	number	19	SENT_167	[p10l461t1327r696b1404],
19	4	CD	NUMBER	4	dep	17	SENT_167	[p10l461t1327r696b1404],
20	;	:	O	;	_	0	SENT_167	[p10l461t1327r696b1404],
21	ll	NN	O	ll	nn	22	SENT_167	[p10l461t1327r696b1404],
22	)	NN	O	)	dep	17	SENT_167	[p10l461t1327r696b1404],
23	and	CC	O	and	_	0	SENT_167	[p10l760t1326r885b1389],
24	z	SYM	O	z	dep	26	SENT_167	[p10l945t1327r1203b1404],
25	‘	CD	NUMBER	‘	number	26	SENT_167	[p10l945t1327r1203b1404],
26	(	CD	NUMBER	(	dep	17	SENT_167	[p10l945t1327r1203b1404],
27	l	NN	O	l	tmod	26	SENT_167	[p10l945t1327r1203b1404],
28	;	:	O	;	_	0	SENT_167	[p10l945t1327r1203b1404],
29	l9	NN	O	l9	nn	30	SENT_167	[p10l945t1327r1203b1404],
30	)	NN	O	)	dep	17	SENT_167	[p10l945t1327r1203b1404],
31	,	,	O	,	_	0	SENT_167	[p10l945t1327r1203b1404],
32	complex	NN	O	complex	nn	33	SENT_167	[p10l1265t1326r1568b1407],
33	karyotype	NN	O	karyotype	appos	30	SENT_167	[p10l1626t1326r1981b1407],
34	are	VBP	O	be	cop	35	SENT_167	[p10l2042t1346r2146b1389],
35	unfavorable	JJ	O	unfavorable	ccomp	4	SENT_167	[p10l6t1433r425b1496],
36	in	IN	O	in	_	0	SENT_167	[p10l485t1433r553b1495],
37	patients	NNS	O	patient	prep_in	35	SENT_167	[p10l611t1433r885b1514],
38	with	IN	O	with	_	0	SENT_167	[p10l947t1433r1103b1496],
39	ALL	NN	O	all	prep_with	37	SENT_167	[p10l1162t1433r1333b1495],
40	of	IN	O	of	_	0	SENT_167	[p10l1393t1433r1470b1495],
41	any	DT	O	any	det	42	SENT_167	[p10l1525t1452r1648b1514],
42	ages	NNS	O	age	prep_of	39	SENT_167	[p10l1710t1452r1882b1514],
43	.	.	O	.	_	0	SENT_167	[p10l1710t1452r1882b1514],

1	WBC	NN	ORGANIZATION	wbc	nn	2	SENT_168	[p10l1944t1433r2145b1496],
2	count	NN	O	count	nsubj	9	SENT_168	[p10l8t1550r204b1603],
3	>	JJR	O	>	dep	2	SENT_168	[p10l221t1556r267b1603],
4	50	CD	NUMBER	50	num	5	SENT_168	[p10l286t1540r371b1603],
5	x	NN	O	x	dep	2	SENT_168	[p10l400t1560r446b1601],
6	109	CD	NUMBER	109	num	7	SENT_168	[p10l483t1523r594b1603],
7	L	NN	O	l	dep	5	SENT_168	[p10l616t1542r669b1602],
8	is	VBZ	O	be	cop	9	SENT_168	[p10l686t1540r741b1603],
9	indicative	JJ	O	indicative	_	0	SENT_168	[p10l760t1540r1105b1603],
10	of	IN	O	of	_	0	SENT_168	[p10l1124t1540r1201b1603],
11	worst	JJS	O	worst	amod	12	SENT_168	[p10l1212t1550r1408b1603],
12	prognosis	NN	O	prognosis	prep_of	9	SENT_168	[p10l1422t1540r1787b1621],
13	,	,	O	,	_	0	SENT_168	[p10l1422t1540r1787b1621],
14	whilst	IN	O	whilst	mark	21	SENT_168	[p10l1808t1540r2024b1603],
15	the	DT	O	the	det	18	SENT_168	[p10l2040t1541r2146b1603],
16	immunological	JJ	O	immunological	amod	18	SENT_168	[p10l7t1647r545b1728],
17	phenotype	NN	O	phenotype	nn	18	SENT_168	[p10l573t1647r943b1728],
18	T	NN	O	t	nsubjpass	21	SENT_168	[p10l972t1649r1025b1709],
19	is	VBZ	O	be	auxpass	21	SENT_168	[p10l1054t1647r1109b1710],
20	also	RB	O	also	advmod	21	SENT_168	[p10l1142t1647r1280b1710],
21	associated	VBN	O	associate	dep	9	SENT_168	[p10l1312t1647r1676b1710],
22	to	TO	O	to	_	0	SENT_168	[p10l1704t1657r1770b1710],
23	a	DT	O	a	det	25	SENT_168	[p10l1802t1667r1839b1710],
24	reduced	VBN	O	reduce	amod	25	SENT_168	[p10l1866t1647r2147b1710],
25	EFS	NNP	O	EFS	prep_to	21	SENT_168	[p10l6t1753r154b1816],
26	even	RB	O	even	advmod	33	SENT_168	[p10l183t1772r346b1815],
27	if	IN	O	if	dep	33	SENT_168	[p10l370t1753r428b1814],
28	such	JJ	O	such	amod	29	SENT_168	[p10l450t1753r608b1815],
29	data	NNS	O	datum	nsubjpass	33	SENT_168	[p10l634t1753r780b1815],
30	is	VBZ	O	be	auxpass	33	SENT_168	[p10l804t1753r859b1815],
31	not	RB	O	not	neg	33	SENT_168	[p10l885t1762r999b1815],
32	universally	RB	O	universally	advmod	33	SENT_168	[p10l1022t1752r1412b1834],
33	conﬁrmed	VBN	O	conﬁrmed	ccomp	21	SENT_168	[p10l1438t1752r1815b1815],
34	.	.	O	.	_	0	SENT_168	[p10l1438t1752r1815b1815],

1	In	IN	O	in	_	0	SENT_169	[p10l114t1863r186b1923],
2	these	DT	O	these	det	4	SENT_169	[p10l228t1861r408b1924],
3	last	JJ	DATE	last	amod	4	SENT_169	[p10l452t1861r575b1924],
4	years	NNS	DATE	year	prep_in	9	SENT_169	[p10l615t1881r799b1942],
5	it	PRP	O	it	nsubjpass	9	SENT_169	[p10l844t1861r892b1924],
6	has	VBZ	O	have	aux	9	SENT_169	[p10l933t1861r1048b1924],
7	been	VBN	O	be	auxpass	9	SENT_169	[p10l1091t1861r1258b1924],
8	extensively	RB	O	extensively	advmod	9	SENT_169	[p10l1301t1861r1699b1942],
9	debated	VBN	O	debate	_	0	SENT_169	[p10l1743t1861r2018b1924],
10	on	IN	O	on	_	0	SENT_169	[p10l2061t1881r2147b1924],
11	the	DT	O	the	det	12	SENT_169	[p10l7t1968r113b2031],
12	inﬂuence	NN	O	inﬂuence	prep_on	9	SENT_169	[p10l146t1968r470b2031],
13	of	IN	O	of	_	0	SENT_169	[p10l504t1968r580b2031],
14	677	CD	NUMBER	677	num	18	SENT_169	[p10l608t1968r735b2031],
15	and	CC	O	and	_	0	SENT_169	[p10l772t1968r897b2031],
16	1298	CD	DATE	1298	num	18	SENT_169	[p10l937t1968r1102b2032],
17	MTHFR	NN	O	mthfr	nn	18	SENT_169	[p10l1137t1970r1443b2030],
18	polymorphisms	NNS	O	polymorphism	prep_of	12	SENT_169	[p10l1473t1968r2025b2049],
19	on	IN	O	on	_	0	SENT_169	[p10l2061t1988r2147b2031],
20	hematological	JJ	O	hematological	amod	21	SENT_169	[p10l6t2074r510b2155],
21	malignancies	NNS	O	malignancy	prep_on	18	SENT_169	[p10l529t2074r1016b2155],
22	.	.	O	.	_	0	SENT_169	[p10l529t2074r1016b2155],

1	In	IN	O	in	_	0	SENT_170	[p10l1039t2075r1111b2135],
2	particular	JJ	O	particular	prep_in	7	SENT_170	[p10l1129t2074r1472b2155],
3	it	PRP	O	it	nsubjpass	7	SENT_170	[p10l1489t2074r1537b2136],
4	has	VBZ	O	have	aux	7	SENT_170	[p10l1555t2074r1670b2136],
5	been	VBN	O	be	auxpass	7	SENT_170	[p10l1690t2074r1857b2136],
6	broadly	RB	O	broadly	advmod	7	SENT_170	[p10l1875t2074r2146b2155],
7	discussed	VBN	O	discuss	conj_and	7	SENT_170	[p10l8t2182r347b2245],
8	the	DT	O	the	det	9	SENT_170	[p10l375t2182r481b2245],
9	roles	NNS	O	role	dobj	7	SENT_170	[p10l510t2182r680b2245],
10	of	IN	O	of	_	0	SENT_170	[p10l712t2182r789b2245],
11	both	DT	O	both	det	12	SENT_170	[p10l811t2182r969b2245],
12	polymorphisms	NNS	O	polymorphism	prep_of	9	SENT_170	[p10l997t2182r1549b2263],
13	on	IN	O	on	_	0	SENT_170	[p10l1581t2202r1667b2245],
14	the	DT	O	the	det	15	SENT_170	[p10l1696t2182r1802b2245],
15	susceptibility	NN	O	susceptibility	prep_on	7	SENT_170	[p10l1835t2182r2144b2263, p10l6t2289r192b2370],
16	to	TO	O	to	_	0	SENT_170	[p10l213t2298r279b2351],
17	the	DT	O	the	det	18	SENT_170	[p10l301t2289r407b2351],
18	development	NN	O	development	prep_to	7	SENT_170	[p10l429t2289r885b2370],
19	of	IN	O	of	_	0	SENT_170	[p10l905t2289r982b2351],
20	ALL	NN	O	all	prep_of	18	SENT_170	[p10l996t2289r1187b2363],
21	,	,	O	,	_	0	SENT_170	[p10l996t2289r1187b2363],
22	on	IN	O	on	_	0	SENT_170	[p10l1211t2308r1297b2351],
23	the	DT	O	the	det	24	SENT_170	[p10l1318t2289r1424b2351],
24	toxicity	NN	O	toxicity	prep_on	7	SENT_170	[p10l1445t2289r1715b2370],
25	in	IN	O	in	_	0	SENT_170	[p10l1736t2289r1803b2351],
26	course	NN	O	course	prep_in	24	SENT_170	[p10l1824t2308r2053b2351],
27	of	IN	O	of	_	0	SENT_170	[p10l2076t2289r2153b2351],
28	chemotherapy	NN	O	chemotherapy	prep_of	26	SENT_170	[p10l7t2396r508b2477],
29	with	IN	O	with	_	0	SENT_170	[p10l539t2396r695b2459],
30	MTX	NN	O	mtx	prep_with	28	SENT_170	[p10l725t2398r921b2458],
31	and	CC	O	and	_	0	SENT_170	[p10l953t2396r1078b2459],
32	more	RBR	O	more	advmod	33	SENT_170	[p10l1107t2416r1288b2459],
33	recently	RB	DATE	recently	advmod	7	SENT_170	[p10l1317t2396r1603b2477],
34	on	IN	O	on	_	0	SENT_170	[p10l1634t2416r1720b2459],
35	the	DT	O	the	det	37	SENT_170	[p10l1750t2396r1856b2459],
36	clinical	JJ	O	clinical	amod	37	SENT_170	[p10l1887t2396r2146b2459],
37	response	NN	O	response	prep_on	33	SENT_170	[p10l6t2523r316b2584],
38	to	TO	O	to	_	0	SENT_170	[p10l341t2513r407b2566],
39	chemotherapy	NN	O	chemotherapy	prep_to	7	SENT_170	[p10l434t2503r947b2584],
40	.	.	O	.	_	0	SENT_170	[p10l434t2503r947b2584],

1	Regarding	VBG	O	regard	csubj	8	SENT_171	[p10l114t2609r481b2690],
2	these	DT	O	these	det	3	SENT_171	[p10l504t2609r684b2671],
3	endpoints	NNS	O	endpoint	nsubj	6	SENT_171	[p10l707t2609r1049b2690],
4	the	DT	O	the	det	6	SENT_171	[p10l1072t2609r1178b2671],
5	existing	VBG	O	exist	amod	6	SENT_171	[p10l1201t2608r1478b2690],
6	data	NNS	O	datum	xcomp	1	SENT_171	[p10l1502t2609r1649b2671],
7	are	VBP	O	be	cop	8	SENT_171	[p10l1671t2628r1775b2671],
8	numerous	JJ	O	numerous	_	0	SENT_171	[p10l1797t2628r2145b2671],
9	and	CC	O	and	_	0	SENT_171	[p10l9t2717r134b2780],
10	not	RB	O	not	neg	11	SENT_171	[p10l167t2727r280b2780],
11	univocal	JJ	O	univocal	conj_and	8	SENT_171	[p10l312t2717r633b2792],
12	,	,	O	,	_	0	SENT_171	[p10l312t2717r633b2792],
13	probably	RB	O	probably	advmod	17	SENT_171	[p10l669t2717r984b2798],
14	because	IN	O	because	dep	17	SENT_171	[p10l1018t2717r1299b2780],
15	they	PRP	O	they	nsubjpass	17	SENT_171	[p10l1333t2717r1482b2798],
16	were	VBD	O	be	auxpass	17	SENT_171	[p10l1517t2737r1688b2780],
17	drawn	VBN	O	draw	dep	8	SENT_171	[p10l1723t2717r1941b2780],
18	from	IN	O	from	_	0	SENT_171	[p10l1976t2717r2148b2780],
19	evaluations	NNS	O	evaluation	prep_from	17	SENT_171	[p10l8t2824r404b2887],
20	of	IN	O	of	_	0	SENT_171	[p10l432t2824r509b2887],
21	non	JJ	O	non	amod	24	SENT_171	[p10l528t2824r1183b2905],
22	—	NN	O	—	nn	24	SENT_171	[p10l528t2824r1183b2905],
23	homogeneous	JJ	O	homogeneous	amod	24	SENT_171	[p10l528t2824r1183b2905],
24	series	NN	O	series	prep_of	19	SENT_171	[p10l1213t2824r1408b2887],
25	of	IN	O	of	_	0	SENT_171	[p10l1436t2824r1513b2887],
26	patients	NNS	O	patient	prep_of	24	SENT_171	[p10l1531t2824r1825b2905],
27	.	.	O	.	_	0	SENT_171	[p10l1531t2824r1825b2905],

1	Aplenc	NNP	O	Aplenc	nsubj	20	SENT_172	[p10l114t2930r368b3011],
2	et	FW	O	et	nn	4	SENT_172	[p10l408t2939r471b2992],
3	al.	FW	O	al.	nn	4	SENT_172	[p10l510t2930r587b2992],
4	[	FW	O	[	rcmod	1	SENT_172	[p10l637t2930r770b3005],
5	20	CD	NUMBER	20	num	6	SENT_172	[p10l637t2930r770b3005],
6	]	NN	O	]	dobj	4	SENT_172	[p10l637t2930r770b3005],
7	in	IN	O	in	_	0	SENT_172	[p10l815t2930r882b2991],
8	a	DT	O	a	det	9	SENT_172	[p10l922t2949r959b2992],
9	population	NN	O	population	prep_in	6	SENT_172	[p10l994t2930r1375b3011],
10	of	IN	O	of	_	0	SENT_172	[p10l1414t2929r1491b2992],
11	pediatric	JJ	O	pediatric	amod	12	SENT_172	[p10l1522t2930r1832b3011],
12	patients	NNS	O	patient	prep_of	4	SENT_172	[p10l1870t2930r2144b3011],
13	affected	VBN	O	affect	partmod	1	SENT_172	[p10l9t3037r290b3099],
14	by	IN	O	by	_	0	SENT_172	[p10l330t3037r418b3115],
15	ALL	NN	O	all	agent	13	SENT_172	[p10l460t3038r632b3098],
16	treated	VBN	O	treat	partmod	15	SENT_172	[p10l673t3037r914b3099],
17	with	IN	O	with	_	0	SENT_172	[p10l956t3037r1112b3099],
18	MTX	NN	O	mtx	prep_with	16	SENT_172	[p10l1153t3039r1349b3098],
19	have	VBP	O	have	aux	20	SENT_172	[p10l1391t3037r1554b3099],
20	shown	VBN	O	show	_	0	SENT_172	[p10l1599t3037r1825b3099],
21	that	IN	O	that	dep	20	SENT_172	[p10l1867t3037r1999b3099],
22	the	DT	O	the	dep	21	SENT_172	[p10l2040t3037r2146b3099],

1	P	NN	O	p	nn	2	SENT_173	[p10l355t3191r376b3214],
2	Chiusolo	NNP	PERSON	Chiusolo	_	0	SENT_173	[p10l390t3190r507b3214],
3	et	FW	O	et	nn	4	SENT_173	[p10l517t3195r541b3214],
4	al.	FW	O	al.	dep	2	SENT_173	[p10l548t3190r579b3214],
5	/	:	O	/	punct	2	SENT_173	[p10l588t3191r603b3214],
6	Leukemia	NNP	ORGANIZATION	Leukemia	nn	7	SENT_173	[p10l608t3190r736b3214],
7	Research	NNP	ORGANIZATION	Research	dep	2	SENT_173	[p10l745t3190r866b3214],
8	31	CD	NUMBER	31	number	9	SENT_173	[p10l876t3190r906b3214],
9	(	CD	NUMBER	(	num	10	SENT_173	[p10l918t3190r1004b3219],
10	2007	CD	DATE	2007	dep	7	SENT_173	[p10l918t3190r1004b3219],
11	)	CD	NUMBER	)	number	12	SENT_173	[p10l918t3190r1004b3219],
12	1669-1674 1673	CD	DURATION	1669-1674 1673	num	10	SENT_173	[p10l1744t3190r1805b3214],[p10l1015t3190r1162b3214],

1	C677T	NN	O	c677t	nn	3	SENT_174	[p10l8t3358r253b3421],
2	variant	JJ	O	variant	amod	3	SENT_174	[p10l292t3358r536b3421],
3	allele	NN	O	allele	nsubjpass	6	SENT_174	[p10l575t3358r763b3420],
4	was	VBD	O	be	auxpass	6	SENT_174	[p10l802t3377r935b3421],
5	statistically	RB	O	statistically	advmod	6	SENT_174	[p10l979t3358r1379b3439],
6	associated	VBN	O	associate	_	0	SENT_174	[p10l1420t3358r1783b3420],
7	with	IN	O	with	_	0	SENT_174	[p10l1822t3358r1978b3421],
8	disease	NN	O	disease	nn	9	SENT_174	[p10l2016t3358r2144b3420, p10l8t3485r158b3528],
9	relapse	NN	O	relapse	prep_with	6	SENT_174	[p10l211t3465r462b3546],
10	(	CD	NUMBER	(	num	11	SENT_174	[p10l519t3465r916b3545],
11	p	NN	O	p	dep	9	SENT_174	[p10l519t3465r916b3545],
12	=	JJ	O	=	amod	14	SENT_174	[p10l519t3465r916b3545],
13	0.036	CD	NUMBER	0.036	tmod	12	SENT_174	[p10l519t3465r916b3545],
14	)	NN	O	)	dep	11	SENT_174	[p10l519t3465r916b3545],
15	.	.	O	.	_	0	SENT_174	[p10l519t3465r916b3545],

1	This	DT	O	this	det	2	SENT_175	[p10l975t3465r1129b3528],
2	association	NN	O	association	nsubj	4	SENT_175	[p10l1186t3465r1579b3528],
3	is	VBZ	O	be	cop	4	SENT_175	[p10l1632t3465r1687b3528],
4	meaningful	JJ	O	meaningful	_	0	SENT_175	[p10l1743t3465r2147b3546],
5	in	IN	O	in	_	0	SENT_175	[p10l7t3572r74b3634],
6	multivariate	JJ	O	multivariate	amod	7	SENT_175	[p10l111t3572r535b3635],
7	analysis	NN	O	analysis	prep_in	4	SENT_175	[p10l575t3572r856b3653],
8	more	RBR	O	more	advmod	4	SENT_175	[p10l895t3592r1076b3635],
9	than	IN	O	than	_	0	SENT_175	[p10l1113t3572r1265b3635],
10	other	JJ	O	other	amod	12	SENT_175	[p10l1303t3572r1484b3635],
11	predictive	JJ	O	predictive	amod	12	SENT_175	[p10l1519t3572r1870b3653],
12	factors	NNS	O	factor	prep_than	8	SENT_175	[p10l1908t3572r2145b3635],
13	as	IN	O	as	_	0	SENT_175	[p10l9t3698r77b3741],
14	bone	NN	O	bone	nn	16	SENT_175	[p10l132t3679r303b3741],
15	marrow	NN	O	marrow	nn	16	SENT_175	[p10l358t3698r630b3742],
16	response	NN	O	response	prep_as	4	SENT_175	[p10l683t3698r993b3760],
17	at	IN	O	at	_	0	SENT_175	[p10l1050t3688r1111b3741],
18	day	NN	DURATION	day	prep_at	16	SENT_175	[p10l1164t3679r1402b3760],
19	+7	CD	NUMBER	+7	num	18	SENT_175	[p10l1164t3679r1402b3760],
20	.	.	O	.	_	0	SENT_175	[p10l1164t3679r1402b3760],

1	A1298G	NN	O	a1298g	nn	2	SENT_176	[p10l1460t3679r1766b3742],
2	polymorphism	NN	O	polymorphism	_	0	SENT_176	[p10l1818t3679r2145b3760, p11l6t20r224b101],

1	did	VBD	O	do	aux	3	SENT_177	[p11l263t20r375b83],
2	not	RB	O	not	neg	3	SENT_177	[p11l413t30r527b83],
3	result	VB	O	result	_	0	SENT_177	[p11l564t20r762b83],
4	associated	VBN	O	associate	dep	3	SENT_177	[p11l801t20r1165b83],
5	with	IN	O	with	_	0	SENT_177	[p11l1204t20r1360b83],
6	relapse	NN	O	relapse	prep_with	4	SENT_177	[p11l1398t20r1667b101],
7	.	.	O	.	_	0	SENT_177	[p11l1398t20r1667b101],

1	The	DT	O	the	det	2	SENT_178	[p11l1711t20r1847b83],
2	authors	NNS	O	author	nsubj	3	SENT_178	[p11l1888t20r2145b83],
3	hypothesized	VBD	O	hypothesize	_	0	SENT_178	[p11l7t127r477b208],
4	that	IN	O	that	complm	15	SENT_178	[p11l514t127r647b189],
5	the	DT	O	the	det	6	SENT_178	[p11l684t127r791b189],
6	inﬂuence	NN	O	inﬂuence	nsubj	15	SENT_178	[p11l830t127r1154b189],
7	of	IN	O	of	_	0	SENT_178	[p11l1195t127r1272b189],
8	the	DT	O	the	det	11	SENT_178	[p11l1304t127r1410b189],
9	677T	NN	O	677t	nn	11	SENT_178	[p11l1451t127r1636b190],
10	variant	JJ	O	variant	amod	11	SENT_178	[p11l1675t127r1919b190],
11	allele	NN	O	allele	prep_of	6	SENT_178	[p11l1958t127r2147b189],
12	on	IN	O	on	_	0	SENT_178	[p11l8t254r94b297],
13	relapse	NN	O	relapse	prep_on	11	SENT_178	[p11l140t234r392b315],
14	could	MD	O	could	aux	15	SENT_178	[p11l440t234r636b297],
15	depend	VB	O	depend	ccomp	3	SENT_178	[p11l684t234r939b315],
16	on	IN	O	on	_	0	SENT_178	[p11l986t254r1073b297],
17	the	DT	O	the	det	18	SENT_178	[p11l1120t234r1226b297],
18	fact	NN	O	fact	prep_on	15	SENT_178	[p11l1274t234r1406b297],
19	that	IN	O	that	complm	28	SENT_178	[p11l1452t234r1585b297],
20	MTHFR	NN	O	mthfr	nn	22	SENT_178	[p11l1630t236r1937b296],
21	variant	JJ	O	variant	amod	22	SENT_178	[p11l1983t234r2145b297, p11l9t351r116b404],
22	allele	NN	O	allele	nsubj	28	SENT_178	[p11l155t341r343b404],
23	with	IN	O	with	_	0	SENT_178	[p11l383t341r540b404],
24	reduced	VBN	O	reduce	amod	25	SENT_178	[p11l578t341r859b404],
25	activity	NN	O	activity	prep_with	22	SENT_178	[p11l899t341r1160b422],
26	might	MD	O	might	aux	28	SENT_178	[p11l1200t341r1407b422],
27	be	VB	O	be	cop	28	SENT_178	[p11l1443t341r1526b404],
28	able	JJ	O	able	ccomp	15	SENT_178	[p11l1567t341r1711b404],
29	to	TO	O	to	aux	30	SENT_178	[p11l1751t351r1817b404],
30	increase	VB	O	increase	xcomp	28	SENT_178	[p11l1857t341r2147b404],
31	5,10	CD	NUMBER	5,10	number	32	SENT_178	[p11l9t448r1132b529],
32	—	CD	NUMBER	—	num	33	SENT_178	[p11l9t448r1132b529],
33	methylenetetrahydrofolate	NN	O	methylenetetrahydrofolate	dobj	30	SENT_178	[p11l9t448r1132b529],
34	and	CC	O	and	_	0	SENT_178	[p11l1170t448r1295b510],
35	dTMP	NN	O	dtmp	dobj	30	SENT_178	[p11l1332t448r1557b510],
36	ﬁnally	RB	O	ﬁnally	advmod	37	SENT_178	[p11l1594t448r1817b529],
37	hampering	VBG	O	hamper	partmod	35	SENT_178	[p11l1853t448r2145b529, p11l7t555r118b636],
38	MTX	NNP	O	MTX	nn	39	SENT_178	[p11l143t557r339b617],
39	action	NN	O	action	dobj	37	SENT_178	[p11l366t555r598b618],
40	.	.	O	.	_	0	SENT_178	[p11l366t555r598b618],

1	Krajinovic	JJ	O	krajinovic	nsubj	7	SENT_179	[p11l116t662r491b743],
2	et	FW	O	et	dep	1	SENT_179	[p11l521t672r583b725],
3	al.	FW	O	al.	nn	4	SENT_179	[p11l611t662r689b725],
4	[	FW	O	[	dep	1	SENT_179	[p11l727t663r861b738],
5	21	CD	NUMBER	21	num	6	SENT_179	[p11l727t663r861b738],
6	]	NN	O	]	dep	4	SENT_179	[p11l727t663r861b738],
7	evaluated	VBD	O	evaluate	_	0	SENT_179	[p11l895t662r1230b725],
8	the	DT	O	the	det	9	SENT_179	[p11l1256t662r1363b725],
9	inﬂuence	NN	O	inﬂuence	dobj	7	SENT_179	[p11l1391t662r1715b725],
10	of	IN	O	of	_	0	SENT_179	[p11l1744t662r1821b725],
11	MTHFR	NN	O	mthfr	nn	12	SENT_179	[p11l1842t664r2148b724],
12	polymorphisms	NNS	O	polymorphism	prep_of	9	SENT_179	[p11l6t768r558b849],
13	Al298C	NN	O	al298c	dep	12	SENT_179	[p11l603t768r902b831],
14	and	CC	O	and	_	0	SENT_179	[p11l948t768r1074b830],
15	C677T	NN	O	c677t	dep	12	SENT_179	[p11l1117t767r1361b831],
16	and	CC	O	and	_	0	SENT_179	[p11l1406t768r1531b830],
17	MTHFD1	NN	O	mthfd1	conj_and	12	SENT_179	[p11l1573t768r1920b829],
18	1958	CD	DATE	1958	num	17	SENT_179	[p11l1980t767r2144b831],
19	among	IN	O	among	_	0	SENT_179	[p11l9t896r247b957],
20	EFS	NNP	O	EFS	prep_among	17	SENT_179	[p11l267t877r415b939],
21	in	IN	O	in	_	0	SENT_179	[p11l439t876r506b938],
22	201	CD	NUMBER	201	num	24	SENT_179	[p11l528t877r650b939],
23	pediatric	JJ	O	pediatric	amod	24	SENT_179	[p11l677t876r986b957],
24	patients	NNS	O	patient	prep_in	7	SENT_179	[p11l1007t876r1281b957],
25	affected	VBN	O	affect	partmod	24	SENT_179	[p11l1305t876r1587b939],
26	by	IN	O	by	_	0	SENT_179	[p11l1605t876r1692b957],
27	ALL	NN	O	all	agent	25	SENT_179	[p11l1713t877r1884b938],
28	receiving	VBG	O	receive	partmod	27	SENT_179	[p11l1903t876r2145b939, p11l7t983r118b1064],
29	MTX	NNP	O	MTX	nn	30	SENT_179	[p11l139t984r335b1045],
30	chemotherapy	NN	O	chemotherapy	dobj	28	SENT_179	[p11l356t983r857b1064],
31	showing	VBG	O	show	xcomp	28	SENT_179	[p11l881t983r1175b1064],
32	that	IN	O	that	complm	40	SENT_179	[p11l1196t983r1329b1045],
33	T	NN	O	t	nn	35	SENT_179	[p11l1348t984r1400b1045],
34	677A1298	CD	NUMBER	677a1298	num	35	SENT_179	[p11l1404t983r1774b1046],
35	haplotype	NN	O	haplotype	nsubj	40	SENT_179	[p11l1797t983r2147b1064],
36	and	CC	O	and	_	0	SENT_179	[p11l9t1089r134b1150],
37	1958A	NN	O	1958a	nn	39	SENT_179	[p11l167t1088r399b1151],
38	variant	JJ	O	variant	amod	39	SENT_179	[p11l424t1089r668b1151],
39	allele	NN	O	allele	nsubj	40	SENT_179	[p11l694t1089r882b1150],
40	have	VBP	O	have	ccomp	31	SENT_179	[p11l907t1089r1070b1151],
41	lower	JJR	O	lower	amod	42	SENT_179	[p11l1095t1089r1295b1151],
42	EFS	NNS	O	ef	dobj	40	SENT_179	[p11l1318t1089r1488b1151],
43	.	.	O	.	_	0	SENT_179	[p11l1318t1089r1488b1151],

1	Our	PRP$	O	we	poss	2	SENT_180	[p11l116t1196r252b1257],
2	results	NNS	O	result	nsubj	3	SENT_180	[p11l289t1195r519b1257],
3	are	VBP	O	be	_	0	SENT_180	[p11l562t1215r666b1257],
4	in	IN	O	in	_	0	SENT_180	[p11l706t1195r774b1256],
5	contrast	NN	O	contrast	prep_in	3	SENT_180	[p11l813t1205r1094b1257],
6	with	IN	O	with	_	0	SENT_180	[p11l1133t1195r1289b1257],
7	those	DT	O	those	prep_with	5	SENT_180	[p11l1327t1195r1513b1257],
8	from	IN	O	from	_	0	SENT_180	[p11l1553t1195r1725b1257],
9	the	DT	O	the	det	10	SENT_180	[p11l1763t1195r1869b1257],
10	abovementioned	JJ	O	abovementioned	prep_from	7	SENT_180	[p11l1911t1195r2144b1257, p11l7t1302r383b1364],

1	groups	NNS	O	group	_	0	SENT_181	[p11l424t1321r662b1383],
2	which	WDT	O	which	nsubj	3	SENT_181	[p11l706t1302r921b1365],
3	evaluated	VBD	O	evaluate	rcmod	1	SENT_181	[p11l963t1302r1298b1365],
4	the	DT	O	the	det	5	SENT_181	[p11l1338t1302r1445b1364],
5	inﬂuence	NN	O	inﬂuence	dobj	3	SENT_181	[p11l1487t1302r1811b1364],
6	of	IN	O	of	_	0	SENT_181	[p11l1854t1302r1931b1364],
7	these	DT	O	these	det	9	SENT_181	[p11l1966t1302r2147b1364],
8	two	CD	NUMBER	two	num	9	SENT_181	[p11l7t1419r137b1472],
9	polymorphisms	NNS	O	polymorphism	prep_of	5	SENT_181	[p11l166t1409r718b1490],
10	in	IN	O	in	_	0	SENT_181	[p11l749t1409r816b1471],
11	pediatric	JJ	O	pediatric	amod	14	SENT_181	[p11l844t1409r1153b1490],
12	standard	JJ	O	standard	amod	14	SENT_181	[p11l1187t1409r1485b1472],
13	risk	NN	O	risk	nn	14	SENT_181	[p11l1513t1409r1647b1472],
14	patients	NNS	O	patient	prep_in	3	SENT_181	[p11l1673t1409r1967b1490],
15	.	.	O	.	_	0	SENT_181	[p11l1673t1409r1967b1490],

1	Due	JJ	O	due	_	0	SENT_182	[p11l2001t1411r2147b1472],
2	to	TO	O	to	_	0	SENT_182	[p11l7t1525r73b1579],
3	the	DT	O	the	det	5	SENT_182	[p11l102t1516r208b1579],
4	higher	JJR	O	higher	amod	5	SENT_182	[p11l236t1516r464b1597],
5	frequency	NN	O	frequency	prep_due_to	17	SENT_182	[p11l491t1516r843b1597],
6	of	IN	O	of	_	0	SENT_182	[p11l873t1516r949b1579],
7	molecular	JJ	O	molecular	amod	8	SENT_182	[p11l971t1516r1328b1579],
8	alterations	NNS	O	alteration	prep_of	5	SENT_182	[p11l1356t1516r1721b1579],
9	in	IN	O	in	_	0	SENT_182	[p11l1752t1516r1819b1578],
10	our	PRP$	O	we	poss	11	SENT_182	[p11l1848t1536r1965b1579],
11	context	NN	O	context	prep_in	8	SENT_182	[p11l1992t1536r2144b1579, p11l7t1631r156b1696],
12	,	,	O	,	_	0	SENT_182	[p11l1992t1536r2144b1579, p11l7t1631r156b1696],
13	MTHFR	NN	O	mthfr	nn	14	SENT_182	[p11l190t1623r495b1683],
14	polymorphisms	NNS	O	polymorphism	nsubj	17	SENT_182	[p11l523t1622r1076b1703],
15	per	FW	O	per	nn	16	SENT_182	[p11l1106t1641r1221b1703],
16	se	FW	O	se	advmod	17	SENT_182	[p11l1252t1641r1320b1684],
17	has	VBZ	O	have	_	0	SENT_182	[p11l1350t1622r1465b1684],
18	not	RB	O	not	neg	20	SENT_182	[p11l1497t1631r1610b1684],
19	enough	JJ	O	enough	amod	20	SENT_182	[p11l1639t1622r1899b1703],
20	power	NN	O	power	dobj	17	SENT_182	[p11l1928t1641r2149b1703],
21	to	TO	O	to	_	0	SENT_182	[p11l7t1739r73b1793],
22	inﬂuence	NN	O	inﬂuence	nn	23	SENT_182	[p11l102t1730r426b1793],
23	DFS	NN	ORGANIZATION	df	prep_to	17	SENT_182	[p11l454t1731r611b1793],
24	and	CC	O	and	_	0	SENT_182	[p11l645t1730r770b1793],
25	EFS	NN	O	ef	conj_and	23	SENT_182	[p11l796t1731r967b1804],
26	,	,	O	,	_	0	SENT_182	[p11l796t1731r967b1804],
27	when	WRB	O	when	advmod	28	SENT_182	[p11l999t1730r1189b1793],
28	compared	VBN	O	compare	advcl	17	SENT_182	[p11l1217t1730r1567b1811],
29	to	TO	O	to	_	0	SENT_182	[p11l1594t1740r1660b1793],
30	classical	JJ	O	classical	amod	32	SENT_182	[p11l1689t1730r1988b1793],
31	risk	NN	O	risk	nn	32	SENT_182	[p11l2015t1730r2149b1793],
32	factors	NNS	O	factor	prep_to	28	SENT_182	[p11l8t1836r264b1898],
33	.	.	O	.	_	0	SENT_182	[p11l8t1836r264b1898],

1	However	RB	O	however	advmod	14	SENT_183	[p11l115t1943r449b2016],
2	,	,	O	,	_	0	SENT_183	[p11l115t1943r449b2016],
3	multivariate	JJ	O	multivariate	amod	4	SENT_183	[p11l486t1942r910b2004],
4	analysis	NN	O	analysis	nsubj	14	SENT_183	[p11l947t1942r1228b2023],
5	in	IN	O	in	_	0	SENT_183	[p11l1264t1942r1331b2003],
6	the	DT	O	the	det	7	SENT_183	[p11l1365t1942r1471b2004],
7	cohort	NN	O	cohort	prep_in	4	SENT_183	[p11l1507t1942r1733b2004],
8	of	IN	O	of	_	0	SENT_183	[p11l1767t1942r1844b2004],
9	patients	NNS	O	patient	prep_of	7	SENT_183	[p11l1871t1942r2145b2023],
10	homogeneously	RB	O	homogeneously	advmod	11	SENT_183	[p11l7t2050r569b2131],
11	treated	VBN	O	treat	partmod	9	SENT_183	[p11l610t2050r852b2113],
12	with	IN	O	with	_	0	SENT_183	[p11l892t2050r1048b2113],
13	MTX	NN	O	mtx	prep_with	11	SENT_183	[p11l1087t2052r1283b2112],
14	revealed	VBD	O	reveal	_	0	SENT_183	[p11l1323t2050r1621b2113],
15	that	IN	O	that	complm	21	SENT_183	[p11l1660t2050r1793b2113],
16	homozygotes	NNS	O	homozygote	nsubj	21	SENT_183	[p11l1832t2050r2145b2131, p11l8t2166r191b2238],
17	for	IN	O	for	_	0	SENT_183	[p11l214t2157r317b2219],
18	the	DT	O	the	det	20	SENT_183	[p11l336t2157r442b2219],
19	C677T	NN	O	c677t	nn	20	SENT_183	[p11l465t2157r709b2220],
20	variant	NN	O	variant	prep_for	16	SENT_183	[p11l730t2157r974b2220],
21	had	VBD	O	have	ccomp	14	SENT_183	[p11l993t2157r1121b2219],
22	a	DT	O	a	det	26	SENT_183	[p11l1142t2176r1179b2219],
23	worse	JJR	O	worse	amod	26	SENT_183	[p11l1199t2176r1408b2220],
24	outcome	NN	O	outcome	nn	26	SENT_183	[p11l1430t2166r1733b2219],
25	(	CD	NUMBER	(	num	26	SENT_183	[p11l1757t2157r1907b2234],
26	HR	NN	DURATION	hr	dobj	21	SENT_183	[p11l1757t2157r1907b2234],
27	0.213	CD	NUMBER	0.213	dep	26	SENT_183	[p11l1927t2157r2144b2231],
28	,	,	O	,	_	0	SENT_183	[p11l1927t2157r2144b2231],
29	95	CD	PERCENT	95	number	30	SENT_183	[p11l9t2264r164b2328],
30	%	NN	PERCENT	%	amod	31	SENT_183	[p11l9t2264r164b2328],
31	Cl	NN	O	cl	appos	26	SENT_183	[p11l200t2265r286b2327],
32	[	CD	NUMBER	[	number	33	SENT_183	[p11l324t2264r848b2342],
33	0.057	CD	NUMBER	0.057	num	31	SENT_183	[p11l324t2264r848b2342],
34	.	.	O	.	_	0	SENT_183	[p11l324t2264r848b2342],

1	—	NN	O	—	_	0	SENT_184	[p11l324t2264r848b2342],
2	.	.	O	.	_	0	SENT_184	[p11l324t2264r848b2342],

1	O.	NNP	O	O.	nsubj	18	SENT_185	[p11l324t2264r848b2342],
2	795	CD	NUMBER	795	number	3	SENT_185	[p11l324t2264r848b2342],
3	]	CD	NUMBER	]	num	4	SENT_185	[p11l324t2264r848b2342],
4	)	NN	O	)	dep	1	SENT_185	[p11l324t2264r848b2342],
5	suggesting	VBG	O	suggest	partmod	1	SENT_185	[p11l884t2264r1260b2345],
6	the	DT	O	the	det	7	SENT_185	[p11l1292t2264r1398b2327],
7	impact	NN	O	impact	dobj	5	SENT_185	[p11l1429t2264r1671b2345],
8	of	IN	O	of	_	0	SENT_185	[p11l1702t2264r1779b2327],
9	this	DT	O	this	det	10	SENT_185	[p11l1803t2264r1928b2327],
10	polymorphism	NN	O	polymorphism	prep_of	7	SENT_185	[p11l1960t2264r2145b2345, p11l7t2371r368b2452],
11	on	IN	O	on	_	0	SENT_185	[p11l391t2391r476b2434],
12	the	DT	O	the	det	13	SENT_185	[p11l498t2371r604b2434],
13	prognosis	NN	O	prognosis	prep_on	10	SENT_185	[p11l626t2371r970b2452],
14	of	IN	O	of	_	0	SENT_185	[p11l995t2371r1072b2434],
15	adult	JJ	O	adult	amod	16	SENT_185	[p11l1090t2371r1266b2434],
16	patients	NNS	O	patient	prep_of	13	SENT_185	[p11l1286t2371r1560b2452],
17	homogeneously	RB	O	homogeneously	advmod	18	SENT_185	[p11l1584t2371r2146b2452],
18	treated	VBN	O	treat	_	0	SENT_185	[p11l7t2477r249b2538],
19	with	IN	O	with	_	0	SENT_185	[p11l273t2477r430b2539],
20	MTX	NN	O	mtx	nn	22	SENT_185	[p11l453t2478r649b2538],
21	(	CD	NUMBER	(	num	22	SENT_185	[p11l677t2477r897b2553],
22	Table	NNP	O	Table	prep_with	18	SENT_185	[p11l677t2477r897b2553],
23	4	CD	NUMBER	4	number	24	SENT_185	[p11l922t2477r1012b2553],
24	)	CD	NUMBER	)	dep	22	SENT_185	[p11l922t2477r1012b2553],
25	.	.	O	.	_	0	SENT_185	[p11l922t2477r1012b2553],

1	Concerning	VBG	O	concern	_	0	SENT_186	[p11l115t2584r528b2665],
2	the	DT	O	the	det	3	SENT_186	[p11l545t2584r651b2647],
3	toxicity	NN	O	toxicity	prep_concerning	16	SENT_186	[p11l668t2584r938b2665],
4	during	IN	O	during	_	0	SENT_186	[p11l956t2584r1185b2665],
5	MTX	NN	O	mtx	nn	6	SENT_186	[p11l1202t2586r1398b2646],
6	therapy	NN	O	therapy	prep_during	3	SENT_186	[p11l1415t2584r1692b2665],
7	,	,	O	,	_	0	SENT_186	[p11l1415t2584r1692b2665],
8	Aplenc	NNP	O	Aplenc	nsubj	16	SENT_186	[p11l1712t2584r1966b2665],
9	et	FW	O	et	dep	8	SENT_186	[p11l1985t2594r2048b2647],
10	al.	FW	O	al.	nn	11	SENT_186	[p11l2065t2584r2142b2647],
11	[	FW	O	[	dep	8	SENT_186	[p11l14t2691r147b2767],
12	20	CD	NUMBER	20	num	13	SENT_186	[p11l14t2691r147b2767],
13	]	NN	O	]	dep	11	SENT_186	[p11l14t2691r147b2767],
14	did	VBD	O	do	aux	16	SENT_186	[p11l179t2691r291b2753],
15	not	RB	O	not	neg	16	SENT_186	[p11l314t2700r428b2753],
16	ﬁnd	VB	O	ﬁnd	_	0	SENT_186	[p11l452t2691r588b2753],
17	any	DT	O	any	det	18	SENT_186	[p11l613t2710r736b2772],
18	correlation	NN	O	correlation	dobj	16	SENT_186	[p11l762t2691r1146b2753],
19	between	IN	O	between	_	0	SENT_186	[p11l1169t2691r1465b2754],
20	MTHFR	NNP	O	MTHFR	nn	21	SENT_186	[p11l1489t2692r1795b2753],
21	polymorphisms	NNS	O	polymorphism	prep_between	18	SENT_186	[p11l1818t2691r2144b2772, p11l6t2797r256b2878],
22	and	CC	O	and	_	0	SENT_186	[p11l279t2797r404b2859],
23	development	NN	O	development	conj_and	18	SENT_186	[p11l423t2797r879b2878],
24	of	IN	O	of	_	0	SENT_186	[p11l897t2797r974b2859],
25	toxicity	NN	O	toxicity	prep_of	23	SENT_186	[p11l987t2797r1269b2878],
26	.	.	O	.	_	0	SENT_186	[p11l987t2797r1269b2878],

1	This	DT	O	this	det	2	SENT_187	[p11l1293t2797r1447b2859],
2	data	NN	O	datum	nsubjpass	4	SENT_187	[p11l1469t2797r1616b2859],
3	was	VBD	O	be	auxpass	4	SENT_187	[p11l1634t2816r1766b2859],
4	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_187	[p11l1788t2796r2148b2859],
5	by	IN	O	by	_	0	SENT_187	[p11l6t2905r93b2986],
6	Shimasaki	NNP	PERSON	Shimasaki	agent	4	SENT_187	[p11l115t2905r481b2968],
7	et	FW	O	et	nn	9	SENT_187	[p11l501t2915r564b2968],
8	al.	FW	O	al.	nn	9	SENT_187	[p11l583t2905r660b2968],
9	[	FW	O	[	dep	6	SENT_187	[p11l690t2906r823b2981],
10	22	CD	NUMBER	22	number	11	SENT_187	[p11l690t2906r823b2981],
11	]	CD	NUMBER	]	dep	29	SENT_187	[p11l690t2906r823b2981],
12	which	WDT	O	which	dobj	29	SENT_187	[p11l849t2905r1064b2968],
13	in	IN	O	in	_	0	SENT_187	[p11l1082t2905r1149b2967],
14	a	DT	O	a	det	16	SENT_187	[p11l1169t2925r1206b2968],
15	small	JJ	O	small	amod	16	SENT_187	[p11l1226t2905r1414b2968],
16	casistic	NN	O	casistic	prep_in	29	SENT_187	[p11l1433t2905r1691b2968],
17	of	IN	O	of	_	0	SENT_187	[p11l1712t2905r1789b2968],
18	15	CD	NUMBER	15	prep_of	16	SENT_187	[p11l1810t2905r1884b2968],
19	patient	NN	O	patient	nsubj	29	SENT_187	[p11l1905t2905r2149b2986],
20	affected	VBN	O	affect	partmod	19	SENT_187	[p11l9t3012r291b3074],
21	by	IN	O	by	_	0	SENT_187	[p11l317t3012r404b3093],
22	acute	JJ	O	acute	amod	23	SENT_187	[p11l434t3021r618b3074],
23	leukemia	NN	O	leukemia	agent	20	SENT_187	[p11l646t3012r971b3074],
24	or	CC	O	or	_	0	SENT_187	[p11l999t3031r1071b3074],
25	lymphoblastic	JJ	O	lymphoblastic	amod	26	SENT_187	[p11l1097t3012r1599b3093],
26	lymphoma	NN	O	lymphoma	conj_or	23	SENT_187	[p11l1629t3012r2009b3093],
27	did	VBD	O	do	aux	29	SENT_187	[p11l2037t3012r2148b3074],
28	not	RB	O	not	neg	29	SENT_187	[p11l7t3129r120b3182],
29	ﬁnd	VB	O	ﬁnd	dep	9	SENT_187	[p11l137t3119r273b3182],
30	any	DT	O	any	det	31	SENT_187	[p11l290t3139r413b3200],
31	correlation	NN	O	correlation	dobj	29	SENT_187	[p11l430t3119r814b3182],
32	between	IN	O	between	_	0	SENT_187	[p11l829t3119r1125b3182],
33	the	DT	O	the	det	34	SENT_187	[p11l1141t3119r1248b3182],
34	toxicity	NN	O	toxicity	prep_between	31	SENT_187	[p11l1265t3119r1534b3200],
35	induced	VBN	O	induce	partmod	34	SENT_187	[p11l1552t3119r1833b3182],
36	by	IN	O	by	_	0	SENT_187	[p11l1847t3119r1934b3200],
37	MTX	NN	O	mtx	agent	35	SENT_187	[p11l1951t3121r2147b3181],
38	and	CC	O	and	_	0	SENT_187	[p11l9t3226r135b3289],
39	the	DT	O	the	det	41	SENT_187	[p11l152t3226r259b3289],
40	MTHFR	NN	O	mthfr	nn	41	SENT_187	[p11l278t3228r584b3288],
41	polymorphisms	NNS	O	polymorphism	agent	35	SENT_187	[p11l600t3226r1172b3307],
42	.	.	O	.	_	0	SENT_187	[p11l600t3226r1172b3307],

1	Also	RB	O	also	advmod	7	SENT_188	[p11l1195t3226r1361b3289],
2	in	IN	O	in	_	0	SENT_188	[p11l1380t3226r1448b3288],
3	this	DT	O	this	det	4	SENT_188	[p11l1466t3226r1591b3289],
4	study	NN	O	study	prep_in	7	SENT_188	[p11l1614t3226r1801b3307],
5	the	DT	O	the	det	6	SENT_188	[p11l1821t3226r1927b3289],
6	series	NN	O	series	nsubj	7	SENT_188	[p11l1949t3226r2145b3289],
7	included	VBD	O	include	_	0	SENT_188	[p11l7t3332r313b3394],
8	pediatric	JJ	O	pediatric	amod	9	SENT_188	[p11l336t3332r645b3413],
9	patients	NNS	O	patient	dobj	7	SENT_188	[p11l670t3332r945b3413],
10	only	RB	O	only	advmod	7	SENT_188	[p11l973t3332r1140b3413],
11	.	.	O	.	_	0	SENT_188	[p11l973t3332r1140b3413],

1	In	IN	O	in	_	0	SENT_189	[p11l114t3441r187b3500],
2	contrast	NN	O	contrast	prep_in	13	SENT_189	[p11l203t3449r484b3501],
3	with	IN	O	with	_	0	SENT_189	[p11l498t3439r655b3501],
4	these	DT	O	these	det	5	SENT_189	[p11l670t3439r850b3501],
5	evidences	NNS	O	evidence	prep_with	2	SENT_189	[p11l867t3439r1233b3513],
6	,	,	O	,	_	0	SENT_189	[p11l867t3439r1233b3513],
7	other	JJ	O	other	amod	8	SENT_189	[p11l1253t3439r1435b3501],
8	authors	NNS	O	author	nsubj	13	SENT_189	[p11l1451t3439r1707b3501],
9	and	CC	O	and	_	0	SENT_189	[p11l1726t3439r1852b3501],
10	we	PRP	O	we	conj_and	8	SENT_189	[p11l1867t3459r1968b3501],
11	have	VBP	O	have	aux	13	SENT_189	[p11l1983t3439r2147b3501],
12	previously	RB	DATE	previously	advmod	13	SENT_189	[p11l6t3546r379b3627],
13	shown	VBN	O	show	conj_and	13	SENT_189	[p11l409t3546r635b3609],
14	a	DT	O	a	det	16	SENT_189	[p11l664t3565r701b3608],
15	strong	JJ	O	strong	amod	16	SENT_189	[p11l729t3555r946b3627],
16	correlation	NN	O	correlation	dobj	13	SENT_189	[p11l975t3546r1358b3608],
17	between	IN	O	between	_	0	SENT_189	[p11l1384t3546r1680b3609],
18	the	DT	O	the	det	19	SENT_189	[p11l1707t3546r1813b3608],
19	development	NN	O	development	prep_between	16	SENT_189	[p11l1842t3546r2144b3627, p11l7t3661r185b3714],
20	of	IN	O	of	_	0	SENT_189	[p11l221t3652r298b3714],
21	hematological	JJ	O	hematological	amod	24	SENT_189	[p11l327t3652r831b3733],
22	and	CC	O	and	_	0	SENT_189	[p11l869t3652r994b3714],
23	hepatic	JJ	O	hepatic	conj_and	21	SENT_189	[p11l1029t3652r1284b3733],
24	toxicity	NN	O	toxicity	prep_of	19	SENT_189	[p11l1322t3652r1605b3733],
25	,	,	O	,	_	0	SENT_189	[p11l1322t3652r1605b3733],
26	and	CC	O	and	_	0	SENT_189	[p11l1646t3652r1772b3714],
27	mucositis	NN	O	mucositis	prep_of	19	SENT_189	[p11l1808t3652r2145b3714],
28	in	IN	O	in	_	0	SENT_189	[p12l7t20r74b82],
29	adult	JJ	O	adult	amod	30	SENT_189	[p12l122t20r297b83],
30	patients	NNS	O	patient	prep_in	27	SENT_189	[p12l340t20r615b101],
31	with	IN	O	with	_	0	SENT_189	[p12l663t20r819b83],
32	ALL	NN	O	all	prep_with	13	SENT_189	[p12l864t21r1035b82],
33	and	CC	O	and	_	0	SENT_189	[p12l1082t20r1207b83],
34	in	IN	O	in	_	0	SENT_189	[p12l1252t20r1319b82],
35	patients	NNS	O	patient	prep_in	13	SENT_189	[p12l1363t20r1637b101],
36	submitted	VBN	O	submit	dep	35	SENT_189	[p12l1688t20r2035b83],
37	to	TO	O	to	_	0	SENT_189	[p12l2080t30r2146b83],
38	hematopoietic	JJ	O	hematopoietic	amod	42	SENT_189	[p12l7t127r509b208],
39	allogeneic	JJ	O	allogeneic	amod	42	SENT_189	[p12l533t127r893b208],
40	stem	NN	O	stem	nn	42	SENT_189	[p12l918t136r1082b189],
41	cell	NN	O	cell	nn	42	SENT_189	[p12l1101t127r1227b189],
42	transplantation	NN	O	transplantation	prep_to	36	SENT_189	[p12l1247t127r1775b208],
43	and	CC	O	and	_	0	SENT_189	[p12l1797t127r1922b189],
44	therefore	RB	O	therefore	advmod	45	SENT_189	[p12l1941t127r2144b189, p12l8t234r148b297],
45	exposed	VBN	O	expose	conj_and	36	SENT_189	[p12l173t234r462b315],
46	to	TO	O	to	_	0	SENT_189	[p12l485t244r551b297],
47	pulsed	JJ	O	pulsed	amod	48	SENT_189	[p12l575t234r807b315],
48	doses	NNS	O	dose	prep_to	45	SENT_189	[p12l832t234r1024b297],
49	of	IN	O	of	_	0	SENT_189	[p12l1052t234r1129b297],
50	MTX	NNP	O	MTX	prep_of	48	SENT_189	[p12l1146t236r1342b296],
51	[	CD	NUMBER	[	num	50	SENT_189	[p12l1373t234r1642b310],
52	16,23	CD	NUMBER	16,23	num	53	SENT_189	[p12l1373t234r1642b310],
53	]	NN	O	]	dobj	36	SENT_189	[p12l1373t234r1642b310],
54	.	.	O	.	_	0	SENT_189	[p12l1373t234r1642b310],

1	Such	JJ	O	such	amod	2	SENT_190	[p12l1673t234r1847b297],
2	data	NNS	O	datum	nsubj	4	SENT_190	[p12l1871t234r2018b297],
3	are	VBP	O	be	cop	4	SENT_190	[p12l2042t254r2147b297],
4	consistingly	JJ	O	consistingly	_	0	SENT_190	[p12l8t341r436b422],
5	conﬁrmed	JJ	O	conﬁrmed	dep	4	SENT_190	[p12l459t341r819b404],
6	although	IN	O	although	dep	5	SENT_190	[p12l841t341r1150b422],
7	in	IN	O	in	_	0	SENT_190	[p12l1171t341r1238b403],
8	different	JJ	O	different	amod	10	SENT_190	[p12l1260t341r1564b404],
9	clinical	JJ	O	clinical	amod	10	SENT_190	[p12l1584t341r1844b404],
10	context	NN	O	context	prep_in	4	SENT_190	[p12l1867t351r2142b404],
11	.	.	O	.	_	0	SENT_190	[p12l1867t351r2142b404],

1	In	IN	O	in	_	0	SENT_191	[p12l7t448r79b508],
2	fact	NN	O	fact	nn	3	SENT_191	[p12l99t447r230b509],
3	Toffoli	NNP	LOCATION	Toffoli	prep_in	18	SENT_191	[p12l248t446r488b509],
4	et	FW	O	et	nn	6	SENT_191	[p12l509t456r572b509],
5	al.	FW	O	al.	nn	6	SENT_191	[p12l591t447r669b509],
6	[	FW	O	[	dep	3	SENT_191	[p12l699t447r833b522],
7	24	CD	NUMBER	24	num	8	SENT_191	[p12l699t447r833b522],
8	]	NN	O	]	dobj	6	SENT_191	[p12l699t447r833b522],
9	in	IN	O	in	_	0	SENT_191	[p12l858t447r925b508],
10	42	CD	NUMBER	42	num	13	SENT_191	[p12l944t447r1031b508],
11	patient	NN	O	patient	nn	13	SENT_191	[p12l1050t447r1292b528],
12	female	NN	O	female	nn	13	SENT_191	[p12l1311t447r1550b509],
13	patients	NNS	O	patient	prep_in	8	SENT_191	[p12l1569t447r1843b528],
14	affected	VBN	O	affect	dep	6	SENT_191	[p12l1866t446r2148b509],
15	by	IN	O	by	_	0	SENT_191	[p12l6t555r93b636],
16	ovarian	JJ	O	ovarian	amod	17	SENT_191	[p12l129t555r390b618],
17	cancer	NN	O	cancer	prep_by	14	SENT_191	[p12l424t575r655b618],
18	showed	VBD	O	show	_	0	SENT_191	[p12l690t555r956b618],
19	an	DT	O	a	det	20	SENT_191	[p12l991t575r1071b618],
20	association	NN	O	association	dobj	18	SENT_191	[p12l1106t555r1498b618],
21	among	IN	O	among	_	0	SENT_191	[p12l1534t575r1771b636],
22	the	DT	O	the	det	23	SENT_191	[p12l1806t555r1912b618],
23	genotype	NN	O	genotype	prep_among	18	SENT_191	[p12l1947t575r2144b636, p12l7t671r158b743],
24	677TT	NN	O	677tt	nsubj	18	SENT_191	[p12l185t662r436b736],
25	,	,	O	,	_	0	SENT_191	[p12l185t662r436b736],
26	high	JJ	O	high	amod	28	SENT_191	[p12l464t662r853b743],
27	—	NN	O	—	nn	28	SENT_191	[p12l464t662r853b743],
28	levels	NNS	O	level	appos	24	SENT_191	[p12l464t662r853b743],
29	of	IN	O	of	_	0	SENT_191	[p12l881t662r957b725],
30	homocysteine	NN	O	homocysteine	prep_of	28	SENT_191	[p12l976t662r1467b743],
31	and	CC	O	and	_	0	SENT_191	[p12l1495t662r1620b725],
32	hematological	JJ	O	hematological	amod	36	SENT_191	[p12l1643t662r2147b743],
33	and	CC	O	and	_	0	SENT_191	[p12l9t768r135b830],
34	extra	JJ	O	extra	amod	36	SENT_191	[p12l156t777r332b830],
35	hematological	JJ	O	hematological	amod	36	SENT_191	[p12l352t768r855b849],
36	toxicity	NN	O	toxicity	conj_and	28	SENT_191	[p12l877t768r1147b849],
37	of	IN	O	of	_	0	SENT_191	[p12l1171t767r1248b830],
38	III/IV	NN	O	iii/iv	nn	39	SENT_191	[p12l1264t768r1468b831],
39	grade	NN	O	grade	prep_of	36	SENT_191	[p12l1492t768r1687b849],
40	according	VBG	O	accord	_	0	SENT_191	[p12l1711t768r2057b849],
41	to	TO	O	to	prepc_according_to	18	SENT_191	[p12l2080t777r2146b830],
42	WHO	WP	O	who	dobj	54	SENT_191	[p12l6t877r217b939],
43	scale	NN	O	scale	nsubj	54	SENT_191	[p12l242t876r415b939],
44	during	IN	O	during	_	0	SENT_191	[p12l438t876r666b957],
45	MTX	NN	O	mtx	nn	46	SENT_191	[p12l689t878r885b938],
46	therapy	NN	O	therapy	prep_during	43	SENT_191	[p12l906t876r1170b957],
47	with	IN	O	with	_	0	SENT_191	[p12l1193t876r1349b939],
48	a	DT	O	a	det	52	SENT_191	[p12l1371t896r1408b939],
49	40	CD	NUMBER	40	num	50	SENT_191	[p12l1428t877r1515b939],
50	times	NNS	O	time	npadvmod	51	SENT_191	[p12l1536t876r1725b939],
51	greater	JJR	O	greater	amod	52	SENT_191	[p12l1750t886r1996b957],
52	risk	NN	O	risk	prep_with	46	SENT_191	[p12l2015t876r2149b939],
53	to	TO	O	to	aux	54	SENT_191	[p12l7t992r73b1045],
54	develop	VB	O	develop	pcomp	18	SENT_191	[p12l100t983r375b1064],
55	toxicity	NN	O	toxicity	dobj	54	SENT_191	[p12l400t983r670b1064],
56	for	IN	O	for	_	0	SENT_191	[p12l696t983r799b1045],
57	homozygotes	NNS	O	homozygote	nn	58	SENT_191	[p12l821t983r1293b1064],
58	patients	NNS	O	patient	prep_for	54	SENT_191	[p12l1319t983r1613b1064],
59	.	.	O	.	_	0	SENT_191	[p12l1319t983r1613b1064],

1	Urano	NNP	O	Urano	nsubj	17	SENT_192	[p12l114t1092r334b1153],
2	et	FW	O	et	nn	4	SENT_192	[p12l363t1100r426b1153],
3	al.	FW	O	al.	nn	4	SENT_192	[p12l454t1090r532b1153],
4	[	FW	O	[	rcmod	1	SENT_192	[p12l570t1090r704b1166],
5	25	CD	NUMBER	25	num	6	SENT_192	[p12l570t1090r704b1166],
6	]	NN	O	]	dobj	4	SENT_192	[p12l570t1090r704b1166],
7	in	IN	O	in	_	0	SENT_192	[p12l737t1090r805b1152],
8	a	DT	O	a	det	9	SENT_192	[p12l834t1110r871b1153],
9	population	NN	O	population	prep_in	6	SENT_192	[p12l895t1090r1276b1171],
10	of	IN	O	of	_	0	SENT_192	[p12l1305t1090r1381b1153],
11	106	CD	NUMBER	106	num	12	SENT_192	[p12l1411t1090r1533b1153],
12	patients	NNS	O	patient	prep_of	4	SENT_192	[p12l1560t1090r1835b1171],
13	affected	VBN	O	affect	partmod	1	SENT_192	[p12l1866t1090r2148b1153],
14	by	IN	O	by	_	0	SENT_192	[p12l6t1197r93b1278],
15	rheumatoid	JJ	O	rheumatoid	amod	16	SENT_192	[p12l129t1197r536b1260],
16	arthritis	NN	O	arthritis	agent	13	SENT_192	[p12l573t1197r844b1260],
17	underlined	VBD	O	underline	_	0	SENT_192	[p12l882t1197r1263b1260],
18	a	DT	O	a	det	20	SENT_192	[p12l1301t1217r1337b1260],
19	greater	JJR	O	greater	amod	20	SENT_192	[p12l1373t1207r1620b1278],
20	probability	NN	O	probability	dobj	17	SENT_192	[p12l1653t1197r2043b1278],
21	to	TO	O	to	aux	22	SENT_192	[p12l2080t1207r2146b1260],
22	develop	VB	O	develop	xcomp	17	SENT_192	[p12l8t1303r283b1384],
23	toxicity	NN	O	toxicity	dobj	22	SENT_192	[p12l317t1303r586b1384],
24	in	IN	O	in	_	0	SENT_192	[p12l620t1303r687b1364],
25	the	DT	O	the	det	26	SENT_192	[p12l719t1303r825b1365],
26	subgroup	NN	O	subgroup	prep_in	22	SENT_192	[p12l862t1303r1187b1384],
27	of	IN	O	of	_	0	SENT_192	[p12l1222t1302r1299b1365],
28	patients	NNS	O	patient	prep_of	26	SENT_192	[p12l1324t1303r1598b1384],
29	with	IN	O	with	_	0	SENT_192	[p12l1634t1303r1790b1365],
30	genotype	NN	O	genotype	nn	31	SENT_192	[p12l1824t1312r2147b1384],
31	677TT	NN	O	677tt	prep_with	28	SENT_192	[p12l9t1411r248b1474],
32	(	CD	NUMBER	(	num	33	SENT_192	[p12l273t1412r341b1491],
33	p	NN	O	p	tmod	17	SENT_192	[p12l273t1412r341b1491],
34	<	JJR	O	<	amod	36	SENT_192	[p12l361t1426r407b1473],
35	0.05	CD	NUMBER	0.05	num	36	SENT_192	[p12l426t1411r606b1489],
36	)	NN	O	)	nsubjpass	47	SENT_192	[p12l426t1411r606b1489],
37	but	CC	O	but	prep	36	SENT_192	[p12l630t1411r743b1474],
38	no	DT	O	no	det	39	SENT_192	[p12l764t1431r850b1474],
39	correlation	NN	O	correlation	dep	37	SENT_192	[p12l874t1411r1258b1474],
40	between	IN	O	between	_	0	SENT_192	[p12l1279t1411r1576b1474],
41	toxicity	NN	O	toxicity	prep_between	39	SENT_192	[p12l1598t1411r1868b1492],
42	and	CC	O	and	_	0	SENT_192	[p12l1893t1411r2019b1474],
43	the	DT	O	the	det	45	SENT_192	[p12l2040t1411r2147b1474],
44	polymorphism	NN	O	polymorphism	nn	45	SENT_192	[p12l6t1518r527b1599],
45	Al298C	NN	O	al298c	prep_between	39	SENT_192	[p12l550t1518r849b1582],
46	was	VBD	O	be	auxpass	47	SENT_192	[p12l876t1538r1008b1581],
47	observed	VBN	O	observe	rcmod	33	SENT_192	[p12l1037t1518r1372b1581],
48	.	.	O	.	_	0	SENT_192	[p12l1037t1518r1372b1581],

1	The	DT	O	the	det	2	SENT_193	[p12l114t1624r250b1685],
2	mechanism	NN	O	mechanism	nsubjpass	11	SENT_193	[p12l282t1624r688b1685],
3	at	IN	O	at	_	0	SENT_193	[p12l721t1633r782b1685],
4	the	DT	O	the	det	5	SENT_193	[p12l812t1624r919b1685],
5	basis	NN	O	basis	prep_at	2	SENT_193	[p12l950t1624r1125b1685],
6	of	IN	O	of	_	0	SENT_193	[p12l1160t1624r1237b1685],
7	this	DT	O	this	det	8	SENT_193	[p12l1263t1624r1388b1685],
8	correlation	NN	O	correlation	prep_of	5	SENT_193	[p12l1422t1624r1806b1685],
9	could	MD	O	could	aux	11	SENT_193	[p12l1838t1624r2034b1685],
10	be	VB	O	be	auxpass	11	SENT_193	[p12l2064t1624r2147b1685],
11	explained	VBN	O	explain	_	0	SENT_193	[p12l8t1731r351b1812],
12	with	IN	O	with	_	0	SENT_193	[p12l379t1731r535b1794],
13	the	DT	O	the	det	14	SENT_193	[p12l563t1731r670b1794],
14	fact	NN	O	fact	prep_with	11	SENT_193	[p12l699t1731r831b1794],
15	that	IN	O	that	complm	28	SENT_193	[p12l857t1731r990b1794],
16	a	DT	O	a	det	19	SENT_193	[p12l1019t1751r1056b1794],
17	reduced	VBN	O	reduce	amod	19	SENT_193	[p12l1082t1731r1363b1794],
18	enzymatic	JJ	O	enzymatic	amod	19	SENT_193	[p12l1392t1731r1753b1812],
19	activity	NN	O	activity	nsubj	28	SENT_193	[p12l1785t1731r2046b1812],
20	of	IN	O	of	_	0	SENT_193	[p12l2076t1731r2153b1794],
21	the	DT	O	the	det	22	SENT_193	[p12l8t1838r115b1900],
22	MTHFR	NNP	O	MTHFR	prep_of	19	SENT_193	[p12l145t1839r452b1900],
23	due	JJ	O	due	_	0	SENT_193	[p12l483t1838r608b1900],
24	to	TO	O	to	_	0	SENT_193	[p12l639t1847r705b1900],
25	677TT	NN	O	677tt	nn	26	SENT_193	[p12l738t1838r977b1901],
26	variant	NN	O	variant	prep_due_to	22	SENT_193	[p12l1008t1838r1253b1901],
27	could	MD	O	could	aux	28	SENT_193	[p12l1283t1838r1479b1900],
28	increase	VB	O	increase	ccomp	11	SENT_193	[p12l1509t1838r1798b1900],
29	the	DT	O	the	det	31	SENT_193	[p12l1829t1838r1936b1900],
30	pharmacological	JJ	O	pharmacological	amod	31	SENT_193	[p12l1966t1838r2149b1919, p12l8t1945r442b2026],
31	effects	NNS	O	effect	dobj	28	SENT_193	[p12l468t1945r699b2008],
32	of	IN	O	of	_	0	SENT_193	[p12l727t1945r804b2008],
33	the	DT	O	the	det	36	SENT_193	[p12l822t1945r929b2008],
34	MTX	NNP	O	MTX	nn	36	SENT_193	[p12l954t1947r1150b2007],
35	causing	VBG	O	cause	amod	36	SENT_193	[p12l1176t1945r1445b2026],
36	toxicity	NN	O	toxicity	prep_of	31	SENT_193	[p12l1470t1945r1753b2026],
37	.	.	O	.	_	0	SENT_193	[p12l1470t1945r1753b2026],

1	Although	IN	O	although	mark	4	SENT_194	[p12l115t2052r451b2133],
2	our	PRP$	O	we	poss	3	SENT_194	[p12l500t2072r618b2115],
3	paper	NN	O	paper	nsubj	4	SENT_194	[p12l663t2072r862b2133],
4	describes	VBZ	O	describe	advcl	22	SENT_194	[p12l909t2052r1236b2115],
5	the	DT	O	the	det	6	SENT_194	[p12l1286t2052r1393b2115],
6	lack	NN	O	lack	dobj	4	SENT_194	[p12l1441t2052r1590b2115],
7	of	IN	O	of	_	0	SENT_194	[p12l1637t2052r1714b2115],
8	association	NN	O	association	prep_of	6	SENT_194	[p12l1758t2052r2151b2115],
9	between	IN	O	between	_	0	SENT_194	[p12l7t2158r303b2221],
10	MTHFR	NNP	O	MTHFR	nn	11	SENT_194	[p12l326t2159r633b2219],
11	polymorphisms	NNS	O	polymorphism	prep_between	8	SENT_194	[p12l653t2158r1206b2239],
12	and	CC	O	and	_	0	SENT_194	[p12l1233t2158r1358b2220],
13	the	DT	O	the	det	14	SENT_194	[p12l1380t2158r1487b2220],
14	response	NN	O	response	prep_of	6	SENT_194	[p12l1509t2177r1820b2239],
15	to	TO	O	to	_	0	SENT_194	[p12l1843t2167r1909b2220],
16	MTX	NNP	O	MTX	prep_to	14	SENT_194	[p12l1932t2159r2148b2232],
17	,	,	O	,	_	0	SENT_194	[p12l1932t2159r2148b2232],
18	it	PRP	O	it	nsubjpass	22	SENT_194	[p12l8t2266r57b2329],
19	should	MD	O	should	aux	22	SENT_194	[p12l83t2266r317b2329],
20	not	RB	O	not	neg	22	SENT_194	[p12l342t2276r455b2329],
21	be	VB	O	be	auxpass	22	SENT_194	[p12l477t2266r560b2329],
22	considered	VBN	O	consider	_	0	SENT_194	[p12l586t2266r971b2329],
23	entirely	RB	O	entirely	advmod	22	SENT_194	[p12l996t2266r1265b2347],
24	conﬂicting	VBG	O	conﬂicting	xcomp	22	SENT_194	[p12l1292t2266r1670b2347],
25	with	IN	O	with	_	0	SENT_194	[p12l1696t2266r1853b2329],
26	the	DT	O	the	det	29	SENT_194	[p12l1877t2266r1984b2329],
27	previous	JJ	O	previous	amod	29	SENT_194	[p12l2008t2286r2149b2347, p12l8t2373r197b2436],
28	published	VBN	O	publish	amod	29	SENT_194	[p12l221t2373r568b2454],
29	data	NNS	O	datum	prep_with	24	SENT_194	[p12l591t2373r738b2435],
30	for	IN	O	for	_	0	SENT_194	[p12l759t2373r863b2435],
31	several	JJ	O	several	amod	33	SENT_194	[p12l887t2373r1130b2436],
32	plausible	JJ	O	plausible	amod	33	SENT_194	[p12l1152t2373r1473b2454],
33	explanations	NNS	O	explanation	prep_for	29	SENT_194	[p12l1497t2373r1962b2454],
34	.	.	O	.	_	0	SENT_194	[p12l1497t2373r1962b2454],

1	First	NNP	ORDINAL	First	nsubj	8	SENT_195	[p12l1989t2373r2152b2435],
2	of	IN	O	of	_	0	SENT_195	[p12l9t2480r86b2543],
3	all	PDT	O	all	predet	4	SENT_195	[p12l120t2480r205b2543],
4	this	DT	O	this	prep_of	1	SENT_195	[p12l243t2480r368b2543],
5	is	VBZ	O	be	cop	8	SENT_195	[p12l408t2480r463b2543],
6	the	DT	O	the	det	8	SENT_195	[p12l503t2480r609b2543],
7	ﬁrst	NN	O	ﬁrst	nn	8	SENT_195	[p12l650t2480r786b2543],
8	study	NN	O	study	_	0	SENT_195	[p12l826t2480r1014b2561],
9	evaluating	VBG	O	evaluate	partmod	8	SENT_195	[p12l1053t2480r1417b2561],
10	the	DT	O	the	det	11	SENT_195	[p12l1456t2480r1562b2543],
11	impact	NN	O	impact	dobj	9	SENT_195	[p12l1601t2480r1843b2561],
12	of	IN	O	of	_	0	SENT_195	[p12l1881t2480r1958b2543],
13	such	JJ	O	such	amod	14	SENT_195	[p12l1993t2480r2152b2543],
14	polymorphisms	NNS	O	polymorphism	prep_of	11	SENT_195	[p12l7t2587r560b2668],
15	on	IN	O	on	_	0	SENT_195	[p12l588t2607r674b2650],
16	the	DT	O	the	det	17	SENT_195	[p12l699t2587r805b2650],
17	EFS	NN	O	ef	prep_on	9	SENT_195	[p12l831t2588r978b2650],
18	and	CC	O	and	_	0	SENT_195	[p12l1009t2587r1135b2650],
19	OS	NN	O	os	prep_on	9	SENT_195	[p12l1161t2588r1267b2650],
20	in	IN	O	in	_	0	SENT_195	[p12l1296t2587r1363b2649],
21	a	DT	O	a	det	22	SENT_195	[p12l1390t2607r1426b2650],
22	group	NN	O	group	prep_in	17	SENT_195	[p12l1452t2607r1655b2668],
23	of	IN	O	of	_	0	SENT_195	[p12l1682t2587r1759b2650],
24	adult	JJ	O	adult	amod	26	SENT_195	[p12l1780t2587r1956b2650],
25	ALL	NN	O	all	nn	26	SENT_195	[p12l1980t2588r2151b2649],
26	patients	NNS	O	patient	prep_of	22	SENT_195	[p12l7t2694r282b2775],
27	characterized	VBN	O	characterize	partmod	26	SENT_195	[p12l308t2694r782b2756],
28	by	IN	O	by	_	0	SENT_195	[p12l804t2694r891b2775],
29	a	DT	O	a	det	31	SENT_195	[p12l918t2713r955b2756],
30	higher	JJR	O	higher	amod	31	SENT_195	[p12l976t2694r1205b2775],
31	incidence	NN	O	incidence	agent	27	SENT_195	[p12l1227t2694r1566b2756],
32	of	IN	O	of	_	0	SENT_195	[p12l1592t2694r1669b2756],
33	unfavourable	JJ	O	unfavourable	amod	34	SENT_195	[p12l1686t2694r2151b2757],
34	risk	NN	O	risk	poss	36	SENT_195	[p12l7t2801r197b2864],
35	’s	POS	O	’s	_	0	SENT_195	[p12l7t2801r197b2864],
36	factors	NNS	O	factor	prep_of	31	SENT_195	[p12l239t2801r500b2875],
37	;	:	O	;	_	0	SENT_195	[p12l239t2801r500b2875],
38	secondly	RB	O	secondly	advmod	64	SENT_195	[p12l547t2801r859b2882],
39	in	IN	O	in	_	0	SENT_195	[p12l899t2801r966b2863],
40	the	DT	O	the	det	42	SENT_195	[p12l1006t2801r1112b2864],
41	Italian	JJ	MISC	italian	amod	42	SENT_195	[p12l1153t2801r1379b2864],
42	population	NN	O	population	prep_in	64	SENT_195	[p12l1417t2801r1798b2882],
43	which	WDT	O	which	nsubjpass	45	SENT_195	[p12l1838t2801r2054b2864],
44	is	VBZ	O	be	auxpass	45	SENT_195	[p12l2094t2801r2149b2864],
45	characterized	VBN	O	characterize	rcmod	42	SENT_195	[p12l9t2908r483b2971],
46	by	IN	O	by	_	0	SENT_195	[p12l510t2908r597b2989],
47	a	DT	O	a	det	49	SENT_195	[p12l628t2928r665b2971],
48	high	JJ	O	high	amod	49	SENT_195	[p12l691t2908r849b2989],
49	prevalence	NN	O	prevalence	agent	45	SENT_195	[p12l876t2908r1257b2989],
50	of	IN	O	of	_	0	SENT_195	[p12l1287t2908r1364b2971],
51	677TT	NN	O	677tt	prep_of	49	SENT_195	[p12l1388t2908r1627b2971],
52	(	CD	NUMBER	(	num	51	SENT_195	[p12l1659t2908r1932b2985],
53	around	IN	O	around	advmod	49	SENT_195	[p12l1659t2908r1932b2985],
54	18	CD	PERCENT	18	num	55	SENT_195	[p12l1969t2908r2149b2985],
55	%	NN	PERCENT	%	pobj	53	SENT_195	[p12l1969t2908r2149b2985],
56	)	CD	NUMBER	)	dep	49	SENT_195	[p12l1969t2908r2149b2985],
57	the	DT	O	the	det	58	SENT_195	[p12l8t3014r115b3076],
58	impact	NN	O	impact	nsubjpass	64	SENT_195	[p12l146t3014r387b3095],
59	of	IN	O	of	_	0	SENT_195	[p12l418t3013r495b3076],
60	the	DT	O	the	det	61	SENT_195	[p12l519t3014r626b3076],
61	polymorphisms	NNS	O	polymorphism	prep_of	58	SENT_195	[p12l656t3013r1209b3095],
62	could	MD	O	could	aux	64	SENT_195	[p12l1242t3014r1438b3076],
63	be	VB	O	be	auxpass	64	SENT_195	[p12l1467t3014r1549b3076],
64	modiﬁed	VBN	O	modiﬁed	parataxis	8	SENT_195	[p12l1581t3014r1897b3076],
65	by	IN	O	by	_	0	SENT_195	[p12l1926t3014r2013b3095],
66	the	DT	O	the	det	67	SENT_195	[p12l2044t3014r2151b3076],
67	level	NN	O	level	agent	64	SENT_195	[p12l8t3122r175b3185],
68	of	IN	O	of	_	0	SENT_195	[p12l206t3122r283b3185],
69	folate	NN	O	folate	prep_of	67	SENT_195	[p12l306t3122r507b3185],
70	and	CC	O	and	cc	64	SENT_195	[p12l538t3122r664b3185],
71	particularly	RB	O	particularly	advmod	64	SENT_195	[p12l691t3122r1101b3203],
72	from	IN	O	from	dep	64	SENT_195	[p12l1131t3122r1303b3185],
73	the	DT	O	the	det	74	SENT_195	[p12l1331t3122r1437b3185],
74	diet	NN	O	diet	pobj	72	SENT_195	[p12l1468t3122r1618b3197],
75	,	,	O	,	_	0	SENT_195	[p12l1468t3122r1618b3197],
76	otherwise	RB	O	otherwise	advmod	64	SENT_195	[p12l1651t3122r1995b3185],
77	one	CD	NUMBER	one	nsubj	79	SENT_195	[p12l2026t3142r2151b3185],
78	might	MD	O	might	aux	79	SENT_195	[p12l8t3229r216b3310],
79	expect	VB	O	expect	dep	64	SENT_195	[p12l250t3238r480b3310],
80	that	IN	O	that	complm	88	SENT_195	[p12l513t3229r647b3291],
81	the	DT	O	the	det	83	SENT_195	[p12l680t3229r786b3291],
82	high	JJ	O	high	amod	83	SENT_195	[p12l821t3229r979b3310],
83	prevalence	NN	O	prevalence	nsubj	88	SENT_195	[p12l1012t3229r1393b3310],
84	of	IN	O	of	_	0	SENT_195	[p12l1429t3229r1506b3291],
85	the	DT	O	the	det	86	SENT_195	[p12l1535t3229r1642b3291],
86	homozygotes	NNS	O	homozygote	prep_of	83	SENT_195	[p12l1676t3229r2149b3310],
87	should	MD	O	should	aux	88	SENT_195	[p12l11t3336r245b3399],
88	induce	VB	O	induce	ccomp	79	SENT_195	[p12l283t3336r518b3399],
89	a	DT	O	a	det	91	SENT_195	[p12l559t3356r596b3399],
90	greater	JJR	O	greater	amod	91	SENT_195	[p12l634t3346r880b3417],
91	incidence	NN	O	incidence	dobj	88	SENT_195	[p12l917t3336r1257b3399],
92	of	IN	O	of	_	0	SENT_195	[p12l1297t3336r1374b3399],
93	relapse	NN	O	relapse	prep_of	91	SENT_195	[p12l1405t3336r1656b3417],
94	compared	VBN	O	compare	_	0	SENT_195	[p12l1696t3336r2046b3417],
95	to	TO	O	to	prepc_compared_to	88	SENT_195	[p12l2084t3346r2150b3399],
96	other	JJ	O	other	amod	98	SENT_195	[p12l9t3443r191b3506],
97	genetic	JJ	O	genetic	amod	98	SENT_195	[p12l216t3443r468b3524],
98	features	NNS	O	feature	pobj	88	SENT_195	[p12l495t3443r793b3506],
99	.	.	O	.	_	0	SENT_195	[p12l495t3443r793b3506],

1	Regarding	VBG	O	regard	_	0	SENT_196	[p12l116t3550r483b3631],
2	toxicity	NN	O	toxicity	prep_regarding	5	SENT_196	[p12l544t3550r815b3631],
3	this	DT	O	this	det	4	SENT_196	[p12l876t3550r1000b3612],
4	report	NN	O	report	nsubj	5	SENT_196	[p12l1062t3559r1276b3631],
5	shows	VBZ	O	show	_	0	SENT_196	[p12l1338t3550r1551b3613],
6	an	DT	O	a	det	7	SENT_196	[p12l1616t3569r1696b3612],
7	association	NN	O	association	dobj	5	SENT_196	[p12l1758t3550r2151b3612],
8	between	IN	O	between	_	0	SENT_196	[p12l7t3656r304b3719],
9	MT	NNP	O	MT	nn	11	SENT_196	[p12l351t3658r484b3718],
10	HFR	NNP	O	HFR	nn	11	SENT_196	[p12l486t3658r659b3718],
11	677TT	NNP	O	677TT	prep_between	7	SENT_196	[p12l708t3656r947b3720],
12	and	CC	O	and	_	0	SENT_196	[p12l998t3656r1123b3719],
13	MTX	NNP	O	MTX	nn	14	SENT_196	[p12l1171t3658r1367b3718],
14	intolerance	NN	O	intolerance	conj_and	11	SENT_196	[p12l1415t3656r1810b3719],
15	in	IN	O	in	_	0	SENT_196	[p12l1859t3656r1926b3718],
16	adult	JJ	O	adult	amod	17	SENT_196	[p12l1976t3656r2152b3719],
17	patients	NNS	O	patient	prep_in	5	SENT_196	[p13l7t29r282b110],
18	affected	VBN	O	affect	dep	17	SENT_196	[p13l319t29r602b92],
19	by	IN	O	by	_	0	SENT_196	[p13l633t29r720b110],
20	ALL	NN	O	all	prep_by	18	SENT_196	[p13l755t30r927b91],
21	and	CC	O	and	_	0	SENT_196	[p13l962t29r1087b92],
22	receiving	VBG	O	receive	dep	17	SENT_196	[p13l1119t29r1447b110],
23	MTX	NNP	O	MTX	dobj	22	SENT_196	[p13l1481t29r1912b92],
24	—	CD	NUMBER	—	num	23	SENT_196	[p13l1481t29r1912b92],
25	based	VBN	O	base	partmod	23	SENT_196	[p13l1481t29r1912b92],
26	maintenance	NN	O	maintenance	dobj	25	SENT_196	[p13l1945t29r2149b92, p13l8t144r296b197],
27	.	.	O	.	_	0	SENT_196	[p13l1945t29r2149b92, p13l8t144r296b197],

1	Larger	JJR	O	larger	amod	3	SENT_197	[p13l343t136r579b216],
2	prospective	JJ	O	prospective	amod	3	SENT_197	[p13l618t135r1025b216],
3	studies	NNS	O	study	nsubjpass	6	SENT_197	[p13l1071t135r1311b197],
4	should	MD	O	should	aux	6	SENT_197	[p13l1358t135r1592b197],
5	be	VB	O	be	auxpass	6	SENT_197	[p13l1632t135r1715b197],
6	undertaken	VBN	O	undertake	_	0	SENT_197	[p13l1757t135r2151b197],
7	to	TO	O	to	aux	9	SENT_197	[p13l8t253r74b306],
8	be	VB	O	be	cop	9	SENT_197	[p13l111t243r194b306],
9	able	JJ	O	able	xcomp	6	SENT_197	[p13l234t243r378b306],
10	to	TO	O	to	aux	11	SENT_197	[p13l416t253r482b306],
11	draw	VB	O	draw	dep	9	SENT_197	[p13l521t243r694b306],
12	recommendations	NNS	O	recommendation	dobj	11	SENT_197	[p13l732t243r1364b306],
13	with	IN	O	with	_	0	SENT_197	[p13l1404t243r1560b306],
14	respect	NN	O	respect	prep_with	11	SENT_197	[p13l1596t253r1849b324],
15	to	TO	O	to	_	0	SENT_197	[p13l1885t253r1951b306],
16	dose	NN	O	dose	nn	17	SENT_197	[p13l1990t243r2151b306],
17	adjustment	NN	O	adjustment	prep_to	11	SENT_197	[p13l10t350r399b431],
18	and	CC	O	and	_	0	SENT_197	[p13l432t350r558b412],
19	to	TO	O	to	aux	20	SENT_197	[p13l590t359r656b412],
20	establish	VB	O	establish	dep	9	SENT_197	[p13l691t350r1001b412],
21	the	DT	O	the	det	22	SENT_197	[p13l1033t350r1139b412],
22	efﬁcacy	NN	O	efﬁcacy	dobj	20	SENT_197	[p13l1173t350r1449b431],
23	of	IN	O	of	_	0	SENT_197	[p13l1483t350r1560b412],
24	MTX	NN	O	mtx	nn	25	SENT_197	[p13l1587t351r1783b412],
25	treatment	NN	O	treatment	prep_of	22	SENT_197	[p13l1816t359r2152b412],
26	according	VBG	O	accord	_	0	SENT_197	[p13l10t456r357b537],
27	to	TO	O	to	prepc_according_to	20	SENT_197	[p13l383t465r449b518],
28	MTHFR	NNP	O	MTHFR	nn	29	SENT_197	[p13l474t457r781b517],
29	polymorphisms	NNS	O	polymorphism	pobj	20	SENT_197	[p13l804t456r1377b537],
30	.	.	O	.	_	0	SENT_197	[p13l804t456r1377b537],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_198	[p13l8t699r744b780],

1	This	DT	O	this	det	2	SENT_199	[p13l116t896r270b959],
2	work	NN	O	work	nsubjpass	4	SENT_199	[p13l299t896r481b959],
3	was	VBD	O	be	auxpass	4	SENT_199	[p13l506t916r639b959],
4	supported	VBN	O	support	_	0	SENT_199	[p13l671t896r1018b977],
5	by	IN	O	by	_	0	SENT_199	[p13l1043t896r1130b977],
6	Associazione	NNP	ORGANIZATION	Associazione	nn	7	SENT_199	[p13l1158t896r1631b959],
7	Italiana	NNP	ORGANIZATION	Italiana	agent	4	SENT_199	[p13l1659t896r1926b959],
8	per	IN	O	per	_	0	SENT_199	[p13l1950t916r2064b977],
9	la	NNP	O	la	prep_per	7	SENT_199	[p13l2089t896r2153b959],

1	Ricerca	NNP	PERSON	Ricerca	nn	3	SENT_200	[p13l8t1002r280b1065],
2	sul	NN	O	sul	nn	3	SENT_200	[p13l306t1002r405b1065],
3	Cancro	NNP	PERSON	Cancro	_	0	SENT_200	[p13l431t1002r685b1065],
4	(	CD	NUMBER	(	num	5	SENT_200	[p13l713t1002r999b1080],
5	AIRC	NNP	ORGANIZATION	AIRC	dep	3	SENT_200	[p13l713t1002r999b1080],
6	)	CD	NUMBER	)	num	5	SENT_200	[p13l713t1002r999b1080],
7	.	.	O	.	_	0	SENT_200	[p13l713t1002r999b1080],

1	Contributions	NNS	O	contribution	_	0	SENT_201	[p13l120t1109r625b1172],
2	.	.	O	.	_	0	SENT_201	[p13l120t1109r625b1172],

1	All	DT	O	all	det	2	SENT_202	[p13l658t1109r769b1170],
2	authors	NNS	O	author	nsubj	3	SENT_202	[p13l799t1109r1056b1171],
3	gave	VBD	O	give	_	0	SENT_202	[p13l1087t1128r1248b1190],
4	substantial	JJ	O	substantial	amod	5	SENT_202	[p13l1279t1109r1656b1171],
5	contributions	NNS	O	contribution	dobj	3	SENT_202	[p13l1684t1109r2149b1171],
6	to	TO	O	to	_	0	SENT_202	[p13l8t1227r74b1280],
7	the	DT	O	the	det	8	SENT_202	[p13l122t1217r228b1280],
8	conception	NN	O	conception	prep_to	3	SENT_202	[p13l277t1217r666b1298],
9	and	CC	O	and	_	0	SENT_202	[p13l715t1217r840b1280],
10	design	NN	O	design	prep_to	3	SENT_202	[p13l887t1217r1117b1298],
11	of	IN	O	of	_	0	SENT_202	[p13l1165t1217r1242b1280],
12	the	DT	O	the	det	13	SENT_202	[p13l1283t1217r1390b1280],
13	study	NN	O	study	prep_of	8	SENT_202	[p13l1440t1217r1642b1298],
14	,	,	O	,	_	0	SENT_202	[p13l1440t1217r1642b1298],
15	analysis	NN	O	analysis	conj_and	13	SENT_202	[p13l1694t1217r1976b1298],
16	and	CC	O	and	_	0	SENT_202	[p13l2027t1217r2152b1280],
17	interpretation	NN	O	interpretation	conj_and	13	SENT_202	[p13l8t1324r487b1405],
18	of	IN	O	of	_	0	SENT_202	[p13l526t1324r603b1387],
19	the	DT	O	the	det	20	SENT_202	[p13l634t1324r740b1387],
20	data	NNS	O	datum	prep_of	13	SENT_202	[p13l779t1324r943b1398],
21	,	,	O	,	_	0	SENT_202	[p13l779t1324r943b1398],
22	drafting	VBG	O	draft	dep	3	SENT_202	[p13l985t1324r1263b1405],
23	and	CC	O	and	_	0	SENT_202	[p13l1303t1324r1429b1387],
24	revising	VBG	O	revise	dep	3	SENT_202	[p13l1465t1324r1748b1405],
25	the	DT	O	the	det	26	SENT_202	[p13l1786t1324r1892b1387],
26	article	NN	O	article	dobj	22	SENT_202	[p13l1932t1324r2151b1387],
27	and	CC	O	and	_	0	SENT_202	[p13l10t1430r135b1492],
28	gave	VBD	O	give	conj_and	3	SENT_202	[p13l177t1449r339b1511],
29	the	DT	O	the	det	31	SENT_202	[p13l380t1430r486b1492],
30	ﬁnal	JJ	O	ﬁnal	amod	31	SENT_202	[p13l529t1430r684b1492],
31	approval	NN	O	approval	dobj	28	SENT_202	[p13l727t1430r1031b1511],
32	of	IN	O	of	_	0	SENT_202	[p13l1074t1430r1151b1492],
33	the	DT	O	the	det	35	SENT_202	[p13l1186t1430r1293b1492],
34	present	JJ	DATE	present	amod	35	SENT_202	[p13l1333t1439r1591b1511],
35	version	NN	O	version	prep_of	31	SENT_202	[p13l1631t1430r1890b1492],
36	of	IN	O	of	_	0	SENT_202	[p13l1932t1429r2009b1492],
37	the	DT	O	the	det	38	SENT_202	[p13l2044t1430r2150b1492],
38	manuscript	NN	O	manuscript	prep_of	35	SENT_202	[p13l8t1538r421b1619],
39	.	.	O	.	_	0	SENT_202	[p13l8t1538r421b1619],

1	In	IN	O	in	_	0	SENT_203	[p13l470t1540r542b1600],
2	particular	JJ	O	particular	prep_in	8	SENT_203	[p13l586t1538r929b1619],
3	Patrizia	NNP	PERSON	Patrizia	nn	4	SENT_203	[p13l973t1538r1243b1601],
4	Chiusolo	NNP	PERSON	Chiusolo	nsubj	8	SENT_203	[p13l1288t1538r1606b1601],
5	and	CC	O	and	_	0	SENT_203	[p13l1654t1538r1780b1601],
6	Giovanni	NNP	PERSON	Giovanni	nn	7	SENT_203	[p13l1826t1538r2150b1601],
7	Reddiconto	NNP	PERSON	Reddiconto	nsubj	8	SENT_203	[p13l8t1645r417b1707],
8	supervised	VBD	O	supervise	_	0	SENT_203	[p13l457t1645r835b1726],
9	the	DT	O	the	det	10	SENT_203	[p13l870t1645r976b1707],
10	study	NN	O	study	dobj	8	SENT_203	[p13l1016t1645r1225b1726],
11	;	:	O	;	_	0	SENT_203	[p13l1016t1645r1225b1726],
12	Giuliana	NNP	PERSON	Giuliana	nn	13	SENT_203	[p13l1267t1645r1573b1708],
13	Farina	NNP	PERSON	Farina	nsubj	20	SENT_203	[p13l1607t1645r1851b1719],
14	,	,	O	,	_	0	SENT_203	[p13l1607t1645r1851b1719],
15	Alessia	NNP	PERSON	Alessia	nn	16	SENT_203	[p13l1890t1645r2153b1707],
16	Fiorini	NNP	PERSON	Fiorini	nsubj	20	SENT_203	[p13l8t1752r248b1815],
17	and	CC	O	and	_	0	SENT_203	[p13l274t1752r399b1815],
18	Mariangela	NNP	PERSON	Mariangela	nn	19	SENT_203	[p13l421t1752r827b1833],
19	Palladino	NNP	PERSON	Palladino	nsubj	20	SENT_203	[p13l848t1752r1181b1815],
20	performed	VBD	O	perform	parataxis	8	SENT_203	[p13l1203t1752r1575b1833],
21	molecular	JJ	O	molecular	amod	22	SENT_203	[p13l1597t1752r1954b1815],
22	analysis	NN	O	analysis	dobj	20	SENT_203	[p13l1976t1752r2149b1815, p13l8t1859r166b1940],
23	;	:	O	;	_	0	SENT_203	[p13l1976t1752r2149b1815, p13l8t1859r166b1940],
24	Alice	NNP	PERSON	Alice	nn	25	SENT_203	[p13l216t1859r407b1922],
25	Mannocci	NNP	PERSON	Mannocci	nsubj	30	SENT_203	[p13l453t1859r807b1922],
26	and	CC	O	and	_	0	SENT_203	[p13l856t1859r982b1922],
27	Giuseppe	NNP	PERSON	Giuseppe	nn	29	SENT_203	[p13l1029t1859r1362b1940],
28	La	NNP	PERSON	La	nn	29	SENT_203	[p13l1408t1861r1502b1922],
29	Torre	NNP	PERSON	Torre	nsubj	30	SENT_203	[p13l1546t1861r1734b1922],
30	performed	VBD	O	perform	parataxis	8	SENT_203	[p13l1780t1859r2152b1940],
31	statystical	JJ	O	statystical	amod	32	SENT_203	[p13l11t1965r363b2046],
32	analysis	NN	O	analysis	dobj	30	SENT_203	[p13l393t1965r698b2046],
33	;	:	O	;	_	0	SENT_203	[p13l393t1965r698b2046],
34	Luana	NNP	PERSON	Luana	nn	35	SENT_203	[p13l730t1966r953b2027],
35	Fianchi	NNP	PERSON	Fianchi	nsubj	42	SENT_203	[p13l979t1965r1265b2039],
36	,	,	O	,	_	0	SENT_203	[p13l979t1965r1265b2039],
37	Federica	NNP	PERSON	Federica	nn	38	SENT_203	[p13l1296t1965r1603b2027],
38	Sora	NNP	PERSON	Sora	nsubj	42	SENT_203	[p13l1633t1964r1793b2028],
39	and	CC	O	and	_	0	SENT_203	[p13l1822t1965r1947b2027],
40	Luca	NNP	PERSON	Luca	nn	41	SENT_203	[p13l1974t1966r2153b2027],
41	Laurenti	NNP	PERSON	Laurenti	nsubj	42	SENT_203	[p13l8t2073r308b2136],
42	collected	VBD	O	collect	parataxis	8	SENT_203	[p13l329t2073r649b2136],
43	clinical	JJ	O	clinical	amod	44	SENT_203	[p13l669t2073r928b2136],
44	data	NNS	O	datum	dobj	42	SENT_203	[p13l949t2073r1116b2148],
45	;	:	O	;	_	0	SENT_203	[p13l949t2073r1116b2148],
46	Giuseppe	NNP	PERSON	Giuseppe	nn	47	SENT_203	[p13l1141t2073r1474b2154],
47	Leone	NNP	PERSON	Leone	nsubj	51	SENT_203	[p13l1493t2075r1714b2136],
48	and	CC	O	and	_	0	SENT_203	[p13l1736t2073r1862b2136],
49	Simona	NNP	PERSON	Simona	nn	50	SENT_203	[p13l1883t2073r2153b2136],
50	Sica	NNP	PERSON	Sica	nsubj	51	SENT_203	[p13l11t2180r161b2243],
51	gave	VBD	O	give	parataxis	8	SENT_203	[p13l186t2200r347b2261],
52	the	DT	O	the	det	54	SENT_203	[p13l372t2180r479b2243],
53	ﬁnal	JJ	O	ﬁnal	amod	54	SENT_203	[p13l505t2180r660b2243],
54	approval	NN	O	approval	dobj	51	SENT_203	[p13l687t2180r991b2261],
55	of	IN	O	of	_	0	SENT_203	[p13l1018t2180r1095b2243],
56	the	DT	O	the	det	57	SENT_203	[p13l1113t2180r1219b2243],
57	manuscript	NN	O	manuscript	prep_of	54	SENT_203	[p13l1245t2180r1657b2261],
58	.	.	O	.	_	0	SENT_203	[p13l1245t2180r1657b2261],

1	References	NNS	O	reference	_	0	SENT_204	[p13l9t2423r420b2487],

1	[	NN	O	[	nn	2	SENT_205	[p13l44t2634r116b2694],
2	l	NN	O	l	_	0	SENT_205	[p13l44t2634r116b2694],
3	]	CD	NUMBER	]	num	5	SENT_205	[p13l44t2634r116b2694],
4	Pui	NNP	PERSON	Pui	nn	5	SENT_205	[p13l152t2633r245b2683],
5	CH	NN	O	ch	dep	2	SENT_205	[p13l261t2633r373b2693],
6	,	,	O	,	_	0	SENT_205	[p13l261t2633r373b2693],
7	Evans	NNP	PERSON	Evans	nn	8	SENT_205	[p13l390t2634r560b2684],
8	WE	NNP	O	WE	appos	5	SENT_205	[p13l574t2634r699b2684],
9	.	.	O	.	_	0	SENT_205	[p13l574t2634r699b2684],

1	Treatment	NN	O	treatment	_	0	SENT_206	[p13l717t2634r1008b2683],
2	of	IN	O	of	_	0	SENT_206	[p13l1022t2633r1084b2683],
3	acute	JJ	O	acute	amod	5	SENT_206	[p13l1095t2641r1242b2683],
4	lymphoblastic	JJ	O	lymphoblastic	amod	5	SENT_206	[p13l1257t2633r1659b2698],
5	leukemia	NN	O	leukemia	prep_of	1	SENT_206	[p13l1675t2633r1949b2683],
6	.	.	O	.	_	0	SENT_206	[p13l1675t2633r1949b2683],

1	NEJ	NN	O	nej	nn	2	SENT_207	[p13l1966t2634r2088b2684],
2	M	NN	O	m	_	0	SENT_207	[p13l2089t2634r2151b2683],

1	[	NN	O	[	_	0	SENT_208	[p13l44t2811r116b2871],
2	2	CD	NUMBER	2	num	1	SENT_208	[p13l44t2811r116b2871],
3	]	CD	NUMBER	]	num	5	SENT_208	[p13l44t2811r116b2871],
4	Thomas	NNP	PERSON	Thomas	nn	5	SENT_208	[p13l152t2810r379b2861],
5	X	NN	PERSON	x	dep	1	SENT_208	[p13l410t2812r475b2870],
6	,	,	O	,	_	0	SENT_208	[p13l410t2812r475b2870],
7	Le	NNP	O	Le	nn	8	SENT_208	[p13l507t2812r581b2861],
8	QH	NNP	O	QH	appos	5	SENT_208	[p13l612t2811r726b2873],
9	.	.	O	.	_	0	SENT_208	[p13l612t2811r726b2873],

1	Prognostic	JJ	O	prognostic	amod	2	SENT_209	[p13l760t2810r1063b2875],
2	factors	NNS	O	factor	_	0	SENT_209	[p13l1094t2810r1284b2861],
3	in	IN	O	in	_	0	SENT_209	[p13l1315t2810r1369b2860],
4	adult	JJ	O	adult	amod	7	SENT_209	[p13l1400t2810r1541b2861],
5	acute	JJ	O	acute	amod	7	SENT_209	[p13l1571t2818r1718b2861],
6	lymphoblastic	JJ	O	lymphoblastic	amod	7	SENT_209	[p13l1748t2810r2150b2875],
7	leukaemia	NN	O	leukaemia	prep_in	2	SENT_209	[p13l153t2899r458b2950],
8	.	.	O	.	_	0	SENT_209	[p13l153t2899r458b2950],

1	Hematology	NNP	O	Hematology	_	0	SENT_210	[p13l482t2899r833b2964],
2	2003	CD	DATE	2003	num	1	SENT_210	[p13l854t2900r991b2950],
3	;	:	O	;	_	0	SENT_210	[p13l1001t2900r1047b2959],
4	8	CD	NUMBER	8	number	5	SENT_210	[p13l1001t2900r1047b2959],
5	:23	CD	NUMBER	:23	dep	1	SENT_210	[p13l1057t2900r1138b2950],
6	3-42	CD	NUMBER	3-42	dep	5	SENT_210	[p13l1145t2900r1299b2950],
7	.	.	O	.	_	0	SENT_210	[p13l1145t2900r1299b2950],

1	[	NN	O	[	_	0	SENT_211	[p13l44t2989r116b3049],
2	3	CD	NUMBER	3	num	7	SENT_211	[p13l44t2989r116b3049],
3	]	NN	O	]	nn	7	SENT_211	[p13l44t2989r116b3049],
4	Nachman	NNP	PERSON	Nachman	nn	7	SENT_211	[p13l152t2988r425b3039],
5	J.	NNP	O	J.	nn	7	SENT_211	[p13l443t2990r483b3039],
6	Clinical	JJ	O	clinical	amod	7	SENT_211	[p13l506t2988r730b3039],
7	characteristics	NNS	O	characteristic	dep	1	SENT_211	[p13l750t2988r1171b3048],
8	,	,	O	,	_	0	SENT_211	[p13l750t2988r1171b3048],
9	biologic	JJ	O	biologic	amod	10	SENT_211	[p13l1192t2988r1424b3053],
10	features	NNS	O	feature	dep	1	SENT_211	[p13l1444t2988r1666b3039],
11	and	CC	O	and	_	0	SENT_211	[p13l1688t2988r1789b3039],
12	outcome	NN	O	outcome	dep	1	SENT_211	[p13l1808t2996r2051b3039],
13	for	IN	O	for	_	0	SENT_211	[p13l2070t2988r2153b3039],
14	young	JJ	O	young	amod	16	SENT_211	[p13l152t3093r328b3142],
15	adult	JJ	O	adult	amod	16	SENT_211	[p13l348t3077r488b3128],
16	patients	NNS	O	patient	prep_for	1	SENT_211	[p13l503t3077r723b3142],
17	with	IN	O	with	_	0	SENT_211	[p13l742t3077r867b3128],
18	acute	JJ	O	acute	amod	20	SENT_211	[p13l886t3085r1033b3128],
19	lymphoblastic	JJ	O	lymphoblastic	amod	20	SENT_211	[p13l1050t3077r1452b3142],
20	leukaemia	NN	O	leukaemia	prep_with	16	SENT_211	[p13l1471t3077r1777b3128],
21	.	.	O	.	_	0	SENT_211	[p13l1471t3077r1777b3128],

1	Br	NN	O	br	nn	3	SENT_212	[p13l1797t3079r1868b3127],
2	J	NN	O	j	nn	3	SENT_212	[p13l1884t3079r1910b3128],
3	Haematol	NN	O	haematol	_	0	SENT_212	[p13l1927t3079r2149b3128, p13l152t3166r226b3216],
4	2005	CD	DATE	2005	dep	3	SENT_212	[p13l247t3166r762b3225],
5	;	:	O	;	_	0	SENT_212	[p13l247t3166r762b3225],
6	130:166	CD	NUMBER	130:166	number	7	SENT_212	[p13l247t3166r762b3225],
7	—	CD	NUMBER	—	dep	3	SENT_212	[p13l247t3166r762b3225],
8	73	CD	NUMBER	73	dep	7	SENT_212	[p13l247t3166r762b3225],
9	.	.	O	.	_	0	SENT_212	[p13l247t3166r762b3225],

1	[	NN	O	[	nn	5	SENT_213	[p13l44t3255r116b3315],
2	4	CD	NUMBER	4	num	5	SENT_213	[p13l44t3255r116b3315],
3	]	CD	NUMBER	]	num	5	SENT_213	[p13l44t3255r116b3315],
4	Cheok	NNP	O	Cheok	nn	5	SENT_213	[p13l153t3254r339b3305],
5	MH	NNP	O	MH	_	0	SENT_213	[p13l353t3256r482b3314],
6	,	,	O	,	_	0	SENT_213	[p13l353t3256r482b3314],
7	Evans	NNP	PERSON	Evans	nn	8	SENT_213	[p13l500t3256r669b3305],
8	WE	NNP	O	WE	appos	5	SENT_213	[p13l686t3256r811b3305],
9	.	.	O	.	_	0	SENT_213	[p13l686t3256r811b3305],

1	Acute	JJ	O	acute	amod	3	SENT_214	[p13l830t3255r999b3305],
2	lymphoblastic	JJ	O	lymphoblastic	amod	3	SENT_214	[p13l1016t3254r1418b3319],
3	leukemia	NN	O	leukemia	_	0	SENT_214	[p13l1435t3254r1709b3305],
4	:	:	O	:	_	0	SENT_214	[p13l1435t3254r1709b3305],
5	a	DT	O	a	det	6	SENT_214	[p13l1731t3270r1761b3305],
6	model	NN	O	model	dep	3	SENT_214	[p13l1776t3254r1953b3305],
7	for	IN	O	for	_	0	SENT_214	[p13l1969t3254r2052b3305],
8	the	DT	O	the	det	9	SENT_214	[p13l2066t3254r2151b3305],
9	pharmacogenomics	NNS	O	pharmacogenomic	prep_for	6	SENT_214	[p13l151t3343r705b3408],
10	of	IN	O	of	_	0	SENT_214	[p13l727t3343r789b3394],
11	cancer	NN	O	cancer	nn	12	SENT_214	[p13l805t3359r990b3394],
12	therapy	NN	O	therapy	prep_of	9	SENT_214	[p13l1008t3343r1229b3408],
13	.	.	O	.	_	0	SENT_214	[p13l1008t3343r1229b3408],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_215	[p13l1253t3345r1355b3394],
2	Rev	NN	PERSON	rev	_	0	SENT_215	[p13l1374t3345r1485b3394],
3	2006	CD	DATE	2006	num	2	SENT_215	[p13l1507t3343r1951b3403],
4	;	:	O	;	_	0	SENT_215	[p13l1507t3343r1951b3403],
5	6:117	CD	NUMBER	6:117	number	6	SENT_215	[p13l1507t3343r1951b3403],
6	—	CD	NUMBER	—	dep	2	SENT_215	[p13l1507t3343r1951b3403],
7	29	CD	NUMBER	29	dep	6	SENT_215	[p13l1507t3343r1951b3403],
8	.	.	O	.	_	0	SENT_215	[p13l1507t3343r1951b3403],

1	[	NN	O	[	nn	5	SENT_216	[p13l44t3432r116b3493],
2	5	CD	NUMBER	5	num	5	SENT_216	[p13l44t3432r116b3493],
3	]	CD	NUMBER	]	num	5	SENT_216	[p13l44t3432r116b3493],
4	Bailey	NNP	PERSON	Bailey	nn	5	SENT_216	[p13l152t3432r336b3497],
5	LB	NNP	O	LB	_	0	SENT_216	[p13l359t3434r464b3492],
6	,	,	O	,	_	0	SENT_216	[p13l359t3434r464b3492],
7	Gregory	NNP	PERSON	Gregory	nn	8	SENT_216	[p13l491t3433r725b3497],
8	JP	NNP	PERSON	JP	appos	5	SENT_216	[p13l748t3434r821b3483],
9	.	.	O	.	_	0	SENT_216	[p13l748t3434r821b3483],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_217	[p13l848t3432r1293b3497],
2	of	IN	O	of	_	0	SENT_217	[p13l1319t3432r1380b3483],
3	methylenetetrahydrofolate	JJ	O	methylenetetrahydrofolate	amod	4	SENT_217	[p13l1399t3432r2151b3497],
4	reductase	NN	O	reductase	prep_of	1	SENT_217	[p13l151t3522r420b3572],
5	and	CC	O	and	_	0	SENT_217	[p13l441t3522r541b3572],
6	other	JJ	O	other	amod	7	SENT_217	[p13l560t3522r706b3572],
7	enzymes	NNS	O	enzyme	prep_of	1	SENT_217	[p13l724t3537r987b3587],
8	:	:	O	:	_	0	SENT_217	[p13l724t3537r987b3587],
9	metabolic	JJ	O	metabolic	amod	10	SENT_217	[p13l1011t3522r1290b3572],
10	signiﬁcance	NN	O	signiﬁcance	dep	1	SENT_217	[p13l1312t3521r1665b3587],
11	,	,	O	,	_	0	SENT_217	[p13l1312t3521r1665b3587],
12	risks	NNS	O	risk	conj_and	10	SENT_217	[p13l1685t3521r1818b3572],
13	and	CC	O	and	_	0	SENT_217	[p13l1840t3522r1940b3572],
14	impact	NN	O	impact	dep	1	SENT_217	[p13l1958t3522r2152b3587],
15	on	IN	O	on	_	0	SENT_217	[p13l153t3626r222b3661],
16	folate	NN	O	folate	nn	17	SENT_217	[p13l242t3610r402b3661],
17	requirement	NN	O	requirement	prep_on	1	SENT_217	[p13l421t3610r780b3676],
18	.	.	O	.	_	0	SENT_217	[p13l421t3610r780b3676],

1	J	NNP	O	J	nn	2	SENT_218	[p13l804t3612r830b3661],
2	Nutr	NNP	O	Nutr	_	0	SENT_218	[p13l849t3612r980b3661],
3	1999	CD	DATE	1999	num	2	SENT_218	[p13l1005t3611r1516b3670],
4	;	:	O	;	_	0	SENT_218	[p13l1005t3611r1516b3670],
5	129:9	CD	NUMBER	129:9	num	6	SENT_218	[p13l1005t3611r1516b3670],
6	l9	NN	O	l9	dep	2	SENT_218	[p13l1005t3611r1516b3670],
7	—	CD	NUMBER	—	number	8	SENT_218	[p13l1005t3611r1516b3670],
8	22	CD	NUMBER	22	dep	6	SENT_218	[p13l1005t3611r1516b3670],
9	.	.	O	.	_	0	SENT_218	[p13l1005t3611r1516b3670],

1	[	NN	O	[	nn	5	SENT_219	[p13l44t3699r116b3760],
2	6	CD	NUMBER	6	num	5	SENT_219	[p13l44t3699r116b3760],
3	]	CD	NUMBER	]	num	5	SENT_219	[p13l44t3699r116b3760],
4	Ueland	NNP	O	Ueland	nn	5	SENT_219	[p13l152t3700r357b3750],
5	PM	NNP	O	PM	_	0	SENT_219	[p13l375t3701r493b3759],
6	,	,	O	,	_	0	SENT_219	[p13l375t3701r493b3759],
7	Hustad	NNP	PERSON	Hustad	nn	8	SENT_219	[p13l514t3699r715b3750],
8	S	NNP	O	S	appos	5	SENT_219	[p13l735t3700r787b3759],
9	,	,	O	,	_	0	SENT_219	[p13l735t3700r787b3759],
10	Schneede	NNP	O	Schneede	nn	11	SENT_219	[p13l810t3700r1080b3750],
11	J	NNP	O	J	appos	5	SENT_219	[p13l1098t3701r1140b3759],
12	,	,	O	,	_	0	SENT_219	[p13l1098t3701r1140b3759],
13	et	FW	O	et	nn	14	SENT_219	[p13l1162t3707r1212b3750],
14	al.	FW	O	al.	appos	5	SENT_219	[p13l1231t3700r1294b3750],
15	.	.	O	.	_	0	SENT_219	[p13l1231t3700r1294b3750],

1	Biological	JJ	O	biological	_	0	SENT_220	[p13l1316t3700r1612b3765],
2	and	CC	O	and	_	0	SENT_220	[p13l1633t3700r1733b3750],
3	clinical	JJ	O	clinical	amod	4	SENT_220	[p13l1751t3700r1959b3750],
4	implications	NNS	O	implication	conj_and	1	SENT_220	[p13l1978t3699r2149b3765, p14l153t19r351b69],

1	of	IN	O	of	_	0	SENT_221	[p14l378t18r440b69],
2	the	DT	O	the	det	5	SENT_221	[p14l459t19r544b69],
3	MTHFR	NN	O	mthfr	nn	5	SENT_221	[p14l568t20r814b68],
4	C677T	NN	O	c677t	nn	5	SENT_221	[p14l838t18r1034b69],
5	polymorphism	NN	O	polymorphism	pobj	1	SENT_221	[p14l1057t18r1488b84],
6	.	.	O	.	_	0	SENT_221	[p14l1057t18r1488b84],

1	Trends	NNS	O	trend	_	0	SENT_222	[p14l1515t19r1708b69],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_222	[p14l1734t19r2038b69],
3	Sci	NNP	O	Sci	dep	1	SENT_222	[p14l2064t18r2151b69],
4	2001	CD	DATE	2001	num	3	SENT_222	[p14l153t107r669b165],
5	;	:	O	;	_	0	SENT_222	[p14l153t107r669b165],
6	22:195	CD	NUMBER	22:195	num	7	SENT_222	[p14l153t107r669b165],
7	-201	CD	NUMBER	-201	dep	1	SENT_222	[p14l153t107r669b165],
8	.	.	O	.	_	0	SENT_222	[p14l153t107r669b165],

1	1674	CD	DATE	1674	num	3	SENT_223	[p14l357t240r419b264],
2	P.	NNP	PERSON	P.	nn	3	SENT_223	[p14l995t241r1016b264],
3	Chiusolo	NNP	PERSON	Chiusolo	_	0	SENT_223	[p14l1030t240r1147b264],
4	er	FW	O	er	nn	5	SENT_223	[p14l1157t245r1181b264],
5	al.	FW	O	al.	dep	3	SENT_223	[p14l1189t240r1219b264],
6	/	:	O	/	punct	3	SENT_223	[p14l1229t241r1244b264],
7	Leukemia	NNP	ORGANIZATION	Leukemia	nn	8	SENT_223	[p14l1248t240r1376b264],
8	Research	NNP	ORGANIZATION	Research	dep	3	SENT_223	[p14l1385t240r1507b264],
9	3	CD	NUMBER	3	num	10	SENT_223	[p14l1516t240r1546b264],
10	]	NN	O	]	dep	8	SENT_223	[p14l1516t240r1546b264],
11	(	CD	NUMBER	(	number	12	SENT_223	[p14l1558t240r1644b269],
12	2007	CD	DATE	2007	num	10	SENT_223	[p14l1558t240r1644b269],
13	)	CD	NUMBER	)	number	14	SENT_223	[p14l1558t240r1644b269],
14	1669-1674	CD	DATE	1669-1674	num	10	SENT_223	[p14l1656t240r1803b264],

1	[	NN	O	[	_	0	SENT_224	[p14l42t422r114b482],
2	7	CD	NUMBER	7	number	3	SENT_224	[p14l42t422r114b482],
3	]	CD	NUMBER	]	dep	1	SENT_224	[p14l42t422r114b482],
4	Weisberg	NNP	PERSON	Weisberg	dep	3	SENT_224	[p14l149t421r415b486],
5	I	PRP	O	I	dep	1	SENT_224	[p14l442t422r479b481],
6	,	,	O	,	_	0	SENT_224	[p14l442t422r479b481],
7	Tran	NNP	O	Tran	nn	8	SENT_224	[p14l507t422r638b471],
8	P	NN	O	p	appos	5	SENT_224	[p14l664t422r709b481],
9	,	,	O	,	_	0	SENT_224	[p14l664t422r709b481],
10	Christensen	NNP	PERSON	Christensen	nn	11	SENT_224	[p14l739t421r1075b472],
11	B	NNP	O	B	appos	1	SENT_224	[p14l1100t422r1161b481],
12	,	,	O	,	_	0	SENT_224	[p14l1100t422r1161b481],
13	et	FW	O	et	nn	14	SENT_224	[p14l1191t428r1241b471],
14	al.	FW	O	al.	appos	1	SENT_224	[p14l1267t421r1330b471],
15	.	.	O	.	_	0	SENT_224	[p14l1267t421r1330b471],

1	A	DT	DURATION	a	det	4	SENT_225	[p14l1359t422r1409b471],
2	second	JJ	DURATION	second	amod	4	SENT_225	[p14l1438t421r1633b471],
3	genetic	JJ	O	genetic	amod	4	SENT_225	[p14l1659t421r1862b486],
4	polymorphism	NN	O	polymorphism	nsubj	11	SENT_225	[p14l1888t421r2150b486, p14l149t510r324b575],
5	in	IN	O	in	_	0	SENT_225	[p14l357t510r411b560],
6	methylenetetrahydrofolate	JJ	O	methylenetetrahydrofolate	amod	7	SENT_225	[p14l445t510r1198b575],
7	reductase	NN	O	reductase	prep_in	4	SENT_225	[p14l1231t510r1500b560],
8	(	CD	NUMBER	(	num	10	SENT_225	[p14l1536t511r1824b572],
9	MTHFR	NN	O	mthfr	nn	10	SENT_225	[p14l1536t511r1824b572],
10	)	NN	O	)	dep	7	SENT_225	[p14l1536t511r1824b572],
11	associated	VBN	O	associate	_	0	SENT_225	[p14l1862t510r2153b560],
12	with	IN	O	with	_	0	SENT_225	[p14l151t599r276b650],
13	decreased	VBN	O	decrease	amod	15	SENT_225	[p14l296t599r576b649],
14	enzyme	NN	O	enzyme	nn	15	SENT_225	[p14l597t615r816b664],
15	activity	NN	O	activity	prep_with	11	SENT_225	[p14l838t599r1057b664],
16	.	.	O	.	_	0	SENT_225	[p14l838t599r1057b664],

1	Mol	NNP	ORGANIZATION	Mol	nn	3	SENT_226	[p14l1080t599r1198b649],
2	Genet	NNP	O	Genet	nn	3	SENT_226	[p14l1219t599r1388b650],
3	Metabol	NNP	O	Metabol	_	0	SENT_226	[p14l1407t599r1643b649],
4	1998	CD	DATE	1998	num	3	SENT_226	[p14l1671t599r1912b659],
5	;	:	O	;	_	0	SENT_226	[p14l1671t599r1912b659],
6	64	CD	NUMBER	64	num	8	SENT_226	[p14l1671t599r1912b659],
7	:	:	O	:	_	0	SENT_226	[p14l1671t599r1912b659],
8	169-72	CD	NUMBER	169-72	dep	3	SENT_226	[p14l1925t599r2145b650],
9	.	.	O	.	_	0	SENT_226	[p14l1925t599r2145b650],

1	[	NN	O	[	nn	6	SENT_227	[p14l42t689r114b748],
2	8	CD	NUMBER	8	num	6	SENT_227	[p14l42t689r114b748],
3	]	CD	NUMBER	]	num	6	SENT_227	[p14l42t689r114b748],
4	De	NNP	PERSON	De	nn	6	SENT_227	[p14l150t689r232b738],
5	Stefano	NNP	PERSON	Stefano	nn	6	SENT_227	[p14l273t688r487b738],
6	V	NNP	PERSON	V	_	0	SENT_227	[p14l528t689r583b747],
7	,	,	O	,	_	0	SENT_227	[p14l528t689r583b747],
8	Chiusolo	NNP	PERSON	Chiusolo	nn	9	SENT_227	[p14l626t688r882b738],
9	P	NN	PERSON	p	appos	6	SENT_227	[p14l922t689r967b747],
10	,	,	O	,	_	0	SENT_227	[p14l922t689r967b747],
11	Paciaroni	NN	LOCATION	paciaronus	nn	12	SENT_227	[p14l1010t688r1276b738],
12	K	NN	LOCATION	k	appos	6	SENT_227	[p14l1318t689r1382b747],
13	,	,	O	,	_	0	SENT_227	[p14l1318t689r1382b747],
14	et	FW	O	et	nn	15	SENT_227	[p14l1425t695r1475b738],
15	al.	FW	O	al.	appos	6	SENT_227	[p14l1515t688r1577b738],
16	.	.	O	.	_	0	SENT_227	[p14l1515t688r1577b738],

1	Prevalence	NN	O	prevalence	_	0	SENT_228	[p14l1621t688r1929b738],
2	of	IN	O	of	_	0	SENT_228	[p14l1970t688r2032b738],
3	the	DT	O	the	det	4	SENT_228	[p14l2067t688r2152b738],
4	677C	NN	O	677c	prep_of	1	SENT_228	[p14l151t776r302b827],
5	to	TO	O	to	_	0	SENT_228	[p14l329t784r382b826],
6	T	NN	O	t	nn	7	SENT_228	[p14l409t777r451b826],
7	mutation	NN	O	mutation	prep_to	4	SENT_228	[p14l476t776r729b826],
8	in	IN	O	in	_	0	SENT_228	[p14l755t776r808b826],
9	the	DT	O	the	det	12	SENT_228	[p14l834t776r920b826],
10	methylenetetrahydrofolate	JJ	O	methylenetetrahydrofolate	amod	12	SENT_228	[p14l946t776r1699b841],
11	reductase	NN	O	reductase	nn	12	SENT_228	[p14l1724t776r1993b826],
12	gene	NN	O	gene	prep_in	1	SENT_228	[p14l2020t792r2152b841],
13	in	IN	O	in	_	0	SENT_228	[p14l150t865r204b915],
14	Italian	JJ	MISC	italian	amod	15	SENT_228	[p14l230t865r411b915],
15	patients	NNS	O	patient	prep_in	12	SENT_228	[p14l435t865r655b930],
16	with	IN	O	with	_	0	SENT_228	[p14l683t865r808b915],
17	venous	JJ	O	venous	amod	19	SENT_228	[p14l834t881r1032b916],
18	thrombotic	JJ	O	thrombotic	amod	19	SENT_228	[p14l1059t865r1370b915],
19	disease	NN	O	disease	prep_with	1	SENT_228	[p14l1398t865r1616b915],
20	.	.	O	.	_	0	SENT_228	[p14l1398t865r1616b915],

1	Thromb	NNP	O	Thromb	nn	2	SENT_229	[p14l1645t865r1873b915],
2	Haemost	NNP	O	Haemost	_	0	SENT_229	[p14l1900t866r2153b915],
3	1998	CD	DATE	1998	num	2	SENT_229	[p14l157t954r596b1013],
4	;	:	O	;	_	0	SENT_229	[p14l157t954r596b1013],
5	79:686	CD	NUMBER	79:686	num	6	SENT_229	[p14l157t954r596b1013],
6	—	NN	O	—	dep	2	SENT_229	[p14l157t954r596b1013],
7	7	CD	NUMBER	7	dep	6	SENT_229	[p14l157t954r596b1013],
8	.	.	O	.	_	0	SENT_229	[p14l157t954r596b1013],

1	[	NN	O	[	nn	4	SENT_230	[p14l42t1043r114b1103],
2	9	CD	NUMBER	9	num	4	SENT_230	[p14l42t1043r114b1103],
3	]	NN	O	]	nn	4	SENT_230	[p14l42t1043r114b1103],
4	Papa	NN	MISC	papa	_	0	SENT_230	[p14l150t1043r288b1107],
5	A	NN	MISC	a	dep	4	SENT_230	[p14l314t1043r379b1102],
6	,	,	O	,	_	0	SENT_230	[p14l314t1043r379b1102],
7	De	NNP	PERSON	De	nn	9	SENT_230	[p14l409t1043r491b1092],
8	Stefano	NNP	PERSON	Stefano	nn	9	SENT_230	[p14l521t1042r734b1093],
9	V	NNP	PERSON	V	appos	5	SENT_230	[p14l763t1043r818b1102],
10	,	,	O	,	_	0	SENT_230	[p14l763t1043r818b1102],
11	Danese	NNP	PERSON	Danese	nn	12	SENT_230	[p14l849t1043r1058b1092],
12	S	NNP	O	S	appos	5	SENT_230	[p14l1087t1043r1139b1102],
13	,	,	O	,	_	0	SENT_230	[p14l1087t1043r1139b1102],
14	et	FW	O	et	nn	15	SENT_230	[p14l1169t1050r1220b1092],
15	al.	FW	O	al.	appos	5	SENT_230	[p14l1248t1042r1310b1092],
16	.	.	O	.	_	0	SENT_230	[p14l1248t1042r1310b1092],

1	Hyperhomocysteinemia	NN	O	hyperhomocysteinemia	_	0	SENT_231	[p14l1342t1042r2024b1107],
2	and	CC	O	and	_	0	SENT_231	[p14l2052t1042r2153b1092],
3	prevalence	NN	O	prevalence	conj_and	1	SENT_231	[p14l149t1131r455b1196],
4	of	IN	O	of	_	0	SENT_231	[p14l494t1131r556b1182],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_231	[p14l588t1131r1032b1196],
6	of	IN	O	of	_	0	SENT_231	[p14l1073t1131r1134b1182],
7	homocysteine	NN	O	homocysteine	nn	11	SENT_231	[p14l1167t1131r1562b1196],
8	metabolism	NN	O	metabolism	nn	11	SENT_231	[p14l1601t1131r2153b1182],
9	—	NN	O	—	nn	11	SENT_231	[p14l1601t1131r2153b1182],
10	related	JJ	O	related	amod	11	SENT_231	[p14l1601t1131r2153b1182],
11	enzymes	NNS	O	enzyme	prep_of	5	SENT_231	[p14l151t1236r397b1285],
12	in	IN	O	in	_	0	SENT_231	[p14l417t1220r471b1270],
13	patients	NNS	O	patient	prep_in	1	SENT_231	[p14l488t1220r708b1285],
14	with	IN	O	with	_	0	SENT_231	[p14l728t1220r854b1271],
15	inﬂammatory	JJ	O	inﬂammatory	amod	17	SENT_231	[p14l872t1220r1255b1285],
16	bowel	NN	O	bowel	nn	17	SENT_231	[p14l1273t1220r1445b1271],
17	disease	NN	O	disease	prep_with	13	SENT_231	[p14l1464t1220r1682b1271],
18	.	.	O	.	_	0	SENT_231	[p14l1464t1220r1682b1271],

1	Am	VBP	O	be	dep	2	SENT_232	[p14l1704t1221r1811b1270],
2	J	NN	O	j	_	0	SENT_232	[p14l1827t1222r1854b1271],
3	Gastroen	JJ	O	gastroen	amod	5	SENT_232	[p14l1873t1221r2150b1271],
4	—	NN	O	—	nn	5	SENT_232	[p14l1873t1221r2150b1271],
5	terol	NN	O	terol	dep	2	SENT_232	[p14l150t1309r279b1359],
6	2001	CD	DATE	2001	dep	5	SENT_232	[p14l300t1310r434b1360],
7	;	:	O	;	_	0	SENT_232	[p14l447t1309r657b1368],
8	96:267	CD	NUMBER	96:267	num	9	SENT_232	[p14l447t1309r657b1368],
9	7-82	CD	NUMBER	7-82	dep	6	SENT_232	[p14l662t1310r817b1360],
10	.	.	O	.	_	0	SENT_232	[p14l662t1310r817b1360],

1	[	NN	O	[	nn	5	SENT_233	[p14l7t1398r114b1458],
2	10	CD	NUMBER	10	num	5	SENT_233	[p14l7t1398r114b1458],
3	]	CD	NUMBER	]	num	5	SENT_233	[p14l7t1398r114b1458],
4	Robien	NNP	PERSON	Robien	nn	5	SENT_233	[p14l150t1397r355b1448],
5	K	NNP	PERSON	K	_	0	SENT_233	[p14l383t1399r447b1457],
6	,	,	O	,	_	0	SENT_233	[p14l383t1399r447b1457],
7	Ulrich	NNP	PERSON	Ulrich	nn	8	SENT_233	[p14l476t1397r658b1448],
8	CM	NN	O	cm	appos	5	SENT_233	[p14l685t1398r807b1448],
9	.	.	O	.	_	0	SENT_233	[p14l685t1398r807b1448],

1	5,10-Methyletetrahydrofolate	JJ	O	5,10-methyletetrahydrofolate	amod	3	SENT_234	[p14l839t1397r1681b1462],
2	reductase	NN	O	reductase	nn	3	SENT_234	[p14l1707t1397r1976b1448],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_234	[p14l2002t1397r2150b1462, p14l150t1486r465b1551],
4	and	CC	O	and	_	0	SENT_234	[p14l493t1486r594b1537],
5	leukemia	NN	O	leukemia	nn	6	SENT_234	[p14l618t1486r880b1537],
6	risk	NN	O	risk	conj_and	3	SENT_234	[p14l903t1486r1024b1537],
7	:	:	O	:	_	0	SENT_234	[p14l903t1486r1024b1537],
8	a	DT	O	a	det	10	SENT_234	[p14l1055t1502r1085b1537],
9	HuGE	NN	O	huge	nn	10	SENT_234	[p14l1109t1487r1290b1537],
10	minireview	NN	O	minireview	dep	3	SENT_234	[p14l1315t1486r1645b1537],
11	.	.	O	.	_	0	SENT_234	[p14l1315t1486r1645b1537],

1	Am	NNP	O	Am	nn	3	SENT_235	[p14l1674t1487r1781b1536],
2	J	NNP	O	J	nn	3	SENT_235	[p14l1804t1488r1831b1537],
3	Epidemiol	NNP	O	Epidemiol	_	0	SENT_235	[p14l1855t1486r2152b1551],
4	2003	CD	DATE	2003	num	3	SENT_235	[p14l151t1575r668b1634],
5	;	:	O	;	_	0	SENT_235	[p14l151t1575r668b1634],
6	157:571	CD	NUMBER	157:571	number	7	SENT_235	[p14l151t1575r668b1634],
7	—	CD	NUMBER	—	dep	3	SENT_235	[p14l151t1575r668b1634],
8	82	CD	NUMBER	82	dep	7	SENT_235	[p14l151t1575r668b1634],
9	.	.	O	.	_	0	SENT_235	[p14l151t1575r668b1634],

1	[	RB	O	[	advmod	2	SENT_236	[p14l7t1664r114b1724],
2	11	CD	NUMBER	11	_	0	SENT_236	[p14l7t1664r114b1724],
3	]	CD	NUMBER	]	num	5	SENT_236	[p14l7t1664r114b1724],
4	Skibola	NNP	O	Skibola	nn	5	SENT_236	[p14l152t1663r368b1714],
5	CF	NN	O	cf	dep	2	SENT_236	[p14l417t1664r511b1723],
6	,	,	O	,	_	0	SENT_236	[p14l417t1664r511b1723],
7	Smith	NNP	ORGANIZATION	Smith	nn	8	SENT_236	[p14l564t1663r732b1714],
8	MT	NNP	ORGANIZATION	MT	appos	5	SENT_236	[p14l780t1665r896b1723],
9	,	,	O	,	_	0	SENT_236	[p14l780t1665r896b1723],
10	Kane	NNP	PERSON	Kane	nn	11	SENT_236	[p14l948t1665r1096b1714],
11	E	NNP	O	E	appos	5	SENT_236	[p14l1144t1665r1202b1723],
12	,	,	O	,	_	0	SENT_236	[p14l1144t1665r1202b1723],
13	et	FW	O	et	nn	14	SENT_236	[p14l1254t1671r1304b1714],
14	al.	FW	O	al.	appos	5	SENT_236	[p14l1353t1663r1416b1714],
15	.	.	O	.	_	0	SENT_236	[p14l1353t1663r1416b1714],

1	Polymorphisms	NNS	O	polymorphism	nsubjpass	8	SENT_237	[p14l1468t1663r1914b1728],
2	in	IN	O	in	_	0	SENT_237	[p14l1964t1663r2018b1713],
3	the	DT	O	the	det	6	SENT_237	[p14l2067t1663r2152b1714],
4	methylenetetrahydrofolate	JJ	O	methylenetetrahydrofolate	amod	6	SENT_237	[p14l150t1752r903b1817],
5	reductase	NN	O	reductase	nn	6	SENT_237	[p14l942t1752r1211b1803],
6	gene	NN	O	gene	prep_in	1	SENT_237	[p14l1250t1768r1382b1817],
7	are	VBP	O	be	auxpass	8	SENT_237	[p14l1422t1768r1506b1803],
8	associated	VBN	O	associate	_	0	SENT_237	[p14l1546t1752r1837b1803],
9	with	IN	O	with	_	0	SENT_237	[p14l1876t1752r2001b1803],
10	susceptibility	NN	O	susceptibility	prep_with	8	SENT_237	[p14l2042t1768r2150b1803, p14l151t1841r438b1906],
11	to	TO	O	to	_	0	SENT_237	[p14l474t1849r526b1892],
12	acute	JJ	O	acute	amod	13	SENT_237	[p14l563t1849r711b1892],
13	leukaemia	NN	O	leukaemia	prep_to	8	SENT_237	[p14l746t1841r1039b1892],
14	in	IN	O	in	_	0	SENT_237	[p14l1073t1841r1127b1891],
15	adults	NNS	O	adult	prep_in	13	SENT_237	[p14l1163t1841r1344b1892],
16	.	.	O	.	_	0	SENT_237	[p14l1163t1841r1344b1892],

1	Proc	NNP	O	Proc	nn	5	SENT_238	[p14l1383t1843r1511b1892],
2	Natl	NNP	O	Natl	nn	5	SENT_238	[p14l1547t1841r1668b1892],
3	Acad	NNP	O	Acad	nn	5	SENT_238	[p14l1703t1841r1853b1892],
4	Sci	NNP	O	Sci	nn	5	SENT_238	[p14l1889t1841r1976b1892],
5	USA	NNP	O	USA	_	0	SENT_238	[p14l2011t1842r2152b1892],
6	1999	CD	DATE	1999	num	5	SENT_238	[p14l157t1930r668b1989],
7	;	:	O	;	_	0	SENT_238	[p14l157t1930r668b1989],
8	96:12810	CD	NUMBER	96:12810	number	9	SENT_238	[p14l157t1930r668b1989],
9	—	CD	NUMBER	—	dep	5	SENT_238	[p14l157t1930r668b1989],
10	5	CD	NUMBER	5	dep	9	SENT_238	[p14l157t1930r668b1989],
11	.	.	O	.	_	0	SENT_238	[p14l157t1930r668b1989],

1	[	NN	O	[	_	0	SENT_239	[p14l7t2019r114b2080],
2	12	CD	NUMBER	12	num	1	SENT_239	[p14l7t2019r114b2080],
3	]	CD	NUMBER	]	num	5	SENT_239	[p14l7t2019r114b2080],
4	Krajinovic	JJ	O	krajinovic	amod	5	SENT_239	[p14l151t2018r453b2084],
5	M	NN	O	m	dep	1	SENT_239	[p14l469t2020r546b2078],
6	,	,	O	,	_	0	SENT_239	[p14l469t2020r546b2078],
7	Lamothe	NNP	PERSON	Lamothe	nn	8	SENT_239	[p14l564t2018r817b2069],
8	S	NNP	O	S	appos	5	SENT_239	[p14l835t2019r886b2078],
9	,	,	O	,	_	0	SENT_239	[p14l835t2019r886b2078],
10	Labuda	NNP	PERSON	Labuda	nn	11	SENT_239	[p14l904t2019r1117b2069],
11	D	NNP	O	D	appos	5	SENT_239	[p14l1131t2020r1197b2078],
12	,	,	O	,	_	0	SENT_239	[p14l1131t2020r1197b2078],
13	et	FW	O	et	nn	14	SENT_239	[p14l1215t2026r1266b2069],
14	al.	FW	O	al.	appos	5	SENT_239	[p14l1281t2019r1344b2069],
15	.	.	O	.	_	0	SENT_239	[p14l1281t2019r1344b2069],

1	Role	NN	O	role	_	0	SENT_240	[p14l1363t2019r1496b2069],
2	of	IN	O	of	_	0	SENT_240	[p14l1513t2018r1575b2069],
3	the	DT	O	the	det	6	SENT_240	[p14l1586t2018r1671b2069],
4	MTHFR	NNP	O	MTHFR	nn	6	SENT_240	[p14l1687t2020r1933b2068],
5	genetic	JJ	O	genetic	amod	6	SENT_240	[p14l1948t2019r2151b2084],
6	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_240	[p14l149t2108r592b2173],
7	in	IN	O	in	_	0	SENT_240	[p14l615t2107r669b2157],
8	the	DT	O	the	det	9	SENT_240	[p14l690t2108r775b2158],
9	susceptibility	NN	O	susceptibility	prep_in	6	SENT_240	[p14l799t2107r1176b2173],
10	to	TO	O	to	_	0	SENT_240	[p14l1198t2115r1251b2158],
11	childhood	NN	O	childhood	nn	14	SENT_240	[p14l1273t2108r1558b2158],
12	acute	JJ	O	acute	amod	14	SENT_240	[p14l1579t2115r1727b2158],
13	lymphoblastic	JJ	O	lymphoblastic	amod	14	SENT_240	[p14l1749t2108r2151b2173],
14	leukaemia	NN	O	leukaemia	prep_to	1	SENT_240	[p14l150t2197r457b2246],
15	.	.	O	.	_	0	SENT_240	[p14l150t2197r457b2246],

1	Blood	NN	O	blood	_	0	SENT_241	[p14l480t2197r654b2246],
2	2004	CD	DATE	2004	num	1	SENT_241	[p14l674t2196r1155b2255],
3	;	:	O	;	_	0	SENT_241	[p14l674t2196r1155b2255],
4	l03	CD	NUMBER	l03	num	5	SENT_241	[p14l674t2196r1155b2255],
5	:252	CD	NUMBER	:252	dep	1	SENT_241	[p14l674t2196r1155b2255],
6	—	NN	O	—	dep	5	SENT_241	[p14l674t2196r1155b2255],
7	7	CD	NUMBER	7	num	6	SENT_241	[p14l674t2196r1155b2255],
8	.	.	O	.	_	0	SENT_241	[p14l674t2196r1155b2255],

1	[	RB	O	[	advmod	2	SENT_242	[p14l7t2285r114b2346],
2	13	CD	NUMBER	13	_	0	SENT_242	[p14l7t2285r114b2346],
3	]	CD	NUMBER	]	num	5	SENT_242	[p14l7t2285r114b2346],
4	Chiusolo	NNP	PERSON	Chiusolo	nn	5	SENT_242	[p14l151t2285r406b2335],
5	P	NN	PERSON	p	dep	2	SENT_242	[p14l424t2286r470b2344],
6	,	,	O	,	_	0	SENT_242	[p14l424t2286r470b2344],
7	Reddiconto	NNP	O	Reddiconto	nn	8	SENT_242	[p14l490t2284r818b2335],
8	G	NNP	O	G	appos	5	SENT_242	[p14l837t2285r901b2344],
9	,	,	O	,	_	0	SENT_242	[p14l837t2285r901b2344],
10	Cimino	NNP	PERSON	Cimino	nn	11	SENT_242	[p14l922t2284r1134b2335],
11	G	NNP	O	G	appos	5	SENT_242	[p14l1153t2285r1217b2344],
12	,	,	O	,	_	0	SENT_242	[p14l1153t2285r1217b2344],
13	et	FW	O	et	nn	14	SENT_242	[p14l1238t2292r1288b2335],
14	al.	FW	O	al.	appos	5	SENT_242	[p14l1307t2285r1369b2335],
15	.	.	O	.	_	0	SENT_242	[p14l1307t2285r1369b2335],

1	Methylenetetrahydrofolate	NNP	O	Methylenetetrahydrofolate	nn	3	SENT_243	[p14l1390t2284r2152b2350],
2	reductase	NN	O	reductase	nn	3	SENT_243	[p14l149t2374r418b2424],
3	genotypes	NNS	O	genotype	nsubj	6	SENT_243	[p14l435t2381r721b2439],
4	do	VBP	O	do	aux	6	SENT_243	[p14l740t2374r808b2424],
5	not	RB	O	not	neg	6	SENT_243	[p14l824t2381r915b2424],
6	play	VB	O	play	_	0	SENT_243	[p14l929t2374r1051b2439],
7	a	DT	O	a	det	8	SENT_243	[p14l1069t2389r1098b2424],
8	role	NN	O	role	dobj	6	SENT_243	[p14l1112t2374r1222b2424],
9	in	IN	O	in	_	0	SENT_243	[p14l1238t2373r1292b2423],
10	acute	JJ	O	acute	amod	13	SENT_243	[p14l1309t2381r1456b2424],
11	lymphoblastic	JJ	O	lymphoblastic	amod	13	SENT_243	[p14l1473t2374r1876b2439],
12	leukemia	NN	O	leukemia	nn	13	SENT_243	[p14l1893t2374r2153b2424],
13	pathogenesis	NN	O	pathogenesis	prep_in	6	SENT_243	[p14l149t2463r516b2528],
14	in	IN	O	in	_	0	SENT_243	[p14l531t2463r585b2512],
15	the	DT	O	the	det	17	SENT_243	[p14l597t2462r682b2513],
16	Italian	JJ	MISC	italian	amod	17	SENT_243	[p14l695t2463r876b2513],
17	population	NN	O	population	prep_in	13	SENT_243	[p14l887t2463r1207b2528],
18	.	.	O	.	_	0	SENT_243	[p14l887t2463r1207b2528],

1	Haematologica	NNP	O	Haematologica	_	0	SENT_244	[p14l1223t2463r1656b2528],
2	2004	CD	DATE	2004	num	1	SENT_244	[p14l1668t2463r1915b2522],
3	;	:	O	;	_	0	SENT_244	[p14l1668t2463r1915b2522],
4	89	CD	NUMBER	89	num	6	SENT_244	[p14l1668t2463r1915b2522],
5	:	:	O	:	_	0	SENT_244	[p14l1668t2463r1915b2522],
6	139-44	CD	NUMBER	139-44	dep	1	SENT_244	[p14l1928t2463r2149b2514],
7	.	.	O	.	_	0	SENT_244	[p14l1928t2463r2149b2514],

1	[	RB	O	[	dep	5	SENT_245	[p14l7t2552r114b2613],
2	14	CD	NUMBER	14	num	5	SENT_245	[p14l7t2552r114b2613],
3	]	CD	NUMBER	]	num	5	SENT_245	[p14l7t2552r114b2613],
4	Franco	NNP	O	Franco	nn	5	SENT_245	[p14l150t2553r346b2602],
5	RF	NNP	O	RF	_	0	SENT_245	[p14l366t2553r461b2611],
6	,	,	O	,	_	0	SENT_245	[p14l366t2553r461b2611],
7	Simoes	NNP	PERSON	Simoes	nn	8	SENT_245	[p14l485t2552r691b2602],
8	BP	NNP	O	BP	appos	5	SENT_245	[p14l711t2553r804b2611],
9	,	,	O	,	_	0	SENT_245	[p14l711t2553r804b2611],
10	Tone	NNP	O	Tone	nn	11	SENT_245	[p14l826t2553r965b2602],
11	LG	NNP	ORGANIZATION	LG	appos	5	SENT_245	[p14l984t2552r1093b2611],
12	,	,	O	,	_	0	SENT_245	[p14l984t2552r1093b2611],
13	et	FW	O	et	nn	14	SENT_245	[p14l1115t2559r1165b2602],
14	al.	FW	O	al.	appos	11	SENT_245	[p14l1185t2552r1247b2602],
15	.	.	O	.	_	0	SENT_245	[p14l1185t2552r1247b2602],

1	The	DT	O	the	det	6	SENT_246	[p14l1270t2552r1379b2602],
2	methylenetetrahydrofolate	JJ	O	methylenetetrahydrofolate	amod	6	SENT_246	[p14l1399t2551r2152b2617],
3	reductase	NN	O	reductase	nn	6	SENT_246	[p14l149t2641r418b2691],
4	C677T	NN	O	c677t	nn	6	SENT_246	[p14l446t2640r642b2691],
5	gene	NN	O	gene	nn	6	SENT_246	[p14l669t2656r801b2706],
6	polymorphism	NN	O	polymorphism	nsubj	7	SENT_246	[p14l827t2641r1245b2706],
7	decrease	VB	O	decrease	_	0	SENT_246	[p14l1271t2641r1514b2691],
8	the	DT	O	the	det	9	SENT_246	[p14l1540t2641r1626b2691],
9	risk	NN	O	risk	dobj	7	SENT_246	[p14l1651t2640r1760b2691],
10	of	IN	O	of	_	0	SENT_246	[p14l1785t2640r1846b2691],
11	childhood	NN	O	childhood	nn	14	SENT_246	[p14l1868t2641r2153b2691],
12	acute	JJ	O	acute	amod	14	SENT_246	[p14l152t2738r299b2780],
13	lymphocytic	JJ	O	lymphocytic	amod	14	SENT_246	[p14l320t2730r674b2795],
14	leukaemia	NN	O	leukaemia	prep_of	9	SENT_246	[p14l694t2730r1001b2780],
15	.	.	O	.	_	0	SENT_246	[p14l694t2730r1001b2780],

1	Br	NN	O	br	nn	3	SENT_247	[p14l1025t2731r1095b2779],
2	J	NN	O	j	nn	3	SENT_247	[p14l1113t2731r1140b2780],
3	Haematol	NN	O	haematol	_	0	SENT_247	[p14l1160t2730r1436b2780],
4	2001	CD	DATE	2001	dep	3	SENT_247	[p14l1457t2730r1591b2780],
5	;	:	O	;	_	0	SENT_247	[p14l1604t2730r1647b2789],
6	1	CD	NUMBER	1	num	7	SENT_247	[p14l1604t2730r1647b2789],
7	l5	NN	O	l5	dep	3	SENT_247	[p14l1662t2730r1938b2780],
8	:616	CD	NUMBER	:616	num	9	SENT_247	[p14l1662t2730r1938b2780],
9	-8	CD	NUMBER	-8	dep	7	SENT_247	[p14l1662t2730r1938b2780],
10	.	.	O	.	_	0	SENT_247	[p14l1662t2730r1938b2780],

1	[	RB	O	[	dep	5	SENT_248	[p14l7t2819r114b2880],
2	15	CD	NUMBER	15	num	5	SENT_248	[p14l7t2819r114b2880],
3	]	CD	NUMBER	]	num	5	SENT_248	[p14l7t2819r114b2880],
4	Thirumaran	NNP	MISC	Thirumaran	nn	5	SENT_248	[p14l150t2819r487b2869],
5	RK	NNP	MISC	RK	_	0	SENT_248	[p14l500t2820r613b2878],
6	,	,	O	,	_	0	SENT_248	[p14l500t2820r613b2878],
7	Gast	NNP	PERSON	Gast	nn	8	SENT_248	[p14l630t2819r759b2869],
8	A	NNP	O	A	appos	5	SENT_248	[p14l771t2819r837b2878],
9	,	,	O	,	_	0	SENT_248	[p14l771t2819r837b2878],
10	Flohr	NNP	PERSON	Flohr	nn	11	SENT_248	[p14l852t2819r1008b2869],
11	T	NN	O	t	appos	5	SENT_248	[p14l1020t2820r1071b2878],
12	,	,	O	,	_	0	SENT_248	[p14l1020t2820r1071b2878],
13	et	FW	O	et	nn	14	SENT_248	[p14l1088t2826r1138b2869],
14	al.	FW	O	al.	appos	11	SENT_248	[p14l1152t2819r1215b2869],
15	.	.	O	.	_	0	SENT_248	[p14l1152t2819r1215b2869],

1	MTHFR	NNP	O	MTHFR	_	0	SENT_249	[p14l1232t2820r1478b2868],
2	genetic	JJ	O	genetic	amod	3	SENT_249	[p14l1491t2819r1694b2884],
3	polymorphisms	NNS	O	polymorphism	dep	1	SENT_249	[p14l1708t2819r2151b2884],
4	and	CC	O	and	_	0	SENT_249	[p14l152t2908r252b2958],
5	susceptibility	NN	O	susceptibility	dep	1	SENT_249	[p14l275t2908r652b2973],
6	to	TO	O	to	_	0	SENT_249	[p14l673t2915r726b2958],
7	childhood	NN	O	childhood	nn	10	SENT_249	[p14l749t2908r1033b2958],
8	acute	JJ	O	acute	amod	10	SENT_249	[p14l1055t2915r1202b2958],
9	lymphoblastic	JJ	O	lymphoblastic	amod	10	SENT_249	[p14l1223t2908r1626b2973],
10	leukaemia	NN	O	leukaemia	prep_to	1	SENT_249	[p14l1648t2908r1955b2958],
11	.	.	O	.	_	0	SENT_249	[p14l1648t2908r1955b2958],

1	Blood	NN	O	blood	_	0	SENT_250	[p14l1979t2908r2153b2958],
2	2005	CD	DATE	2005	num	1	SENT_250	[p14l151t2997r668b3055],
3	;	:	O	;	_	0	SENT_250	[p14l151t2997r668b3055],
4	106:2590	CD	NUMBER	106:2590	num	5	SENT_250	[p14l151t2997r668b3055],
5	—	NN	O	—	dep	1	SENT_250	[p14l151t2997r668b3055],
6	1	CD	NUMBER	1	dep	5	SENT_250	[p14l151t2997r668b3055],
7	.	.	O	.	_	0	SENT_250	[p14l151t2997r668b3055],

1	[	RB	O	[	dep	3	SENT_251	[p14l7t3085r114b3146],
2	16	CD	NUMBER	16	number	3	SENT_251	[p14l7t3085r114b3146],
3	]	CD	NUMBER	]	_	0	SENT_251	[p14l7t3085r114b3146],
4	Chiusolo	NNP	PERSON	Chiusolo	nn	5	SENT_251	[p14l151t3085r406b3135],
5	P	NN	PERSON	p	dep	3	SENT_251	[p14l465t3086r510b3144],
6	,	,	O	,	_	0	SENT_251	[p14l465t3086r510b3144],
7	Reddiconto	NNP	O	Reddiconto	nn	8	SENT_251	[p14l571t3085r898b3135],
8	G	NNP	O	G	appos	3	SENT_251	[p14l958t3085r1022b3144],
9	,	,	O	,	_	0	SENT_251	[p14l958t3085r1022b3144],
10	Casorelli	NNP	O	Casorelli	appos	8	SENT_251	[p14l1084t3085r1339b3135],
11	I	PRP	O	I	dep	10	SENT_251	[p14l1398t3086r1435b3144],
12	,	,	O	,	_	0	SENT_251	[p14l1398t3086r1435b3144],
13	et	FW	O	et	nn	14	SENT_251	[p14l1496t3092r1546b3135],
14	al.	FW	O	al.	appos	8	SENT_251	[p14l1605t3085r1667b3135],
15	.	.	O	.	_	0	SENT_251	[p14l1605t3085r1667b3135],

1	Preponderance	NNP	O	Preponderance	_	0	SENT_252	[p14l1729t3085r2152b3150],
2	of	IN	O	of	_	0	SENT_252	[p14l151t3174r213b3224],
3	methylenetetrahydrofolate	JJ	O	methylenetetrahydrofolate	amod	6	SENT_252	[p14l288t3174r1041b3239],
4	reductase	NN	O	reductase	nn	6	SENT_252	[p14l1122t3174r1390b3224],
5	C677T	NN	O	c677t	nn	6	SENT_252	[p14l1472t3174r1668b3224],
6	homozygosity	NN	O	homozygosity	prep_of	1	SENT_252	[p14l1748t3174r2152b3239],
7	among	IN	O	among	_	0	SENT_252	[p14l152t3278r343b3328],
8	leukemia	NN	O	leukemia	nn	9	SENT_252	[p14l389t3263r650b3313],
9	patients	NNS	O	patient	prep_among	6	SENT_252	[p14l694t3263r913b3328],
10	intolerant	JJ	O	intolerant	amod	1	SENT_252	[p14l960t3263r1234b3313],
11	to	TO	O	to	_	0	SENT_252	[p14l1279t3270r1331b3313],
12	methotrexate	NN	O	methotrexate	prep_to	10	SENT_252	[p14l1378t3263r1763b3313],
13	.	.	O	.	_	0	SENT_252	[p14l1378t3263r1763b3313],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_253	[p14l1812t3263r1934b3312],
2	Oncol	NNP	PERSON	Oncol	_	0	SENT_253	[p14l1980t3263r2152b3313],
3	2002	CD	DATE	2002	num	2	SENT_253	[p14l151t3351r632b3408],
4	;	:	O	;	_	0	SENT_253	[p14l151t3351r632b3408],
5	13:1915	CD	NUMBER	13:1915	number	6	SENT_253	[p14l151t3351r632b3408],
6	-8	CD	NUMBER	-8	dep	2	SENT_253	[p14l151t3351r632b3408],
7	.	.	O	.	_	0	SENT_253	[p14l151t3351r632b3408],

1	[	NN	O	[	nn	5	SENT_254	[p14l6t3440r114b3500],
2	17	CD	NUMBER	17	num	5	SENT_254	[p14l6t3440r114b3500],
3	]	CD	NUMBER	]	num	5	SENT_254	[p14l6t3440r114b3500],
4	Annino	NNP	PERSON	Annino	nn	5	SENT_254	[p14l150t3439r362b3489],
5	L	NNP	PERSON	L	_	0	SENT_254	[p14l383t3440r440b3499],
6	,	,	O	,	_	0	SENT_254	[p14l383t3440r440b3499],
7	Vegna	NNP	O	Vegna	nn	8	SENT_254	[p14l464t3440r641b3504],
8	ML	NNP	O	ML	appos	5	SENT_254	[p14l661t3440r781b3499],
9	,	,	O	,	_	0	SENT_254	[p14l661t3440r781b3499],
10	Camera	NNP	O	Camera	nn	11	SENT_254	[p14l806t3439r1027b3490],
11	A	NNP	O	A	appos	5	SENT_254	[p14l1046t3440r1112b3499],
12	,	,	O	,	_	0	SENT_254	[p14l1046t3440r1112b3499],
13	et	FW	O	et	nn	14	SENT_254	[p14l1135t3447r1186b3489],
14	al.	FW	O	al.	appos	5	SENT_254	[p14l1207t3439r1270b3489],
15	.	.	O	.	_	0	SENT_254	[p14l1207t3439r1270b3489],

1	Treatment	NN	O	treatment	dep	8	SENT_255	[p14l1295t3440r1585b3489],
2	of	IN	O	of	_	0	SENT_255	[p14l1606t3439r1667b3489],
3	adult	JJ	O	adult	amod	6	SENT_255	[p14l1685t3439r1826b3489],
4	acute	JJ	O	acute	amod	6	SENT_255	[p14l1847t3447r1995b3489],
5	lymphoblastic	JJ	O	lymphoblastic	amod	6	SENT_255	[p14l2016t3439r2147b3504, p14l149t3528r441b3593],
6	leukemia	NN	O	leukemia	prep_of	1	SENT_255	[p14l457t3528r718b3578],
7	(	CD	NUMBER	(	dep	8	SENT_255	[p14l733t3529r931b3590],
8	ALL	NN	O	all	dep	13	SENT_255	[p14l733t3529r931b3590],
9	)	CD	NUMBER	)	dep	8	SENT_255	[p14l733t3529r931b3590],
10	:	:	O	:	_	0	SENT_255	[p14l733t3529r931b3590],
11	long	JJ	O	long	amod	13	SENT_255	[p14l951t3528r1075b3593],
12	term	NN	O	term	nn	13	SENT_255	[p14l1091t3535r1221b3578],
13	follow-up	NN	O	follow-up	_	0	SENT_255	[p14l1235t3528r1512b3593],
14	of	IN	O	of	_	0	SENT_255	[p14l1529t3528r1591b3578],
15	the	DT	O	the	det	17	SENT_255	[p14l1600t3528r1686b3578],
16	GIMEMA	NNP	O	GIMEMA	nn	17	SENT_255	[p14l1702t3528r1997b3579],
17	ALL	NN	O	all	prep_of	13	SENT_255	[p14l2012t3529r2149b3578],
18	0288	CD	DATE	0288	num	17	SENT_255	[p14l150t3618r288b3668],
19	randomized	VBN	O	randomize	partmod	13	SENT_255	[p14l310t3617r647b3667],
20	study	NN	O	study	dobj	19	SENT_255	[p14l669t3617r829b3682],
21	.	.	O	.	_	0	SENT_255	[p14l669t3617r829b3682],

1	Blood	NN	O	blood	_	0	SENT_256	[p14l852t3617r1026b3667],
2	2002	CD	DATE	2002	num	1	SENT_256	[p14l1046t3617r1526b3677],
3	;	:	O	;	_	0	SENT_256	[p14l1046t3617r1526b3677],
4	99:863	CD	NUMBER	99:863	number	5	SENT_256	[p14l1046t3617r1526b3677],
5	—	CD	NUMBER	—	dep	1	SENT_256	[p14l1046t3617r1526b3677],
6	71	CD	NUMBER	71	dep	5	SENT_256	[p14l1046t3617r1526b3677],
7	.	.	O	.	_	0	SENT_256	[p14l1046t3617r1526b3677],

1	[	NN	O	[	_	0	SENT_257	[p14l6t3706r114b3767],
2	18	CD	NUMBER	18	number	3	SENT_257	[p14l6t3706r114b3767],
3	]	CD	NUMBER	]	dep	1	SENT_257	[p14l6t3706r114b3767],
4	Magrath	NNP	PERSON	Magrath	nn	5	SENT_257	[p14l150t3706r390b3771],
5	IT	NNP	O	IT	dep	3	SENT_257	[p14l443t3707r517b3756],
6	.	.	O	.	_	0	SENT_257	[p14l443t3707r517b3756],

1	Management	NN	O	management	_	0	SENT_258	[p14l573t3707r945b3771],
2	of	IN	O	of	_	0	SENT_258	[p14l997t3706r1059b3756],
3	high	JJ	O	high	amod	6	SENT_258	[p14l1106t3706r1414b3771],
4	—	NN	O	—	nn	6	SENT_258	[p14l1106t3706r1414b3771],
5	grade	NN	O	grade	nn	6	SENT_258	[p14l1106t3706r1414b3771],
6	lymphomas	NNS	O	lymphoma	prep_of	1	SENT_258	[p14l1467t3706r1813b3771],
7	.	.	O	.	_	0	SENT_258	[p14l1467t3706r1813b3771],

1	Oncology	NNP	O	Oncology	nn	2	SENT_259	[p14l1870t3706r2148b3771],
2	l998	NN	O	l998	_	0	SENT_259	[p15l157t19r560b78],
3	;	:	O	;	_	0	SENT_259	[p15l157t19r560b78],
4	l2	NN	O	l2	dep	2	SENT_259	[p15l157t19r560b78],
5	:40	CD	NUMBER	:40	num	4	SENT_259	[p15l157t19r560b78],
6	—	NN	O	—	dep	4	SENT_259	[p15l157t19r560b78],
7	8	CD	NUMBER	8	num	6	SENT_259	[p15l157t19r560b78],
8	.	.	O	.	_	0	SENT_259	[p15l157t19r560b78],

1	[	NN	O	[	_	0	SENT_260	[p15l6t108r114b168],
2	19	CD	NUMBER	19	num	1	SENT_260	[p15l6t108r114b168],
3	]	CD	NUMBER	]	num	5	SENT_260	[p15l6t108r114b168],
4	Frosst	NNP	ORGANIZATION	Frosst	nn	5	SENT_260	[p15l149t108r324b157],
5	P	NN	ORGANIZATION	p	dep	1	SENT_260	[p15l355t108r400b167],
6	,	,	O	,	_	0	SENT_260	[p15l355t108r400b167],
7	Blom	NNP	O	Blom	nn	8	SENT_260	[p15l434t107r593b157],
8	HJ	NNP	O	HJ	appos	5	SENT_260	[p15l624t108r717b167],
9	,	,	O	,	_	0	SENT_260	[p15l624t108r717b167],
10	Milos	NNP	PERSON	Milos	nn	11	SENT_260	[p15l751t107r914b157],
11	R	NNP	PERSON	R	appos	5	SENT_260	[p15l948t108r1009b167],
12	,	,	O	,	_	0	SENT_260	[p15l948t108r1009b167],
13	et	FW	O	et	nn	14	SENT_260	[p15l1044t115r1095b157],
14	al.	FW	O	al.	appos	5	SENT_260	[p15l1127t107r1189b157],
15	.	.	O	.	_	0	SENT_260	[p15l1127t107r1189b157],

1	A	DT	O	a	det	5	SENT_261	[p15l1225t108r1275b157],
2	candidate	NN	O	candidate	nn	5	SENT_261	[p15l1307t107r1578b157],
3	genetic	JJ	O	genetic	amod	5	SENT_261	[p15l1611t107r1814b172],
4	risk	NN	O	risk	nn	5	SENT_261	[p15l1847t107r1954b157],
5	factor	NN	O	factor	_	0	SENT_261	[p15l1985t107r2150b157],
6	for	IN	O	for	_	0	SENT_261	[p15l150t196r232b246],
7	Vascular	JJ	O	vascular	amod	8	SENT_261	[p15l249t196r484b246],
8	disease	NN	O	disease	prep_for	5	SENT_261	[p15l501t196r720b246],
9	:	:	O	:	_	0	SENT_261	[p15l501t196r720b246],
10	a	DT	O	a	det	12	SENT_261	[p15l744t212r774b246],
11	common	JJ	O	common	amod	12	SENT_261	[p15l790t212r1038b246],
12	mutation	NN	O	mutation	dep	5	SENT_261	[p15l1056t196r1308b246],
13	in	IN	O	in	_	0	SENT_261	[p15l1325t196r1379b246],
14	methylenetetrahydrofolate	JJ	O	methylenetetrahydrofolate	amod	15	SENT_261	[p15l1396t196r2149b261],
15	reductase	NN	O	reductase	prep_in	12	SENT_261	[p15l149t285r432b335],
16	.	.	O	.	_	0	SENT_261	[p15l149t285r432b335],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_262	[p15l455t286r558b335],
2	Genet	NNP	PERSON	Genet	_	0	SENT_262	[p15l578t285r747b335],
3	1995	CD	DATE	1995	num	5	SENT_262	[p15l772t285r1013b344],
4	;	:	O	;	_	0	SENT_262	[p15l772t285r1013b344],
5	10	CD	NUMBER	10	dep	2	SENT_262	[p15l772t285r1013b344],
6	:	:	O	:	_	0	SENT_262	[p15l772t285r1013b344],
7	1	CD	NUMBER	1	number	8	SENT_262	[p15l1027t286r1047b334],
8	1	CD	NUMBER	1	dep	2	SENT_262	[p15l1062t286r1083b334],
9	1-3	CD	NUMBER	1-3	dep	8	SENT_262	[p15l1098t286r1211b335],
10	.	.	O	.	_	0	SENT_262	[p15l1098t286r1211b335],

1	[	RB	O	[	dep	3	SENT_263	[p15l6t374r114b434],
2	20	CD	NUMBER	20	number	3	SENT_263	[p15l6t374r114b434],
3	]	CD	NUMBER	]	_	0	SENT_263	[p15l6t374r114b434],
4	Aplenc	NN	O	aplenc	nn	5	SENT_263	[p15l150t373r353b438],
5	R	NN	O	r	dep	3	SENT_263	[p15l397t375r458b433],
6	,	,	O	,	_	0	SENT_263	[p15l397t375r458b433],
7	Thompson	NNP	PERSON	Thompson	nn	8	SENT_263	[p15l503t373r807b438],
8	J	NNP	PERSON	J	appos	3	SENT_263	[p15l849t375r891b433],
9	,	,	O	,	_	0	SENT_263	[p15l849t375r891b433],
10	Han	NNP	O	Han	appos	8	SENT_263	[p15l936t375r1054b424],
11	P	NN	O	p	dep	10	SENT_263	[p15l1095t375r1141b433],
12	,	,	O	,	_	0	SENT_263	[p15l1095t375r1141b433],
13	et	FW	O	et	nn	14	SENT_263	[p15l1187t381r1237b424],
14	al.	FW	O	al.	appos	8	SENT_263	[p15l1280t373r1342b424],
15	.	.	O	.	_	0	SENT_263	[p15l1280t373r1342b424],

1	Methylenetetrahydrofolate	NNP	O	Methylenetetrahydrofolate	_	0	SENT_264	[p15l1388t373r2149b438],
2	reductase	NN	O	reductase	nn	3	SENT_264	[p15l149t462r418b513],
3	polymorphisms	NNS	O	polymorphism	dep	1	SENT_264	[p15l434t462r877b527],
4	and	CC	O	and	_	0	SENT_264	[p15l898t462r999b513],
5	therapy	NN	O	therapy	nn	6	SENT_264	[p15l1016t462r1227b527],
6	response	NN	O	response	dep	1	SENT_264	[p15l1244t478r1493b527],
7	in	IN	O	in	_	0	SENT_264	[p15l1511t462r1565b512],
8	pediatric	JJ	O	pediatric	amod	11	SENT_264	[p15l1582t462r1830b527],
9	acute	JJ	O	acute	amod	11	SENT_264	[p15l1850t470r1998b513],
10	lymphoblastic	JJ	O	lymphoblastic	amod	11	SENT_264	[p15l2016t462r2147b527, p15l149t551r441b616],
11	leukemia	NN	O	leukemia	prep_in	1	SENT_264	[p15l462t551r735b602],
12	.	.	O	.	_	0	SENT_264	[p15l462t551r735b602],

1	Cancer	NNP	O	Cancer	nn	2	SENT_265	[p15l760t552r961b602],
2	Res	NNP	O	Res	_	0	SENT_265	[p15l979t553r1083b602],
3	2005	CD	DATE	2005	num	2	SENT_265	[p15l1105t551r1586b611],
4	;	:	O	;	_	0	SENT_265	[p15l1105t551r1586b611],
5	65:2482	CD	NUMBER	65:2482	num	6	SENT_265	[p15l1105t551r1586b611],
6	—	NN	O	—	dep	2	SENT_265	[p15l1105t551r1586b611],
7	7	CD	NUMBER	7	dep	6	SENT_265	[p15l1105t551r1586b611],
8	.	.	O	.	_	0	SENT_265	[p15l1105t551r1586b611],

1	[	NN	O	[	_	0	SENT_266	[p15l6t641r114b701],
2	21	CD	NUMBER	21	num	1	SENT_266	[p15l6t641r114b701],
3	]	CD	NUMBER	]	num	5	SENT_266	[p15l6t641r114b701],
4	Krajinovic	JJ	O	krajinovic	amod	5	SENT_266	[p15l151t640r452b705],
5	M	NN	O	m	dep	1	SENT_266	[p15l493t642r570b700],
6	,	,	O	,	_	0	SENT_266	[p15l493t642r570b700],
7	Lemieux	NNP	PERSON	Lemieux	appos	5	SENT_266	[p15l612t640r1184b691],
8	.	.	O	.	_	0	SENT_266	[p15l612t640r1184b691],

1	—	NN	O	—	_	0	SENT_267	[p15l612t640r1184b691],
2	.	.	O	.	_	0	SENT_267	[p15l612t640r1184b691],

1	Blanchard	NNP	PERSON	Blanchard	nn	2	SENT_268	[p15l612t640r1184b691],
2	E	NNP	O	E	_	0	SENT_268	[p15l1223t642r1280b700],
3	,	,	O	,	_	0	SENT_268	[p15l1223t642r1280b700],
4	Chiasson	NNP	PERSON	Chiasson	nn	5	SENT_268	[p15l1324t640r1584b691],
5	S	NNP	O	S	appos	2	SENT_268	[p15l1625t641r1677b700],
6	,	,	O	,	_	0	SENT_268	[p15l1625t641r1677b700],
7	et	FW	O	et	nn	8	SENT_268	[p15l1720t648r1771b691],
8	al.	FW	O	al.	appos	5	SENT_268	[p15l1811t640r1874b691],
9	.	.	O	.	_	0	SENT_268	[p15l1811t640r1874b691],

1	Role	NN	O	role	_	0	SENT_269	[p15l1917t640r2051b691],
2	of	IN	O	of	_	0	SENT_269	[p15l2092t640r2154b691],
3	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_269	[p15l149t729r591b794],
4	in	IN	O	in	_	0	SENT_269	[p15l634t729r688b779],
5	MTHFR	NN	O	mthfr	nn	8	SENT_269	[p15l728t731r974b779],
6	and	CC	O	and	_	0	SENT_269	[p15l1016t729r1116b780],
7	MTHFDl	NN	O	mthfdl	conj_and	5	SENT_269	[p15l1156t730r1434b779],
8	genes	NNS	O	gene	prep_in	3	SENT_269	[p15l1482t745r1641b794],
9	in	IN	O	in	_	0	SENT_269	[p15l1683t729r1737b779],
10	the	DT	O	the	det	11	SENT_269	[p15l1778t729r1863b780],
11	outcome	NN	O	outcome	prep_in	1	SENT_269	[p15l1905t737r2149b780],
12	of	IN	O	of	_	0	SENT_269	[p15l151t818r212b869],
13	childhood	NN	O	childhood	nn	16	SENT_269	[p15l257t818r541b869],
14	acute	JJ	O	acute	amod	16	SENT_269	[p15l590t826r737b869],
15	lymphoblastic	JJ	O	lymphoblastic	amod	16	SENT_269	[p15l786t818r1188b883],
16	leukaemia	NN	O	leukaemia	prep_of	11	SENT_269	[p15l1238t818r1544b869],
17	.	.	O	.	_	0	SENT_269	[p15l1238t818r1544b869],

1	Pharmacogenom	NN	O	pharmacogenom	nn	2	SENT_270	[p15l1596t818r2076b883],
2	J	NN	O	j	_	0	SENT_270	[p15l2123t820r2149b869],
3	2004	CD	DATE	2004	dep	2	SENT_270	[p15l151t907r560b966],
4	;	:	O	;	_	0	SENT_270	[p15l151t907r560b966],
5	4:66	CD	NUMBER	4:66	number	6	SENT_270	[p15l151t907r560b966],
6	—	CD	NUMBER	—	dep	2	SENT_270	[p15l151t907r560b966],
7	72	CD	NUMBER	72	dep	6	SENT_270	[p15l151t907r560b966],
8	.	.	O	.	_	0	SENT_270	[p15l151t907r560b966],

1	[	NN	O	[	nn	4	SENT_271	[p15l6t996r114b1056],
2	22	CD	NUMBER	22	num	4	SENT_271	[p15l6t996r114b1056],
3	]	NN	O	]	nn	4	SENT_271	[p15l6t996r114b1056],
4	Shimasaki	NN	ORGANIZATION	shimasakus	_	0	SENT_271	[p15l152t995r445b1046],
5	N	NN	ORGANIZATION	n	nn	4	SENT_271	[p15l480t997r545b1055],
6	,	,	O	,	_	0	SENT_271	[p15l480t997r545b1055],
7	Mori	NN	LOCATION	morus	nn	8	SENT_271	[p15l582t995r723b1046],
8	T	NN	LOCATION	t	appos	4	SENT_271	[p15l757t997r809b1055],
9	,	,	O	,	_	0	SENT_271	[p15l757t997r809b1055],
10	Samejima	FW	PERSON	samejima	dep	4	SENT_271	[p15l848t995r1131b1060],
11	H	NN	PERSON	h	dep	4	SENT_271	[p15l1164t997r1229b1055],
12	,	,	O	,	_	0	SENT_271	[p15l1164t997r1229b1055],
13	et	FW	O	et	nn	14	SENT_271	[p15l1267t1003r1317b1046],
14	al.	FW	O	al.	appos	11	SENT_271	[p15l1352t995r1414b1046],
15	.	.	O	.	_	0	SENT_271	[p15l1352t995r1414b1046],

1	Effects	NNS	O	effect	nsubj	18	SENT_272	[p15l1452t995r1649b1046],
2	of	IN	O	of	dep	1	SENT_272	[p15l1686t995r1748b1046],
3	methylenete	NN	O	methylenete	nn	6	SENT_272	[p15l1777t995r2147b1060],
4	—	NN	O	—	nn	6	SENT_272	[p15l1777t995r2147b1060],
5	trahydrofolate	NN	O	trahydrofolate	nn	6	SENT_272	[p15l150t1084r553b1149],
6	reductase	NN	O	reductase	pobj	2	SENT_272	[p15l578t1084r846b1135],
7	and	CC	O	and	_	0	SENT_272	[p15l874t1084r974b1135],
8	reduced	VBD	O	reduce	conj_and	2	SENT_272	[p15l999t1084r1224b1135],
9	folate	JJ	O	folate	amod	10	SENT_272	[p15l1249t1084r1410b1135],
10	carrier	NN	O	carrier	iobj	8	SENT_272	[p15l1437t1084r1622b1135],
11	1	CD	NUMBER	1	num	12	SENT_272	[p15l1653t1085r1674b1134],
12	polymorphisms	NNS	O	polymorphism	dobj	8	SENT_272	[p15l1705t1084r2147b1149],
13	on	IN	O	on	_	0	SENT_272	[p15l151t1189r220b1224],
14	high	JJ	O	high	amod	17	SENT_272	[p15l248t1173r374b1239],
15	dose	NN	O	dose	nn	17	SENT_272	[p15l404t1174r532b1224],
16	methotrexate	NN	O	methotrexate	nn	17	SENT_272	[p15l561t1173r1183b1224],
17	—	NN	O	—	prep_on	12	SENT_272	[p15l561t1173r1183b1224],
18	induced	VBD	O	induce	_	0	SENT_272	[p15l561t1173r1183b1224],
19	toxicities	NNS	O	toxicity	dobj	18	SENT_272	[p15l1211t1174r1470b1224],
20	in	IN	O	in	_	0	SENT_272	[p15l1500t1174r1555b1223],
21	children	NNS	O	child	prep_in	18	SENT_272	[p15l1584t1174r1816b1224],
22	with	IN	O	with	_	0	SENT_272	[p15l1846t1174r1971b1224],
23	acute	JJ	O	acute	amod	24	SENT_272	[p15l2001t1181r2149b1224],
24	lymphoblastic	JJ	O	lymphoblastic	amod	25	SENT_272	[p15l150t1262r552b1328],
25	leukemia	NN	O	leukemia	prep_with	18	SENT_272	[p15l591t1262r851b1313],
26	or	CC	O	or	_	0	SENT_272	[p15l888t1278r946b1313],
27	lymphoma	NN	O	lymphoma	prep_with	18	SENT_272	[p15l982t1263r1300b1328],
28	.	.	O	.	_	0	SENT_272	[p15l982t1263r1300b1328],

1	J	NNP	O	J	nn	4	SENT_273	[p15l1341t1264r1367b1313],
2	Pediatric	NNP	O	Pediatric	nn	4	SENT_273	[p15l1404t1262r1656b1313],
3	Hematol	NNP	O	Hematol	nn	4	SENT_273	[p15l1694t1263r1939b1313],
4	Oncol	NNP	O	Oncol	_	0	SENT_273	[p15l1977t1263r2149b1313],
5	2006	CD	DATE	2006	num	4	SENT_273	[p15l151t1351r560b1410],
6	;	:	O	;	_	0	SENT_273	[p15l151t1351r560b1410],
7	28:64	CD	NUMBER	28:64	number	8	SENT_273	[p15l151t1351r560b1410],
8	—	CD	NUMBER	—	dep	4	SENT_273	[p15l151t1351r560b1410],
9	8	CD	NUMBER	8	dep	8	SENT_273	[p15l151t1351r560b1410],
10	.	.	O	.	_	0	SENT_273	[p15l151t1351r560b1410],

1	[	NN	O	[	_	0	SENT_274	[p15l6t1440r114b1500],
2	23	CD	NUMBER	23	num	1	SENT_274	[p15l6t1440r114b1500],
3	]	CD	NUMBER	]	num	5	SENT_274	[p15l6t1440r114b1500],
4	Ulrich	NNP	PERSON	Ulrich	nn	5	SENT_274	[p15l150t1440r331b1490],
5	CM	NN	PERSON	cm	dep	1	SENT_274	[p15l349t1440r472b1499],
6	,	,	O	,	_	0	SENT_274	[p15l349t1440r472b1499],
7	Yasui	NNP	PERSON	Yasui	nn	8	SENT_274	[p15l493t1440r650b1490],
8	Y	NN	PERSON	y	appos	5	SENT_274	[p15l668t1441r724b1499],
9	,	,	O	,	_	0	SENT_274	[p15l668t1441r724b1499],
10	Storb	NNP	PERSON	Storb	nn	11	SENT_274	[p15l746t1440r896b1490],
11	R	NNP	O	R	appos	5	SENT_274	[p15l914t1441r975b1499],
12	,	,	O	,	_	0	SENT_274	[p15l914t1441r975b1499],
13	et	FW	O	et	nn	14	SENT_274	[p15l996t1447r1046b1490],
14	al.	FW	O	al.	appos	5	SENT_274	[p15l1064t1440r1126b1490],
15	.	.	O	.	_	0	SENT_274	[p15l1064t1440r1126b1490],

1	Pharmacogenetics	NNS	O	pharmacogenetic	nsubj	9	SENT_275	[p15l1147t1440r1664b1505],
2	of	IN	O	of	_	0	SENT_275	[p15l1684t1439r1746b1490],
3	methotrexate	NN	O	methotrexate	prep_of	1	SENT_275	[p15l1759t1440r2144b1490],
4	:	:	O	:	_	0	SENT_275	[p15l1759t1440r2144b1490],
5	toxicity	NN	O	toxicity	dep	3	SENT_275	[p15l150t1528r366b1594],
6	among	IN	O	among	_	0	SENT_275	[p15l396t1544r586b1594],
7	transplantation	NN	O	transplantation	nn	8	SENT_275	[p15l615t1528r1039b1594],
8	patients	NNS	O	patient	prep_among	5	SENT_275	[p15l1066t1529r1285b1594],
9	Varies	VBZ	O	vary	_	0	SENT_275	[p15l1315t1529r1480b1579],
10	with	IN	O	with	_	0	SENT_275	[p15l1511t1529r1636b1579],
11	the	DT	O	the	det	17	SENT_275	[p15l1664t1529r1749b1579],
12	methylenete	NN	O	methylenete	nn	17	SENT_275	[p15l1777t1529r2147b1594],
13	—	NN	O	—	nn	17	SENT_275	[p15l1777t1529r2147b1594],
14	trahydrofolate	NN	O	trahydrofolate	nn	17	SENT_275	[p15l150t1617r553b1683],
15	reductase	NN	O	reductase	nn	17	SENT_275	[p15l578t1618r847b1668],
16	C677T	NN	O	c677t	nn	17	SENT_275	[p15l874t1617r1070b1668],
17	polymorphism	NN	O	polymorphism	prep_with	9	SENT_275	[p15l1095t1618r1525b1683],
18	.	.	O	.	_	0	SENT_275	[p15l1095t1618r1525b1683],

1	Blood	NN	O	blood	_	0	SENT_276	[p15l1554t1618r1728b1668],
2	2001	CD	DATE	2001	num	1	SENT_276	[p15l1754t1618r2150b1677, p15l149t1708r198b1758],
3	;	:	O	;	_	0	SENT_276	[p15l1754t1618r2150b1677, p15l149t1708r198b1758],
4	98:2314	CD	NUMBER	98:2314	dep	1	SENT_276	[p15l1754t1618r2150b1677, p15l149t1708r198b1758],
5	.	.	O	.	_	0	SENT_276	[p15l1754t1618r2150b1677, p15l149t1708r198b1758],

1	[	NN	O	[	nn	5	SENT_277	[p15l6t1798r114b1858],
2	24	CD	NUMBER	24	num	5	SENT_277	[p15l6t1798r114b1858],
3	]	CD	NUMBER	]	num	5	SENT_277	[p15l6t1798r114b1858],
4	Toffoli	NNP	PERSON	Toffoli	nn	5	SENT_277	[p15l150t1797r342b1848],
5	G	NNP	PERSON	G	_	0	SENT_277	[p15l366t1798r430b1857],
6	,	,	O	,	_	0	SENT_277	[p15l366t1798r430b1857],
7	Russo	NNP	PERSON	Russo	nn	8	SENT_277	[p15l455t1799r627b1848],
8	A	NNP	O	A	appos	5	SENT_277	[p15l649t1798r715b1857],
9	,	,	O	,	_	0	SENT_277	[p15l649t1798r715b1857],
10	Innocenti	NNP	PERSON	Innocenti	nn	11	SENT_277	[p15l739t1798r1007b1848],
11	F	NN	O	f	appos	5	SENT_277	[p15l1029t1799r1077b1857],
12	,	,	O	,	_	0	SENT_277	[p15l1029t1799r1077b1857],
13	et	FW	O	et	nn	14	SENT_277	[p15l1102t1805r1152b1848],
14	al.	FW	O	al.	appos	5	SENT_277	[p15l1175t1798r1237b1848],
15	.	.	O	.	_	0	SENT_277	[p15l1175t1798r1237b1848],

1	Effect	NN	O	effect	_	0	SENT_278	[p15l1262t1797r1435b1848],
2	of	IN	O	of	_	0	SENT_278	[p15l1456t1797r1518b1848],
3	methylenetetrahydrofolate	JJ	O	methylenetetrahydrofolate	amod	6	SENT_278	[p15l1535t1798r2147b1863, p15l150t1886r311b1937],
4	reductase	NN	O	reductase	nn	6	SENT_278	[p15l335t1887r604b1937],
5	677CT	NN	O	677ct	nn	6	SENT_278	[p15l630t1886r826b1937],
6	polymorphism	NN	O	polymorphism	prep_of	1	SENT_278	[p15l850t1886r1267b1952],
7	on	IN	O	on	_	0	SENT_278	[p15l1292t1902r1362b1937],
8	toxicity	NN	O	toxicity	nn	12	SENT_278	[p15l1386t1886r1602b1952],
9	and	CC	O	and	_	0	SENT_278	[p15l1629t1887r1730b1937],
10	homocysteine	NN	O	homocysteine	nn	12	SENT_278	[p15l1754t1886r2149b1952],
11	plasma	NN	O	plasma	nn	12	SENT_278	[p15l149t1976r352b2041],
12	level	NN	O	level	prep_on	1	SENT_278	[p15l380t1976r513b2026],
13	after	IN	O	after	_	0	SENT_278	[p15l544t1976r673b2026],
14	chronic	JJ	O	chronic	amod	16	SENT_278	[p15l701t1976r912b2026],
15	methotrexate	NN	O	methotrexate	nn	16	SENT_278	[p15l942t1976r1312b2026],
16	treatment	NN	O	treatment	prep_after	1	SENT_278	[p15l1342t1983r1611b2026],
17	of	IN	O	of	_	0	SENT_278	[p15l1640t1976r1701b2026],
18	ovarian	JJ	O	ovarian	amod	20	SENT_278	[p15l1726t1976r1935b2026],
19	cancer	NN	O	cancer	nn	20	SENT_278	[p15l1965t1992r2150b2026],
20	patients	NNS	O	patient	prep_of	16	SENT_278	[p15l149t2065r384b2130],
21	.	.	O	.	_	0	SENT_278	[p15l149t2065r384b2130],

1	Int	NN	O	int	nn	3	SENT_279	[p15l408t2066r487b2115],
2	J	NN	O	j	nn	3	SENT_279	[p15l505t2066r531b2115],
3	Cancer	NN	O	cancer	_	0	SENT_279	[p15l552t2065r753b2115],
4	2003	CD	DATE	2003	dep	3	SENT_279	[p15l772t2065r1253b2124],
5	;	:	O	;	_	0	SENT_279	[p15l772t2065r1253b2124],
6	l03	CD	NUMBER	l03	num	7	SENT_279	[p15l772t2065r1253b2124],
7	:294	CD	NUMBER	:294	dep	3	SENT_279	[p15l772t2065r1253b2124],
8	—	CD	NUMBER	—	number	9	SENT_279	[p15l772t2065r1253b2124],
9	9	CD	NUMBER	9	dep	7	SENT_279	[p15l772t2065r1253b2124],
10	.	.	O	.	_	0	SENT_279	[p15l772t2065r1253b2124],

1	[	NN	O	[	nn	5	SENT_280	[p15l6t2153r114b2215],
2	25	CD	NUMBER	25	num	5	SENT_280	[p15l6t2153r114b2215],
3	]	CD	NUMBER	]	num	5	SENT_280	[p15l6t2153r114b2215],
4	Urano	NNP	O	Urano	nn	5	SENT_280	[p15l150t2155r326b2204],
5	W	NNP	O	W	_	0	SENT_280	[p15l359t2155r434b2213],
6	,	,	O	,	_	0	SENT_280	[p15l359t2155r434b2213],
7	Taniguchi	NNP	PERSON	Taniguchi	nn	8	SENT_280	[p15l469t2154r751b2219],
8	A	NNP	O	A	appos	5	SENT_280	[p15l784t2154r849b2213],
9	,	,	O	,	_	0	SENT_280	[p15l784t2154r849b2213],
10	Yamanaka	NNP	PERSON	Yamanaka	nn	11	SENT_280	[p15l885t2154r1183b2204],
11	H	NNP	O	H	appos	5	SENT_280	[p15l1214t2155r1279b2213],
12	,	,	O	,	_	0	SENT_280	[p15l1214t2155r1279b2213],
13	et	FW	O	et	nn	14	SENT_280	[p15l1315t2161r1365b2204],
14	al.	FW	O	al.	appos	5	SENT_280	[p15l1398t2154r1461b2204],
15	.	.	O	.	_	0	SENT_280	[p15l1398t2154r1461b2204],

1	Polymorphisms	NNS	O	polymorphism	nsubjpass	7	SENT_281	[p15l1497t2154r1942b2219],
2	in	IN	O	in	_	0	SENT_281	[p15l1977t2154r2031b2203],
3	the	DT	O	the	det	5	SENT_281	[p15l2063t2154r2149b2204],
4	methylenetetrahydrofolate	NN	O	methylenetetrahydrofolate	nn	5	SENT_281	[p15l150t2243r902b2308],
5	gene	NN	O	gene	prep_in	1	SENT_281	[p15l921t2259r1053b2308],
6	were	VBD	O	be	auxpass	7	SENT_281	[p15l1072t2259r1208b2293],
7	associated	VBN	O	associate	_	0	SENT_281	[p15l1228t2243r1519b2293],
8	with	IN	O	with	_	0	SENT_281	[p15l1537t2243r1662b2293],
9	both	CC	O	both	preconj	11	SENT_281	[p15l1679t2243r1806b2293],
10	the	DT	O	the	det	11	SENT_281	[p15l1824t2243r1909b2293],
11	efﬁcacy	NN	O	efﬁcacy	prep_with	7	SENT_281	[p15l1928t2243r2148b2308],
12	and	CC	O	and	_	0	SENT_281	[p15l151t2332r252b2382],
13	the	DT	O	the	det	14	SENT_281	[p15l282t2332r367b2382],
14	toxicity	NN	O	toxicity	conj_and	11	SENT_281	[p15l399t2332r614b2397],
15	of	IN	O	of	_	0	SENT_281	[p15l647t2332r708b2382],
16	methotrexate	NN	O	methotrexate	prep_of	7	SENT_281	[p15l735t2332r1104b2382],
17	used	VBN	O	use	partmod	16	SENT_281	[p15l1135t2332r1266b2382],
18	for	IN	O	for	_	0	SENT_281	[p15l1296t2332r1379b2382],
19	the	DT	O	the	det	20	SENT_281	[p15l1409t2332r1493b2382],
20	treatment	NN	O	treatment	prep_for	17	SENT_281	[p15l1525t2339r1794b2382],
21	of	IN	O	of	_	0	SENT_281	[p15l1825t2332r1886b2382],
22	rheumatoid	JJ	O	rheumatoid	amod	23	SENT_281	[p15l1912t2332r2147b2382, p15l150t2421r260b2471],
23	arthritis	NN	O	arthritis	prep_of	20	SENT_281	[p15l292t2421r526b2480],
24	,	,	O	,	_	0	SENT_281	[p15l292t2421r526b2480],
25	as	IN	O	as	mark	26	SENT_281	[p15l561t2437r616b2471],
26	evidenced	VBN	O	evidence	advcl	17	SENT_281	[p15l649t2421r935b2471],
27	by	IN	O	by	_	0	SENT_281	[p15l965t2421r1035b2486],
28	single	JJ	O	single	amod	29	SENT_281	[p15l1069t2421r1235b2486],
29	locus	NN	O	locus	prep_by	26	SENT_281	[p15l1267t2421r1414b2471],
30	and	CC	O	and	_	0	SENT_281	[p15l1448t2421r1549b2471],
31	haplotype	NN	O	haplotype	nn	32	SENT_281	[p15l1579t2421r1859b2486],
32	analyses	NNS	O	analysis	prep_by	26	SENT_281	[p15l1892t2421r2145b2486],
33	.	.	O	.	_	0	SENT_281	[p15l1892t2421r2145b2486],

1	Pharmaco	NNP	ORGANIZATION	Pharmaco	nn	2	SENT_282	[p15l150t2510r433b2560],
2	genetics	NNS	O	genetics	_	0	SENT_282	[p15l437t2510r666b2575],
3	2002	CD	DATE	2002	dep	2	SENT_282	[p15l689t2510r846b2569],
4	;	:	O	;	_	0	SENT_282	[p15l689t2510r846b2569],
5	l	NN	O	l	dep	2	SENT_282	[p15l858t2510r878b2559],
6	2	CD	NUMBER	2	num	8	SENT_282	[p15l888t2510r935b2560],
7	:	:	O	:	_	0	SENT_282	[p15l888t2510r935b2560],
8	183-90	CD	NUMBER	183-90	dep	5	SENT_282	[p15l949t2510r1169b2561],
9	.	.	O	.	_	0	SENT_282	[p15l949t2510r1169b2561],

